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Abstract 
Title: 
A qualitative multiple case study investigating information exchange at lung cancer consultations. 
 
Background: 
Effective information exchange is an asset to effective lung cancer care. Although a considerable body 
of evidence informs the approaches to ‘diagnostic bad news delivery’, the exchange of information 
that takes place between patients with cancer and professionals with whom they interact thereafter 
is less well documented. Information exchange has an influential role throughout the lung cancer care 
continuum, providing patients and professionals with details relative to the cancer diagnosis and the 
subsequent choices to be made in its management. Information on disease extent, treatment and 
related side-effects, rehabilitation and prognosis are judged by patients as the most prominent for 
them. Despite awareness of the specific categories relevant to information exchange needs, there is 
little evidence available exploring the information exchange process, per se, within cancer generally 
and even less within the lung cancer context. 
 
Aim: 
To investigate information exchange processes during lung cancer consultations, specifically exploring 
information content which is both exchanged and not exchanged.  
 
Design: 
Qualitative, multiple case study design. 
 
Methods: 
A case centred on a patient with lung cancer.  Within the case were the patients, the health 
professionals they consulted with and accompanying companions. Seven cases were recruited, which 
included 12 companions. Data were collected in outpatient clinics between 2010 and 2011. Data were 
digital recordings of consultations; debrief interviews immediately post-consultation and later in-
12 
 
depth patient interviews. All interviews were transcribed and analysed for pattern matching and 
coding. 
 
Findings:  
Analysis of categorical data indicated cases were typical of the Scottish lung cancer population across 
all demographic domains, accept age and performance status. The preliminary analysis showed across 
cases, almost universal satisfaction with the level and content of information exchange for the main a 
priori categories of diagnosis, treatment and treatment outcome. Substantive analysis revealed that 
information content across the a priori categories was influenced by the presence of the 
accompanying companion. Within the clinical consultation, companion influence on information 
exchange was shown to be mediating, moderating or neutral. A key finding which emerged showed 
companion accompaniment to be a negotiated process, with three identifying levels of 
accompaniment. Non-negotiated companion presence at the clinic was associated with influential and 
expert companions who significantly moderated the content, direction and flow of information 
exchange, using the constructs of companion control, companion agenda and companion as expert. 
Persuasive influences further shaped non-negotiated accompaniment and were identified as 
demographic characteristics and relationship alliances. Patient and professional perspective regarding 
companion accompaniment was shown to be discordant.  
 
Conclusions:  
The level of negotiated companion presence at lung cancer clinics has direct implications for clinical 
care. There needs to be greater understanding among professionals of ways in which information 
exchange can be influenced by companions.  
 
Key words: lung cancer, information exchange, patient-professional-companion interaction, 
negotiated accompaniment, mediating and moderating influence. 
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Chapter 1: Introduction and overview of the thesis 
 
1.1. Introduction to the thesis 
Lung cancer is a disease with many biomedical and psychological symptoms and for many patients 
diagnosed with the disease there remains few possibilities of being cured (Salander and Henriksson, 
2005). This underlines the need for personalised or patient-centred care, tailoring communication to 
the specific needs, values and preferences of each individual patient (Kissane, Bultz, Butow and Finlay, 
2010). Quality lung cancer care includes effective patient-healthcare professional communication and 
information exchange about the disease and treatment, patient preference and goals of care (Griffin, 
Koch, Nelson and Cooley, 2007). To inform rational decision-making about therapy and adequate 
planning for expected outcomes, patients and their families need information about the extent of the 
disease and the chances that it may be cured (Hagerty, Butow and, Ellis, 2005). Additionally, whether 
the prognosis is favourable, poor or uncertain healthcare professionals should elicit each patient’s 
values and preferences to offer a concordant plan of patient-centred care (Nelson, Gay, Berman, 
Powell, Salazar-Schicchi and Wisnivesky, 2011).  
 
In the context of patient-centred cancer care, communication with healthcare professionals can be 
important to help patient need for information and other forms of support. It can influence a wide 
range of cancer care outcomes both positively (Neumann, Wirtz, Bollschweiler, Mercer, Warm and 
Wolf 2007; Clayton, Butow, Arnold and Tattershall, 2005; Roberts, Benjamin, Gavigan, Gesme and 
McCarthy, 2005; Schneider, Kaplan, Greenfield and Wilson, 2004; Schofield, Butow, Thompson, 
Tattershall, Beeney and Dunn, 2003) and negatively (Thorne, Hislop, Armstrong and Oglo, 2008), 
impacting for example on treatment adherence (Roberts et al, 2005; Schneider et al, 2004;), patient 
anxiety and depression (Fogarty, Curbow, Wingard, McDonnell and Somerfield, 1999; Schofield et al, 
2003), and patient satisfaction (Kim, Kaplowitz and Johnston, 2004; Schneider et al, 2004). 
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There is a tangible body of evidence which suggests that communication with healthcare professionals 
can affect the extent to which patients feel cared for, respected and involved (Burkitt-Wright, 
Holcombe and Salmon, 2004; Step, Rose, Albert, Cheruvu and Siminoff,  2009; Kruijver, Kerkstra, 
Bensing and van de Wiel, 2000; Thom 2000). These latter studies can be interpreted as suggesting that 
patients seem to value communication at least in part because of what it signals about healthcare 
providers’ attitudes towards them, with inference about the importance of the interpersonal aspects 
of healthcare provider-patient relationships (Skea, MacLennan, Entwistle and N’Dow, 2014). Evidence 
points to the significance of what has been referred to as health professionals ‘seeing the person in 
the patient’ (Goodrich and Cornwell, 2008) or treating patients ‘as persons’ (Entwistle and Watt, 
2013). Good clinical communication can be valued both in its own right as a key element of patient-
centred healthcare delivery (Street, Makoul, Arora and Epstein, 2009; Epstein and Street, 2007) and 
for its contributions to patients’ health status and abilities to lead the kinds of lives they want to live 
(Entwistle, Firnigi, Ryan, Francis and Kinghorn, 2012).  
 
Clinical communication can be defined as the dynamic, interpersonal process of mutual influence that 
occurs during the exchange of verbal and non-verbal messages between patients and healthcare 
professionals (Albrecht, Penner, Cline, Eggly and Ruckdeschel, 2009). Ong, de Haes, Hoos and Lammes 
(1995), signalled the scope of this influence and noted three basic communication functions in the 
cancer context, creating effective interpersonal processes, exchanging information and facilitating 
appropriate treatment decisions.   
 
Despite the growing body of evidence above, the literature is less clear on certain fundamental aspects 
of communication such as information exchange processes. Thus, within lung cancer management I 
believed there was a need to better understand the fundamental aspects of patient-centred care and 
communication and to choose to explore information exchange between healthcare professionals and 
patients owing to a particular lack of research in this area. 
16 
 
1.2. Background to the thesis 
This study developed from my clinical experience within lung cancer nursing, where for the past 
twenty years I have practised as a clinical nurse specialist. In this time I have witnessed the influence 
of information on patient care and the changes that have taken place both through transformations 
in patient-professional interaction and importantly patient-centred care, mainly as a consequence of 
policy directives and a strong desire to place patients and their families at the heart of healthcare. I 
was also cognisant of the key role that clinically usable information and information exchange plays in 
helping patients with lung cancer manage the impact of their health or ill-health, especially in relation 
to their diagnosis and subsequent treatment. Unless patients have insight into and understanding of 
their situation and are able to share their opinion and perspective then they are unable to make 
decisions about their care (Fallowfield, 2010). However, in my experience exchanging information 
about diagnosis and prognosis to patients with cancer who are ill and frightened is never easy.  
 
In lung cancer management, there is a clear need to embed patient-centred care – an approach which 
ensures that all lung cancer patients are offered a co-ordinated package of advice, information, 
treatment and support, tailored to their ongoing needs and preferences (United Kingdom Lung Cancer 
Coalition [UKLCC], 2013). To inform practice at local and national level, I believed it was imperative to 
investigate the most fundamental aspect of this approach, namely the information exchange process 
as it occurred between patients and professionals. I was primarily interested in both the information 
which was exchanged and that which may have not have been exchanged by patients (and their 
companions and professionals). Cancer patients are often reluctant to disclose their concerns to the 
healthcare team, often believing that depression, pain, fatigue etc. are inevitable consequences of 
their illness (Bakker, Fitch, Gray, Reed and Bennett, 2001); or that nothing can be done to alleviate 
problems, so there is no point in mentioning them (Arora, 2003). This avoidance of information 
exchange perhaps reinforced by the reluctance of professionals to inquire about patient concerns 
17 
 
(Ford, Fallowfield and Lewis, 1996) and by their evasion of certain information, especially relating to 
treatment outcome (Quirt, Mackillop, Ginsburg, Sheldon, Brundage, Dixon and Ginsburg, 1997).   
 
A significant catalyst for undertaking this research was identifying that there was no empirical 
evidence about information exchange within the specialist area of lung cancer. Consequently, after 
discussions with clinical colleagues, it was agreed that this would be an area worthy of investigation 
to inform practice 
 
1.3. Rationale of the thesis  
Increasingly, across the spectrum of cancer care literature, there is an awareness of the impact of 
clinical encounter information exchanges on the illness experience (Albrecht et al, 2009; Baile and de 
Moor, 2005). Although a considerable body of evidence informs the approaches to ‘diagnostic bad 
news delivery’ (Barclay, Blackhall and Tulsky, 2007; Bredart, Boulec and Dolbeault, 2005), the 
exchange of information that takes place between patients with cancer and professionals with whom 
they interact thereafter is less well documented (Beach, Easter, Good and Pigeron, 2005). While 
psychosocial support is identified as essential to quality cancer care, it is often interpreted as access 
to specialised services of psychologists, counsellors and psychiatrists, by the subset of cancer patients 
who have serious psychosocial distress, and not as a component of general oncology care (Bultz, 
Thorne and Fitch, 2004). Subsequently, much of the communication research emphasis has originated 
in the specialised psychology support domain and not the general cancer care context (Surbonne, 
Baider, Weitzman, Brames, Rittenberg and Johnson, 2009).  
 
Patient-centred research consistently reveals that information exchange encounters with 
professionals who manage and deliver oncology care can have a profound influence on many aspects 
of a patient’s wellbeing (Epstein and Street, 2007). Essentially, information exchange impacts many 
domains of care, including emotional wellbeing and quality of life. Fundamentally for this thesis, 
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information exchange has an influential role throughout the cancer care continuum, providing 
patients and professionals with details relative to the cancer diagnosis and the subsequent choices to 
be made in its management (Thorne, Hislop, Armstrong and Oglov, 2008; Jenkins Fallowfield and Saul, 
2001).  
 
With reference to lung cancer care, Earle (2004) audited the literature on lung cancer outcomes and 
determined that although there is rapid growth in quality of life and cost analyses studies, quality of 
care studies, including doctor-patient communication and decision-making, appear in publication less 
often. This weak evidence base has been blamed on myriad reasons, including a mix of disease 
characteristics, discouraging treatment outcomes, as well as, professional nihilism (Holtz, 2003). Lung 
cancer is the UK’s biggest cancer killer and the equivalent of 96 people die of the disease every day. 
This is more than breast, prostate, bladder cancer and leaukaemia combined 
(www.info.cancerresearchuk.org/cancerstats/types/lungcancer-accessed01.02.2009).  
 
Consequently, outcomes research in lung cancer, by virtue of the disease’s poor prognostic outlook, 
is largely focused on the palliative/end of life care trajectory. The irreconcilable difference for lung 
cancer researchers is that, in a cancer with an unpredictable care pathway, where information 
exchange is critical and often predicated by additional complexity and urgency, patients may be 
excluded from participation, or pertinent stages of the care journey neglected from research (Thorne 
et al, 2008; Earle, 2004). Consequently, information exchange in lung cancer care required further 
investigation.  
 
1.4. The importance of information – the evidence and policy context 
Although the exploration of information exchange within the cancer context is important, a particular 
lack of research in the context of lung oncology has been noted. Of eighteen reviews of cancer 
communication carried out in the past 10 years none provide specific evidence of information 
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exchange in lung cancer care that can be used to inform practice (Rodin, Mackay, Zimmerman, Mayer, 
Howell, Katz, Sussman and Browers, 2009). Although they confirm that patients have information 
needs across the continuum of care, they conclude that the diversity among patients in terms of their 
needs and preferences means it is impossible to conclude that any one method of communicating 
information is necessarily guaranteed to be superior (Rodin et al, 2009).  
Two systematic reviews conducted a decade apart, summarised the categories of information which 
patients with cancer thought were most relevant to their requirements. Patients judged information 
on disease extent, treatment and related side-effects, rehabilitation and prognosis as the most 
prominent for them (Rutten, Arora, Bakos, Aziz and Rowland, 2005; Mills and Sullivan, 1995).  Despite 
awareness of the specific categories relevant to information exchange needs, there is little evidence 
available exploring the information exchange process, per se, within cancer and even less within the 
lung cancer context.  
 
However, investigation of the information exchange process within lung cancer is important as there 
is a wealth of policy initiatives recommending professionals target specific patient-centred categories 
of information (UK Lung Cancer Coalition [UKLCC], 2007; National Institute Clinical Excellence, 2005; 
Scottish Intercollegiate Guidelines Network, 2005). In order to realise the ambition of providing people 
with lung cancer patient-centred care, there are a number of challenges that the NHS must meet to 
deliver quality care, the most central being: responding to patients’ full range of care and treatment 
needs as a result of the physical, psychological, practical and informational impact of the disease 
(UKLCC, 2007). A key feature of the UKLCC directive was ensuring patients have a positive cancer 
experience, facilitated through information exchange to enable patients to be fully involved in 
decisions about treatment and care, in turn, supporting patients to exercise choice about how and 
where they receive care and treating patients as individuals, ‘not a set of symptoms’.   
Providing care based on the needs of individual service users/patients is one of the fundamental 
principles of the NHS (Department of Health, 2012a).  The provision of patient-centred care is now 
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regarded as an integral part of efforts to improve the quality of services (Department of Health, 
2012b). Efforts to improve the quality of NHS services are underpinned by the NHS Outcomes 
Framework which sets out the indicators for measuring health outcomes at national and local level 
(Department of Health, 2012b). Patient-centred care is defined as care that is respectful of and 
responsive to individual patient preferences, needs and values, that ensures that patient values guide 
all clinical decisions (Institute of Medicine, 2001). It involves putting patients and their families at the 
centre of all decisions. This principle objective is both contemporary and crucial within the UK 
healthcare system, especially in light of the Francis Inquiry Report (2013) which renewed and 
reaffirmed personal and organisational commitment to the patient-centred values of the NHS, 
following the concerns and subsequent public enquiry of poor patient care and high mortality within 
an NHS hospital in England. Francis (2013) recommended a patient-centred, collaborative approach 
to healthcare, where patients come first in every aspect of care.  
 
Healthcare professionals should create collaborative patient-centred relationships with patients (and 
their families) in which clinical decisions are made using best available information and evidence from 
all participants. However, this ideal is rarely achieved (Epstein, Alper and Quill, 2004). Typically less 
than 1 minute out of a 20 minute consultation is spent discussing treatment and planning (Epstein et 
al, 2004) and although patients generally want more information from their healthcare professional 
this is not always achieved.  
 
Given policy directives and lack of evidence in the lung cancer context, there is clear need for more 
research. The imperative for research was also influenced by the knowledge that the exchange of 
information between patients and professionals is often fraught with problems. In her review of 
physician communication behaviour, Arora (2003) stated physicians cannot assume patients will 
volunteer all relevant information. Equally, professionals are often reluctant to give full disclosure 
about cancer and its treatment (Jenkins et al, 2001). This non-exchange of relevant information within 
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the clinical encounter, by either party, may theoretically impact the quality of the cancer diagnosis 
and treatment decisions taken (Liang, Burnett, Rowland, Meropol, Eggert, Hwang, Silliman, Weeks and  
Mandelblatt, 2002; Gafni, Charles and Whelan 1998).  
1.5. Conceptualisation of information 
Epstein and Street (2007) advocated that healthcare professionals embrace a process model of 
information exchange that focuses on the reciprocal efforts of both patient and professional to 
manage information and achieve, even negotiate, a shared understanding of the medical and personal 
issues underlying the patient’s health condition. The imperative being to assist patients to understand 
the clinical information required for informed decision-making.  
It was not the intention of my research to focus on information exchange within the related context 
of shared decision-making (SDM). However, there are important parallels regarding the process and 
conceptualisation of information exchange found in the extant literature on SDM, hence at this point 
it is important to conceptually explore information, as it is the central focus of this thesis. 
Shared decision-making is the most dominant and widely advocated model used in contemporary 
healthcare policy and practice (Charles, Gafni and Whelan, 1999, 1997). SDM is increasingly advocated 
as an ideal model of treatment decision-making, and this interactional model is distinguished from the 
other widely discussed models of paternalistic and informed (patient) decision-making (Bugge, 
Entwistle and Watt, 2006). Sharing decisions in healthcare is dependent on an approach where 
professionals and patients share the best available evidence when faced with the task of making 
decisions, and patients are supported to consider options to achieve informed preferences.  
There are three analytical stages identified for treatment decision making: 
1. Information exchange 
2. Deliberation about treatment options 
3. Decision on the treatment to implement 
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Information exchange is important for professionals to formulate diagnoses and recommend 
treatment and for patients to have the opportunity to make choices about their therapy options 
(Elwyn and Charles, 2001). More significantly for my research, information exchange has three distinct 
features: 
• Flow and direction – two way flow of information (professional ↔ patient) 
• Type – medical and personal  
• Amount – all relevant for decision-making 
Information needs to flow between the participants, whether dyadic, triadic or more. Additionally, the 
lay knowledge of the patient and the expert knowledge of the professional are equally as important 
(Edwards, Davies and Edwards, 2009). At a minimum, the professional must communicate biomedical 
information to the patient regarding the diagnosis, as well as all available treatment options and 
potential side-effects. Patients might exchange information about their values and preferences for the 
above, as well as personal health details, such as past medical history and presenting complaints. The 
amount of information conveyed is theoretically infinite and difficult to determine. However, it is 
usually understood to require professionals to communicate medical knowledge about healthcare 
options and associated outcomes and patients to communicate their values (Bugge et al, 2006; 
Coulter, 2002). 
Within SDM information exchange and content is influenced by several factors ranging from 
professional expertise and ability to elicit and exchange information, often impacted by medical 
training and professional culture, to clinical environment, constrained by time and conflicting clinical 
commitments (Feldman-Stewart, Brundage and Tishelman, 2005). Information exchanges can be 
significantly influenced by the dynamics and interactions of participating members. Although dyadic 
encounters remain common, frequently in healthcare practice more than two participants, both 
professional and lay, are part of the clinical consultation (Charles et al, 1999).   
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A key consideration in clinical practice is that information may not be exchange by professionals and 
patients during encounters, which impacts on the professional’s ability to arrive at an appropriate 
diagnosis and treatment prescription and limits patient ability to fully engage in decision-making. As 
information provision by all participants is essential to the development of partnerships within the 
clinical encounter, it is therefore important to recognise (i) what information is not exchanged and (ii) 
possible explanations for non-exchange. This would provide a more comprehensive understanding of 
both patient and professional constraints on information exchange and contribute to the 
development of interventions aimed at achieving a more equitable encounter (Edwards, et al, 2009).  
 
Therefore, in my thesis information exchange was conceptualised as a process of information flow 
during the clinical encounter, between participants with individual knowledge (lay and expert), as well 
as values and beliefs about that knowledge. Each participant brings to the interaction information 
content that is material to the success of the consultation. The process relies on the conveying and 
receiving of information, an iterative process driven by the information exchange, including not only 
what was said, but also what was left unsaid. The concept recognises that information exchange does 
not occur in a vacuum and that during the clinical encounter, information exchange may be impacted 
by external factors including environment, individual perspective and the presence of additional 
participants. 
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Consequently, the following research question was devised: 
What information is exchanged and what information is withheld between patients with lung cancer, 
healthcare professionals and any companions patients bring to the clinical consultations? 
 
1.6. Organisation of the thesis 
In the second chapter of the thesis, the evidence concerning information exchange from the 
perspective of lung cancer care is reviewed and clinical context provided. The literature review will 
start by overviewing the literature on lung cancer epidemiology. To provide policy context the 
literature is reviewed in relation to Government and NHS initiatives directed at improving the 
information experience of patients with cancer. The primary aim of the review is to consider the 
evidence relevant to information exchanged and not exchanged. Additionally, the literature examines 
the evidence pertaining to the importance of information within the clinical encounter. Further it 
appraises the evidence concerning the positive and negative influence of information exchange on 
patient care.  
 
Chapter three outlines the methodological approach I adopted to answer the research question. The 
rationale underpinning the use of a case study design, which adopted a qualitative, constructivist 
approach, is described. A specific focus of the chapter is to illustrate the case study design for data 
collection and analysis. 
 
In chapter four the practical and procedural aspects of the study, namely case identification and 
recruitment, recruitment challenges, data collection methods and data analysis strategies are 
described. The processes of ethical approval are also described, alongside consideration of the ethical 
aspects of the study. 
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Chapter five presents the initial findings of the first two stages of data analysis. Firstly, the ordering 
and comparison of the primary descriptive, categorical data for the cases, both within and across 
cases, is illustrated. Assignment and ordering of a priori categories around the identified themes of 
diagnosis, treatment and treatment outcomes are described. Then, from this data, the emergence of 
the key theoretical proposition is explored in chapter six. 
 
Substantive analysis is presented in chapter seven. Here, leading on from the key theoretical 
proposition identified in chapter six, the theory building process is developed and outlined, namely - 
companion influence. Companion influence, as a mediator or moderator of information exchange is 
described, alongside patient preference for companion presence at consultations. 
 
Chapter eight is the substantive discussion considering the findings of the thesis which generated new 
knowledge. The discussion considers the extant literature as well as the strengths and limitations of 
the study. Finally, chapter nine concludes with the implications of the findings in relation to clinical 
practice and future research. 
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Chapter 2: Literature review 
2.1. Introduction to literature review 
Chapter 1 outlined information exchange within the context of the clinical encounter. Information 
exchange was conceptualised as a mutual exchange of information between primarily the patient and 
the professional(s) they consult with during lung cancer consultations. The two-way mutual exchange 
of information is fundamental to this thesis. Equally the information content which is exchanged 
during clinical encounters is a primary consideration for my research and is further underpinned by 
policy directives.  In this chapter, the literature was reviewed with consideration to the process of 
information exchange, with information content explored in detail. Such exploration is important to 
underpin the research question and to consider patient perspective of the information exchange 
process. 
The literature review is outlined in individual sections with each intended to add specific components 
to support my thesis. Section 2.3 will provide clinical context by detailing lung cancer from an 
epidemiological perspective. Similarly, section 2.4 will present evidence relating to the healthcare 
policy priorities surrounding lung cancer management. In section 2.5 the literature will be reviewed 
investigating the importance of information which is exchanged. Finally, in section 2.6 the literature 
will be explored with specific focus on information content which is not exchanged during clinical 
interactions. 
2.2. Search strategy 
The literature in relation to information exchange was searched using the following key words and 
concepts; lung cancer, out-patient clinic consultations, professional-patient relations, communication, 
information and information exchange. The following electronic databases were searched; Medline, 
Medline in Process, Embase, PsycInfo, British Nursing Index, AMED, CINAHL, Cochrane Library, Ebsco 
Biomedical and Health Sciences. Both information and clinic consultations were not searched with 
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exclusivity to the lung cancer or cancer literature. Concepts were combined using AND or OR. The 
search was exploded to include the PUBMED database and Synonyms were introduced and included–
clinical encounters/clinic consultations/interactional analysis studies. Literature on decision-making, 
shared decision-making and information needs was further accessed for background information and 
cross-referencing.  
 
Retrieval was limited to articles in English and excluded letters, but did allow editorials primarily for 
information, as the evidence base for data relating specifically to lung cancer was so scarce. Cancer 
sites on the Internet were also investigated for general information on the most recent cancer 
publications. Sites searched were CancerWEB, Cancer ResearchUK and all lung cancer sites such as 
Global Lung Cancer Coalition, Roy Castle Foundation were also regularly accessed. Additional 
references were located searching the bibliographies of related papers and using search engines such 
as Google. 
 
Context setting concerning lung cancer epidemiology and current policy initiatives will be addressed 
first. Then the main areas of the literature relating to information exchange between patients and 
professionals at consultations with relevance to this thesis will be reviewed. 
 
2.3. Epidemiology of lung cancer 
Lung cancer is the most prevalent cancer in the world (International Agency for Research on Cancer 
[IARC], 2007). With 1.8 million new cases diagnosed and 1.2 million deaths every year, it accounts for 
over 13% of all new cancer cases (IARC, 2007). The disease is responsible for more cancer deaths than 
prostate and breast cancer combined and every 30 seconds, someone, somewhere in the world dies 
from the disease (IARC, 2007). With approximately 400, 000 new cases annually it is the most common 
cancer in Europe. With just under 350, 000 deaths per annum it is accountable for 20% of Europe’s 
total cancer mortality (Ferlay Autier, Boniol, Heanue, Colombet and Boyle, 2007). In the United 
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Kingdom, lung cancer is liable for 1:7 new cancer cases and approximately 40,000 people are 
diagnosed yearly. Prognostic outlook is poor in the UK and over 75% of those diagnosed will die within 
one year of diagnosis (www.info.cancerresearchuk.org/cancerstats/lungcancer-
accessed10/02/2009). Lung cancer is a formidable health problem in Scotland and leads the 
international tables in both incidence and mortality. In 2005, whilst there were 4, 500 newly diagnosed 
cases, 4, 000 deaths were recorded (Information and Statistic Division [ISD], 2008).  
 
2.3.1. Pathology of lung cancer 
Small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) are the two main histological types 
of lung cancer. More than one in ten lung cancer cases are classified as SCLC. It is commonly associated 
with a history of smoking (Janssen-Heijnen and Coebergh, 2003). Without treatment SCLC is the most 
aggressive type of lung cancer, with median survival from diagnosis only 2-4 months (National Cancer 
Institute [NCI], 2009a). Because of its high proliferation rate, SCLC is responsive to chemotherapy and 
radiotherapy. However, relapse and recurrence are common and cure seldom possible (Moore, 2009). 
SCLC is often disseminated at diagnosis.  
 
The majority of lung cancer cases (approximately 75-80%) are classified as non-small cell lung cancer 
(Moore, 2009). Classification includes adenocarcinomas, squamous and large cell sub-types (Hoffman, 
Mauer and Vokes, 2000). In early stage NSCLC surgical resection offers the best chance of cure. 
However, when surgery is not feasible, combination chemo-radiation has been shown to offer survival 
benefit in fit patients with locally-advanced disease (Jassem, 2002). 
 
2.3.2. Clinical presentation of lung cancer 
Regardless of cell pathology, patients with lung cancer may present with many different symptoms, both 
respiratory specific and generally systemic. Dyspnoea, cough, haemoptysis and chest pain are the 
predominant presenting features. Additionally systemic symptoms may be present such as weight 
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loss, anorexia and fatigue (Tod, Craven and Allmark, 2008). Often symptoms are insidious and non-
specific (Corner, Hopkinson and Fitzsimmons, 2005). Such subtle and vague symptoms can often 
remain unrecognized by patients and professionals resulting in late presentation and subsequent 
advanced disease (Hamilton, Peters, Round and Sharp, 2005; Koyi et al, 2002). Approximately one-
third of patients present to their General Practitioner (GP) within one month of new symptoms, one-
third present between 1 and 3 months and one-third present later than 3 months after their new 
symptom (Kesson, Bucknall, McAlpine, Milroy, Hole, Vernon, MacBeth and Gillis, 1998). In 
international and national studies the median duration from first tumour related symptom to hospital 
referral has been shown to be 43 and 45 days respectively (Koyi, Hillerdal and Branden 2002; 
Fergusson, Gregor, Dodds and Kerr, 1996).  
 
International research has shown that patient reported delays of symptoms from 7 days in Italy and 6 
months in United States (Jensen, Mainz and Overgaard, 2002). A UK study revealed a delay of over a 
year among patients (Corner et al, 2005).  To explore the pathway to diagnosis, Corner et al (2005) 
interviewed 22 men and women from two cancer centres in the north and south of England. Patients 
remembered having symptoms for many months, typically over the year, before a diagnosis was 
established. Patients experienced both respiratory and systemic symptoms which disrupted their 
quality of life but did not interpret them as serious and hence failed to take action.  
 
Patients minimize or explain symptoms away, through a combination of stoicism, fear or because of 
other health-related issues (Tod et al, 2008). Tod et al’s qualitative study investigated diagnostic delay 
in lung cancer in community and hospital settings in England. Twenty patients reported a wide 
variation in symptoms. However, as symptoms were often not as severe as expected and patients had 
a fatalistic view of cancer therapy, they delayed reporting their concerns to the GP. Delay to diagnosis, 
whether it be patient or professional, was recognized as an important factor in overall outcome of 
treatment (Bowen and Rayner, 2002; Bozcuk and Martin, 2002). 
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2.3.3. Relationship of disease stage and survival within lung cancer 
In lung cancer, the most important factor for survival is the stage of disease at diagnosis, which in turn, 
depends on how early the tumour is discovered. Eighty per cent of patients with lung cancer present 
with locally advanced or metastatic and therefore incurable stage disease (Gregor and Milroy, 2001). 
The majority of those diagnosed present at stage III or stage IV 
(www.info.cancerresearchuk.org/cancerstats/lung-accessed05/04/2008). One-year survival from 
lung cancer is strongly related to the stage of the disease at diagnosis. Patients presenting at stage I 
have the highest survival rates (71%). Survival is much lower for those diagnosed with stage IV disease 
(14%) (www.info.cancerresearchuk.org/cancerstats/lung-accessed05/04/2008). One year survival in 
relation to disease stage is shown in table 1. 
 
Table 1: One-year Relative Survival (%) by stage 
 
 
Reproduced with permission from: www.info.cancerresearchuk.org/cancerstats/lungcancersurvival-accessed05/04/2008 
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2.3.4. Management of lung cancer 
Management of lung cancer is based on pathology of the cancer, stage of the disease and the 
performance status (PS) of the patient. PS is an attempt to quantify a cancer patient’s general well-
being and activities of daily living to determine suitability for treatment (Oken, Creech, Tormey, 
Horton, Davis, McFadden and Carbonne, 1982). Surgery, radiotherapy and chemotherapy, used as 
individual therapies or combination modalities, are treatment options for lung cancer. More recently 
biological therapies have become part of the management profile (Moore, 2009). Management 
guidelines for lung cancer were first published in 2005 in England and Wales, with concurrent guidance 
produced in Scotland by the Scottish Intercollegiate Guidelines Network [SIGN], (2005). A basic 
summary of treatment interventions for both cell types is detailed in table 2. Although cited references 
are dated, treatment interventions and survival benefits are still largely applicable, as notwithstanding 
the use of more advanced cytotoxic regimens and targeted therapies overall survival in lung cancer 
has remained unchanged and poor.  
Table 2: Summary of treatment interventions  
(Gregor and Milroy, 2001) 
 
Population Intervention  % Survival benefit  Reference  
SCLC + chemotherapy  Thoracic Irradiation  9.2 vs. 17.4% at 2 
years  
Pignon et al (1992)  
Post Cranial Irradiation  15.3 vs. 20.7% at 2 
years  
Auperin et al (1999)  
NSCLC  Platinum chemotherapy Range of benefit  NSCLC collab. Group (1995)  
NSCLC  
Localised  
Regional  
Addition to surgery/RT    
-1-10% at 5 years 
1- 4% at 5 years  
NSCLC collab. Group (1995)  
NSCLC  
Metastatic  
Addition to best supportive 
care  
5-15% at 1 year  NSCLC collab. Group (1995)  
NSCLC without 
chemotherapy  
CHART compared to 
standard RT  
21 vs. 32 % at 2 
years  
Saunders et al (1997)  
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2.3.5. Summation 
Lung cancer is one of the main causes of cancer death in the Western world. This malignancy is 
associated with significant morbidity and in 80% of patients with lung cancer the disease is inoperable 
due to advanced stage at presentation (Tod et al, 2008). Receiving such a diagnosis will be for most 
patients an overwhelming experience. In these circumstances, the provision and exchange of 
appropriate and understandable information is important. Consequently, information exchange in the 
general cancer and specific lung cancer context has been informed by a plethora of policy initiatives 
aimed at improving the care experience and importantly, the provision of information therein. The 
following section will discuss some of the current policy drivers.  
 
2.4. Current policy initiatives in cancer communication 
Patients with lung cancer face an ever increasing amount of new and complex information, at a time 
when their ability to process and understand it can be impaired by the physical and emotional stress 
of their illness (National Institute Clinical Excellence [NICE], 2011). The amount, nature and content of 
the information required by patients and given by professionals will change throughout the care 
continuum, as additional information is gathered about diagnosis, stage of disease and suitability for 
treatment (NICE, 2011). Clinical encounters with patients with lung cancer should facilitate patient 
choice about treatment decisions (assuming the patient wishes to participate in the decision-making 
process). Information provided should be appropriate to patient wishes and level of understanding 
(SIGN, 2005).  
 
In the current NICE guideline (2011) on lung cancer management, good communication is recognised 
as vital at all stages of the care pathway. In accordance with other policy directives (Department of 
Health, 2010; Department of Health, 2007; Scottish Executive, 2000), the guideline chose to focus its 
communication section on information in relation to decision-making in lung cancer. A key guideline 
statement was issued stating, in deciding treatment, patients (and carers) require information that 
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they can understand, so they can make an informed decision.  Yet, the volume of evidence for this 
subject was extremely limited and of poor quality and evidence, with no clear indication of what 
information was required. The recommendations for practice were based on limited and poor phase 
1 studies and cross sectional surveys (Gabrijel, Grize, Helfenstein, Brutsche, Grossman, Tamm and Kiss, 
2008; Dubley, Brown, Esmond, Bowers, Healy and Schiller, 2005; Brundage, Feldman-Stewart, Cosby, 
Gregg, Dixon, Youssef, Davies and MacKillop, 2001). Subsequently, lack of specific evidence limited 
the recommendations to several good practice points, none of which indicated the most appropriate 
communication methods in helping patients make informed decisions about treatment options.  
 
The Cancer Reform Strategy (DOH, 2007, p71), stated that stakeholders consulted ‘had strongly 
recommended that the issues of information, better face-to-face communication and support for 
decision-making should be given the highest priority with regards to actions to improve the patient 
experience’. Yet an overview of the research evidence for the Reform Strategy conducted by Coulter 
(2007) found that although the evidence suggests shared decision-making is beneficial, it is not widely 
practiced. In essence, patients cannot express informed preferences unless they are given sufficient 
and appropriate information, including detailed explanation about their condition and the likely 
outcomes, with and without treatment (Coulter, 2007).  
 
Guideline recommendations have been formulated by leading lung cancer advocacy groups and 
charities with specific emphasis on important information and communication aspects in the lung 
cancer context. Working in partnership with UK governments, health departments and NHS 
professionals, the UK Lung Cancer Coalition [UKLCC] (2007) developed a 12-point plan to improve lung 
cancer patient care, advocating for a group of patients they describe as disenfranchised. A key priority 
stated: 
Information and support: we call on the UK governments to ensure lung cancer patients feel informed 
about their disease and the support available, and empowered to make decisions about their 
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treatment options in partnership with health professionals. Every lung cancer patient should be offered 
high quality information at key points in their cancer journey, tailored to their individual needs. 
Information should be evidence based. 
In 2009, the UKLCC revisited the plan nationally and for the key point above, although some 
improvement had been made, progress was limited. Specific reasons for limited progress were not 
discussed, but the UKLCC called for greater government involvement and support of the key 
recommendation in the next review period.  
The importance of information provision and exchange was further highlighted in key policy 
documents devised and subsequently revised by the British Thoracic Society [BTS] (2008, 2013). The 
documents were developed to advise professionals on sharing information with lung cancer patients. 
The intention of the guidance is to standardise and complement the information that is delivered by 
professionals and aimed to assist with information exchange around the diagnosis and therapeutic 
options available (BTS, 2013; BTS, 2008). There was unequivocal recognition from the BTS that this is 
an area where robust evidence is difficult to come by. Therefore, the document contained evidence-
based guidance where it existed but also expert opinion from experienced practitioners (BTS, 2013). 
Key recommended subjects for information sharing included; diagnosis, treatment options, potential 
treatment related side-effects and prognosis. 
2.4.1. Summation 
The central recommendation in the drivers set by both UK and Scottish governments and leading lung 
cancer patient advocates is the importance of clear and open communication shared between 
patients and professionals (BTS, 2013; UKLCC, 2009; Scottish Executive, 2008; DOH, 2007). Yet, sharing 
information with people affected by cancer is complex, patients often finding it difficult to take in 
information given during consultations, especially immediately after hearing a diagnosis of cancer 
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(Scottish Executive, 2006). Despite recognition of the importance of information exchange written as 
policy guidelines, recommendations are at times difficult to realise in clinical practice.   
 
2.5. Information exchange 
 
2.5.1. Introduction 
Patients with cancer seek information about the cause, diagnosis, treatment, prognosis, and 
psychosocial aspects of the illness (Epstein and Street, 2007). Attending to information needs is 
important to help the patient gain knowledge about their illness, to develop a strong patient-
professional relationship, reduce uncertainty and assist with decision-making (Wolff, Chan, Harris, 
Sheridan, Braddock , Kaplan, Krist A and O'Connor 2005). Information is essential for decision-making, 
as without accurate and current information on diagnosis, all potential treatment options and 
prognosis, it is not possible for patients to be part of the decision-making process or give informed 
consent (DOH, 1998).  
2.5.2. Information exchange in lung cancer 
Despite information exchange being central to the delivery of cancer care (Dieppe, Rafferty and Kitson, 
2002), there have been no studies found informing the process within lung cancer patient 
management. Review of the literature uncovered little evidence about information exchange in 
connection to lung cancer and no studies were identified which investigated the process during 
patient and professional interaction at clinic consultations. Research concerning the content and 
conduct of the lung cancer consultation is limited even though patients indicate that their healthcare 
professional was the major source of their information and the clinic encounter remains an important 
component of healthcare which impacts on health outcomes (Tattershall, 2003).  Whilst none of the 
studies examined in the current literature review explored the information exchange process per se, 
they did emphasise the importance of accurate information for assisting patients with understanding 
their diagnosis and stating a preference for treatment options.  
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A Canadian prospective study investigating how much patients with recently diagnosed lung cancer 
knew about their disease revealed that misunderstandings are common (Quirt, Mackillop, Ginsburg, 
Sheldon, Brundage, Dixon and Ginsburg, 1997). One hundred patients undergoing radiotherapy or 
chemotherapy were interviewed to determine their view of the diagnosis, the extent of the cancer, 
the intent of treatment, and the risks and benefits of therapy. Their physicians’ views were elicited 
using a self-administered questionnaire. Patients tended to underestimate the extent of their cancer 
and overestimate the effectiveness of therapy. Patients failed to recall side-effects of treatment, with 
many stating they had never been informed of treatment related toxicities (even though the doctors 
maintained they had exchanged this information). Doctors frequently believed that patients 
understood more than they actually did about both the diagnosis and treatment and failed to 
recognise patient misconception about the intent of treatment and prognosis. Many patients did not 
understand their situation well enough to make a truly autonomous treatment decision. Why such 
discrepancies existed between patients and professionals in this study remain unclear. A possible 
explanation is that patients did not have the key issues explained to them. Equally, patients may either 
chose to interpret information selectively, or simply their recall of events may be poor. Regardless of 
the reasons for incongruence, overestimation of treatment benefits led patients to accept treatment 
which was inappropriate for them and their doctors often failed to recognise this. 
 
Using semi-structured interviews, Sell, Devlin, Bourke, Munro, Corris and Gibson (1993) conducted a 
qualitative study of 50 patients with lung cancer, one week after the diagnostic consultation. Despite 
having been told the diagnosis, two patients appeared unaware that they had lung cancer. One patient 
had difficulty understanding the diagnosis and one was in denial. Ninety-two per cent of patients 
indicated that it was right to be told the full extent of the diagnosis. Despite being told ‘bad news,’ 
62% of the patients felt more reassured after the consultation, whereas 10% were less assured and 
28% were uncertain. Importantly, 26% of the participants felt they were not given enough information 
pertaining to survival and prognosis. The study by Sell et al was conducted within a week of diagnosis, 
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with professionals perhaps preferring to defer exchanging information about prognostic outcome so 
soon after diagnosis and prior to treatment. Nonetheless, when information concerning health issues 
are not given or given but not understood, the health implications can be considered as potentially 
problematic (Elwyn and Charles, 2001).  
 
Gabrijel et al (2008) examined the extent to which patients acquire and recall accurate information 
regarding diagnosis, therapy procedure, and aim of treatment, after initial disclosure of lung cancer. 
Structured interviews were conducted with 71 consecutive patients newly diagnosed at a large 
teaching hospital in Switzerland. Ninety per cent correctly recalled information about diagnosis. 
Proposed treatment modality was known by 83% of the patients. Only 49% accurately recalled the 
treatment intent. Even when the aim of treatment was curative, 42% could not recall being told this. 
Nearly three-quarters of the participants were satisfied with the exchange of information about 
diagnosis, yet only 39% were satisfied with communication about prognosis. The authors proposed 
the main reasons for low congruence between patients and physicians may have been that although 
professionals provided accurate explanations to patients, it was not suited to individual patient’s 
momentary needs. Another possibility was that professionals informed patients but patients were 
unable to process the information due to the stressful circumstances.  
 
Despite the incongruence noted in the studies above, evidence suggests that the majority of patients 
newly diagnosed with lung cancer want information on diagnosis, treatment and outcome (Pardon, 
Deschepper, Stichele, Bernheim, Mortier and Deliens, 2010; Davidson, Brundage and Feldman-
Stewart, 1999). In a study examining lung cancer patients’ desire for information and participation in 
treatment decisions, across the 21 patients interviewed there was a breadth of information required. 
Davidson et al (1999) found that regardless of desired roles in decision-making, patients preferred 
maximal information, with highest priority on information about treatment regimens, side-effects, 
survival and effect of therapy on disease symptoms.  
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In considering the preferences of patients with lung cancer for patient-centred information and 
decision-making, Pardon et al (2010) reported findings mirroring those of Davidson et al (1999). 
Ninety-nine percent of patients interviewed desired information about the diagnosis, 97% wanted 
treatment related details and 96% wished to know if the cancer could be cured. These findings are 
also consistent with evidence from general oncology studies (Hagerty, Butow, Ellis, Lobb, Dimitry and 
Tattershall, 2005), but contrast to earlier data which indicated that patients with lung cancer 
inherently seek less information from professionals than other cancer sub-groups (Blanchard, 
Labrecque, Ruckdeschel and Blanchard, 1988). Some caution is required generalising from Pardon et 
al’s data to the wider lung cancer population as the sample was younger (mean age of 64 years) and 
had a better performance status (p=0.0006), with evidence to support that younger, fitter patients 
desire a higher level of information exchange and involvement in clinical consultations than older, less 
well patients (Street, Gordon, Ward, Krupat and Kravitz, 2005). 
Importantly, many patients with lung cancer either do not have sufficient information or there is 
significant misunderstanding of the issues, to preclude an autonomous decision. To be autonomous a 
decision must be made intentionally, without controlling influences, but also with true understanding 
of the relevant information (Faden and Beauchamp, 1988). Of relevance to my research is that these 
studies failed to capture the actual content of the information exchanged. The primary focus of these 
studies was retrospective analysis, using semi-structured interviews or questionnaires that relied on 
patient recollection of events and these methods fail to capture the interaction to the best extent. 
Without audiotaped transcriptions of the information exchange process, it is impossible to accurately 
report what information the professionals and patients exchanged (Hagerty et al, 2005; Gattellari, 
Voigt, Butow and Tattersall, 2002).  
A significant consideration within my research was recognising the specific information content 
important to the individual patient, with focus on the type, direction and flow of the exchange 
between the participants at the encounter. As there was no evidence to inform this crucial aspect of 
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the clinical encounter in the literature, I identified this as a key requirement for further investigation.  
Importantly, as there was insufficient empirical evidence within the speciality of lung oncology 
regarding the specifics of information exchange, the cancer literature was explored more generally.  
2.5.3. Information exchange in general cancer 
With respect to information exchange, the key requirement of patients is the need to know and 
understand (Ong et al, 1995). International studies have consistently reported that the majority of 
cancer patients desire detailed information on a variety of topics such as diagnosis, treatment options, 
associated side-effects and prognosis (Cox, Jenkins, Catt, Langridge and Fallowfield, 2006; Jenkins et 
al, 2001; Sanson-Fisher, Grigis, Boyes, Bonevski, Burton and Cook, 2000).  
The majority of patients with cancer in the UK want to receive all information, good or bad, regarding 
their diagnosis and treatment (Cox et al, 2006; Jenkins et al 2001). A 250 patient stratified sample, 
typical of West of Scotland cancer patients (Meredith, Symonds, Webster, Lamont, Pyper, Gillis and 
Fallowfield, 1996) and a more heterogeneous study of 2331 patients across the UK (Jenkins et al, 
2001), showed that patients wanted to know the diagnosis and specific details about treatment and 
prognosis. Results from the Scottish survey conducted at a regional cancer centre showed that 79% of 
patients wanted as much information as possible, and 96% had a need or an absolute need to know if 
they had cancer. Most patients (91%) wanted to know the chance of cure, with 94% wanting details 
about treatment side-effects. When results were cross tabulated according to age, sex, deprivation 
score and type of treatment, there was a linear trend for patients from more affluent areas to want 
more information. There was a strong preference for diagnosis information to be given by a hospital 
doctor [60%] (Meredith et al, 1996).  
Similar findings were seen in the multi-centre study exploring information preference of patients with 
cancer, attending 34 hospital oncology consultations (Jenkins et al, 2001). Of this sample 87% wanted 
all possible information, both good and bad, with 98% preferring to know if the diagnosis was cancer.  
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In agreement with Meredith et al’s findings, 95% wished to know their prognosis and 97% wanted to 
know all possible treatment options. Cross tabulation of responses revealed no significant differences 
in information preferences for tumour site or treatment aims. In contrast to the Scottish study, 
preference was influenced by age and sex where, in comparison to men, women preferred to know 
the specific name of the illness.  
A multi-centred UK study evaluated multidisciplinary communication, information needs, decision-
making preferences and information experiences of 394 cancer patients (Cox et al, 2006). In line with 
previous research, the majority of patients wanted all possible information, both good and bad (87%), 
with 39% wishing to share responsibility for decision-making. The majority of patients rated the 
information they received as helpful, and 7.6% as unhelpful. All patients indicated they had been given 
information about diagnosis and treatment, with 87% recalling information exchange about prognosis, 
a slightly lower figure than previous studies (Jenkins et al, 2001; Meredith et al, 1996). Respondents 
were recalling the type of information they received retrospectively, therefore there was no objective 
measure of information exchange content.  
In all of the studies cited, a small minority of patients expressed reservations about professionals 
exchanging completely frank information about diagnosis and prognosis. Among the sample of 
Scottish patients, 4% of people did not wish to know they had malignant disease. And approximately 
10% did not wish information about chance of cue (Meredith et al, 1996). Within the Jenkins et al 
(2001) study 13% of patients preferred ‘to leave it up to the doctor’ or ‘to have information only if it 
was good’, thereby signalling significant reservation about overall truth disclosure. Schattner and Tal 
(2002) cautioned that because of the heterogeneity of patients, professionals should realise that a 
substantial minority may not want to know everything about their condition, especially if the 
information is pessimistic or threatening. 
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A body of research identifying cancer patients’ information needs and the professional sources with 
who they exchange cancer-relevant information has emerged (Rutten et al, 2005). The significance of 
information exchange in the consultation is readily apparent. For the professional, information is 
crucial for formulating diagnoses and prescribing treatment. For the patient, the benefits of 
information include increased involvement in decision-making and greater satisfaction with treatment 
choice (Arraras, Wright, Greimel, Holzner, Kuljanic-Vlasic, Velikova, Eisemann and Visser, 2005); 
improved ability to cope throughout all stages of the care pathway (Davidson and Mills, 2005); 
decreased anxiety (Deane and Degner, 1998; Ream and Richardson, 1996) and increased satisfaction 
with the cancer experience with subsequent reduction in disruption to quality of life (Arora, Johnson, 
Gustafson, McTavish, Hawkins and Pingree, 2002).  
Information exchange research focusing on cancer patients’ health outcomes has been dominated by 
site specific cancers, predominantly breast, gastro-intestinal and prostatic malignancies. For example, 
Bakker et al (2001) used a qualitative research methodology to describe the experience of women 
with breast cancer interacting with professionals. Two key features were identified. Firstly, 
information was viewed as a valuable asset to get through the various phases of the cancer journey. 
Possessing information equated with power and control. Secondly, they viewed professionals as 
‘information experts’ whom they expected to play a major communication role throughout the cancer 
journey. Information was especially crucial, as in line with other literature, it allowed women to take 
on active self-care roles, all of which promoted control and participation (Galloway Graydon, Harrison, 
Evans-Boyden, Palmer-Wickham, Burlein-Hall, Rich-van der Bij, West and Blair 1997; Ream and 
Richardson, 1996; Grahn and Danielson, 1996). Although the women in this study perceived the 
professionals as the primary source of information, they viewed themselves as equal partners, with 
the focus on sharing information and being active consumers of care, rather than passive recipients 
(Bakker et al, 2001). The study emphasised the significance of the ‘interactional’ nature of the breast 
cancer consultation. However, findings may not be immediately generalisable between the young 
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(most were between 40-50 years old) and well educated (62% had a college/university education) 
women with breast cancer, historically high information seekers, and other site specific groups such 
as lung cancer. 
Davison, Parker and Goldenberg (2004) found that the majority of men with prostatic cancer attending 
out-patient clinics in Vancouver had a strong preference for detailed information about their cancer, 
with 43% wanting an active and 47% wanting a collaborative role in decisions about their treatment. 
Evidence suggested that the clear majority of men (90%) wanted detailed information about their 
cancer, investigation results, treatment options, side-effects of treatment and effect on quality of life. 
They had high expectations about the knowledge, skills and expertise of their physicians to deliver this 
information during out-patient consultations.  
Parker, Baile, de Moor Lenzi, Kudelka and Cohen (2001) reported similar findings when assessing 
patient preference for communication among patients with various cancers. However, lung cancer 
patients were not sampled therefore the opportunity was lost to assess lung cancer patient preference 
regarding information exchange, and to compare their perspective with those of other cancer groups.  
2.5.4. Summation 
In conclusion, there is little evidence to inform information exchange within lung cancer care. The 
available data provides evidence that although patients have a desire for information, following 
information exchanges there is incongruence between patients and professionals understanding, with 
the possibility patients misunderstand the status of their disease and the aim of treatment. Within 
general oncology evidence suggests that patients desire information on diagnosis, treatment and 
treatment outcomes, with professionals the preferred source of information. Importantly, whereas 
these studies are influential in identifying patient preference for information, they utilised 
retrospective data collection to elicit opinion and the actual content of the interaction (the 
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information both given and withheld) has yet to be investigated. Directly observed discussions capture 
actual interactions and allow for an analysis of the process of the information exchange.  
2.6. Information not exchanged 
2.6.1. Introduction 
Information exchange can be problematic. It relies on patient and professional each providing the 
information required by the other. However, evidence suggests that information is sometimes not 
exchanged (Bugge et al, 2006). This section will explore information that is not exchanged in lung 
cancer care specifically and cancer care more generally.  
 
2.6.2. Non exchange of information in lung cancer 
Given that cancer patients who have more concerns and unresolved issues are likely to experience 
worse health outcomes, disclosure and exchange of information is vital (Maguire, 1999). However, 
within lung cancer care the lack of empirical data makes it difficult to confirm or contest this 
hypothesis, with only one study found investigating the concerns of newly diagnosed lung cancer 
patients. Hill, Amir, Muers, Connelly and Round (2003) interviewed 80 patients with lung cancer within 
a fortnight of diagnosis. Patients were asked to rate 17 specific items of concern. Diagnosis and 
concerns for the future were the two most dominant concerns. Unmet psychosocial needs in patients 
with lung cancer appear unchanged since Houts, Yasko, Kahn, Schelzel and Marconi (1986) found that 
patients with the malignancy had more unresolved concerns than any other cancer group. 
Psychosocial concerns were more worrying for patients than physical symptoms yet the ones least 
likely to be discussed and addressed between patients and professionals. Patients do not mention 
psychosocial issues during consultations as they are often diverse and not thought to be relevant. 
Professionals often do not elicit concerns of this nature, as they are viewed as time consuming (Elwyn, 
Edwards and Kinnersley, 1999). Subsequently, information remains un-exchanged.     
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Only one other study was identified which focused on the role of collusion (The, Hak, Koeter and van 
der Wal, 2000). This ethnographic study of 35 patients with small cell lung demonstrated that patients 
with a limited prognosis showed a ‘false optimism’ about their recovery, in that patient interpretation 
of the prognosis was considerably more optimistic than what they had been told. Many patients 
informed their relatives that they have been told they were ‘cured’ when in fact their life expectancy 
was a maximum of two years (The et al, 2000). The authors argued that professionals colluded, using 
‘medical activism’, sustaining the optimism through ongoing chemotherapy sessions and limiting 
discussion on prognostic information. Patients, focused on current activity (chemotherapy), preferring 
to ‘forget’ the uncertain future. The authors portray collusion as a strategy by which professionals and 
patients sidestep information relevant to treatment outcome. Other studies have found similar 
collusive tendencies in patient-professional communication in oncology more generally (Kirwan, 
Tincello and Lavender, 2003). Evasion of information allowed patients not to acknowledge explicitly 
what they should know about cancer, its therapy and outcome and it may thus have implications for 
the treatment choices patients made.     
Collusion and complicity are important considerations in information exchange and as such will be 
discussed in the results chapter. However, a wider perspective was required to consider specifically 
information which is not exchanged in cancer care. The lack of evidence relating to lung cancer 
particularly necessitated a need to widen the search field to include general cancer.  
 
2.6.3. Non exchange of information in general cancer 
Within the general oncology literature there is a small body of evidence that non-exchange of 
information is prevalent. Thorne, Bultz and Baile (2005) reviewed literature which suggested 
professionals often failed to recognise psychiatric morbidity in cancer patients (Fallowfield, Ratcliffe, 
Jenkins and Saul, 2001) and neglected to elicit patient’s psychosocial concerns (Rogers and Todd, 
2002). Further studies suggested professionals may neglect the psychosocial concerns of patient, 
45 
 
whilst concentrating on the biomedical aspects of disease (Cox et al, 2006; Hack, Degner and Parker, 
2005). Information exchange in outpatient clinics is organised according to a hierarchy and used to 
make treatment decisions and not primarily for addressing either symptom or psychological concerns 
of the patient (Rogers and Todd, 2002). 
Fagerlind, Linbald, Bergstrom, Nilsson, Naucler, Glimelius and Ring (2008) found that in a gastro-
intestinal oncology clinic little attention was given to psychosocial concerns. Mean time for 
consultation was 19 minutes – mean proportion of time spent discussing clinical and medical 
information was 78%, with only 16% of time spent on patient-centred topics. Although, cancer 
patients predominantly want information about their disease, its treatment and possible side-effects 
and prognosis (Cox et al, 2006; Rutten et al, 2005), some also want to discuss psychosocial aspects of 
care (Sanson-Fisher, Girgis, Boyes, Boneveski, Burton and Cook, 2000). Similarly, Stead, Fallowfield, 
Brown and Selby (2002) reported that while all but one of 43 professionals participating in their 
ovarian cancer study agreed they should discuss patient psychosexual concerns, only 25% actually 
engaged in such discussions.  
Studies have reported the importance of reconciling the findings of research, which often measure 
patient outcomes weeks or even months after potentially critical exchanges, with the results of 
research generated during real-time consultations (Hack et al, 2005; Beach and Anderson, 2003a). Of 
critical importance to studies investigating information exchange within cancer consultations is that 
what participants say about the process often stands in contrast to how interactions actually happen 
(Beach and Anderson, 2003b). Previous interactional research by Hack et al (2005) revealed that the 
primary emphasis has been individuals' self-reported experiences rather than observing naturally 
occurring interactions between cancer patients and professionals. What has been absent has been a 
thorough explication and understanding of the information exchange during consultations (Beach and 
Anderson, 2003b). As there was no empirical data identified at literature review, I deemed observing 
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this naturally occurring exchange of information crucial to understanding the information which was 
both exchanged and not exchanged within lung cancer consultations.  
2.6.4. Non exchange of information in general practice 
Studies within the general, non-cancer literature have informed clinical practice relating to 
information exchange (Charles et al, 1997; Roter, Stewart, Putman, Lipkin, Sytiles and Inui, 1997). 
Resonating with the findings reported in the cancer literature, the general research has also found 
reluctance from both patients and professionals in primary care to present all relevant information, 
especially concerning psychosocial issues. Patients commonly fail to mention emotional or 
psychological concerns, for fear of wasting the doctor’s time (Cape and McCulloch, 1999), and even 
fear of stigmatisation or because of embarrassment (Hirschfield, Keller, Panico, Arons et al, 1997). 
Across general and primary care settings, professionals report that the process of eliciting emotional 
and psychosocial concerns takes time, which they feel they do not have. They argue they often lack 
the training and expertise to deal with such issues; they lack the informational skills to convey the 
correct and appropriate information and they lack the skills needed to ‘share’ information with 
patients (Elwyn, Edwards, Gwyn and Grol, 1999; Marteau, 1989).  
When patients do not exchange all relevant information concerning past medical history, life style or 
opinions and concerns, they are forcing professionals to diagnose and treat when full disclosure has 
not been achieved. Studies have confirmed that both patients and professionals feel there have been 
times within the clinical consultation when they have not exchanged sufficient information, that may 
have been important for decision-making (Bell, Kravitz, Thom, Krupat and Azari, 2001; Barry, Bradley, 
Britten, Stevenson and Barber, 2000; Britten, Stevenson, Barry, Barber and Bradley, 2000). Equally, 
professionals are reported to have withheld information pertaining to alternative treatment regimens 
and survival outcomes at consultations (Entwistle, Williams, Skea, MacLennan and Bhattacharya, 
2006; Britten et al, 2000).  
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Bugge et al (2006) investigated the significance for decision-making when both patients and 
professionals did not exchange information. Across 5 diverse clinic settings, including general and 
cancer contexts, their findings concurred with previous research and found that patients withheld 
information because the clinician’s behaviour was off putting (Kaplan, Greenfield, Gandek, Rogers and 
Ware, 1996), the clinic environment was not conducive to the exchange (Fadiman, 1997), or patients 
did not think that the information was relevant or appropriate (Barry et al, 2000). Health professionals 
felt they lacked the skills to adequately deal with certain types of information (Lampic and Sjoden, 
2000) or they judged that the decision was theirs alone to make (Fagerlind et al, 2008). Significantly, 
the evidence highlighted that patients felt they gave insufficient information to professionals. Likewise 
professionals did not provide all relevant information about diagnoses and treatment options that 
patients would have liked and which they deemed important for participation (Bugge et al, 2006). 
2.6.5. Summation 
Information exchange between professionals and patients is a critical component of clinical 
encounters. It is especially challenging in cancer care where the complexity of the medical 
information, the uncertainty regarding the disease, and the treatment outcomes add a potentially 
greater emotional dimension to the interaction. Information exchange difficulties between patients 
and professionals have been investigated by researchers from different disciplines and clinical 
contexts who have tried to explore why these occur. If either professionals or patients refrain from 
full exchange of information about their concerns, relating to the patient’s problem within the 
interaction, they may not reach a shared understanding of the issues that need to be addressed. The 
lack of a shared understanding about the nature of the problem is a poor basis for effective shared 
working towards decisions about a course of action to deal with the presenting problem (Bugge et al, 
2006). 
Studies in cancer care focusing on the actual information exchange process during the clinical 
encounter are relatively limited, informed by general and primary care evidence and frequently 
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retrospective (Arora, 2003). Additionally, despite the focus on interactions within the oncology 
context, a review of the literature revealed that the primary emphasis has been individuals' self-
reported experiences rather than observing naturally occurring interactions between cancer patients 
and professionals.  
As there was no empirical evidence investigating the phenomenon of information exchange within 
the lung cancer context, my research explored this premise. My study was conducted with the 
expectation of making a contribution to current practice by providing an understanding of information 
exchange within this specialised area. By providing accounts of individual patient perspective of the 
information exchange process, it was hoped that such evidence would not only help professionals to 
better understand the patient experience, but also provide useful data to inform practice and policy 
regarding the process in general.  
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Chapter 3: Rationale for methodology  
3.1. Introduction 
The following chapter will describe the rationale underpinning the use of the qualitative case study 
methodology used in this thesis. The case study method is grounded in a constructivist paradigm 
guiding the empirical inquiry of the contemporary phenomena of information exchange (Anthony and 
Jack, 2009).  The rationale for the use of this paradigm to address the research question will be 
explored and the basis for this approach will be examined, with particular emphasis on case study 
processes in research design, data collection and data analysis.  
3.2. Justification for a qualitative approach 
A qualitative case study is a potentially valuable approach to conducting investigations aimed at 
understanding the complexity of care situations (Hewitt-Taylor, 2002). Chapter 2 illustrated that 
information exchange is highly complex and  despite the centrality of the clinical encounter to patient 
and professional information exchange, its true scope and nature have not been well articulated 
(Dieppe et al, 2002). There is a paucity of empirical literature on which to formulate and develop local 
and national policy and also a lack of qualitative research to inform professional practice within the 
specialist area of lung cancer. 
My thesis aimed to explore the complex process of information (both that exchanged and not 
exchanged) and further required to investigate the process from a participant perspective. A 
qualitative methodology suited to describing and explaining complex issues of relevance to healthcare 
and nursing and one which involved specific focus on the richness of the real-life context, seemed the 
most appropriate for my research (Yin, 2009). This method is concerned with developing explanations 
of social phenomena, eliciting the opinions and experiences of individuals and offering both richness 
and depth of information in order to understand participant perspective within their social and 
situational context (Hancock, 2002).  
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Miles and Huberman (1994, p10) stated that a major strength of qualitative data is the focus on 
naturally occurring ordinary events in natural settings so that there is a strong handle on what ‘real 
life’ is like.  The empirical literature I reviewed lacked a clear understanding of this real life situation 
concerning information exchange between patients with lung cancer and professionals. Consequently, 
the cornerstone of my thesis concerns itself with the clinical context and is buttressed by what Miles 
and Huberman (1994) termed local groundedness, whereby data is collected in close proximity to the 
specific real life situation and embedded within its context. Within this situational context, rich 
descriptions, with a ring of truth are revealed, leaving a strong impact on the reader. It was this 
description and the lived experience of the lung cancer patient that qualitative methodology would 
channel. Consequently, the use of the method was considered key for my research.  
 
There were other mitigating factors which led me to conclude that a qualitative method was the most 
appropriate approach to address the research question. These are detailed in table 3.  
 
Table 3: Advantages of a qualitative research method  
 
Provides depth and detail looks deeper than analysing ranks and counts by 
recording attitudes, feelings and behaviours 
Creates openness encouraging people to expand on their responses can 
open up new topic areas not initially considered 
Stimulates people’s individual experiences a detailed picture can be built up about why people 
act in certain ways and their feelings about these 
actions 
 
My research required a methodology which would allow me to study a complex, yet unexplored area 
of cancer within the real-life context of the patient perspective.  
 
3.3. Justification for a constructivist paradigm 
Maxwell (2004) portrayed four alternative paradigms which compete for acceptance as the paradigm 
of choice in informing and guiding qualitative inquiry; Positivism, Advocacy, Pragmatism and 
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Constructivism (table 4). Paradigms may be viewed as a basic belief system or worldview that 
philosophically guides the researcher to make claims about what knowledge is (ontology), how we 
know it (epistemology), what values go into it (axiology), how we write about it (rhetoric) and the 
process for studying it (methodology) (Cresswell, 2004).  
 
Table 4: Alternative paradigms  
(Maxwell, 2004) 
 
Positivism 
Determination 
Reductionism 
Empirical observation & measurement 
Theory verification 
Constructivism 
Understanding 
Multiple participant meanings 
Social & historical construction 
Theory generation 
Advocacy 
Political 
Empowerment issue orientated 
Collaborative 
Change –orientated 
Pragmatism 
Consequence of actions 
Problem centred 
Pluralistic 
Real-world practice orientated 
 
 
A constructivist approach seemed to me to be an appropriate method by which to explore the concept 
of information exchange from the perspective of the participants. Positivism reflects a deterministic 
philosophy where intent is to reduce the ideas into discrete theories to test. Therefore, I rejected this, 
as the aim of my study was theory generation. Researchers using an advocacy paradigm believe inquiry 
needs to be intertwined with a political agenda, aimed at reforming the lives of the participants and 
although policy initiatives have an important role within my study they are not the sole orientation. 
Within the pragmatic paradigm, instead of methods being important, the problem takes precedence 
and for my research I needed a paradigm which was more holistic and contextual than problem-
solving. Assumptions identified within the constructivism paradigm hold that individuals seek 
interpretation of the world in which they live and work. They develop subjective meanings of their 
experiences which are varied and multiple, leading the researcher to look for meaning in complex 
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situations (Cresswell, 2004). My research would be best explored using this paradigm as it allow me 
to ‘reveal the multiplicity of factors which have interacted to produce the unique and complex 
character of the entity that is the subject of the study’ (Yin, 2009, p82). 
Constructivism maintains that the truth is relative and dependent on one’s perspective. It recognises 
the importance of the subjective human creation of meaning and is built on the premise of a social 
construction of reality (Searle, 1995). As I was concentrating on exploring and giving an account of 
how people make sense of a situation (information exchange), at a particular point in time (lung cancer 
consultations) this paradigm was an obvious choice (Blaxter, Hughes and Tight 2006).  
Additionally, constructivist research focuses on the meanings embedded in textual and verbal 
accounts and generally involves the analysis of archival materials, documentary sources and/or oral 
and personal histories and narratives, garnered through data collection strategies such as interviews. 
It was very much in tandem with the data collection methods which my research would employ. The 
utilisation of a constructivist approach would allow me to give meaning to the way things are within 
the real-life experience of the clinical encounter and to identify factors that otherwise could not be 
described through metrics and statistics. The goal of the research is to rely on the participants’ views 
of the situation and the construct and meaning which is forged through information exchanges 
(Cresswell, 2004). The constructivist paradigm was chosen as the most appropriate because the focus 
was on subjectivity, where the research was attempting to understand the phenomenon of 
information exchange through directly observed data collection, but also what the participants create 
and associate with their own subjective meanings of information, as they interact with the world 
around them, including at times the researcher (during de-brief interviews and more comprehensively 
at the in-depth interview) (Walsham, 2006). 
3.4. Justification for case study design  
A research design is the logic that links the data to be collected and the conclusions to be drawn to 
the initial questions of a study: essentially, it ensures coherence (Rowley, 2002). The case study design 
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is defined as ‘an empirical inquiry that investigates a contemporary phenomenon within its real-life 
context, especially when the boundaries between phenomenon and context are not clearly evident’ 
(Yin, 2009, p 13). Importantly for my research, the design draws upon the principles of an inquiry, 
seeking to understanding complex social systems (Bennet and Elman, 2006; Denscombe, 2003), where 
the intention is to comprehend the nature of current processes in a previously little-studied area 
(Cresswell, 2004; Eisenhardt, 1989).  
 
Given the nature of the research problem as outlined in Chapter 2, I judged this design as the most 
appropriate for this study. It is well suited to new research areas for which existing theory seems 
inadequate, as demonstrated in the literature review section, which highlights the paucity of data to 
guide information exchange in lung cancer. Furthermore, I realised that this design was compatible 
with my research as there were three distinctive factors of key consideration and these are identified 
in table 5. 
Table 5:  Key factors guiding the use of case study design 
 
Research question being posed Case study design is the preferred 
research strategy when ‘how’, 
‘what’ and ‘why’ questions are 
being asked 
 
My research question is: what 
information is exchanged and not 
exchanged between patients with lung 
cancer and healthcare professionals at 
clinic consultations 
The extent of control over 
behavioural events 
Case study design is valuable when 
the researcher has little or no 
control over the event 
My research seeks to investigate the 
phenomenon of information exchange 
from a participant’s perspective, without 
controlling either the clinical encounter 
or the meaning people ascribe to the 
experience 
Research is being carried out in the 
real life context 
Case study is beneficial for 
contemporary events 
My research was conducted within the 
real-life contemporary context of the 
clinic consultation  
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As with paradigm justification there are numerous alternative research designs to select, as figure 1 
displays: 
 
Figure 1: Alternative research designs  
 
 
 
However, Yin (2009) stated there are distinguishing features of case study design which discern it from 
the other strategies. In particular case study design: 
 
 Copes with the technically distinctive situation in which there will be many more variables of 
interest than data points 
 Relies on multiple sources of evidence, with data needing to converge in a triangulating 
fashion 
 
As such, as my research, congruent with clinical practice and concerned with investigating complex 
situations, where the real-world context is central and when multiple perspectives are required, 
judged that this design has much to recommend it over other research methods.  
 
In summary, a case study design was appropriate to this research because the questions posed were 
of the ‘what’ type genre; the focus was on contemporary as opposed to historical events and, as a 
researcher, I did not seek to control events or behaviours. Importantly, case study design was relevant 
to use because the phenomenon of information exchange would be studied in a total, contemporary 
CASE STUDY
Experimental
Grounded theory
Action research
Ethnography
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and real-life context. The constructivist paradigm was chosen as the most applicable for my research 
because the focus was on subjectivity – exploring meanings, experiences and perspectives of the 
participants in relation to information exchange. 
 
3.5. Case study design  
The case study provides a form of inquiry that elevates a view of life and its complexity (Thomas, 
2009). Stake (2005) suggested that the case study is not a method in itself, but rather a focus on one 
thing, looked at in-depth and from many angles. However, Yin (2009) argued that the design must 
relate to the context of the study and importantly, the research question. With particular reference 
to my research, concerned with exploring multiple perspectives within the real-life context of 
information exchange processes, I was persuaded by the literature to consider this definition of case 
study design. For my thesis the definition which encompassed the fundamental premise of my 
research was: 
Case study design is an in-depth exploration from multiple perspectives of the complexity and 
uniqueness of a particular project, policy, institution, programme or system, in a real life context. It is 
research-based, inclusive of different methods and is evidence led. The primary purpose is to generate 
in-depth understanding of a specific subject to generate knowledge and /or inform policy development 
or professional practice (Simons, 2009, p21).  
 
There are several proponents of case study design (Eisenhardt and Graebner, 2007; Gillham, 2001; 
Merriam, 1998; Miles and Huberman 1994; Eisenhardt, 1989). The two most prominent Yin (2009) 
and Stake (2005) used different terms to describe a variety of cases. According to Stake (2005), three 
categories of case study can be identified in terms of their broad purpose, namely; intrinsic, 
instrumental and collective. Yin (2009) categorised case studies as explanatory, exploratory or 
descriptive. He further described the primary distinction in case design being between single and 
multiple case designs based on either holistic or embedded designs.  
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The use of a single case design is considered when studying unique or extreme cases, or to confirm or 
challenge a theory or for cases where the researcher did not have access to before. Multiple (or 
collective) case designs are preferred as analytical conclusions from more than one case will provide 
more powerful data than from a single case, with more compelling evidence. Consequently, multiple 
case designs are useful for predicting similar results (literal replication) or predicting contrasting 
results but for predictable reasons (theoretical replications) providing valuable information for the 
study (Baxter and Jack, 2008).  
 
Within my research, multiple case study design would enable investigation of a case, utilising 
informative and contextual data to interpret my findings about the phenomenon being explored. My 
interpretation would lead to a more complete understanding of the process of information exchange 
and provide effective data that could not be collected otherwise (Brown, Hill, Burant and Siminoff, 
2008). As such, I required a multiple case study design which would provide varied real-life perspective 
as well as rich description and insight and one which necessitated the identification of diverse cases 
from a range of: 
 
 patients (male and female)          healthcare professionals        accompanying companions  
 types of lung cancer                         stages of the disease                proposed treatment options         
 potential treatment outcomes 
The application of a multiple case design would allow me to analyse each individual case and would 
have the potential to provide a unit of analysis to be analysed within case. Additionally, throughout 
the aggregate of cases, a multiple case design would allow more robust and compelling evidence 
across-cases (Yin, 2009).   As such, the design I employed was the collective or multiple design, ideal 
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for comparative cross case analysis, to understand and explore the similarities and difference between 
the cases.  
3.6. Case definition 
Case selection is a primordial task for the case study researcher. In choosing cases, one also sets out 
an agenda for studying those cases (Seawright and Gerring, 2008). The case is defined by Miles and 
Huberman (1994, p25) as, ‘a phenomenon of some sort occurring in a bounded context’. The case is, 
in effect, the unit of analysis, the major entity being analysed in the study and its bounded 
components. Subsequently, case selection should reflect the characteristics and problems identified 
in the empirical literature and the underlying research question (these were defined in Chapter 2) 
whilst representing the topic of the study.  
 
As stated by Simons (2009) the case study is the in-depth exploration from multiple perspectives of 
the complexity of a particular case. Consequently for my research, the patient with lung cancer needs 
to be seen within the complexity of a case, coming to understand the activity within the full and 
important circumstances of the process of information exchange (Stake, 2005). Thomas (2009) viewed 
the case as a container composed of objects, which intermesh in myriad ways and the result is 
inherently highly complex data. A case study is about seeing the case in its completeness, looking at it 
from many angles (Thomas, 2009). Stake (2005) reasoned if qualitative research requires that cases 
to be chosen, making a proper selection of cases is crucial. The composition of a case in my research 
is delineated in figure 2. 
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Figure 2: Case composition 
 
 
 
For my research I referred to some of the principles offered by Miles and Huberman (1994), namely 
that: 
 Case selection should be relevant to the conceptual framework and address the research 
questions  
 Each case should be likely to generate rich, contextual information on the type of phenomena 
which need to be studied 
 Cases should produce believable descriptions and explanations 
Additionally, within the Miles and Huberman (1994) teachings, the case is the ‘heart’ of the study and 
a somewhat indeterminate boundary defines the edge of the case: what will not be studied. This 
boundary will be defined further by sampling or case selection, which for my study is outlined below. 
3.7. Case selection strategy and case binding 
Researchers define this particular section, which I have named case selection, as sample selection. I 
made the decision to follow the principles of Thomas (2009) and Stake (2005) and viewed the cases, 
not as a sample of a population, but cases drawn from one. The point of a case study is not to find a 
portion that shows the quality of the whole, but to look at case ‘selection’, focusing on one, two or a 
few, without any expectation that it represents a wider population. In case study design, the 
researcher is trading breadth of coverage (i.e. case numbers) for depth of understanding (Thomas, 
2009). It is in the multi-faceted nature of the case design that the opportunity arises to relate one 
Case
•Patient with lung cancer
•Accompanying companion(s)
•All healthcare professionals with whom they consult 
•Sources of evidence: transcripts from all interviews and field notes
•Demographic data
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piece of data to another (within case) whilst offering explanation based on the interrelationships 
between them (across case). 
 
In case study design a common pitfall is the tendency to attempt to answer a question that is too 
broad or has too many objectives and includes an unrealistic number of cases (Baxter and Jack, 2008).  
Yin (2009) and Stake (2005) suggested placing boundaries on cases, hence preventing this explosion 
from happening. Suggestions for binding a case include; by time and place (Cresswell, 2004), time and 
activity (Stake, 2005) definition and context (Miles and Huberman, 1994). Binding ensures the study 
remains reasonable in scope, by indicating what will and will not be studied in the research. Binding is 
closely aligned to inclusion and exclusion criteria (see chapter 4) as well as assisting with the selection 
strategy which the research employs.   
 
Multiple cases are regarded as equivalent to multiple experiments; the more cases/experiments that 
can be marshalled to establish or refute a theory, the more robust and compelling the research 
outcomes (Rowley, 2002). My study will follow the principles of qualitative case study selection that 
commends researchers to work with small case numbers, nested in their context and studied in-depth. 
Essentially my research will explore a small lung cancer population, their companions and 
professionals, all with expert experience and insight into the disease.  
Thus, there is a need to select context-based cases which answer the research questions determined 
by the study. To accomplish this I utilised a purposive selection technique. The research question 
exploring the information exchange process and individual case perspectives would be best answered, 
more meaningful and context laden, if drawn from a strategically and purposively selected group of 
cases (table 6). 
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Table 6: Criteria for purposive case selection 
 
Patients with lung cancer 
 Gender Age Performance status 
 Male & female <65 years 
>65 years 
1 – 3 
     
Lung cancer Type Stage Treatment Treatment intent 
 NSCLC 
SCLC 
Mesothelioma 
Limited 
Advanced 
Chemotherapy 
Radiotherapy 
Surgery 
Combination  
Best supportive care 
Palliative outcome 
Curative outcome 
     
Healthcare 
professionals 
Clinical nurse 
specialist 
Respiratory 
consultant 
Oncologist Thoracic surgeon 
     
 
 
Within my research the multiple case design would be subject to purposive case selection allowing 
comparison among diverse components of the selected cases. Despite the dangers of selection bias 
when researchers employ a purposive technique to select cases, yet more serious problems would 
likely be encountered if one chooses a very small case group in a completely random fashion 
(Seawright and Gerring, 2008). Randomised selection will often produce cases which are substantially 
unrepresentative of the population. It is true that purposive selection cannot entirely overcome the 
inherent unreliability of ‘generalising’ from small case sizes, however, it can make an important 
contribution to the inferential process by enabling the researcher to choose the most appropriate 
cases for a given research strategy (Seawright and Gerring, 2008).  
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3.8. Case size  
Within multiple case designs it is suggested that, to increase the quality of the research, the selection 
of cases needs to be driven by two issues: 
 
1. Appropriateness: demonstrating a fit to both the purpose of the research and the 
phenomenon of inquiry 
2. Adequacy: concerned with how many cases are enough (Kuzel, 1999; Miles and Huberman, 
1994) 
Within this design a significant principle, guiding both case selection and size, is the prospect of literal 
or theoretical replications. Multiple cases allow for within and across case comparison, particularly in 
diverse settings (Darke, Shanks and Broadbent, 1998). However, Stake (2005) cautioned that the 
number of cases to allow this is crucial. Benefits may be limited if there are fewer than four cases or 
more than ten to fifteen because the researcher could be overwhelmed by data.  
Case size is contentious, ambiguous and no simple solution is provided (Patton, 2002; Rowley, 2002). 
Cases need to be carefully selected so they either produce similar results offering corroboration with 
each other (literal replication), or generate contrasting results but for predictable reasons (theoretical 
replication). The replication logic requirement of the multiple case design provides suggestions to 
determining the number of cases (Shakir, 2002). The ability to conduct 6-10 case studies, arranged 
effectively within a multiple case design, is analogous to the ability to conduct 6-10 experiments on 
related topics. A few cases (2 or 3) would be literal replications, whereas a few more (4 to 6) might be 
designed to pursue different patterns of theoretical replications (Yin, 2009). 
I took a pragmatic stance early in the research to select study sites with access to multi-professional 
healthcare teams (respiratory physicians, lung cancer clinical nurse specialists, oncologists and 
thoracic surgeons), who as individuals, could provide expert knowledge and insight into information 
exchange, from a specialist, oncology perspective. Equally, they were selected for their experience in 
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the complex management of patients with lung cancer. These would be selected using a purposive 
technique, to provide diversity within the cases, with the aim of providing the greatest coverage and 
best chance of identifying patterns of difference or similarity (Shakir, 2002). 
 
I judged that the research may provide literal replication, with similarities evident in the cases. Equally 
during data analysis, theoretical replication may be apparent. I used the replication logic strategy 
developed by Yin (2009) [table 7] and, as overall theoretical replication may have been evident, 
decided that 6 to 10 cases was considered the number of cases required for my study.  
 
Table 7: Replication logic strategies for determining case size in multiple case design 
 (Yin, 2009) 
 
Replication logic strategies When the…. 
 Difference between rival theories is 
 Degree of certainty required is 
 Differences between the cases is 
 
Initial number of cases 
Literal replication Low  3- 4  
Theoretical replication High  6-10 
 
 
3.9. Data collection  
Case study research excels at conveying an understanding of a complex issue and emphasizes detailed 
contextual analysis of a limited number of events and their relationships 
(www.ischool.utexas.edu/case study research method-accessed 14.11.2009). As such, case study data 
collection features which are thought to benefit complex evaluations require the use of multiple data 
sources (Baxter and Jack, 2008). Each data source is one piece of the puzzle, with each piece 
contributing to the researcher’s understanding of the whole phenomenon. This convergence adds 
strength to the findings, as various strands of the data are woven together to promote a greater 
understanding of the case and its relationships with other cases (Baxter and Jack, 2008).   
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Yin (2009) considered the case study’s unique strength is its ability to deal with a full variety of 
evidence, including documents, artefacts, interviews and observations. The benefits of these multiple 
data sources can be maximised if three key principles are followed: 
 Use of multiple sources of evidence  
 Creation of a case study database 
 Maintaining a chain of evidence 
3.9.1. Use of multiple sources of data 
A major strength of case study data collection is the opportunity to use different sources of evidence, 
to address a broader range of contextual and behaviour issues (Thomas, 2009; Yin, 2009; Baxter and 
Jack, 2008). The most important advantage is the development of converging lines of inquiry, a process 
of triangulation and corroboration (Yin, 2009). Conclusions drawn from case study design are likely to 
be more convincing and accurate, if based on several different sources of data, corroborating the same 
phenomenon (Yin, 2009; Hewitt-Taylor, 2002). 
My research was principally concerned with exploring the information exchange process and 
capturing the actual communication taking place between the participants, gaining a description of 
the meaning and perspective that the participants themselves placed on the information they either 
exchanged or did not. To gain an accurate picture of the phenomenon and its related complexities, 
data required to be collected from multiple perspectives. A useful strategy when the contemporary 
health problem has complexities which are not clearly understood or has little researched evidence, 
as was the case with my research (Thomas, 2009). Each of the various sources employed would require 
a different approach to their interrogation but would consequently yield diverse but converging 
insights into the phenomenon of information exchange. The strategies I employed are illustrated in 
figure 3.  
64 
 
The principle of triangulation followed within my study pertains specifically to data and not 
investigator, theory or methodological triangulation (Patton, 2002). The use of triangulation in order 
to undertake the pattern-matching analysis used in case study design strengthens the credibility 
(construct validity) of the research – the establishment of the correct operational measures for the 
concepts being studied (Bergen and While, 2000). Yin (2009) asserted that, with data triangulation the 
potential problems of construct validity can also be addressed, because multiple sources of evidence 
essentially provide multiple measures of the same phenomenon (Yin, 2009).  
 
 
Figure 3: Convergence of multiple sources of evidence 
 
 
 
 
3.9.1.1. Audio-taped interactions during clinical consultations 
The main strength of audio-taping the interaction between the participants during clinical 
consultations was the provision of direct access to the social phenomena under consideration. Instead 
of reliance on self-report, interactions within the clinical context are recorded verbatim. An audio-
taped recording of the interaction and information exchange between the study participants was a 
key requirement for providing factual accounts of the information both exchanged and not exchanged. 
The intention was to record the clinical encounters as they occurred as real-life events, where the 
focus is on understanding the meanings participants, in the contexts observed, attribute to events and 
DATA
Audio-taping interactions 
during clinical consultations
Audio-taping de-brief 
interviews immediately post 
consultation
Audio-taping in-depth semi-
structured interviews
OTHER SOURCES -
demographic data, field 
notes and observations
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actions. This type of observation is viewed as interpretative and fits with the constructivist paradigm 
important to my study design.  
 
This strategy permits a permanent record of the interaction, events and behaviour. It also allowed 
further analysis or subsequent comparisons across time where the data was not subject to memory 
and bias recall of the participants. Additionally, observer bias whereby the researcher records not 
what actually happened, but what they either wanted to see/hear, expected to see/hear, or merely 
thought they saw/heard, with the potential to undermine study reliability and validity, was reduced 
in my study as I was not present during the clinical consultation whilst data was being collected. The 
very act of being observed poses a risk of influencing the participants during the process, such as the 
Hawthorne Effect whereby people modify their behaviour as they know they are being studied 
(Cormack, 2000). Researcher influence, bias and reflexivity are explored in Chapter 4. 
 
3.9.1.2. De-brief interviews 
De-briefing was critical to capture the immediate perspectives of the participants post consultation. A 
de-briefing is a semi-structured conversation with an individual who has just experienced or witnessed 
an event. It is used to refer to the process whereby qualitative feedback is sought from the 
participants, usually about interviews conducted beforehand (Lavrakas, 2008). The immediacy of the 
interaction yields useful information regarding people’s motivations and concerns about the 
consultation. Additionally, it also provided a platform on which to base additional questions and acted 
as an aide memoire at the in-depth interview.   
 
3.9.1.3. Semi-structured in-depth interviews 
Interviews are an ideal method of data collection as they are a highly efficient way to gather rich, 
empirical data when the phenomenon of interest is highly complex yet episodic (Eisenhardt and 
Graebner, 2007). In contrast to other data collection strategies, interviews are insightful and focus on 
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the meanings individuals assign to events and the complexity of their attitudes, behaviours and 
experiences. Stake (2005) described interviews as the road to multiple realities where the decision to 
use face-to-face interviewing implies a value on personal language as data (Ritchie and Lewis 2003). 
To arrive at a description of the meaning of information exchange for patients with lung cancer, and 
their companions, gaining an accurate picture of the phenomenon from their perspective, semi-
structured, yet in-depth, interviews were a key source of data collection. This strategy in conjunction 
with data collected from the clinical consultations provided breadth and depth to the study and 
ensured complete and thorough findings (Speziale and Carpenter, 2007).  
 
Yin (2009) described interviews as guided conversations rather than structured queries.  Although 
pursuing a consistent line of enquiry between all cases, the actual stream of questions is likely to be 
more fluid than rigid (Rubin and Rubin, 1995). Albeit a sense of conversation is ideal in interviewing, 
the research question dictated specific a priori topics which required to be addressed. Whilst flexibility 
and latitude are evident in case a study method, an interview guide was devised (Appendix 1) to 
ensure that all participants were asked to discuss the same topics, ensuring similar types of data were 
collected (Holloway and Wheeler, 2002). Standardisation of at least some of the questions added to 
data reliability, as unstructured interviewing with spontaneous questions, makes the data difficult to 
quantify and analyse (Thomas, 2009). Questions used in the interview guide were formulated 
following consultation with an Advisory Group. All patient related documentation was reviewed by 
members of a Focus Group, set up in consultation with the Roy Castle Foundation (a leading lung 
cancer advocacy group). They assisted me in developing the content of the guide and reviewed all 
patient materials for suitability of language and content.  
3.9.1.4. Field notes and case sheets 
In addition to data collected during the clinical encounter and interviews as transcribed material, other 
forms of data would be collected via case sheet compilation and researcher observation recorded as 
field notes. Case studies use a combination of case sheets, field notes, and databases to categorise 
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and reference data so that it is readily available for subsequent reinterpretation. Case sheets allow 
the recording of all categorical data for individual cases and their composition will be discussed in 
chapter 4. Similarly researcher observation, recorded as field notes throughout all periods of 
interaction with study participants, records testimonies, stories and illustrations which can be used in 
later reports (www.ischool.utexas.edu/case study research method-accessed 14.11.2009). Keeping a 
record of the interview is part of the artistry (Stake, 2005).  
3.9.1.5. Case demographic data 
Demographic data collection was instrumental in the study. It was necessary to determine whether 
the cases were a typical representation of the wider population and essentially as it provided 
important data relating to the characteristics of the participants. All demographic data provides 
contextual background information and it further informs data analysis in relation to within and across 
case analysis. 
 
The triangulation of these data collection strategies; audio-taped observed interaction, de-brief 
interviews, in-depth interviews, field notes, case sheets and demographic data documentation, 
essentially provide multiple measures of the same phenomenon. In so doing, the depth and quality of 
data offered to answer the research questions should be increased. 
3.10. Creating a case study database 
Multiple sources of data are required to be organised, documented and stored, comprehensively and 
systematically, in formats that can be referenced, in order that converging lines of enquiry and 
patterns can be uncovered (Baxter and Jack, 2008). Categorised and referenced data should in this 
way be readily available for subsequent re-interpretation and the design of the databases should be 
such that other researchers would be able to use the material based on the descriptions contained in 
the documentation (www.ischool.utexas.edu/case study research method-accessed 14.11.2009).  
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The main proponents of case study design recognise the importance of database creation in the 
organisation of complex and multiple sources of data (Yin, 2009; Stake, 2005). Its omission within the 
research design is viewed as a major shortcoming (Yin, 2009). Its construction essentially establishes 
a data warehouse for subsequent cross case analysis (Davis, 2010). I used the software package Nvivo 
9® which facilitated the recording of source detail, including all key documents, tabular materials, 
audio files and narratives. The software allowed accurate recording of time and date of data collection, 
storage and search capabilities, and importantly, for retrieval of patient narratives, which were 
referenced and identifiable (Wickham and Woods, 2005). 
3.11. Chain of evidence 
The final principle advocated by Yin (2009) was maintaining a chain of evidence, the predominant aim 
of which is to further ensure reliability of the evidence. An evidence chain essentially allows an 
external observer to follow the derivation of the study evidence and to trace the steps in either 
direction. Yin (2009) suggested that the links between the report and the database are transparent 
and my research adhered to this principle. All evidentiary sources were stored and organised within 
Nvivo 9® software and remain available for independent inspection. These three key principles of case 
study design will be explored in more detail in chapter 4. 
 
3.12. Data analysis 
Case study analysis is driven by one of the realities of this design: a staggering volume of data. To 
prevent ‘death by data asphyxiation’ (Pettigrew, 1988), case study researchers recommend coding  
data to allow unique patterns of each case to emerge prior to further across case analysis (Yin, 2009; 
Miles and Huberman, 1994; Eisenhardt, 1989). In this way large volumes of data can be reduced into 
manageable units (Miles and Huberman, 1994). Software programmes, such as Nvivo 9®, are 
beneficial in coding and categorising raw data derived from patient narratives, verbatim transcripts of 
interviews and written materials, where the research is attempting to derive meaning from words and 
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patterns (Yin, 2009). Yet, to systematically analyse and identify themes and patterns, a clear analytical 
strategy is essential to convey data from preliminary coding to reasoned and compelling conclusions 
(Yin, 2009). 
 
To prevent being initially overwhelmed by considerable amounts of raw data and to aid initial pattern 
identification a priori specification of categories is useful to shape the primary design and to permit 
the researcher to measure constructs more accurately (Eisenhardt, 1989). Relying on predetermined 
or a priori categories helps to focus the attention on certain data, whilst ignoring data less relevant to 
the research. Yin (2009) considered the prioritising of data based on categories which relate to the 
original research questions as the preferred approach in case study design.  
 
Once a pattern or category is identified, it is interpreted in terms of the social situation in which it 
occurred and the researcher moves from describing the social context to a more in-depth 
interpretation of its meaning (Neuman, 1997). The ultimate goal of case study analysis is to uncover 
patterns, determine meanings, refine constructs and build theory (Patton and Appelbaum, 2003). 
Similar analytical strategies, for analysing case study evidence, have been advocated by Yin (2009) and 
Eisenhardt (1989). Whereas Eisenhardt (1989) described the process of building theories inductively 
from the data, Yin (2009) proposed explanation building from the initial theoretical propositions. In 
both strategies the process is highly iterative and closely linked to the extant literature. The approach 
is especially appropriate in new topic areas, with resultant theory often novel and empirically valid 
(Eisenhardt, 1989).  
 
Utilising principles from both Yin and Eisenhardt’s analytical strategies I identified four key stages of 
data analysis relevant to my own research and these are shown in figure 4. Whilst these are discussed 
in more detail in chapter 4, the stages described here identify the analytical strategy to be used from 
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initial a priori category specification and categorical data ordering through to substantive analysis of 
the theoretical proposition.  
 
Figure 4: Stages of data analysis 
 
 
 
3.13. Quality in case studies 
Although I have used terms such as validity and reliability especially in relation to Yin’s (2009) criteria 
for judging quality in case study design in this thesis, I am more persuaded by the work of other 
researchers. The quality of a case study depends less on ideas of validity and reliability and more on 
conception, construction and conduct (Thomas, 2009). Assessing the standards for the quality of a 
study’s conclusions, Miles and Huberman (1994, p277) considered that there are countless 
possibilities and definitions. Subsequently they remained in the ‘critical realist’ tradition and focused 
on issues of confirmability, dependability, credibility and transferability. Other exponents of 
qualitative design reflected that the following key issues were predominant criteria for evaluating 
Stage 1
Ordering and comparison of primary categorical data
Within and across cases
Stage 2
Qualitative data assigned and ordered to a priori categories
Within and across cases
Stage 3
Emergence and development of theoretical proposition & construct refinement
Within and across cases
Stage 4
Substantive analysis
Within and across cases
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design in the constructivism paradigm, and as my research is grounded in this concept, I considered 
them valid measures to apply to my work (Lincoln and Guba, 2005; Denzin and Lincoln, 2003; Riege, 
2003). 
 
i. Confirmability: is analogous to objectivity and the basic issue of freedom from unacknowledged 
research biases. It closely corresponds to external reliability (Miles and Huberman, 1994) and 
construct validity (Riege, 2003). The test assesses whether the interpretation of data is drawn in a 
logical and unprejudiced manner to ensure the conclusions are the most reasonable ones obtained 
from the data. Confirmability, within my research, was enhanced through the selection of appropriate 
operational measures, data collection tools and methodology for the study under investigation. In 
accordance with the principles advocated by Yin (2009), three tactics were employed to increase 
reliability throughout this research. Firstly, to encourage convergent lines of enquiry, triangulation of 
multiple sources of evidence was used and was observable with the inclusion of all interview transcript 
narratives, field note annotations as well as demographic data compiled for each individual case. Such 
data established a chain of evidence throughout data collection whereby all documentation was 
computerised and all stages of the analytical process logged both within document folders and in the 
software package Nvivo 9®. Finally a case study database was established and stored in this manner 
for peer review and scrutiny. Additionally, transcripts and drafts of the evolving case study were 
reviewed by university supervisors for consistency and accuracy. 
 
ii. Dependability: is analogous to the notion of reliability and the purpose is to show indications of 
stability and consistency in the process of the study (Riege, 2003). I judged that dependability was 
primarily enhanced through strict adherence to the approved study protocol, which reported the 
entire conduct of the case study accurately and transparently. Although the protocol was revised on 
two occasions it was subject to Ethical committee approval and is available for peer review. The 
development of a case study database not only inferred dependability but also enhanced reliability 
72 
 
with the provision of transparent and accurate documentation. Within the database all data collected 
during the study was organised to facilitate retrieval for peer review (Yin, 2009) and to facilitate 
replication of the study. To enhance the reliability of interview data management I audio-taped all 
interviews, carefully transcribed the narratives and presented each case’s experience and perspective 
with extracts of pertinent statements in the research report.  My familiarity of the subject matter and 
geographical setting for the research also lent itself to the reliability of the research findings.  
 
iii. Credibility: is analogous to internal validity and the purpose is to demonstrate that the study was 
carried out in such a way it ensures the account ‘rings true’, makes sense or seems convincing (Miles 
and Huberman, 1994). I considered that the use of triangulation techniques, such as the use of 
multiple sources of evidence during data collection, would enhance my data’s credibility. Also 
credibility was evidenced in my study through pattern matching and constant comparative analysis of 
the data. The data followed a credible line of evidence from recognition and analysis of original a priori 
categories to the emergence of the theoretical proposition, all documented and analysed in Nvivo. 
Use of peer debriefing techniques, such as presenting the data analysis and emerging themes to 
university supervisors, also fostered credibility within my own research. Miles and Huberman (1994) 
stated credibility is also synonymous with achieving an authentic portrait of what we are studying 
where the researcher captures meaningful, context-rich descriptions. Within my research capturing 
the perspectives of the participants verbatim, accurately and comprehensively as audio-recordings, 
ensured I had access to the lived experience of information exchange and a plausible personal account 
of the phenomenon.   
iv. Transferability: is analogous to the function of external validity or generalisation and is achieved when 
the research shows similar or different findings of a phenomenon amongst respondents (Riege, 2003). 
Generalisability is grounded in the intuitive belief that theories must be shown to account for 
phenomena, not only in the setting in which they are studied, but also in other settings (Gibbert and 
Ruigrok, 2010). The aim of my study was not to generalise the results to the wider Scottish lung cancer 
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population but, instead, lean more towards the development of theory that could inform future 
research and practice. Generalisation of the case study so that it contributed to theory was an 
important driver.  
 
Each case was the starting point for theory development, with theory tested, replicated and analysed 
within and across cases. In my study, when two or more cases were shown to support the same theory, 
replication could be claimed. Replication logic allowed knowledge to accumulate across cases and 
strengthened the opportunity for analytical generalisation, in which a previously developed theory 
was used as a template with which to compare the empirical results of the case study. The study 
represented analytical rather than statistical generalisation denoting the process of generalisation 
from empirical observations to theory, rather than inferring conclusions about a population (Lee and 
Baskerville, 2003). Researchers advise that transferability is enhanced by data and analysis which 
facilitates a ‘fix’ on where the cases fit with the wider population (Hammersley, 2008; Lincoln and 
Guba, 2005). Consequently, the study strength was the demographic diversity of patients and 
companions who participated. Case selection was purposive to select a group of patients with lung 
cancer, who would be typical, in terms of their demographic variables, of the wider Scottish population 
and who were, therefore, more likely to illuminate the research questions.  
 
3.14. Methodological strengths 
Case study methods have a number of specific advantages. Primarily, by restricting the focus to a 
relatively small number of cases the research can facilitate the construction of an in-depth 
understanding of the subject under study. Hodkinson and Hodkinson (2001) judged case studies to be 
grounded in the lived reality of personal experiences whereby complexity and the real-life context 
may be explored in detail. Multiple data collection methods, such as interview transcripts, 
demographic data and directly observed behaviours can produce robustly evidenced understanding 
of social processes. In addition, multiple case studies can enable research to focus on the significance 
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of the idiosyncratic. Across case comparison of individuals or groups can focus on the unique as 
opposed to the shared experience (Hodkinson and Hodkinson, 2001). Case studies can show the 
processes involved in causal relationships, demonstrating the depth and complexity of the ways such 
correlated factors influence each other. 
Case study methods can facilitate the exploration of the unexpected and the unusual, revealing 
significant issues which were unanticipated when the research commenced, with the complexity and 
depth of the data generating new theoretical concepts. A major strength of theory building in case 
study method is its likelihood of generating novel theory. Bartunek and Seo (2002) argued that an 
attempt to reconcile evidence across and between cases types of data and literature increases the 
chance of creative reframing into a new theoretical vision.  
An additional strength is the emergent theory is likely to be testable with constructs that can be 
measured, because they already have been during the theory building process. Also, Eisenhardt (1989) 
argued the resultant theory is likely to be empirically valid. The likelihood of valid theory is high 
because the theory-building process is so closely aligned with evidence that it is very likely the 
resultant theory will be consistent with empirical observation. In well executed theory-building case 
study research, researchers answer to the data from the beginning of the study. It is this intimate 
interaction with the actual evidence that often produces theory which closely reflects reality 
(Eisenhardt, 1989). 
3.15. Methodological limitations 
Case study methods have a number of specific disadvantages. Foremost as this method concentrates 
on relatively small case numbers a common concern is they provide little basis for generalisation to 
larger populations (Yin, 2009). It is generally agreed that case studies, like experiments, are 
generalisable to theoretical propositions and not to populations or universes (Hammersley and 
Gomm, 2000). Case study researchers are more interested in finding the conditions under which 
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specific outcomes occur and the mechanisms through which they occur, than uncovering the 
frequency with which they arise (George and Bennett, 2004, p31). Eisenhardt (1989) cautioned that 
theory building from cases may result in narrow theory where the risk is that it describes a very 
distinctive phenomenon and the researcher is then unable to raise the level of generality. Likewise, 
selection bias can occur and cases can be skewed towards having or not having a particular attribute; 
for example patients with lung cancer with limited stage disease or better performance status. 
Case studies can take too long to complete and result in massive, unreadable documentation (Yin, 
2009). Given the typically staggering volume of rich data, there may be a temptation to build theories 
which attempt to capture everything. The resultant effect is a theory rich in detail but one that lacks 
the simplicity of overall perspective (Eisenhardt, 1989). Researchers lose their sense of proportion as 
they confront voluminous data and are unable to assess which are the most important relationships 
and which are peculiar to a particular case (Eisenhardt, 1989). Equally, Hodkinson and Hodkinson 
(2001) cautioned that when case studies are successful in revealing the complexities of social contexts 
there are difficulties presenting accessible and realistic representation of that complexity in writing.  
3.16. Summation  
Case study methods have both strengths and limitations. An important consideration for my research, 
with an interest in theory-building processes, related to case study size and subsequent issues of 
generalisation. With respect to generalisability, my case study, with seven cases, fitted with the 
replication logic proposed by Yin (2009). My case study, like the experiment does not represent a 
sample and the goal was to build, expand and generalise theories (analytical generalisation) and not 
to enumerate frequencies (statistical generalisation). Such theory development in case study research 
may have important strengths like novelty and testability, which arise from the intimate linkage with 
empirical literature (Eisenhardt, 1989). Correspondingly, given the strengths of this case study 
approach and its independence from past empirical observation it is particularly well suited to new 
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research or research areas for which existing theory seems inadequate (Eisenhardt and Greabner, 
2007).  
Despite the fact my case study cannot be representative of all patients with cancer or even lung cancer 
it can provide more than a simple idiosyncratic understanding. The issue is what the cases can tell 
about each individual case itself and about situations beyond the actual cases studied (Hodkinson and 
Hodkinson, 2001). Where case studies generate new thinking, that thinking has a validity that does 
not entirely depend upon the cases from which it is drawn, but with findings which ‘ring true’ in other 
settings.  
This chapter described the rationale for my chosen research design strategy. It outlined why the case 
study approach was appropriate to this research because the questions posed were of the ‘what’ type: 
the focus was on contemporary events and the researcher had only limited control over actual 
behavioural events. Furthermore, a constructivist paradigm allowed for a broader and deeper 
understanding of the process of information exchange as constructed by each individual participant. 
The chapter further detailed the overall research design from case definition and selection, through 
data collection and analysis. Chapter 4 will explore the research design in more depth from a practical 
and logistical stance. 
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Chapter 4: Research methods 
4.1. Introduction 
The justification for choosing a qualitative, constructivist approach and case study design was defined 
in chapter three. This chapter will now describe the practical and procedural aspects of the study. The 
chapter will begin with a description of the ethical approval considerations required for this 
investigation. This will be followed by discussion of the processes relevant to ethical considerations 
for my research. Discussion will also demonstrate the processes undertaken in relation to case 
identification and recruitment, data collection methods and data analysis strategies.  
 
4.2. Ethical approval application and access to cases 
Ethical approval was sought and granted from the Department of Nursing and Midwifery at the 
University of Stirling and simultaneously from the Health Board Research Ethics Service (REC 1) and 
Research and Development (R & D) Management. More details of the process are outlined below. 
 
4.2.1. University Ethics Department 
The Research Proposal and an Integrated Research Application System (IRAS) form were submitted to 
the Department of Nursing and Midwifery at the University of Stirling on 18th March 2009. Committee 
approval was granted on 14th May 2009. As per University guidelines, annual progress reports were 
submitted, specifying both progress and changes. 
 
4.2.2. Health Board Research Ethics Service (REC 1) 
Original submission of IRAS form (REC ref 09/S0703/106) was submitted to the Health Board Research 
Ethics Service (REC 1) for consideration on 10th September 2009. This submission and all accompanying 
documentation were reviewed at an Ethical Review meeting on 6th October 2009. Following 
attendance at the meeting where the study was discussed and questions answered to committee 
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satisfaction, a favourable opinion was granted on 11th November 2009, subject to minor amendments 
(Appendix 2). 
 
In the initial stages of recruitment and data collection it was recognised that in the majority of cases, 
patients with lung cancer were accompanied to the consultation. Additionally the literature identified 
companions often accompany patients to the consultation to provide practical, emotional and 
informational support, as well as participate in medical decision-making (Clayman, Roter and Wissow 
and Bandeen-Roche, 2005). There was recognition that companions were an integral part of the 
clinical encounter, with the potential to have a significant contribution and influence on the 
information exchange process. After discussion with study site clinicians and on further reflection a 
Substantial Amendment Form (1) was submitted on 5th July 2010, requesting REC approval for the 
submission of documentation relating to Companion Accompaniment. Ethical approval was granted 
for Amendment 1 on 19th July 2010.  
An important and salient explanation of the original research question and its aims is required at this 
point. The original research proposal submitted to the Ethical Committees initially sought to explore 
information exchange between women with lung cancer and healthcare professionals at clinic 
consultations. There was both scientific justification and a deep sense that women’s informational 
issues were of significant consequence and worthy of further research in this specialist oncology field.  
However, this gender specific study was not without challenges. Notably for the first six months of the 
study recruitment was gender specific and uptake was poor. Clinically there were also concerns raised 
among clinicians at the exclusion of males, and at a time when recruitment was poor overall, a decision 
was made to change study criteria to allow both genders to be approached for participation. 
Recruitment difficulties are discussed in more depth in section 4.4.4 
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A revised Study Protocol and Substantive Amendment Form (2) were submitted for ethics committee 
consideration on 22nd November 2010 for the inclusion of male participants. A favourable ethical 
opinion was granted on 14th December 2010. 
 
4.2.3. Research and Development (R & D) Management Approval 
All stages of the approval process for REC shown in section 4.2.2. were paralleled for Research and 
Development (R & D) Management. Dates of submission and approval were synchronous (Appendix 
3). R & D management approval granted access to all clinical study sites. Written approval was also 
sought from the Director of Nursing. Additionally, as well as seeking approval from Lead Nurses and 
Service Managers within the local Directorates for Medicine and Acute Emergency Services, I 
presented my research proposal to the Director of Nursing and all Lead Nurses at their monthly 
scheduled meeting in December 2009. 
4.2.4. Ethics Committee at National Waiting Times Centre Board (NWTCB)  
Concurrent ethical approval was also requested and granted for access to the tertiary thoracic centre, 
as there was potential for participants to receive surgical resection at this third study site. Ethical 
approval was sought on 7th September 2009. As this site was an independent Health Board, with an 
autonomous Ethics Committee review procedure, I required a letter of access, which was granted on 
27th October 2009. An application to Disclosure Scotland, allowing the NWTCB to access details of any 
cautions and convictions was also submitted and returned approved on 20th October 2009. 
Management Approval for the study was granted at this site on 11th December 2009 (Appendix 4).  
4.3. Ethical considerations 
Epidemiological data suggests that patients with lung cancer, especially those with advanced disease, 
can present with poor performance status (Sethi, 2004) and, also, be a very vulnerable group 
(Montazeri, Hole, Milroy, McEwen and Gillis, 2003). I was cognisant of the fact that all potential 
participants were at a particularly vulnerable stage of their cancer journey immediately following 
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diagnosis. Vulnerability is inferred by virtue of health status, position on the disease pathway and even 
communication skills (Phipps, 2002). Ethical debates exist in the literature surrounding the suitability 
and acceptability of approaching such vulnerable patients (Hopkinson, Wright and Corner, 2005; 
Casarett and Karlawish, 2000). In this current study careful consideration was given to strategies to 
minimise risk and these are defined below. 
4.3.1. Informed consent 
I considered informed consent to be the major ethical consideration for minimising risk and protecting 
the participant’s right to autonomy within this study (Beauchamo and Childres, 2001). As such 
particular consideration was given to these aspects of informed consent: 
 
 Information sheets: Availability and distribution of clear written information sheets for all 
potential patients, companions and professional participants. Potential patient and companion 
participants were approached and made aware of the study by a professional they were already 
familiar with, usually the CNS or respiratory consultant. 
 Written consent: Obtained from all participants – patients, companions and professionals with 
copies given to each individual. 
 Recruitment protocol: Recognising the importance of patients not being coerced into study 
participation. Both participant information sheets and informed consent procedures articulated 
that participation was voluntary, with participants retaining the right to withdraw from the study 
at any stage. It is widely recognised that, in order to avoid coercion or undue influence, the 
recruitment process should allocate sufficient time to both communicate a thorough explanation 
of the study and to give the potential participant adequate time to consider the information 
before making a decision to participate. A period of 48 hours was allowed between receiving study 
information and contact by the researcher.  
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4.3.2. Beneficence 
My over-riding duty, as a researcher, was not to cause harm to any of the participants, or indeed 
myself. Disclosing intimate and sensitive details about their lives can increase the sense of vulnerability 
and anxiety by participants (Ford and Reutter, 1990). Equally, learning such details can impact 
significantly on researchers. Support networks for participants, in the form of ongoing contact and 
assistance from their own medical and nursing professionals were available throughout the duration 
of the study. Participants were notified and gave consent that their general practitioner would be 
informed of their entry into the study and additional support existed in the primary care setting if 
required. For researcher support, academic supervision via regularly scheduled meetings at Stirling 
University was ongoing throughout the research period. Additionally, I have worked within this 
specialty for two decades, dealing with this patient, companion and professional group and felt I had 
the necessary skills and attributes required.  
4.3.3. Confidentiality and anonymity 
The issue of confidentiality is closely aligned with beneficence. Potential participants were informed, 
within the patient information sheet and informed consent form, that their right to anonymity and 
confidentiality would be protected throughout the study’s duration. The management of confidential 
data was of primary concern, with any data sheets stored securely in a locked drawer, separated from 
all other data, in the researcher’s office, which no one else had access to. Participants’ identity was 
not linked with personal responses but identified through an alias. The participant’s right to 
confidentiality and anonymity was in congruence with the Data Protection Act (Scottish Executive, 
1998) and in adherence to the NHS Code of Practice on Protecting Patient Confidentiality (Scottish 
Executive, 2003). 
4.4. Recruitment process 
As I considered a case to be inclusive of patients, companions and professionals, the recruitment 
process naturally involved participation of all members of the triad (chapter 3). The natural order of 
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recruitment suggested study sites and professionals were identified and approached first, with the 
healthcare team then responsible for identification of patient and companion participants. 
 
4.4.1. Study site and professional recruitment 
Two study sites were selected on the basis of my prior knowledge of lung cancer service management 
in the geographical area. I identified two acute teaching hospitals, which operated different clinic 
consultation models, for patients with lung cancer. Another inherent feature for site selection was the 
high incidence rate of lung cancer in the geographical areas they covered.  
Study Site A is an acute teaching hospital with approximately 450 beds, serving a population of more 
than 200, 000 people. Three Respiratory Consultants offer specialist respiratory care, including lung 
cancer patient management. The multidisciplinary team includes a respiratory physician, a lung cancer 
CNS, a clinical oncologist from the regional cancer centre, a specialist palliative care team member 
and thoracic surgical team support. This site operates a multidisciplinary clinic model, where patients 
are reviewed at clinic, following a multidisciplinary meeting. In 2007 at this hospital, 131 patients were 
diagnosed with lung cancer [60 females and 71 males] (Office for Audit and Clinical Effectiveness, 
2008). 
Study site B is a large acute teaching hospital with over 1000 beds, serving a population of 300, 000. 
There are a total of 4 Respiratory Consultants divided across respiratory sub-specialities, which include 
lung cancer patient management. The multidisciplinary team includes a respiratory physician, a lung 
cancer CNS, a clinical and medical oncologist from the regional cancer centre, specialist palliative care 
team member and thoracic surgery team support. This site operates a sequential clinic model, where 
patients are reviewed following the multidisciplinary meeting by the respiratory consultant and then 
referred to the most appropriate speciality clinic thereafter. In 2007 at this site, 187 patients were 
diagnosed with lung cancer [82 females and 105 males] (Office for Audit and Clinical Effectiveness, 
2008). 
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Formal introductions were made by letter to the Lead Lung Cancer Clinician and Lung Cancer CNS as 
well as Lead Nurses and Service Managers at each site. An invitation to meet the researcher was 
extended via a recruitment pack (Appendix 5: Healthcare Professional Introduction Letter; Appendix 
6: Healthcare Professional Information Sheet; Appendix 7: Healthcare Professional Consent Form) and 
followed by informal discussions with the researcher. Written consent was obtained from all identified 
professionals who agreed to participate. 
The same process was followed for Study site C, which is a national resource centre for Scotland, 
offering regional and national heart and lung surgical procedures. This acute surgical site has over 200 
beds and offers thoracic surgery to patients. Potential patient participants considered for surgical 
resection were cared for at this tertiary site.   
 
4.4.2. Patient and companion recruitment 
Participants were selected explicitly to encompass instances in which the phenomenon under study 
was likely to be found (Zach, 2006). I wanted to select a broad range of patients with lung cancer (with 
or without their companions) who possessed particular qualities or characteristics and specific 
knowledge about the disease. They would thus be an important source of experience and expertise 
regarding information exchange.  
Patients with primary lung cancer (and their companions) attending clinical consultations at both 
Study site A and B, referred for any treatment modality and deemed by their professional team to be 
(i) well enough to be selected and (ii) met eligibility criteria, were considered for study participation. 
Professionals were asked to purposively select cases to include the following range of characteristics 
and demographic variables where possible; age (range from 18 years on), gender (male and female), 
performance status (0-3), disease classification and stage (range of lung cancer type and range of 
stages local to advanced), treatment types (all ranges from palliative therapy to resection), treatment 
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outcome (range from palliative therapy to curative), educational level (range from secondary to higher 
education), socio-economic (range of deprivation scores scores).  
 
4.4.3. Method of recruitment 
Potential participants were identified by the healthcare team following discussion at the multi-
disciplinary team meeting (MDTM) and again when they initially attended the diagnostic clinic to be 
informed of a lung cancer diagnosis. Professionals used their clinical discretion to determine patient 
suitability for the study and applied the following eligibility criteria to assist with case selection:  
 
Inclusion criteria: 
• Patients will have a diagnosis of primary lung cancer and be aware of the diagnosis 
• Patients will be attending lung cancer clinics at the outpatient department 
• Patients will be 18 years of age or over and agree to participate in the study 
• Patients will be able to understand English  
 
Potential participants were not approached at the diagnostic clinic, but were contacted 24-48 hours 
later by the CNS (as per standard practice at both sites). Consequently, potential participants were 
initially approached by a member of staff known to them. Then using their professional judgement 
and their knowledge of the individual, the CNS introduced the study to potential participants and 
determined if: 
1. Potential participants would be willing to consider having the Patient Information Pack 
(Patient Introduction Letter; Appendix 8: Patient Information Sheet, Appendix 9 and Patient 
Consent Form, Appendix 10) sent to them by post 
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2. Potential participants would require a Companion Information Pack (Companion Introduction 
Letter, Appendix 11, Companion Information Sheet, Appendix 12 and a Companion Consent 
Form, Appendix 13) to be sent along with their Patient Information Pack 
3. Potential participants would be willing to consent to their contact details being given to the 
researcher. 
The CNS completed a log of all potential participants approached to participate in the study (Appendix 
14: Potential Participants Data Sheet). The details of potential participants willing to consider study 
participation and who gave permission for their details to be given to the researcher then had a Patient 
Information Pack (+/- the Companion Information Pack) sent to them, using first class mail. The CNS 
also informed the potential participant that the researcher would contact them in the next 48 hours 
to answer any queries about the study and if they were agreeable and discuss the next stage of the 
process with them. 
Potential participants were contacted by telephone within the specified time period by the researcher. 
Patients who agreed to participate in the study consented to meet the researcher at their next clinical 
encounter for more detailed discussions regarding the research study. They were also given contact 
numbers should questions arise in the interim. At the first meeting between the researcher and the 
participants, written informed consent was taken, after the study rationale was explained in person 
and the opportunity for questions was given. This above process is illustrated in Figure 5. 
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Figure 5: Recruitment process 
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4.4.4. Recruitment challenges 
4.4.4.1. Study site and healthcare professional recruitment 
Initial recruitment of both study sites and healthcare professionals ran well as I was familiar with the 
sites and gaining access to clinical teams was facilitated by my knowledge of the local managed clinical 
networks. The initial period of recruitment required comprehensive preparation and included 
numerous meetings with medical, nursing and managerial staff members, as I established 
relationships with professionals who were crucial to site access approval. I disseminated study 
information using mediums such as letter, secure email, telephone and face to face meetings. When 
requested I gave presentations to staff-side colleagues to facilitate a more precise overview of study 
requirement and impact on clinical sites. However, on reflection as uncomplicated as this preliminary 
phase of recruitment was, perhaps establishment of an advisory group consisting of managerial 
representation may have offered strategies to assist me with collaborations and partnerships. 
 
Table 8 shows the challenges considered relevant to study site and professional recruitment and 
illustrates methods to overcome the challenges faced, as well as my reflections on the specific 
considerations. 
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Table 8: Study site and healthcare professional recruitment challenges 
 
Points to consider Methods to overcome Reflections 
Relationship establishment 
with study site 
communities  
 
Strategies to ensure 
collaboration 
o Formal written approach to management  
colleagues to achieve ‘buy-in’ 
o Presentations to senior management to 
reassure clinical impact from study would be 
minimal 
o Ensure researcher is readily available and 
contactable to answer any ongoing queries 
Could have established an Advisory Group with 
representation from managerial, clinical and 
lay members to facilitate ongoing planning and 
updates 
 
Suggested regular updates / progress 
Clinician concerns re study 
protocol 
o Regular meetings, emails or phone calls to 
raise issues and deal with concern 
o Presentation of study protocol and scientific 
rationale for gender specific study 
Could have established an Advisory Group with 
representation from managerial, clinical and 
lay members to facilitate ongoing planning and 
updates. This group then may have been able 
to facilitate an expedited solution to clinicians 
concerns 
 
This concern was discussed for some months, 
with all scientific justifications presented. 
However, impasse was reached which had to 
be overcome in order for the study to progress 
(see table 9) 
 
Recruitment of healthcare professionals likely to be present during clinic consultations (including 
specialist palliative care team members) was also unproblematic. All professionals approached 
provided written informed consent. The three clinical nurse specialists at each of the study sites were 
identified as Site Specific Investigators and were instrumental identifying potential patient 
participants and completing study documentation. Preliminary discussions with study site teams and 
available audit data suggested potential patient participant numbers (6-10 patients) would be 
achievable. 
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Throughout this period of negotiation with clinical and managerial teams the research proposal for 
the original research ‘exploring information exchange between women with lung cancer and 
healthcare professionals’ was discussed and consented to by all healthcare participants. Unfortunately 
as the study progressed despite written informed consent there was a concern raised by a member of 
the team regarding female only recruitment. Gender-specific recruitment was felt to be to the 
detriment of the male population, who would then be denied the opportunity to participate and have 
their perspective voiced. The objection was sustained for some months with arguments raised from 
both viewpoints re inclusion of men. Impasse was reached and I had to make a decision which had the 
potential to impact the whole ethos of the study. 
 
4.4.4.2. Patient and companion recruitment 
Overall study patient/companion recruitment was prolonged and ran from January 2010 to December 
2011. Challenges faced within this period were multifactorial and described in table 9.  
 
The major consideration was the objection to gender-specific recruitment. Whilst this discussion was 
ongoing and unresolved there was no recruitment taking place within one site.  In addition the study 
was slow to recruit any participants and with only one site fully engaged the decision was taken to 
include men in the study. 
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Table 9: Patient recruitment challenges 
 
Points to consider Methods to overcome Reflections 
Barriers to patient 
recruitment 
- Gender specific 
participants 
A suspension of the study 
occurred at one of the 
study sites during 
discussion re gender 
concerns 
 
As a direct result this site 
effectively only recruited 
and participated in the final 
6 months of the data 
collection period 
- Study slow to recruit 
o Regular discussion re scientific justification for 
studying female only population 
o Frequent meetings with university supervisor, 
allowing progress/situation updates as well as 
suggestions for way through impasse 
o Decision taken to either include male 
participation or recruit another study site with 
other HCP 
o AS STUDY SLOW TO RECRUIT – DECISION WAS 
TO INCLUDE MALES IN THE STUDY 
o Continual discussion and updates with study 
sites re changes to research protocol 
o Substantial amendment submitted to REC 
o Weekly communication (email and telephone) 
with CNSs regarding potential participants 
identified at MDT and diagnostic clinic 
o Regular email correspondence to all HCP 
reminding of eligibility criteria etc. 
o Communication re recruitment completion 
date and target enrolment numbers 
There was recognition and empirical evidence that 
information exchange was not examined across 
both genders. However, as a researcher and clinician 
with an interest in women’s lung cancer issues I was 
initially keen to investigate cancer communication 
and information exchange from a female 
perspective. However, despite the methods 
described to overcome challenges, recruitment was 
slow and I thought the inclusion of men (although 
costly in terms of time and effort for substantial 
ethics amendment) was preferable to a stalled 
study, which was recruiting few patients at the time 
or a new process of study site and HCP recruitment 
I instigated weekly contact with the CNSs at both 
sites, to facilitate discussion re potential 
participants. Despite the large numbers of lung 
cancer patients being diagnosed across the Health 
Board, recruitment was slow. I was keen to reinforce 
eligibility criteria to ensure all potential participants 
were identified. There were times despite initial 
contact I was unaware of progress or stage of 
communication. As a CNSs I was cognisant of how 
busy the clinicians were and at times did not push 
too hard for potential numbers, preferring to leave 
it to the discretion of the recruiters.  
 
A noteworthy consideration was how I viewed my 
role both a researcher and CNS. I was keen to recruit 
patients to the study, but anxious not to upset the 
clinicians by appearing pushy. On reflection there 
may have been a familiarity between us, as were 
colleagues and lung cancer networks are small, 
which in fact hindered rather than enhanced 
recruitment. I may have initiated more contact with 
colleagues I was unfamiliar with. 
Advisory Board perspective may have highlighted 
such a situation and offered alternative strategies  
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Additionally, there were external influences and challenges which necessitated a study length 
extension, over which I as a researcher had little control and thus little in the way of strategies for 
overcoming them. These are listed as follows:  
 
1. Researcher ill health which required a leave of absence.  
2. The study sites merged their services between February 2011 and July 2011 and no 
recruitment took place during this time to allow for the transition.  
3. The CNS at study site A had maternity leave during the recruitment period and there were 
periods of sick leave.  
4. There was no clinical nursing cover when the CNS began her maternity leave. 
 
4.5. Data collection 
A key strength of case study design is the use of multiple sources and techniques in the data collection 
process. In the following sections I will define the practical processes of multiple data source use, 
employed alongside the other two principles of database creation and maintaining an evidence chain 
(Yin, 2009). 
 
4.5.1. Multiple data sources 
To address the aims of the study it was essential that the research accommodated a rich variety of 
data sources, which would in turn strengthen the research process. Significant volumes of data would 
be collected from the clinical encounters where the information exchanges were being executed and 
from the interviews (both de-brief and in-depth). The process of data collection for each is detailed.  
 
4.5.2. Audio-taping of clinical consultations 
In person introductions to patient and companion participants was facilitated by either the CNS or the 
respiratory physician at the start of the clinic. A clinic room was provided to take written consent and 
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answer questions, as well as conduct any de-brief interviews. I remained in the clinic area, (but not 
the consultation room) for as long as necessary to collect data for all participants in each case. All 
participants gave written consent for the clinical consultations and interviews to be audio-taped. I 
opted to audio rather than video-tape consultations and interviews. Although video is recommended 
researching professional-patient interaction, as it captures all modalities of the exchange (Haidet, 
Tate, Divirgilio-Thomas, Kolanowski, Eberly and Happ, 2009), I was concerned the intrusiveness of 
video recording equipment and the presence of a camera might alter the consulting behaviours of 
participants.  I was conscious of the potential, modifiable, Hawthorn Effect that both my presence and 
that of the recording equipment may have on patient and professional participants alike and tried to 
minimise the impact (Cormack, 2000). At no time was I present during the consultation. The device 
used for audio was digital and discrete and placed away from the participants but it still accurately 
recorded the exchange. The professionals were asked to operate the equipment, after a period of 
instruction by the researcher. If for any reason during the interview the participant wished to 
terminate the study, the professional would halt the audiotape and the clinic consultation would 
proceed as normal. This situation never arose during data collection at clinical encounters.  
 
4.5.3. Audio-taping of debrief interviews 
De-brief interviews were viewed as a powerful means of extracting valuable information from patients 
and professionals in the immediate aftermath of their clinical encounter, when recall of events is 
strong and first impressions can be captured (Appendix 15: Patient Debrief Interview Guide and 
Appendix 16: Professional Debrief Interview Guide). Additionally, information could then inform 
further in-depth interview questioning. De-brief duration ranged from 1 – 5 minutes and was always 
carried out post-consultation in privacy. No patient or companion declined to be de-briefed. Only one 
professional de-brief was declined due to clinical commitment. 
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4.5.4. Audio-taping in-depth semi-structured interviews 
The third process of data collection within this study was the semi-structured interviews. One of the 
most important sources of case study information is the interview (Yin, 2009). As the study was 
interested in exploring the experience of information exchange from the perspective of the 
participants, the use of semi-structured, but in-depth interviews was an ideal data collection method 
to address the aims of the research question. It has been shown that patients with lung cancer (96% 
of those surveyed in a Glasgow study) indicated that they found being interviewed acceptable 
(Montazeri, Milroy, Gillis and McEwen 1996). Importantly, patients with similar demographic and 
geographic backgrounds to those in my research reported they found interviews conversational and 
relaxing. Montazeri et al (1996) also found that of the 126 patients they surveyed over half preferred 
to be interviewed at home.  
 
Following the de-brief interview with patients and companions I secured a date, time and venue for 
the in-depth interview. All cases were given the option of interview location. Five cases wanted to be 
interviewed at home, one at work and the remaining case during his hospital stay. In order to facilitate 
greater clarity of recall and reduce the potential for bias following the clinic encounter, the in-depth 
interview was scheduled to take place as soon as possible after the final consultation but prior to 
treatment commencing. This was a pragmatic decision whereby it was hoped that, if carried out before 
therapy patients, would be more focused on the events of the consultation and conversation would 
not be complicated by treatment related information issues, or by potential treatment related side 
effects such as pain, nausea and lethargy.  
 
Prior to beginning the interview I ensured that all present were happy to proceed with the research 
and agreeable to the interview being audio-taped. Written informed consent was taken from any 
companion participant joining the study at this point (this applied to Cases A and E). Interview duration 
was variable but approximately an hour long in the majority of cases. 
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4.6. Reflexivity in research practice 
Parahoo (2006) defined reflexivity as the continuous process of reflection by the researcher on his or 
her values, preconceptions, behaviour or presence and those of the participants, which can affect the 
interpretation of responses. Essentially it requires researchers to recognise that they are part of the 
social world under study, whilst acknowledging one’s position in relation to the research (Herr and 
Anderson, 2005). Qualitative researchers are interested in how meanings are produced and 
reproduced within particular social, cultural and relational contexts, with the interview itself as one 
such context of interactive meaning-making. Therefore, interpreting qualitative data requires 
reflection on the entire research process (www.utsc.utoronto.ca/reflexivity-accessed29/10/2014). 
Reflecting on the research process and trying to understand how one’s values and views may influence 
research findings adds credibility to the research (Jootun, 2009). In order that trustworthiness, 
dependability, transferability and credibility can be established the research process must be 
transparent, with an integral aspect of this being reflexivity, an in-depth self-awareness of one’s 
perspective, strengths and limitations (Patton, 2002).  
 
Hall and Callery (2001) suggested that to fulfil these quality expectations throughout the research 
thesis, the researcher should make explicit how data was constructed and questioned their 
preconceptions throughout the process. To fulfil this recommendation I kept a reflexive diary. Within 
my diary I logged my thoughts, opinions and field notes relating to the research process and cases. I 
also entered any concerns or questions for my supervisors as they arose. In this manner, the intention 
was to provide particular detail to the understanding of real-world research (Anthony and Jack, 2009). 
For the purpose of the thesis I have chosen to reflect on three major areas of concern which required 
a great deal of reflection at particular time frames during the research. 
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4.6.1. Recruitment 
As previously discussed in chapter 4.4.4. recruitment to the study was challenging. Despite a successful 
Ethics submission with a scientific rationale for exploring information exchange in a gender-specific 
lung cancer population, at the point of recruitment a concern was raised that the exclusion of men 
would fail to allow the perspective of the full lung cancer population to be voiced. Whilst debate was 
ongoing over the issue, recruitment was suspended at one site. In order to progress recruitment 
(which was slow at the first site too), there were two choices presented to me; either recruit an 
alternative study site with new healthcare professional participants (which necessitated a Substantial 
Amendment to Ethics and perhaps transfer of the study to a different location in the city) or include 
men in the study. After a prolonged period of time and much deliberation I opted for the second 
option. This major issue was discussed via email with the medical clinicians, with periods of inactivity 
in correspondence, prompting me to turn to other HCP participants for assistance, as this email 
excerpt and my notes reflect: 
 
VIGNETTE 1 
EMAIL: 
I am sorry to ask this of you, but do you know if there has been any more consideration of my study. I 
have written a few times asking if involvement isn’t possible can I approach another HCP 
NOTES: 
Staff failed to respond to several emails and I have now been forced to contact another member of 
staff for assistance. This feels awkward and I do get concerned that I am playing on goodwill and 
familiarity by doing so, but I am pretty desperate for a solution! 
 
As shown in table 9, I hypothesise that my familiarity with the HCP participants made me cautious in 
my approach to them. On reflection I was attempting to preserve my nursing professional 
relationships with them and not have them judge me as overbearing researcher. In comparison to 
several other researchers I assumed that all my preliminary meetings and presentations prior to the 
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research had fully engaged the HCP participants and that knowing staff and the environment would 
make recruitment easier (Larkin, 2013; McNeill and Nolan, 2011). Like Larkin (2013) I found that the 
insider status of my role as researcher was more complex than I anticipated. In some respects I was 
an insider, knowing all the HCP participants and gatekeepers. Yet, as Labaree (2002) stated insiderness 
is transformed by the situation and decided by the participants not the researcher. Importantly for 
me as a researcher I learned that despite considering myself an insider, this did not prove 
advantageous when it came to recruitment. 
 
4.6.2. Duality of role at interviewing 
The duality of my role as researcher and nurse was made transparent to patients and companions as 
my professional title and the nature of the research was explained on all Information Sheets. I was 
aware that I was entering the research process with my own history and experience, which could 
influence how I understood and managed data collection and analysis. However, Colbourne and Sque 
(2004, p303) stated, ‘if the nurse cannot be removed from the researcher, why pretend?’ It was my 
clinical experience and judgement, in addition to reviewed literature, that identified the paucity of 
evidence underpinning information exchange in this specialist area and which ultimately, led me to 
conduct the research. I aimed for reflexivity which Dowling (2006) described as ‘closing the door on 
the belief that distance between researcher and participant is paramount, and providing momentum 
for a move towards a position where the boundaries between the two are surrendered’.  
 
The duality of my role had strengths and limitations during the data collection period and more 
specifically during interviews. I aimed, where possible, to appear neutral when I conducted data 
collection. Aside from Health Board identification worn during clinical encounters I had no other sign 
of professional status. I dressed in my normal working clothes (non-clinical) (Allen, 2004) and, during 
interviews conducted at patients’ homes; I aimed for a relaxed approach, using first names if patients 
and companions were comfortable with this. I have 20 years of experience undertaking home visits as 
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part of my routine clinical practice and hoped this was evident during data collection. As a lung cancer 
nurse interacting with patients and their companions living with a condition I am accustomed to, I was 
in familiar territory. I understood the processes they were talking about and this allowed them to 
communicate their perspective without interruption. My familiarity provided insight into the 
experience that might not have been evident to a researcher without an oncology background.  
 
However, the nature of my clinical background may have created assumptions for the patients and 
companions. There were instances (discussed in chapter 5) where participants asked me clinical 
questions. They understood my clinical role and, in some cases, took the opportunity to ask probing 
questions regarding diagnosis, treatment and treatment outcome.  
In a study carried out by Anderson (1991) where she interviewed Chinese and Anglo-Canadian women 
with diabetes about their illness experience, the participants asked her for clinical information based 
on her social role as a nurse. The realities of the participants’ lives, coupled with their requests for 
help, were addressed by Anderson through a reciprocal process. She obtained information and 
provided information in return. Whilst some research approaches, such as participatory action 
research and feminist methodologies highlight the importance of reciprocation (Kemmis and 
McTaggart, 2000) I was conscious of my social part of the research process. Therefore, exchanging 
information about prognosis with companions, when I was not part of the clinical team and the 
patients themselves were uncomfortable with the direct line of questioning, was inappropriate.  
Undertaking the reflexive process allowed me to be aware of what was influencing all of our 
responses, while simultaneously being sensitive of relationships to the research topic and the 
participants needs (Dowling, 2006). The possibility of becoming clinically enmeshed with participants 
may have led to me having difficulty maintaining the neutral role I had originally aimed for.  
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VIGNETTE 2 
Agnes even asked clinical questions of the researcher, which at times Alex appeared uncomfortable 
with, especially in view of the positive perspective he had taken regarding his treatment outcome. 
 
Agnes: Now, after the second radiothera…, eh, chemotherapy, if it hasn’t shrunk, is there any other 
type of chemotherapy that he can get that would be a different kind of treatment? 
Researcher: It’s difficult for me to say, because I don’t work for Dr Allan. 
Agnes:  No, uh huh..  
Alex: That’s right – see, that’s how I says to you, it’s getting over the first one and moving on from 
there. That’s the best thing. A lot depends on how much it shrinks (In-depth 
interview/Alex/Agnes, Ref 16) 
 
 
4.6.3. Companion role – influence on professional practice 
Research activity is recognised as a principle ingredient to the potential success of future healthcare 
practice and service provision (Department of Health, 2010). Consequently there is increasing 
emphasis within contemporary health care for practitioners/researchers to actively engage in practice 
orientated research with a view to making inroads into influencing mainstream patient healthcare and 
practice (Clark and Thomson, 2013). An important aspect of reflexivity is identifying specific ways in 
which my own perceptions and clinical practice may be influenced by the research, those researched 
and the research findings.  
 
The novel finding of negotiated companion presence impacted my clinical practice on a fundamental 
level. Prior to undertaking the research, within my sphere of clinical practice the multi-disciplinary 
team endorsed the recommendation from national organisations and suggested to patients they bring 
a companion to consultations to discuss the diagnosis and management of their condition (BTS, 2013; 
NICE, 2005; SIGN, 2005). There may now be a need for lung cancer clinicians to be cognisant of and 
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responsive to patient preference for accompaniment above the universal recommendation of 
companion accompaniment.  
 
Reflecting on this innovative finding for my own practice I believe it is imperative to be aware and 
respect patient preference for accompaniment. To achieve individualistic, patient-centred care I 
recognise that, for some patients, being un-accompanied to consultations fulfils their informational 
and decision-making needs and as a clinical nurse specialist my role is to be aware and respect patient 
preference.  
 
VIGNETTE 3 
Post research practice 
o Within my clinical practice instead of universally recommending that patients bring a 
companion to their diagnostic consultation, I instigate conversation outlining options for 
accompaniment, emphasising that patient preference is paramount and will be supported by 
all team members. 
o Raising awareness among colleagues that as clinicians we should review national guidelines in 
relation to patient accompaniment to consultations and adopt a patient-centred and patient-
preference approach to accompaniment. 
 
The development of a decision trail explaining the impact on data collection and analysis throughout 
the study were logged within my field notes. All instances were documented in my journal and field 
notes to raise awareness of such influences on my interpretation of the data and their relationship to 
the research themes and case studies. Multiple sources of evidence including interview transcripts, 
reflexive journal notes, field notes and audit trails, documented and organised in this manner further 
strengthen the study’s credibility and are available for inspection by examiners (Hammersley, 2008). 
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4.7. Case sheets and field notes 
Collation of case sheets (Appendix 17) began when initial demographic data relating to Case A was 
sent by the CNS at Study Site A. Seven case sheets were developed in total. Each case was assigned an 
individual case sheet which included demographic data, checklists, field note summaries, a case study, 
thematic frameworks and all other relevant documentation. These were categorised and stored in 
individual databases in Nvivo 9® and were updated frequently. Case sheets were finalised after 
completion of all data collection and were entered as important documentation into the case study 
database.  
Field notes allowed me to record feelings and intuitive hunches, pose questions, and document the 
work in progress. I prepared field notes after each case encounter, listing key features which struck 
me about the patients, their companions and professionals. I detailed ideas about the clinical and 
home environment, noting aspects of the information exchange process requiring clarification, 
observing the minutiae of what happened, when and how others reacted. Essentially, I prepared an 
interpretive commentary (Stake, 2005). These first analytical notes gave rise to the start of data 
analysis at the beginning of the interpretative process providing insight and depth to my early across 
case evaluations (Hammersley and Atkinson, 2007; Payne, Field, Rolls, Hawker and Kerr, 2007).  
 
4.8. Demographic data 
Participants gave permission for demographic data to be collected (Appendix 20: Demographic Data 
Sheet.). Data was obtained either from patients or their healthcare team. Evidence suggested that 
variables such as gender, age, educational status and stage of disease impact on information exchange 
between patients and professionals (Street, 1991). Demographic data had a valuable role within this 
study, for direct comparison with existing research findings and as illustrated in Chapter 6. Both 
patient and companion categorical data was thought to influence information exchange within this 
study. Demographic information was entered into the individual case sheets. 
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My prior knowledge, as a nurse specialist, did afford me insight into disease aspects but I verified all 
clinical demographic data during the course of the discussions with the healthcare team. I neither 
sought permission for nor planned on accessing documentation such as case files for any demographic 
data verification. 
 
4.9. Data management  
Patient’s personal details such as name, address and CHI number were initially required to allow the 
researcher and the professional to track the number, sequence and timing of clinic consultations and 
importantly, to facilitate interviews carried out in the community setting. This information was 
separated from all data collected and held in a locked cabinet, in a secure location at all times. Patients 
were coded with an ID number and an alias, which was used on all study documentation. Immediately 
after the recruitment of Case A data collection and subsequent data management commenced. All 
audio-tapes were transcribed personally by me. Although this was both, labour and time intensive, 
the advantages of personally transcribing ensured there was accuracy and clarity in the transcripts 
and it allowed me to become immersed in the data. Similar to patient details, all audio was stored in 
a secure locked drawer, with all electronic transcriptions stored on password encrypted computers.  
 
4.10. Case study database 
Database creation permits organisation and documentation of all study data. Observing the second 
principle of case study data collection, I created an electronic research database using Nvivo 9®. Within 
this database I organised and stored all documentation relating to the cases and primarily ordered 
these around nodes for each individual case.  Additionally, entries to the database folders recognised 
the original a priori categories which I established to answer the research questions. As analysis 
unfolded emerging sub-categories were added to reflect areas of information exchange. Then as the 
research developed and data analysis identified the emerging theoretical proposition the constructs 
relating to companion influence were also documented within specific nodes and categories. The 
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database included all field notes, demographic data, transcripts and audio recordings, as well as, a 
journal of my interpretative analysis notes. It was a valuable resource tool during comparative 
analysis.  
 
4.11. Maintaining a chain of evidence 
Demonstrating a clear evidence trail further enhances the reliability of case study data and, 
importantly, is the third principle of case study data collection. In my study, all data relevant to 
individual cases, from potential case identification through to all transcribed interview data was made 
available for observer review. Correspondingly, all study material, including audio-tapes, 
transcriptions and case sheets were reviewed and discussed with my principle university supervisor 
and remain available for inspection.  
 
4.12. Data analysis 
Chapter 3 illustrated the theoretical approaches to data analysis in case study research, with specific 
reference to multiple sources of evidence that require to be referenced and coded in order that 
converging lines of inquiry and patterns can be uncovered (Stake, 2005). This section will detail the 
actual data analysis process undertaken in this study describing the four key stages of analysis and is 
represented in figure 6. 
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Figure 6: Data analysis process 
 
 
 
Before embarking on coding and pattern matching in order to initially manage the volume of data 
generated and to provide a robust and clear synthesis of the raw data I followed basic principles (Box 
1) stipulated by Thomas (2011, p171). These were useful at the start of data analysis to put the 
evidence into preliminary order.  
 
 
 
 
 
 
 
 
 
 
Stage 1
Ordering and comparison of primary categorical data
Within and across cases
Stage 2
Qualitative data assigned and ordered to a priori 
categories
Within and across cases
Stage 3
Emergence and development of theoretical proposition & 
construct refinement
Within and across cases
Stage 4
Substantive analysis
Within and across cases
Categorical data 
Gender, Age, Performance status, Disease stage, Cell type, 
Treatment regimen, Employment, Residence, Marital status, 
Educational status, Smoking status 
 
A priori categories 
Diagnosis – Type of cancer, Stage of cancer, Symptoms of cancer 
Treatment – Regimen, Intent, Outcome, Treatment side-effects 
Treatment outcome - Continuum 
 
 
Emergent theory & construct refinement 
Mediator – Physical, Emotional, Informational 
Moderator – Companion control, Companion agenda, 
Companion as expert 
Neutral – Prior knowledge and Relationships 
 
Substantive analysis 
 
Companion influence on information exchange 
Moderating impact of companion presence 
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Box 1: General process of analysis  
Thomas (2011, p171) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.12.1. Stage one - analysis of categorical data 
Stage one analysis involved the ordering and comparison of demographic characteristics relating to 
each case. Each case was assigned both a case sheet and database file within Nvivo 9®. Within the 
software database it was then possible to develop and review nodes for all categorical variables within 
and across cases. The twelve demographic variables analysed are shown in table 10 - chapter 5. The 
aim of this stage of analysis was to provide descriptive data about the cases being studied, whilst more 
specifically identifying and describing particular attributes such as age, disease stage and performance 
status, and how these compared across the cases to determine if the cases were typical or atypical of 
the wider population. This stage of analysis compared data between participant cases, cases that 
declined to participate and cases not approached by professionals. 
 
• Examine all of your data – read the transcripts, diaries, notes and listen to audio-recordings  
• Make copies of all raw data – keep one uncorrupted and use the other as a working data document 
• Re-examine the data, highlighting important parts to give an impression of recurring and emerging 
themes (as I originally used a priori categories such as diagnosis, treatment and treatment outcome I 
used these as broad themes and ordered emerging categories around these) 
• Read the data again, using the list of original constructs draw up a grid and reference the evidence 
and make notes and observations 
• Identify second-order constructs which seem a good fit with the data and use to summarise the 
important themes  
• When you are satisfied these constructs capture the essence of the data – label as themes 
• Think about how the themes connect across cases, look for comparisons, contrasts, contradictions 
• Find ways to map your themes 
• Select appropriate quotes/narratives 
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4.12.2. Stage two – analysis of qualitative data 
Qualitative data was assigned to a priori categories based on key stages of the cancer care continuum 
and identified, empirically, as the recommended topics for information exchange and communication 
between professionals and patients. These were recognised as: 
 
• Diagnosis 
• Treatment 
• Treatment outcome 
 
During analysis and coding of the consultation transcripts it was apparent that the primary focus for 
participants was not solely the three broad categories detailed. Inductive data analysis revealed that 
information was exchanged around sub-themes for each category, with the exception of treatment 
outcome, where information was either exchanged or not. Such sub-categorisation (again within 
Nvivo 9®) permitted large amounts of data to be more easily managed and identified for across case 
comparison, providing essential units for further analysis (Thomas, 2011). 
 
4.12.3. Stage three – emergence & development of theoretical proposition & construct refinement 
Stage three of the analysis marked a shift of emphasis within the data. To this point, analysis identified 
data which encompassed categorisation of the information exchange process as it occurred between 
the participants within the cases. Constant comparative analysis indicated that across cases 
information exchange, per se, was regarded as important but performed to a level which each case 
found suited their needs. Analysing the data relationships within cases and comparing across cases 
within Nvivo 9® I detected that actual information content was impacted by other factors which 
consequently determined what course information exchange assumed.    
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Companion influence emerged as a significant consideration impacting information exchange during 
both clinical consultations and the in-depth interview process. As this new data occurred I reviewed 
the audio-tapes and transcriptions again to identify, more inductively, any themes or connections to 
substantiate the new emerging theory. I followed the explanation building process considered by Yin 
(2009) whereby the eventual theory is likely to be series of iterations: 
 
• Make an initial theoretical statement or proposition  
• Compare the findings of one case against the proposition 
• Revise the proposition 
• Compare the revision of the facts with a 2nd, 3rd or more cases 
 
The final explanation or theory may not be the one stipulated at the beginning of the study and, 
therefore, differs to an extent to the pattern-matching process described in chapter 3. As I became 
more familiar with and compared the data across cases the new proposition of companion influence 
began to emerge (Yin, 2009). Then, as the next step in iterative analysis is the constant comparison 
between the emerging data from the cases and the empirical literature (Yin, 2009; Eisenhardt, 1989), 
I re-examined the evidence relating to both, factors impacting information exchange and the specific 
constructs impacted. A ‘close fit’ is important to the development of a theoretical proposition because 
it takes advantage of the new insights emerging from the data and the literature and yields an 
empirically valid theory, which in my study was linked to companion influence (Eisenhardt and 
Graebner, 2007).  
 
4.12.4. Stage four – substantive analysis 
Before substantive analysis could be undertaken, I refined the constructs pertinent to companion 
influence and these are explored in chapter 6. Reasons for this were two-fold: 
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1. To further refine and describe codes relating to the new theory 
2. Build evidence between my data and that reviewed empirically to support the constructs I had 
identified – moderating, mediating and neutral companion influence 
 
I considered it important to further re-define the broad concepts of companion influence and 
investigate what specific features or attributes of companions and the patients they accompanied to 
consultations might additionally impact information exchange processes. From this further data 
analysis it emerged that although patient attributes (such as age, gender) could not be considered as 
influential considerations overall, companion characteristics were. These were further characterised 
in a novel resultant theory – negotiated companion presence – the detail of which will be illustrated 
in chapter 7. 
4.13. Summation 
In chapter 4 the study design and method described in chapter 3 has been operationalised. The 
specific processes relevant to case identification and selection via the recruitment process have been 
documented. Subsequently, the methodological processes of data collection and analysis have been 
illustrated, with attention to the three principles of case study design, multiple data sources, creation 
of a study database and maintaining a chain of evidence. 
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Chapter 5: Results  
5.1. Introduction 
The following chapter will present two of the three stages of data analysis. The first stage, described 
in section 5.2, is the ordering and comparison of primary categorical data for the cases. Within this 
analysis two methods were utilised to inform the data:  
 
1. Within-case analysis - this involves organising the data by specific cases for in-depth study 
2. Across-case analysis - used to explore similarities and differences across cases.  
 
Section 5.3 reports on the second stage of analysis where qualitative data was assigned and ordered 
to a priori codes, identifying and developing themes from more inductive analysis, leading to the key 
substantive theoretical proposition. The third stage of data analysis development of the key 
theoretical proposition will be the focus of chapter 6, whereby its emergence will be detailed and 
reported. This will be followed by a more extensive analysis of the substantive theoretical findings in 
chapter 7, before an in-depth discussion in chapter 8. 
 
Chapter 5 will begin with an overview of the recruitment summary as well as a brief overview of 
categorical data for the non-participant cases to add context and investigate reasons why certain 
patients may not be approached for study participation.  
 
5.2. Primary categorical data analysis  
Before detailing the categorical data from the cases, this section will firstly give some contextual 
background and descriptive detail on recruitment. Recruitment to the study continued for an 
extended period of time, January 2010 to December 2011. The reasons for prolonged recruitment 
were multifactorial and discussed in-depth in Chapter 4.  
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5.2.1. Recruitment summary 
Twenty patients were identified as potential participants, with 7 cases recruited to the study. A 
summary of recruitment is shown in figure 7. 
 
Figure 7: Recruitment summary 
 
 
 
5.2.2. Non-participation in the study 
Of the non-participants (both not approached and approached but declined) 13 were female. This 
reflected the time line within the recruitment process where Study Site A only approached women 
and Study Site B only started to recruit in the last six months of the recruitment period. Basic 
demographic data were collected using the previously described Potential Patient Demographic Sheet. 
Additional demographic information was collected from professionals at the clinical consultations. The 
seven demographic domains are displayed in table 10 alongside the explanations given by 
professionals for not approaching potential participants. The reasons given by those patients who 
were approached, but declined are also listed. 
 
No. of patients identified 
at Lung MDT by hcp as 
potential participants
n = 20
No. of potential 
participants NOT 
approached by hcp
n = 7
No. of potential 
participants approached 
by hcp
n = 13
No. declined to participate
n = 6
No. consented to 
paricipate
n =  7
Females  n = 4
Males n = 3
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Table 10: Baseline demographic characteristics of non-participant patients 
 
Characteristics No of non-participants 
  
Gender 
Male 
Female 
 
1 
12 
Age 
< 50 
50-59 
60-69 
>70 
 
0 
0 
2 
11 
Performance status 
0 
1 
2 
3 
4 
 
0 
5 
5 
3 
0 
Disease stage 
Limited 
Advanced 
 
2 
11 
Histological cell type 
NSCLC 
MESO 
SCLC 
NO HISTOLOGY 
 
9 
1 
2 
1 
Treatment regimen 
Chemotherapy 
Radiotherapy 
Surgery 
Combined 
Palliative care 
 
4 
5 
1 
2 
1 
Treatment intent 
Curative 
Palliative 
Best supportive Care 
 
2 
10 
1           n = 13 
Reasons for non-approach by healthcare professionals (n = 
7) 
Severe memory impairment due to dementia 
No cell type and decision taken not to pursue 
diagnosis 
Too upset at diagnosis 
Severe confusion due to brain metastases 
Patient diagnosed with mesothelioma 
 
 
1 
 
1 
3 
1 
1           n = 7 
Reasons for non-participation cited by patients & 
companions (n = 6) 
Too overwhelmed by all information  
Too much other things to cope with at moment  
 
 
5 
1           n = 6 
  
 
A significant number of cases (n = 9) were diagnosed with non-small cell lung cancer. All of the non-
participant cases were over 60 years old, with the majority older than seventy and 6 were in their 
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eighties. This combined with poor performance status (PS); where 8 patients had a PS of 2 or above, 
advanced stage of disease (n=11) and the palliative intent of therapy (n=11) could explain why this 
group of patients were either not approached to participate or declined when asked.  
 
5.2.3. Case study participants 
This section will concentrate specifically on data pertaining to the characteristics of the cases who did 
participate in the study. The focus is initially on the study sites and professionals before discussing the 
cases studies comprehensively within and across case. 
5.2.3.1. Study site and healthcare professional participants 
The study had the potential to be carried out across three hospital sites. The main study sites were 
two acute teaching hospitals (Study Sites A and B). Cases referred for surgical intervention would be 
seen within the third Study Site (C) which provides Thoracic Surgical Services. During the study period 
the Health Board launched a major service redesign which included the amalgamation of Study Sites 
A and B into a central unit. Redesign had an impact on recruitment, which was temporarily postponed, 
but otherwise the study remained unaffected.  
 
All healthcare professionals approached to participate in the study gave written consent. The main 
Study Sites and healthcare participants are listed in table 11. 
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Table 11: Characteristics of the study sites and healthcare professionals 
 
Study site Geographical & demographic 
data 
Clinical modality Healthcare 
professionals who 
participated 
Gender 
     
A Large teaching hospital, with 
440 in-patient bed capacity, 
delivers a broad range of 
regional, supra-regional and 
national acute clinical services 
Joint 
respiratory/oncology 
clinics 
Patients seen by team in 
one afternoon 
Respiratory physician 
Clinical oncologist 
Clinical nurse specialist 
Clinical trials nurse  
M 
M 
F 
 
F 
     
B Large teaching hospital, with 
1077 bed capacity, delivers a 
broad range of regional, supra-
regional and national acute 
clinical services 
Separate modality clinics 
Patients seen by 
specialists in sequential 
clinics 
Respiratory physician 
Clinical oncologist 
Clinical nurse specialist 
M 
F 
F 
     
C. Thoracic 
centre 
200 bedded hospital provides 
regional and national services 
for cardiac and thoracic 
services 
Specialist thoracic clinics 
only 
 
  
 
 
Despite the Thoracic centre being a potential site for information exchange, the opportunity for their 
inclusion was not realized. No case at Study Site A was considered suitable for resection and only one 
case [Case F - Flo] (Study Site B) was seen by the Thoracic Surgeon. Unconventionally, due to industrial 
action, she did not attend an out-patient consultation and was reviewed on admission to the thoracic 
centre. Although the patient consented to the audio-taping of the in-patient consultation, the surgeon 
declined and the opportunity to record what would have been the only surgical-related information 
exchange encounter was missed. 
 
5.2.3.2. Within-case data analysis of participant cases 
Seven patients were recruited to the study: 4 women and 3 men. All seven consented to the audio-
recording of their out-patient consultations, de-brief interviews post clinical encounter and later to an 
in-depth interview. Seven healthcare professionals consented to the audio-recording of the 
consultation and post-consultation de-brief. A total of 12 companions consented to participate in the 
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study and gave permission for audio-taping of consultations; de-brief interviews and in-depth 
interviews they may have participated in. All participants were assigned an alias.  
 
Baseline demographic data were collected using the Patient Demographic Sheet. Originally 
demographic data captured information on eleven domains. However, following discussion with 
university supervisors, another domain of smoking status was included. Although smoking history was 
never requested, all 7 cases mentioned smoking at some point during data collection. Consequently, 
as tobacco use is linked to the development of lung cancer and a very contemporary issue, another 
domain was created to record this data. Each case will be analysed within-case, incorporating the 12 
domains, whilst considering multiple sources of evidence relating to them. Table 12 illustrates the 
categorical data for each case. 
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Table 12: Baseline demographic characteristics of participant cases 
Cases 
Alias 
M/F Age P
S 
Cell type Stage Smoking status Treatment Intent Employment Residence Marital status Educational 
status 
Study 
site 
Healthcare professional 
seen 
Companion(s) present Debrief 
 interviews 
In-depth  
interview 
  
                  
 
 
A 
Alex 
M 71 0 NSCLC T4 N0 Ex-smoker Chemotherapy + / - 
radiotherapy 
Curative Retired 
(caulker-burner) 
City Widowed Secondary 
school  
A Dr Andrews Respiratory 
physician 
 
Dr Allan Clinical oncologist 
 
Sr Alcorn Clinical nurse 
specialist 
Daughter (Ann) 
(consultation) 
 
Partner (Agnes) (in- 
depth) 
Alex 
 
Dr Andrews 
 
Dr Allan 
 
Sr Alcorn 
Alex 
 
Agnes  
(contributed) 
 
 
 
                   
B 
Ben 
M 69 0 MESO None/not 
recorded 
Never smoker Chemotherapy Palliative Self-employed 
mechanic 
City Widowed City & Guild Cert A Dr Andrews Respiratory 
physician 
 
Dr Allan Clinical oncologist 
Daughter (Betty) 
(consultation) 
 
Alone (in-depth) 
Ben 
 
Dr Andrews 
 
Dr Allan 
Ben  
 
 
                   
C 
Celia 
F 71 1 NSCLC T4 N2 Smoker Radiotherapy Palliative Retired 
(sales assistant) 
City Widowed Secondary 
school 
A Dr Andrews Respiratory 
physician 
 
Dr Allan Clinical oncologist 
 
Sr Alcorn Clinical nurse 
specialist 
Brother (Colin)  
(consultation) 
 
Alone (in-depth) 
Celia & Colin 
 
Dr Andrews 
 
Dr Allan 
 
Sr Alcorn 
Celia  
 
 
                   
D 
Delia 
F 55 0 NSCLC T4 N2 Smoker Chemotherapy Palliative Unemployed 
(car valet) 
 
 
City Married Secondary 
school 
A Dr Andrews Respiratory 
physician 
 
Dr Allan Clinical oncologist 
 
Clinical trials nurse 
Husband & daughter  
(Davie & Denise) 
(consultation) 
 
Husband (in-depth) 
Delia & Davie 
 
Dr Andrews 
 
Dr Allan 
 
Delia  
 
Davie 
(contributed) 
 
 
 
                   
E 
Eve 
F 65 0 SCLC T4 N2 M1 Smoker Chemotherapy Palliative Retired  
(engineering plant 
worker) 
City Divorced Secondary 
school 
B Dr Boyd Respiratory 
physician 
 
Dr Brown Clinical oncologist 
 
Sr  Baxter Clinical nurse 
specialist 
Son  (Eric) (1st 
consultation) 
 
Son & daughter (Eric & 
Elaine) (2nd consultation) 
 
Son & 2nd son ( (Eric & 
Ewen) in-depth) 
Eve & Eric 
 
Dr Boyd 
 
Sr  Baxter 
 
Dr Brown 
 
Eve 
 
Eric  
(later – Ewen) 
(contributed) 
 
 
 
                   
F 
Flo 
F 67 0 NSCLC T2 NO Ex- smoker Surgery Curative Retired (clerical 
assistant) 
City Married Secondary 
school 
B Dr Boyd Respiratory 
physician 
 
Sr  Baxter Clinical nurse 
specialist 
Husband & daughter 
(Frank & Fiona) 
(consultation) 
 
Husband (Frank) 
 (in-depth) 
Flo & Frank 
 
Dr Boyd 
 
Sr  Baxter 
Flo 
 
Frank 
(contributed) 
 
 
 
                   
G 
Gordon 
M 53 0 NSCLC T4 N2 Smoker Chemotherapy + / - 
radiotherapy 
Palliative Sick leave (from full 
time employment as a 
carer) 
City Divorced Secondary 
school 
B Dr Boyd Respiratory 
physician 
 
Dr Brown Clinical oncologist 
 
Ex-wife  (Grace) 
(consultation) 
 
Alone (in-depth) 
Gordon & 
Grace 
 
Dr Brown 
Gordon  
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5.2.3.3. Case study A (Alias Alex) 
Alex was a 71 year old man diagnosed with T4 N0 non-small cell lung cancer. He presented to his 
general practitioner with a persistent cough. Despite a history of prostatic cancer for which he had 
radical radiotherapy, he was well with a PS of 0. He was an ex-smoker, having stopped 10 years ago. 
Alex left school with secondary education qualifications and worked as caulker-burner in the 
construction industry before retiring due to a back injury. Widowed, he lived in a large inner-city area. 
Primary treatment was chemotherapy, followed by adjuvant radiotherapy, if the cancer responded. 
Treatment intent was considered curative. He attended Study Site A with his daughter (Ann) and 
together they had consultations with a respiratory physician (Dr Andrews), a clinical oncologist (Dr 
Allan) and the Clinical Nurse Specialist (Sr Alcorn). Case study data was collected at de-brief interviews 
from Dr Andrews, Dr Allan and Sr Alcorn as well as Alex.  At in-depth interview, the patient was 
accompanied by his partner (Agnes), who was not present throughout other data collection 
encounters.  
 
5.2.3.4. Case study B (Alias Ben) 
Diagnosed with mesothelioma (not staged) Ben was the only case with this diagnosis. He was a 69 
year old man, who continued to work as a self-employed car mechanic. He left secondary school and 
then gained City and Guild Certification. He was a non-smoker. Widowed, he lived in an inner city area. 
His main presenting symptom was chest pain. He was not physically debilitated by pain and his PS was 
recorded at 0. He had no significant past medical history. The treatment modality was chemotherapy, 
with the intent being local control and palliation. Ben attended his clinic consultations at Study Site A 
with his daughter (Betty) and they consulted with Dr Andrews and Dr Allan. Data was also available 
from de-brief interviews with both doctors and the patient. At the time of the in-depth interview, Ben 
was un-accompanied. 
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5.2.3.5. Case study C (Alias Celia) 
Celia was a 71 year old lady, with a history of breast cancer, who had been diagnosed with non-small 
cell lung cancer, after developing posterior chest pain. Her PS was 1. Celia was a retired shop assistant, 
who had secondary school education. At the time of data collection she lived alone in an inner city 
area and was a widow. Celia was a current smoker. As her cancer was staged as T4 N2 Celia was offered 
palliative radiotherapy. When she attended Study Site A, her brother (Colin) was present and they 
consulted with Dr Andrews, Dr Allan and Sr Alcorn. Additional data was collected at de-brief interviews 
with Celia and the three professionals. Celia was un-accompanied at the in-depth interview. 
 
5.2.3.6. Case study D (Alias Delia) 
Diagnosed with T4 N2 non-small cell lung cancer, Delia was a 55 year old woman who presented with 
pleuritic chest pain. This was a new symptom on a background of severe Chronic Obstructive 
Pulmonary disease (COPD). Delia was unemployed due to ill-health as a result of her airways disease. 
She previously worked as a cleaner and car valet. She left school with secondary school qualifications. 
She was married and lived with her husband (Davie) in an inner city area and her PS was described as 
0. At the time of data collection Delia was a smoker. Treatment regimen was chemotherapy, with the 
intent being symptom control and palliation. The patient attended clinic consultations at Study Site A 
and was reviewed by Dr Andrews, Dr Allan and the Clinical Trials Nurse. Data was collected at the 
consultations with these professionals and also at de-briefs with the patient, her husband and her 
daughter (Denise), Dr Andrews and Dr Allan. At the in-depth interview Delia was again accompanied 
by her husband. 
 
5.2.3.7. Case study E (Alias Eve) 
Eve was a 65 year old woman who presented with increasing dyspnoea and pain. She had been 
diagnosed with small cell lung cancer, staged at T4 N2 M1. Despite the extent of her disease the 
patient’s PS was 0. Eve lived with her son, Eric (as he moved home to look after her) in an inner city 
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area. She was divorced and left school with secondary school qualifications and worked in an 
engineering plant until she retired. Eve was a current smoker, with co-morbid conditions which 
included oesteo-arthritis and COPD. Originally Eve consented to a local clinical trial involving 
concurrent chemotherapy and radiotherapy, but this was altered to chemotherapy when she was 
diagnosed with cerebral spread. The intent of therapy was palliative. This lady attended Study Site B 
and was seen at sequential clinics by Dr Boyd and Dr Brown, as well as Sr Baxter (the CNS).  She was 
accompanied by Eric to the first consultation and then by both Eric and daughter Elaine to the second. 
All consultations were recorded and data collected. Debrief interviews included all members of the 
healthcare team and the patient and her companions. At the in-depth interview Eve was accompanied 
by her sons (Eric and Ewen). 
 
5.2.3.8. Case study F (Alias Flo) 
The fifth case of the study was Flo, a 67 year old lady diagnosed with T2 N0 non-small cell lung cancer. 
Her cancer was diagnosed following investigation of recurrent chest infections. She had no significant 
past medical history and stopped smoking over 20 years ago. PS was 0. Since leaving school with 
secondary school qualifications, Flo worked as a clerical assistant until she retired. She was married 
and lived with her husband (Frank) in a suburb. The treatment modality was surgical resection with a 
curative intent. Flo was diagnosed at Study Site B and attended consultations there with Dr Brown and 
Sr Baxter. She was accompanied by Frank and daughter (Fiona). De-brief interviews were recorded 
and data collected from Flo and her companions and her health team. As a surgical candidate, she was 
reviewed at the thoracic centre as an in-patient but this consultation and de-brief were not part of 
data collection. The in-depth interview data was collected from Flo and her husband. 
 
5.2.3.9. Case study G (Alias Gordon) 
Gordon was a 53 year old man who presented with painful knees, but his GP was concerned about 
accompanying weight loss and anorexia. Investigations revealed a T4 N2 non-small cell lung cancer. 
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Gordon was previously well, with no significant past medical history and with a PS of 0. He worked as 
a carer, but was on sick leave. He left school with secondary school educational qualifications. He was 
a current smoker. He lived on his own in an inner city area. Chemotherapy was the treatment 
prescribed, with additional radiotherapy if there was a good anti-cancer response. Treatment intent 
was palliative. Gordon attended consultations at Study Site B with his ex-wife Grace. Although this 
was a sequential clinic site he was seen at the same session by Dr Boyd and Dr Brown. De-brief 
interviews were conducted with Gordon and Grace and with Dr Brown. Dr Boyd was called to an 
emergency. The in- depth was carried out in the cancer centre ward, at the patient’s request and he 
was un-accompanied.  
 
5.3. Across-case analysis of categorical data 
All seven cases recruited were Caucasian and diagnosed with primary lung cancer.  These were a rich 
and diverse group of cases, with all seven presenting a varied categorical data set for analysis. Yin 
(2009) considered that between 6 to 10 cases are sufficient to provide compelling support for the 
initial set of propositions. These cases were selected purposively and defined as critical to the study, 
due to their knowledge of the phenomenon under research. 
 
5.3.1. Gender 
During the period of data collection, more women (n=421) than men (n=405) were diagnosed with 
lung cancer across both study sites (Office for Audit and Clinical Effectiveness, 2008).  During data 
collection 4 women were recruited to the study which allowed for a comparable division of gender and permitted data to 
be gathered and analysed from both male and female cases.  
 
5.3.2. Age 
Although lung cancer is strongly correlated to age and usually diagnosed in patients over the age of 
65 years (www.cancerresearchuk.org/lungcancer/keyfacts-accessed 09.03.2013) this study recruited 
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cases from a diverse range of age groups. Cases ranged in age from 53-71 years, with median age 
being 64 years.   
 
5.3.3. Performance status (PS) 
Six cases were classified as having PS 0, indicating they were fully active and maintained close to pre-
diagnosis performance with no or minimal restriction (Oken et al, 1982). Performance status is shown 
in Appendix 21. PS classification is vital as it determines a patient’s fitness and suitability for therapy. 
The prevalence of poor PS (3 or above) among lung cancer patients is generally high (Lilenbaum, Cashy, 
Hensing, Young and Cella, 2008). Conversely, in this study all but one of the cases recorded good PS 
(PS 0). Celia was classified as PS 1 due to co-morbid disease and stage of current diagnosis. This was 
the only domain with little variation across the cases, in relation to standard functional status. 
 
5.3.4. Cell type 
Five of the seven cases were diagnosed with non-small cell lung cancer, paralleling national statistics, 
where approximately 75% of the lung cancer population has this cell type. However, differentiation 
across cases was noted, as small cell and mesothelioma classifications were included in analysis.  
 
5.3.5. Disease stage 
Only 2 cases were identified as having limited stage disease - (Alex – T4, N0 and Flo - T2, N0).   Five 
cases in the study were diagnosed at an advanced stage, compatible with the vast majority of lung 
cancer cases throughout Scotland. Ben’s mesothelioma was never assigned a classification as 
historically pleural mesothelioma is only formally accurately staged post mortem. Variable data in such 
an important domain, which impacts directly on treatment and treatment intent, has the potential to 
influence the type and content of information exchanged at the clinical encounter between all case 
participants.   
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5.3.6. Treatment 
Treatment decisions are based on many of the categorical data listed, as well as the risk to the patient 
from therapy related toxicity, with any potential benefit in survival balanced against the risk of 
additional toxicities (NICE, 2005). Five cases received chemotherapy as first line treatment, with two 
cases (Alec and Gordon) scheduled to have adjuvant radiotherapy, depending on the outcome of the 
initial therapy. Celia was too frail for systemic chemotherapy and had palliative radiotherapy. Only Eve 
was considered for a chemotherapy clinical trial. Study protocol indicates patients undergo CT imaging 
of head and at this conjuncture Eve was found to have cerebral metastases and therefore was 
ineligible for the trial. She received standard chemotherapy. Across cases, only Flo was considered for 
resection. Again across cases, there is heterogeneous data for this domain, with the possibility to 
impact information exchange on many levels.  
 
5.3.7. Treatment outcome/intent 
Two cases (Alex and Flo) were reported as having potentially curative treatment: chemo-radiation and 
surgery respectively. For the remaining five cases the prognostic outlook following treatment could 
be measured in terms of months, with median survival of 4 months in patients with advanced disease 
(BTS, 2008). 
 
5.3.8. General demographic data 
Two cases (Ben and Gordon) were in employment, although Gordon was incapacitated by his 
symptoms and on sick leave. Ben continued to work, but carrying out less manual labour then pre-
diagnosis. Delia was unemployed due to long-standing ill health and the rest of the cases were retired. 
Other than Ben, who has City and Guild Certification, everyone else had secondary school educational 
qualifications.  Two patients were married, 3 were widowed and 2 divorced. Four of the cases lived 
alone. All cases lived in a large urban area of Scotland, with 6 of them residing in the most deprived 
areas of the city (DepCat 7). The Carstairs and Morris Index of Deprivation is a measure of quantifying 
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socioeconomic deprivation or affluence in different localities across Scotland. Deprivation scores are 
derived by combining four census variables which best indicate material disadvantage (proportion of 
households with male unemployment, lack of car ownership, overcrowded housing and the head of 
household being in social class IV or V) for each postcode sector in Scotland (McCloone, 2004). There 
are seven deprivation scores, with DepCat 1 being the most affluent and DepCat 7 being the most 
deprived.  
Originally smoking status was not one of the original categorical domains but throughout the data 
collection period smoking history was referred to by all of the cases. Consequently, data on the domain 
could be recorded. Six of the seven cases were either current or ex-smokers. Only Ben was a never 
smoker and his mesothelioma was directly attributable to asbestos exposure.  
5.3.9. Study site demographic data and data collection episodes   
Cases A - D were diagnosed at Study Site A. Every case was reviewed by a respiratory physician (Dr 
Andrews) and a clinical oncologist (Dr Allan). At the consultations, Cases A and C were also reviewed 
by the CNS (Sr Alcorn). Cases C and D were reviewed by the clinical trials nurse. All cases were 
accompanied to the consultation by a companion.  
Similar findings were in evidence at Study site B where Cases E, F and G were diagnosed. Clinic 
consultations are usually sequential at this site. All cases were reviewed by a respiratory consultant 
(Dr Boyd) and 2 cases by a clinical oncologist (Dr Brown). Data was not captured for information 
exchange between Gordon and Sr Baxter, as she was not at clinic on the day. Flo was the only case 
assessed off site at the thoracic centre. All cases were accompanied by companion(s). Table 13 
illustrates all data collection episodes for each case. 
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Table 13: Data collection episode for each case 
 
Study 
site 
Case Clinical consultations  
(separate clinical encounters) 
 
De-brief 
interviews 
In-depth 
interviews 
Demographic 
details/Field 
notes 
A Alex Dr Andrews (Respiratory physician) 
Dr Allan (Oncologist) 
Sr Alcorn (Clinical Nurse Specialist) 
 
Dr Andrews 
Dr Allan 
Sr Alcorn 
Alex and Ann 
Alex & Agnes √ 
A Ben Dr Andrews (Respiratory physician) 
Dr Allan (Oncologist) 
 
Dr Andrews 
Dr Allan 
Ben & Betty 
Ben √ 
A Celia Dr Andrews (Respiratory physician) 
Dr Allan (Oncologist) 
Sr Alcorn (Clinical Nurse Specialist) 
 
Dr Andrews 
Dr Allan 
Sr Alcorn 
Celia & Colin 
Celia √ 
A Delia Dr Andrews (Respiratory physician) 
Dr Allan (Oncologist) 
Clinical Trials Nurse 
Dr Andrews 
Dr Allan 
Delia, Davie & 
Denise 
Delia & Davie √ 
B Eve Dr Boyd (Respiratory physician) 
Dr Brown (Oncologist) 
Sr Baxter (Clinical Nurse Specialist) 
Dr Boyd 
Dr Brown 
Sr Baxter 
Eve, Eric & Elaine 
Eve, Eric & Ewen √ 
B Flora Dr Boyd (Respiratory physician) 
Sr Baxter (Clinical Nurse Specialist) 
Dr Boyd 
Sr Baxter 
Flo, Frank & Fiona 
Flo & Frank 
 
√ 
B Gordon Dr Boyd (Respiratory physician) 
Dr Brown (Oncologist) 
Dr Brown 
Gordon & Grace 
Gordon √ 
No of data 
collection 
episodes 
Cases 
n = 7 
Consultations  
n = 18 
De-briefs 
n = 23 
In-depth 
n = 7 
Demo/notes 
n = 7 
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5.3.10. Summary of categorical data   
Overall the data illustrated more similarities than differences, between the non-participant and 
participant cases, and generally within the most significant categorical domains. Data for all the cases 
in the study reflect the Scottish population. Across cases (both non-participant and participant) 
patients were diagnosed with advanced stage lung cancer, usually non-small cell type, where 
definitive treatment consisted of palliative therapies (usually chemotherapy and/or radiotherapy). 
There were notable differences with regard to age and performance status between the groups. For 
example, patients in the non-participant group were older – with 11 aged over 70 years and the other 
2 cases over sixty. The non-participant group had poorer health status with 8 of the 11 cases classified 
as PS 2, with advanced stage disease recorded in all cases. The implications that recruiting younger 
and healthier patients to the study and the influence, if any, this has on information exchange will be 
considered further in chapter seven.  
It is not the aim to generalise these cases to the rest of the lung cancer population. However, it is 
apparent that the cases in the majority of domains reflect the Scottish lung cancer population. As such 
they are an appropriate group of cases on which to expand and generalise theories (analytical 
generalisation) and upon which to base further analysis. Additionally, across cases there is also a 
degree of heterogeneity with each case providing valuable and rich data which impacts on information 
exchange. 
5.4. Assignment and ordering of qualitative data from a priori codes 
5.4.1.  Introduction 
The second stage of data analysis involved the ordering and coding of qualitative data. The study 
explored information which was either exchanged or not exchanged between professionals and 
patients, as they met along the cancer care continuum (shown in figure 8). The current model of the 
lung cancer continuum divides the patient journey and periods of information exchange into discrete 
stages; namely diagnosis, treatment and treatment outcome. Information is exchanged at these key 
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stages of the care continuum. I reflected that a sound foundation for categorical data collection and 
subsequent analysis should focus on specified a priori categories. I judged information per se to be a 
vast and complex area to study and after careful review of the empirical literature, deemed diagnosis, 
treatment and treatment outcome as the most important stages of the patient care pathway, where 
patient-professional information exchanges were crucial. These key categories informed the a priori 
codes during data collection in my research.    
 
At the time of data collection for this study, the referral stage of the pathway was complete and thus 
not influential in forming the a priori codes. 
 
Figure 8: Cancer care continuum  
(BTS, 2013) 
 
 
 
 
The following three sections and corresponding subsections describe the second stage of data 
analysis, where qualitative data was assigned and ordered to key a priori codes. The section will detail 
the findings, observations and selected quotes in relation to the three a priori codes outlined above. 
 
5.4.2. Analysis of diagnosis related information  
The first a priori code developed, was information relating to the diagnosis of lung cancer. The study 
began after the referral and investigation stages of the pathway and in all cases the diagnosis of lung 
cancer had been communicated at earlier consultations, with some patients having more information 
than others.  For Cases A through D, the patients had been made aware of diagnosis specific 
(Referral)
Diagnosis
Treatment
Treatment outcome
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information at clinics the week before. Cases E, F and G, although aware they had lung cancer, were 
returning for discussions relating to this specific aspect of their disease.  
 
From the original a priori code of diagnosis other sub-codes emerged inductively, as the data was 
analysed. Sub-codes for diagnosis are shown in table 14. 
 
Table 14: Sub-codes for diagnosis 
 
 
Key a priori code 
 
Sub-code 
  
Diagnosis Type of lung cancer 
 Stage of lung cancer 
 Symptoms of lung cancer 
 
 
5.4.3. Type of lung cancer 
A histological diagnosis of lung cancer was confirmed in 6 cases. Ben had a histologically proven 
diagnosis of pleural mesothelioma. For example: 
Mesothelioma, that’s what the pathology has shown, so we know exactly what it is (Consultation/Dr 
Allan/Ben, Ref 6) 
During the period of data collection, three of the patients were informed of the specific cell type of 
their cancer (Cases A, B and E). Moreover, the level of detailed information exchanged about the 
diagnostic cell type, varied significantly across cases. In some cases very little histological detail was 
provided as shown below: 
And that test has confirmed it’s cancer and it’s told us what sort of cancer it is (Consultation/Dr Andrews/Delia, 
Ref 1) 
 
 
In contrast to the above, Eve’s information exchange regarding cell type was significantly more in-
depth, with the exchange occurring across both clinical consultations. The patient continued to talk 
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about her cell type at her de-brief and in-depth interview, with her understanding of her cancer, its 
treatment and treatment outcome, developing from one consultation to the next: 
 
We’ve got a sample back and there’s a bit of a surprise…we were expecting one type of lung cancer, but we 
saw another type of lung cancer, and the type of lung cancer you have is called a small cell lung cancer yeah? 
(Consultation/Dr Boyd/Eve, Ref 5)  
 
OK, so there’s two types of lung cancer – one is a faster growing cancer, and one is a slower growing cancer, 
and you have the one that is a faster growing cancer. And it’s called small cell lung cancer (Consultation/Dr 
Brown/Eve, Ref 7) 
 
But the biggest shock I’ve got the day is she’s just telt me I’ve got fast track cancer . He said ‘small cell cancer’. 
He didn’t say it was a fast growing cancer. He didn’t say I was snuffing it quicker, put it that way (De-brief 
interview/Eve, Ref 8) 
 
The inference to the growth rate of the cancer was mentioned in only two cases (E and A). In the latter 
case the patient and more so his companion, referred to his cancer type as slow growing on numerous 
occasions, perhaps seeking reassurance that the outcome from this particular ‘slow growing’ cell type 
would be more favourable: 
 
A non- small cell or something, very slow growing (In-depth interview/Agnes, Ref 1) 
 
Ben was diagnosed with a malignant tumour affecting the lining of his lung, almost exclusively caused 
by exposure to asbestos. Although cell type is an important prognostic indicator there was limited 
information exchanged regarding classification. For example: 
 
So that’s what the pathology has shown, so we know exactly what it is. And that’s, we know it’s a tumour that 
can affect the lining of the lung, and I think he’s talked to you about asbestos does seem to be a factor in it 
(Consultation/Dr Allan/Ben, Ref 6) 
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The classification of cancer is an important issue, with correlation of tumour type and biological 
behaviour vital in cancer management. However, there is no evidence across cases, apart from Eve 
and to some extent Alex, that the presence or absence of information about this, made a significant 
difference to how patients viewed their cancer diagnosis. It is possible that for the rest of the cases, 
just knowing they had a lung cancer was all the information they required. For these cases, there 
appeared to be more importance placed on information regarding the stage and extent of the cancer, 
and this will be discussed in the next section. 
Overall, both professionals and patients, when questioned, expressed the view that they had 
exchanged all of the diagnosis related information they wanted to or to a level that was satisfactory 
for them. 
5.4.4. Stage of lung cancer 
All cases in this study received information regarding the location and extent of their disease and 
subsequently, there was some type of justification given by the healthcare professional for a 
treatment rationale based on tumour location:  
 
Yes – it starts off on what we call the pleural lining of the lung, rather than the middle of the lung itself, and 
that’s got swollen and it’s affected by a sort of tumour, like a rind in the lung, Now, because of where it is, and 
it is quite stuck onto the lining of the lung, it can’t be removed (Consultation/Dr Allan/Ben, Ref 1)   
 
Whereas cell classification did not seem relevant for some of the cases in the study, as discussed 
previously, the extent and location of the cancer appeared to be germane for all of them:  
 
Well you were doing it to see how far it’s spread, if it’s on the other side of my lung or if it’s just in my lung, or 
behind it or around about it…. (Consultation/Dr Boyd/Flo, Ref 19) 
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Although all patients had information exchanged regarding staging, similar to cell classification there 
were differences in the amount and detail explained. Some clinicians would explain disease staging 
comprehensively whilst showing the location on the CT monitor: 
 
We had a look at your PET scan today, and that did not show up anything on the left. And the other tiny 
nodules on the right also did not show up much….. It’s a tiny nodule, it could be unrelated, it could be a scar, 
it could be nothing. And we know that your lymph glands are swollen in the midline, and again that would be, 
really making us think of other treatments than surgery. You have got quite a nasty aggressive-looking tumour 
on the right side, which is close to the main line (Consultation/Dr Boyd/ Gordon, Ref 24) 
 
However in other cases there was very little information exchanged in relation to disease extent: 
 
There’s a tumour affecting the left lung and it’s obviously it’s a little bit stuck to the where the rib is 
(Consultation/Dr Allan/ Celia, Ref 2) 
 
Additionally, when healthcare professionals were giving information about the diagnosis there was 
variation in the language employed. In some cases there was evidence of strong, descriptive language 
used by the healthcare professionals. For example: 
 
Lung cancer is a very nasty cancer (Consultation/Dr Brown/Eve, Ref 12) 
 
Whereas for others euphemistic descriptions were employed: 
 
Well, it’s in a very important area. A busy traffic area, it’s very near major blood vessels and such 
(Consultation/Dr Andrews/Alex, Ref 2) 
 
The reasons for the variation were not investigated and remain unclear. It could simply be related to 
the communication style of individual practitioners and their educational and experiential 
backgrounds, regarding the communication of diagnosis.  There was no data suggesting that patients 
were influenced or distressed by either too much or too little detail, about the stage of their disease 
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or by the language used. But staging information did seem to be an important component of their 
cancer care, with many recalling information regarding this theme at their in-depth interview. For 
example: 
Well, it’s near the spine as well you see? It’s going near the spine he says. It’s a very, very sensitive area. 
There’s a lot of tissue there he says, so em, he says you need to be careful (Celia, in-depth interview, Ref 13) 
 
Information concerning staging was significant for these patients as it was directly related to both 
treatment and treatment outcome. This will be discussed in greater detail in section 5.5. Also, whereas 
there is evidence that companion input was limited during information exchange regarding cell 
classification, their input was more noticeable when discussion focused on staging.  
 
Alex’s companion Agnes appeared to have insight that the location and staging of his cancer signified 
that surgery was not an option. She independently raised the subject of disease extent during the in-
depth interview: 
Agnes: Yeah, it’s 5 cms  
Alex:  I’m not too sure if that’s big or small 
Agnes: Well, where it is, it’s near the heart and the aorta, so they can’t operate. It’s too dangerous, so 
it is (In-depth interview/Agnes & Alex, Ref 6) 
 
By contrast Delia’s husband, whilst stating he felt that explanations regarding diagnosis and stage of 
disease were carried out well, did not appear to fully understand the significance of the information. 
It would appear for this family that despite understanding the diagnosis, there is misunderstanding in 
relation to the significance of a few spots actually representing disseminated disease. 
I think they explained it well to us, yes. I understood it, my daughter understood it. We were actually relieved 
a bit relieved it was only spots…I was expecting a big mass! (In-depth interview/Davie, Ref 10) 
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Study data indicates that information is exchanged along a continuum, with the capacity for 
professionals to exchange information with patients and their companions at a variety of clinical 
encounters. As previously stated, this study only collected data at specific and pre-determined 
information exchange interactions and cannot comment on further information which may have been 
given regarding staging elsewhere. That said, when questioned all participants comment that they 
exchanged the information which was suitable for their current needs. 
 
5.4.5. Symptoms of lung cancer 
Another inductive theme to emerge from analysis of the qualitative data was that of symptoms of lung 
cancer. Effective diagnosis of lung cancer relies to a great extent on identifying symptoms. 
Unfortunately few patients will be or will remain asymptomatic through the cancer continuum. Across 
cases, every case presented with symptoms. Flo was the least symptomatic, with her cancer 
essentially found coincidently. That said, she was being treated for pneumonia and had been treated 
for recurrent chest infections, a common symptom of the disease. 
 
 Although all seven cases in this study presented with one or more cancer related symptoms 
(summarised in table 15) there was great variation in the time devoted to discussing these. One 
limitation of this study is that data collection commenced after the diagnosis was established. 
Therefore it cannot comment on clinical encounters where information on symptoms may have been 
discussed extensively, especially in the referral stage of the pathway, when it can be theorised that 
symptom related information would be exchanged more comprehensively. 
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Table 15: Symptoms reported 
 
 A B C D E F G 
Dyspnoea        
Pain        
Cough        
Weight loss        
Chest infection        
Anorexia        
 
Analysis showed that whereas study site B exchanged detailed information regarding stage of lung 
cancer, in all cases, little emphasis was placed on information exchange about symptoms. Eve and Flo 
had no symptom related conversations with the healthcare team. A potential reason for Study site A 
spending time in this type of information exchange, could relate to the fact that almost all the cases 
diagnosed had high symptom burden and treatment intent was palliative [aside from Alex who had 
only one symptom and a curative intent]. 
So I was going to just have a chat to you first, just to find out how you, what your symptoms have been. So 
you had a sort of pleurisy type illness? And did you get pain and a cough with that? (Consultation/Dr 
Allan/Delia, Ref 2) 
 
Significantly Gordon, the youngest patient, with one of the highest symptom burdens across the cases, 
did not appear to have his symptoms discussed at either of the two clinical consultations. When 
exchange did take place it was at the instigation of Gordon’s companion:  
 
He’s been eating and sleeping less…but that’s more about stress and there’s the cough (Consultation/Dr 
Brown/Grace/Gordon, Ref 1) 
 
Without companion intervention these symptoms may not have been highlighted. Across cases this 
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appeared to be the trend. Accompanying companions were noted to intervene during exchanges 
about symptoms, often prompting patients or answering for them when questioned. In this way 
companions contributed to the clinical encounter either to provide information requested or at times 
investigate their own information agendas. For example: 
 
I think you’ve found that, haven’t you…if you do too much… you get pain [Betty in response to Dr Andrews 
asking Ben about symptoms] (Consultation/Ben/Betty, Ref 1) 
 
This issue of companion agenda will be explored in more detail in chapter six. However, there were 
examples of their influence throughout all aspects of the information exchange encounters, for all a 
priori codes. This will continue to be considered as data analysis is examined.  
 
5.5. Treatment related information analysis 
The second a priori code relating to treatment was analysed. As with data related to diagnosis, analysis 
identified treatment data inductively and led to the classifications of treatment type and treatment 
side-effects. 
 
Table 16: Sub-codes for treatment 
 
 
Key a priori code 
 
Sub-code 
  
Treatment Treatment type 
 Treatment related side-effects 
 
 
5.5.1. Treatment type analysis 
For all cases, information about type of treatment was exchanged. Across cases, every medical 
professional exchanged information about treatment to a lesser or greater extent. When the CNS was 
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present at clinic they too exchanged treatment related information, but it was the medical staff who 
consistently gave more in-depth communication. For example: 
 
Small cell lung cancer is very difficult to treat, because sometimes, some of the cells, they are kind of immune 
to the chemotherapy and they kind of survive and then start up trouble at a later stage. So sometimes, 
although your chemotherapy is very successful, initially, you can have more trouble later on and that would 
require more treatment. And in order to reduce the chance of that happening we would like to combine 
radiotherapy and try to catch everything we know is there right now and use a double treatment, yeah? 
(Consultation/Dr Boyd/Eve Ref 28) 
 
The CNS built on the data given by their medical colleagues across cases, often supplementing 
biomedical information with practical advice. When chemotherapy was the modality of choice, only 
one of the physicians named the chemotherapy drugs they planned to prescribe (Dr Allan/Ben). In all 
other chemotherapy cases (for Cases A, B and E) this data was given by the clinical nurse specialist, 
who also gave thorough information about the actual regimen. For example: 
 
Now, we’ve got the information about the chemotherapy for you as per Dr Allan ok? Now this tells you about 
it. It’s Vinoralbine and Cisplatin – so it’s two drugs given together (Consultation/Sr Alcorn/Alex Ref 10) 
 
Each professional gave discrete amounts of detail when discussing this category. The observed routine 
of the clinics favoured an initial discussion from the respiratory physicians, leading to a more detailed 
exchange at the specialist oncology clinic.  This observed practice was evident in all cases at study site 
A where Cases A to D were reviewed on the same day by both the respiratory and oncology consultant. 
For some cases the routine was made explicit, as could be seen in the following: 
 
But I’m hoping that Dr Allan, the cancer specialist from the cancer centre will be able to advise on some 
potentially quite good treatment, and I’m not the cancer specialist (yeah) – I’m not going to tell him his job, 
but I think it may well be he would want to use anti-cancer drugs called chemotherapy, first of all 
(Consultation/Dr Andrews/ Alex Ref 1) 
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There was evidence that patients demarcated the roles and specialism of the healthcare teams. Two 
cases (Eve and Gordon) commented on the fact that information exchange regarding treatment 
evolved between the generalist and specialist clinic consultations. And as witnessed in the case of Eve 
the news moved from generally positive to negative: 
 
See when we spoke to Dr Boyd? Just, obviously he’s no a cancer specialist, but he was saying that Dr Brown 
was, like the specialist, and she would explain it a lot better than, you know what I mean? So fae last week, 
everything is positive, like, do you know what I mean? There was good treatment then. But on Friday, it was 
eh… a bit of a shock, like, know what I mean? (In-depth interview/Eric, Eve’s companion, Ref 7) 
 
There was one example where the generalist exchanged more information regarding diagnosis and 
treatment than the specialist did. The reasons for this could be multi-factorial and not necessarily 
relevant to the study but just reflected the information Dr Boyd exchanged at this particular 
consultation: 
 
So we, we’re always talking about other treatments than surgery, and the treatments we are talking about 
would be chemotherapy and radiotherapy, and the question now is in what order, and what do we do first, 
and how much do we do of each? The idea is that we’re giving you some chemotherapy upfront, and we’ll give 
you a couple of cycles of chemotherapy and then do another scan and see what’s now left for treatment. 
Because it may be that the area that we need to treat with the radiotherapy has shrunk considerably. We will 
also be able to see whether the small nodules that we looked at have changed or not (Consultation/Dr Boyd/ 
Gordon Ref 42) 
 
As with the category of diagnosis, this study lacks data regarding previous consultations held between 
the cases and their general physicians. It assumes that there may have been previous information 
exchanged on the subject of treatment. This is corroborated by the clinical nurse specialists in 
particular, who alluded to the fact they have spoken with the patients on many previous occasions at 
the generalist clinics: 
I think I did. I think coz I’ve had a couple of conversations with him before, with his results appointment, we’d 
kind of covered some things then (Consultation/Sr Alcorn/ Alex Ref 2) 
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It is beyond the remit of this study to comment with any certainty on the reasons for the varying 
amounts of data from each healthcare professional and it could merely allude to their differing 
communicative styles, as well as clinical time commitment and clinic model.  
 
When information exchange concerning treatment was taking place, patient involvement was varied. 
As expected, at consultations where professionals hold expert knowledge about therapy they, 
exchanged more information as patients and companions listened. Patient exchange ranged from 
declining to question (such as Ben summarised below) to frequently asking for information: 
 
Dr Andrews  Would it be helpful if I summarised things again? 
Ben    Not really. 
Dr Andrews:  Not really? 
Ben  Because you’ve already told me everything that I need to know, doctor. I’m not 
being disrespectful, but you’ve already told me everything about it – there’s really 
nothing more I can ask you without…without getting depressed (Consultation/Dr 
Andrews/Ben, Ref 15) 
 
Like Ben, Gordon and Flo participated very little in the treatment related exchange, whereas Delia and 
Eve asked some questions, although these were not consistent throughout the encounter. That said, 
Eve did seem to have a firm grasp of the CONVERT trial which she had been asked to consider and 
came to her second consultation having decided that she would start the trial. Not having full insight 
into the process of randomisation, she incorrectly decided which of the therapies she would take, only 
to be told that was not her decision as the trial was randomised: 
 
See this trial thing….to get the two treatments- the chemotherapy plus the radio….taking both at once. What 
I’d like to do is try the two at once the first time and if it’s kinda heavy on me, just go back to daeing wan at a 
time. OK? (Consultation/Eve/ Dr Brown Ref 29) 
Delia had prior knowledge of lung cancer and chemotherapy, having nursed her mother in law with 
the same condition and this may have meant she already felt informed about treatment options. Of 
136 
 
all the cases, Alex engaged the most with his healthcare team when discussing his treatment. His 
questions ranged from length of inpatient stay, how many courses were required, to how the 
chemotherapy is given and finally what effect treatment would have on him between courses? His 
discussion may have been fuelled by his perceived lack of knowledge and apprehension regarding 
chemotherapy. Unlike Ben who stated that asking questions and having more information served to 
depress him, Alex believed that information relieved his anxiety and gave him hope: 
 
Now, that’s fine. I’ve got everything I want to hear anyway Dr Allan. It’s actually put my confidence right, the 
way it’s always been (Consultation/Alex/ Dr Brown Ref 10)  
 
Across cases, Flo was the only patient referred for consideration of surgery. Unfortunately due to 
industrial action which forced clinic cancellations, her consultation with the surgeon was not recorded. 
However, her respiratory physician did exchange detailed and comprehensive information regarding 
the rationale and process involved in surgery. A detailed exchange was necessary as Flo’s case was 
complex with lymph node involvement and may have required a one or two stop approach to surgery: 
 
So it could be a two-step approach or a one-step approach. What we want to avoid is surgery that is done for 
the wrong reasons and is basically not achieving its target, which is to cure you. Yeah, because that’s a 
disaster, when you do surgery and you don’t – you then find you have to close up again because it goes all 
wrong. Yeah, we don’t want to do that, yeah. So we’re doing all these tests to really make sure that we find 
the right patients for the surgeon, yeah? And we rule out those that aren’t right for them beforehand, before 
they get on the table (Consultation/Dr Boyd/Flo, Ref 38) 
In three cases information was exchanged about entry into a national clinical trial. Cases C and D were 
given information concerning the FRAGMATIC study and Case E was considered for the CONVERT Trail. 
There was no data available to inform why Case A and G were not considered for trial entry. There 
were not trials open for consideration for Case B and F.  
Despite the concern at having to undertake anticancer therapy, for some patients there was also relief 
that they were offered treatment. Some expressed the concern that there may have been no 
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treatment options available to them: 
 
So you’re actually walking on cloud nine, coming out of there, because you’re saying ‘brilliant, I’m going to 
get treatment’, instead of turning round and saying, ‘there’s nothing’. At the end of the day I’m happy I’m 
getting treatment (In-depth interview/Alex, Ref 15) 
 
Whereas others were glad that they were offered one type of treatment over another: 
 
No, well I was glad they didn’t say chemo, right enough, I was glad. I’d have been bitterly disappointed, if they 
had said chemo. I felt ok about getting radiotherapy. I was actually delighted it was radio and not chemo (In-
depth interview/Celia, Ref 23) 
 
When questioned immediately post consultation, all cases stated that they had exchanged the 
information that they wanted to in respect of treatment: 
 
Aye well, I know what’s happening now. D’you know?  I know what’s going on now. Whereas, I know he told 
us some of it the last time, we know mair now (De-brief interview/Delia, Ref 14) 
 
Similarly de-brief interview analysis for the professionals showed that, all but one commented that 
they had exchanged the information which they wanted and had planned to with the patients during 
the consultation. For example: 
 
That was the main things I wanted to talk to them about, and then we’ve covered the issues that they were 
concerned about (Consultation/Sr Alcorn/ Celia, Ref 6) 
 
However, Dr Brown had concerns that her consultation with Eve was not conducive to adequate 
exchange of information regarding the planned chemotherapy treatment: 
 
No, I think what I wanted, what I normally have done also, is gone through the actual chemotherapy 
treatment. Sometimes I mention the drugs and explain to patients that it’s given over 3 weeks and that they 
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receive 4 cycles. I didn’t really get the opportunity to do that. Most of the consultation was dominated by the 
stress of her smoking and her family (Consultation/Dr Brown/Eve, Ref 8) 
 
 
As previously recorded, professionals and patients reported they had exchanged the treatment 
related information they wanted to or to a level that was satisfactory for them. Although for 
professionals their views were only elicited transiently at the de-brief interviews, nonetheless the 
immediacy and unsolicited nature of their opinions immediately post consultation, permitted 
important insight into their perception of the exchange. Aside from Dr Brown’s consultation with Eve, 
all were by and large satisfied with the exchange. There were other unsolicited comments regarding 
companion involvement but this will be expanded in chapter 6. Where information was not exchanged 
in relation to treatment it usually took the form of: 
 
 Naming the chemotherapy agents 
 Introducing clinical trials 
 Discussing adjuvant therapy 
 
In relation to exchanging information regarding adjuvant therapy, professionals may conceivably have 
felt that it was too soon to enter into discussion on a second treatment when the response to the first 
was unknown. Initial tumour response to chemotherapy would dictate dose and ultimately outcome 
of radiotherapy and, at this time, that was an unknown quantity. An exception to this was when Dr 
Boyd did exchange information with Flo about the possibility of adjuvant chemotherapy post 
operatively. However, this exchange was not initiated by either the patient or the professional.  
Instead it was prompted by Flo’s companion (her daughter Fiona) who was asking questions which 
appeared to be based on her own information needs agenda: 
And you don’t think any chemo or radiation after it? But again it all depends on what there…? 
(Consultation/Fiona, Dr Boyd, Ref 9) 
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Data analysis highlighted that across cases companions influenced information exchange relating to 
the main a priori categories. Their influence was witnessed in the majority of cases but to varying 
degrees, depending on the agenda that each companion appeared to have.   
 
Whereas data showed the main therapy modalities were identified and categorised as chemotherapy, 
radiotherapy and surgery, there was no instance where best supportive care or no treatment option 
were included within therapy domains. It is logical that for these seven cases, with symptomatic 
disease and good performance status, all would be offered a therapeutic treatment option, to not 
only relieve symptoms but to confer survival benefit. Hence for these cases there was no rationale for 
best supportive care or no treatment.  
Of relevance is that across all cases there appears to be a strong indication from patients that they 
wanted some type of therapy. In some cases patients stated that they were relieved to be offered 
treatment, with the concern being that there may have been no therapeutic option available for them. 
Throughout data collection there is no discussion with any case of a no treatment option or active 
surveillance, whereby their cancer is closely monitored but not actively treated. Indeed, there is no 
data from the analysis which identified any active exchange between patients and professionals 
regarding patient preference for a specific therapy. Data did not identify any instance of shared 
decision-making in relation to treatment modalities throughout this study. Professionals did not 
enquire about patient preference and patients did not volunteer their opinion.  
5.5.2. Treatment related side-effect analysis 
Treatment related side-effects vary considerably across the three therapies used to treat lung cancer. 
Across all cases there was evidence that information relating to treatment side-effects was exchanged. 
Consequently, as the proposed first line treatment for five of the cases was chemotherapy, the 
majority of the information exchanged concerning treatment related side-effects, focused on this 
modality. However, each professional discussed treatment related side-effects differently.  
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In some cases the information was superficial:  
 
It can cause a bit of tiredness, can affect your immunity, so you might be a bit more prone to infection. 
Sometimes this particular one can cause a bit of thinning to the hair, although it’s not always a problem 
(Consultation/Dr Allan/Delia Ref 9) 
 
Contrastingly for other cases the exchange was fairly detailed: 
 
With the chemotherapy, the side-effects are based upon the fact that the chemotherapy works on fast-
growing cells. So anything in your body that normally grows quite fast will be affected. That is your hair cells, 
so your hair might fall out; the lining of your gullet and your stomach and your bowel gets normally 
replenished quite quickly, so that may suffer and you may get nausea and vomiting and diarrhoea. And your 
bone marrow cells grow quite fast, so you may not be making as much blood as usually, and your immune 
cells may suffer and you may be open to infections, sometimes severe enough to go into hospital 
(Consultation/Dr Boyd/ Gordon Ref 19) 
 
In certain cases when discussing potential therapy related side-effects, the direction the exchange 
took and subsequent information exchange was influenced by questions from companions. For 
example: 
Colin: I know this is a naïve question, but if the radiotherapy can shrink the tumour to some extent, 
why can it not destroy it altogether? Is it because of the harsh side-effects? 
Dr Allan: Well, no, it’s a very good question. Sometimes we can destroy and get rid of tumours with 
radiotherapy. The difficulty with this one is, partly, it’s a relatively large tumour and it’s very 
close to the spinal cord which is the nerves going down the back, and we always have to take 
into …( Consultation/Dr Allan/ Celia/ Colin, Ref 4) 
There was no indication from the transcriptions that patients appeared upset or voiced any objection 
to the influence of their companions for this category.  
There was some prior knowledge of anti-cancer therapies noted during data collection. Alex and Celia 
both had cancer previously and were aware of the side-effects of radiotherapy and chemotherapy 
respectively. As mentioned in the last section, Delia had nursed her mother in law who had lung cancer 
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and was treated with chemotherapy and radiotherapy.  
 
It was never the intention of this study to explore prior insight and knowledge. However significantly, 
data analysis revealed that both patients and companions could be described as ‘expert’, with some 
cases displaying either previous experience or acquired knowledge of the disease and/or anti-cancer 
therapies. The relevance of ‘expert’ may have significance in relation to information exchange and will 
be considered in chapter 6. 
 
Data showed that across cases patients varied, not only in their previous cancer and therapy 
knowledge but also in their desire to know about therapy side-effects. Of all cases, Ben exchanged the 
least information and asked very little in connection with treatment side-effects: 
Dr Allan So can you think, it’s an awful lot of information about treatment and such – can you think 
of anything else you want to ask? 
Ben: Not really. You’ve explained it wonderfully well. You’ve explained it wonderfully well. 
Dr Allan: Mm hmm. So there will be leaflets you can have as well, that you can take away with you 
and read about it. 
Ben: I think things like that will probably just depress me (Consultation/Ben/Dr Allan Ref 7) 
 
By contrast having information about potential side-effects had a positive effect in other cases: 
 
Aye I feel a lot better after that… Aye well I'm quite happy with what I’ve been told you know what I mean. 
And what's gonnae happen wie the treatment and what to expect in the way of side-effects (De-brief 
interview/Delia Ref 10) 
 
When the CNS was present they reinforced information exchanged between the patient and the 
doctor. In the majority of cases they offered written information about treatment and side-effects, in 
line with national guidelines (NICE, 2005): 
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So I’ll give you that to start off with. This wee booklet just gives you a bit of detail about the radiotherapy and 
some side-effects you might get. It’s just so you can refer back to it, because you’ve had a lot of info today and 
it’s hard to take it all in (Consultation/Sr Alcorn/Celia, Ref 4) 
 
All patients have access to the CNS throughout the cancer journey, with the CNS role viewed as pivotal 
in maintaining contact and support for patients and their companions. Therefore, these cases could 
have theoretically contacted the CNS at any time point for information regarding treatment related 
side-effects. 
 
Throughout other periods of data collection treatment related side-effects were mentioned but not 
extensively.  Nausea was the most common side-effect identified and one that certain cases expected 
to experience as a consequence of chemotherapy. Alec based his fear on prior knowledge: 
 
Well, actually, I’m a bit apprehensive about that, coz the people, from what I’ve seen, have been very sick 
(Consultation/Alex/Dr Allan Ref 1) 
 
Whereas Alex feared being sick, Eve took it for granted that she would be: 
Alright, so I’m gonna be sick. I’m gonna be very sick through it. Well, that’s that (De-brief interview/Eve, 
Ref 1) 
For others, avoidance of the issue was the preferred stance: 
I didnae really want to ask any questions. I think I, I just wanted tae come in and get us on the first set of 
treatment and that kind of stuff, and that and then. Just get through it, do you know what I mean, and see 
what the next day brings, see how it makes me feel, do you know what I mean? (In-depth interview/Gordon, 
Ref 24) 
 
During the interview with Eve her companion (a second son Ewen, who was not present during her 
clinic consultations) raised his own concerns regarding short and longer term effects from chemo. 
These concerns appeared to be related to Ewen’s information needs agenda and had not been raised 
by Eve or any other companion prior to the interview: 
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Aye, I know. And that was another one, an aw. It said there, when I read it to you, see that one there – it said 
something aboot, some patients don’t have any of the symptoms, nausea and feeling ill all the time, and some 
of them, you might be kind of a, and some people get bad. That wan said something about in your body, years 
later, you can get like growths and all that, or like lumps and that…tumours (In-depth interview/Ewen, Ref 17) 
 
Despite the forthright nature of his enquiry, linking chemotherapy effects to life threatening illness 
and to secondary cancers, there was no indication that Eve was unhappy with this type of information 
exchange.  
 
The same qualification applies to information not exchanged in this category as that of the preceding 
categories. This study was a snapshot of only some consultations for these cases and can only 
comment on the data exchanged or not exchanged witnessed during these. When questioned 
professionals and patients stated they had exchanged treatment related side- effect information and 
to a level which was satisfactory for them. The exception was Dr Brown and the consultation with Eve 
and her companions, where companion information agenda was a significant and important influence 
on the information exchange. Instead of discussing chemotherapy and its potentially life changing/ 
life limiting side-effects, the opportunity for dialogue on this category was lost, as the companion 
agenda of smoking and treatment outcome took precedence. This is more appropriately discussed 
and analysed under treatment outcome in section 5.6.  
5.6. Analysis of treatment outcome  
The final a priori code identified was treatment outcome. Data demonstrated patients are individuals 
and the desire for this type of information by patients and their companions was as variable as the 
provision of it by healthcare professionals.  
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Table 17: Sub-codes for treatment outcome 
 
 
Key a priori code 
 
Sub-code 
  
Treatment outcome Information exchange continuum 
 
 
Information exchange relating to outcome appeared to flow along a continuum. It varied from cases, 
who asked direct questions about treatment outcome (or their companions did), to others who 
commented it was something they could not or would not enquire about. In the continuum there were 
also cases that may have mentioned the issue but did not appear to focus one way or the other on the 
significance. There was also a noticeable distribution of information exchange regarding outcome 
from individual professionals. In some cases patients asked a very open and frank question: 
And what’s the outlook in your opinion (Consultation/Flo/Dr Boyd, Ref 84) 
The clinician replied in an open and honest manner, providing a detailed amount of information. For 
example: 
If we do the operation and we take this bit of cancer out that we know is cancer and they take out all the other 
lymph glands when they do the operation and they check them, and there isn’t any cancer in the lymph glands, 
then we would regard it as a curative operation. And the chances of being cured for lung cancer are then quite 
high. Yeah? (Consultation/Dr Boyd/Flo, Ref 85) 
 
Notably, Flo appeared engaged on this topic of information exchange. Later, during the in-depth 
interview, she commented that she never asked any questions of professionals in the past and on no 
occasion would she have used the word cancer: 
 
I would just, whatever he, whatever he told me, I would have accepted it and that was, I wouldnae have 
questioned it or asked or prodded into it or anything like that. I would just have went with the flow. I wouldnae 
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ask any questions. Never entered my head. Never entered my head…it was a word I would never use (In-depth 
interview/Flo, Ref 88 & 89) 
 
Contrary to her later stated opinion Flo was engaged on this category and appeared content with 
information provision by the clinician:  
 
And it wasnae, it wisnae bad, if you know what I mean, what he told me you know and, like, he gave me that 
wee bit of hope, do you know? Like maybe they’ve got it in time. You know, and you’re gonna have a few 
years, you know and…? Well, I think, well I think he explained it quite well, really, you know? He didnae paint, 
you know, a garden. But no, I think, he didnae, he didnae frighten me either, sorta thing, like, you know? (In-
depth interview/Flo, Ref 93) 
 
Gordon was equally to the point: 
How bad is it? (Consultation/Gordon/Dr Boyd, Ref 99) 
 
The information given in response to this question was fairly detailed and involved data about 
prognostic outlook and chance of cure: 
 
…..and it may be possible at that point to give you what’s called radical radiotherapy, that’s called high-dose, 
which has a better chance of keeping the disease at bay for longer. Yeah? And perhaps even curing it…But a 
cure is not guaranteed with what we’re doing here..It’s, you know, it’s, it’s a long shot, but we’re trying. Yeah? 
So I think you’re still in with a shout. I mean it’s, but it’s never 100 per cent, it’s never 100 per cent guaranteed. 
For any treatment in this case, yeah (Consultation/Dr Boyd/ Gordon, Ref 100) 
 
By contrast Eve did not personally seek information regarding outcome. However, for her companions 
prognostic information seemed an important component of their information agenda, with their 
questions and exchanges influencing and controlling the content and direction of the consultation:  
She says the chances of curing you are very small. So it’s pretty bad then? (Consultation/Eric/ Dr Brown, Ref 
71) 
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For Eric the importance of knowing treatment outcome was a significant consideration during 
exchanges and he re-iterated this during the in-depth interview: 
 
 I think the only burning question any of us has got is ‘time’, innit? That’s it (In-depth interview/Eric, Ref 83) 
 
Information exchange during the consultation with the oncologist, Dr Brown, was intense and entirely 
companion led at the start. There is no indication that Eve would have asked for this type of 
information. It was only after a long exchange about percentage survival between the oncologists and 
her companions did she ask: 
 
But there’s nae chance of cure wae me, basically? (Consultation/Eve/ Dr Brown, Ref 73) 
There is a chance, and that’s why I’m recommending you have this treatment or them both together – it’s to 
give you the best chance. But I don’t know what your, I can’t predict how you’re going to react to this, and 
how your tumour is going to react to this. So we would have to wait and see, but it at least gives you some 
idea of what the chances are (Consultation/Dr Brown/ Eve, Ref 74) 
Case E demonstrated not only the changing emphasis, but also the impact of information given across 
consultations, by different professionals. The previous week Dr Boyd explained prognosis as such: 
Well, in a way, it’s good news because you’ve got what we call limited stage disease, and there is, at least, a 
chance of curing you, although it’s hard to achieve that in the longer term. But you’re very likely to respond 
well to treatment, initially, and perhaps you won’t need any further treatment after. That’s what we’re hoping 
for, yeah (Consultation/Dr Boyd/Eve, Ref 10) 
One week later the oncologists quoted: 
It’s more a 20% chance of cure and 80% chance of not (Consultation/Dr Brown/Eve, Ref 71) 
For Eve and her companions this change was difficult to comprehend: 
So fae last week, everything is positive, like, do you know what I mean? There was good treatment then. But 
on Friday, it was eh… a bit of a shock, like, know what I mean? (In-depth interview/Eric/ Ref 78) 
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In other cases (Celia and Delia) information appeared more subliminal, with no direct exchange of 
survival statistics but still reference to the incurable nature of the cancer: 
 
Oh, he can’t cure it. But they say you may recommend radiotherapy and then I said ‘is that not just prolonging 
the inevitable (Consultation/Celia/ Dr Brown, Ref 45) 
 
As Dr Allan said, we can’t get rid of it, we can’t take it away, but we can shrink it down (Consultation/Dr 
Brown/ Celia, Ref 46) 
 
For Alex, who had a potentially curable cancer, data showed information was impacted by the ability 
to recall and understand the information. The following narratives show Alex’s comprehension of the 
exchange. Dr Allan exchanged the following information: 
 
And he’s explained to you that we feel it’s not going to be possible to remove it all, but there are treatments 
that can help to shrink it. So there’s no guarantees (Consultation/Dr Allan/ Alex, Ref 1) 
 
However, less than a week later Alex’s recall of the information is different to that discussed: 
No, well that Dr Allan has gave me all the confidence when he said that – “once we shrink it”. It’s not a case 
of ‘if’, it was “once we shrink it down so far, then we’ll concentrate and get the radiotherapy and try and get 
rid of it altogether” (In-depth interview/Alex, Ref 17) 
 
Analysis showed like Eve’s companions, Alex’s companion Agnes, appeared to have her own 
information needs agenda and this at times appeared to control the content and direction of 
information exchanges. Agnes asked clinical prognostic questions of the researcher, which at times 
Alex appeared uncomfortable with, especially in view of the positive perspective he had taken 
regarding his treatment outcome: 
 
Agnes: Now saying it’s a slow growing one – a non-small cell, if the treatment shouldn’t work, with it being 
a slow growing one, does that give you an specific length of time, if the treatment doesn’t work (In-
depth interview/Agnes/ Alex, Ref 23) 
148 
 
Alex: Ach well, it’s just a case of waiting to see, that’s all, nothing else for it (In-depth interview/ Alex, Ref 
17) 
At the opposite end of the continuum was Ben. Contrasting to all other cases, Ben was not prepared 
to enter into exchange about treatment outcome. Neither he nor his companion Betty asked about 
treatment intent or survival. Betty was a registered nurse working in oncology and her knowledge and 
expertise may have negated the need to engage in discussions. Equally, she may have maintained the 
role of daughter and not nurse and deliberately decided to limit her contribution to only prompting 
Ben, allowing him to engage and exchange information for himself. Ben was informed that his disease 
was incurable: 
Now because of where it is, and it’s quite stuck onto the lining of the lung, it can’t be removed – but we…there 
are treatments that can help to shrink it a bit and firstly help to get it under control (Consultation/Dr Andrews/ 
Ben, Ref 27) 
 
Both professionals at the de-brief interviews commented Ben was not keen on exchanging 
information regarding his prognosis and they respected his wishes: 
He didn’t want to talk about prognosis, so we didn’t focus on that specifically (De-brief interview/Dr Allan, 
Ben, Ref 30) 
Across cases, Ben appeared to want the least information exchange, especially in relation to treatment 
outlook. Malignant pleural mesothelioma is a rare aggressive tumour, with very little prospect for cure 
and Ben often referred to his cancer as a living thing. For example: 
 
The thing wouldn’t bother me, as long as I wasn’t, the monster within wasn’t just eating away at me and 
doing things it shouldn’t be, I need to keep my other organs are kept away from it (In-depth interview/Ben, 
Ref 28) 
 
Ben declined Dr Andrews’s invitation to discuss the diagnosis further. During the in-depth interview 
he was quite vociferous, stating his opinion that there was no point to asking questions about any 
aspect of his cancer, especially this feature: 
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Well, I’m never going to ask them ‘how long am I going to live’. I’m definitely not going to ask them that. I 
wouldn’t put anyone in that position. I could be here in 10 years’ time, I could be here in a year’s time – I don’t 
know. I don’t want to know (In-depth interview/Ben, Ref 40) 
 
Specifically within this category there were polarised information exchanges shown across cases, with 
evidence that desire for outcome information was at times a companion and not patient agenda. 
Analysis identified companion role and influence was a central emerging theme throughout the 
information exchange process relating to all a priori codes, with a significant role identified in 
connection with treatment outcome in particular. 
 
5.7. Summary of a priori coded qualitative data 
The preceding sections of this chapter have presented the preliminary results of the data analysis and 
key findings have emerged, which will be summarised below. The intrinsic aim of the research was to 
explore information both exchanged and not exchanged between the cases, which essentially 
comprised the a priori codes of diagnosis, treatment and treatment outcome and the associated sub 
categories along the cancer care continuum.  
From this analysis key findings have emerged: 
 Diagnosis 
• Type of lung cancer: all cases were made aware of a lung cancer or mesothelioma diagnosis. 
Although the histological cell type may not have been explained to patients, they did not appear 
to have any complaints about this aspect of information. Overall, both patients and professionals 
expressed the view that the information exchange process concerning diagnosis was conducted 
to a level at which they appeared content. A significant emerging influence on diagnostic 
information exchange was the role of the companion and the effect of their information agenda 
on the process.  
• Stage of lung cancer: all cases were made aware of the cancer stage. The level of descriptive detail 
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given by professionals varied but on the whole, all cases stated the information exchanged 
regarding lung cancer stage suited their needs. Data emerged that, whereas patients may not 
always seek information regarding this category, it was frequently a companion who did.    
• Symptoms of lung cancer: although all cases were symptomatic from their cancer, there was 
variation in the depth and amount of information exchanged on this category. However across 
cases, patients and professionals did not raise any concerns about the details of information for 
this category. Companions were again influential in guiding the content of the exchange, often 
answering for patients by prompting them, regarding their presenting or current symptoms. 
 
 Treatment:  
• Type: across all cases information was exchanged relating to treatment type but to varying levels. 
Patient exchange differed depending on the amount of explanation each desired. Nonetheless, 
patients felt they gave and received the right treatment related information to suit their needs. A 
consideration influencing this category was companion information agenda, with notable 
inferences from professionals expressing concern that information exchange was greatly 
impacted by companion presence. 
• Treatment related side-effects: similar to other a priori codes, information exchange concerning 
this category differed for all cases, with some patients being very involved in discussion and others 
preferring not to. That said, all cases stated they had the type and amount of information 
exchanged which suited their needs. Comparable with other categories, companion information 
agenda was evident during discussion concerning side–effects and influenced the content and 
direction of the exchange.  
 
 Treatment outcome: 
This a priori code appeared to contrast with the others in some respects, perhaps due to the emotive 
nature surrounding prognostic information concerning one’s own mortality, from patients as well as 
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professionals. Information exchange ranged from comprehensive to minimal, with professionals 
stating they followed patient agenda thus avoiding prognostic information disclosure (discussed in 
chapter 2). The variation in information exchange across cases can be attributed to the influence of 
both the patient and professional and to companion effect.  
Across cases, data demonstrated that, from a patient and professional perspective, there was almost 
universal satisfaction with the level and content of information exchanged. Aside from one oncologist 
expressing the view that important elements of her exchange were not appropriately addressed, in all 
other cases, information appeared to be exchanged to a level which suited the information needs of 
the participants. Chapter seven will discuss these findings in greater detail.  
However, a key finding which emerged was the influential role that companion presence exerted on 
both the content and direction of information during the consultation. Chapter six will examine the 
emergence and development of the theoretical proposition which arose from the substantive analysis 
of the a priori codes namely, companion influence.  
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Chapter 6: Emergence of the theoretical proposition – companion influence 
6.1. Introduction 
A key component of healthcare delivery is the patient-healthcare professional encounter and the 
exchange of information which takes place therein. Information exchange accounts for a large 
percentage of time within the clinical consultation, at which patients with cancer, seek information 
about their diagnosis, treatment and prognosis (Epstein and Street, 2007). As such, my case study 
developed the original a priori codes around these three main constructs, in order to answer the 
research question. Yin (2009) stated that original theory development as part of the design phase is 
essential. 
 
However, because the case study strategy used in my research is suited to exploration of issues in-
depth and, following leads into new areas of innovative constructions of theory, the theoretical 
framework at the beginning was not the one that survived to the end (Hartley, 2004, p 328). Theory 
was emergent in that it was situated in and developed by recognising patterns of relationships among 
constructs within and across cases and their underlying logical arguments. There was no pre-
determined theory underpinning the potential emergence of factors which might influence 
information exchange in the current study. Instead, the theory-building process occurred via recursive 
cycling among the case data, emerging theory and later extant literature (Eisenhardt and Graebner, 
2007). 
 
Traditional models of human interaction suggest that communication occurs on content [i.e. transfer 
of information] (Albrecht et al, 2009). The data from my study suggested that information content is 
important. Clinicians required contextual information from patients about past medical history, 
presenting symptoms as well as previous experience and current expectations to formulate a 
diagnosis and treatment plan. Likewise patients needed information regarding all available therapies, 
potential side-effects and expected outcomes to make informed choices.  
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Preliminary findings recognized the importance of the content of the information between patients 
and professionals. As summarised in section 5.4, analysis of the data demonstrated that across all 
seven cases, information exchange took place throughout all a priori codes (to a lesser or greater 
extent). Importantly, from both patient and professional perspectives, to a level which they felt suited 
their information exchange needs at the time. Furthermore, none of the participants expressed the 
opinion that they were given or gave too much or too little information during the consultations.  
 
However, my research revealed a shift of focus. Whilst consideration of the content of the exchange 
was important, there appeared to be factors across cases which influenced how content was 
determined and ultimately, what form the information exchange process assumed. As this tentative 
theme began to emerge it was important to re-interrogate the literature, as the next step in iterative 
analysis is the constant comparison between the emerging data from the cases and the empirical 
literature (Yin, 2009).  
 
The content of information is influenced by a number of practical and contextual factors. Challenges 
professionals confront interacting with patients at oncology consultations highlight potential 
influencing factors effecting information exchange, among them; lack of clinical time to deal 
effectively with communication issues  (Spiece, Harkness, Laneri, Frankel, Roter and Kornblith, 2000), 
lack of specialist knowledge and training (Slort, Schweitzer, Blankstein, Abarshi et al, 2011), poor 
continuity of care from the healthcare team (Kendall, Boyd, Campbell, Cormie et al, 2006), use of 
medical terminology by health professionals (Gattellari et al, 2002) as well as employment of 
avoidance techniques by doctors and nurses (van Bruinessen, van Weel, van Gouw, Ziljlstra et al, 
2013).  
 
At patient level, a systematic review identified barriers and facilitators to effective information 
exchange between patients and general practitioners, ranging from patient characteristics such as 
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age, gender and medical condition to language and cultural factors (Slort et al, 2011). These specific 
demographic traits have been identified in other general oncology literature as having an impact on 
communication within the clinical consultation. Schilling, Scatena, Steiner, Albertson, Lin et al (2002) 
found that communication was not significantly impacted by patient gender but was related to age. 
Older patients with cancer are often more deferential to professionals and less likely to complain that 
their communication needs were unmet. Patient passivity and limited exchange of information has 
been identified as a cultural/racial trait, whereby doctors are perceived as less informative (Gordon, 
Street, Sharf and Souchek, 2006) and use less supportive communication when interacting with non-
Caucasian patients (Street et al, 2005).  
 
The literature examining the patient–professional communication interface is large, challenging to 
integrate, and of varying quality (Rodin et al, 2009). Overall, the evidence suggests the way in which a 
professional relates to and exchanges information with patients can be profoundly impacted by wide-
ranging, external factors such as those previously mentioned (Edwards et al, 2009). It is beyond the 
scope of my research to investigate all the influencing factors impacting on information exchange, but 
my data demonstrated there were potential areas worth consideration. 
 
Preliminary analysis from my study revealed that, across cases, a significant influence on information 
exchange at the clinical encounter was the presence of the patient companion. As overwhelmingly 
patients with cancer are accompanied to the clinical consultation by companions (Shepherd, 
Tattershall and Butow, 2008), their potential to influence the exchange, either in a facilitative or non-
facilitative manner warrants further analysis. My research indicated that companions have the 
potential to add extraordinary dynamics to the clinical interaction and the reasons for this are myriad 
and will be discussed in more depth in the discussion chapter 8.  
Examination of the contemporary literature on medical communication found that research has 
primarily focused on professional–patient exchanges, leaving the influence of companions relatively 
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unexplored (Arora, 2003). Despite this, a diverse, albeit disjointed research base has begun to highlight 
the potential role companions play during clinical consultations. The major problem with existing 
literature is there has been little synthesis of data in this area, potentially due to diverse disciplines 
investigating the subject matter (medicine, linguistics, sociology, psychology) as well as the range of 
consultations under investigation (care of the elderly medicine, primary care, diabetes) (Laidsaar-
Powell, Butow, Bu, Charles, Gafni,  Lam, Jansen et al, 2013). The current pool of literature informing 
companion influence in the cancer care context is small with only a few in-depth studies. None have 
focused specifically on the information exchange process or, more pertinently, have studied the 
influence of companions within the context of lung cancer care.  
 
This paucity of data guiding companion role in relation to cancer communication was cited in the 
National Cancer Institute’s Monograph (Epstein and Street, 2007). It concluded that, not only does 
cancer have a major impact on families, but companions play a crucial role in communication in cancer 
settings. Thus, the strength of findings from my study suggested that companion influence was a 
significant avenue of analysis to pursue and one which would offer a clear and original contribution to 
the literature.  
 
My data showed that companions can have both a negative and positive impact on information 
exchange within the lung cancer consultation, often influencing the communication process. As there 
did not appear to be deficiencies or concerns with content level (either in relation to information 
exchanged or not exchanged) there needed to be analysis which could explore the data beyond 
information per se, analysing the factors which influenced and guided the content itself. The central 
design of my case study was to constantly compare theory and data – iterating towards a theoretical 
proposition drawn from and ‘fitting’ both. Eisenhardt (1989) commented that a ‘close fit’ is important 
to the development of a theoretical proposition, because it takes advantage of the new insights 
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emerging from the data and the literature, and yields an empirically valid theory.  In the following 
section data analysis supporting companion influence as the theoretical proposition will be described.  
 
6.2. Development of the theoretical proposition and construct refinement 
The research questions explored information which was exchanged and information not exchanged 
during clinical encounters between professionals and patients (with or without companion 
accompaniment). As discussed in section 5.7, the data established that there were instances 
throughout the a priori codes where information was given across all categories analysed and others 
where certain information was not exchanged (for example in relation to cell type, disease stage and 
eliciting presenting symptoms). The professional-patient interaction is frequently situated in a triadic 
relationship consisting of the healthcare clinician, the patient and a third party, usually at least one 
key family member or companion (Tsai, 2007). Evidence from my study showed the presence of a third 
party/companion fundamentally influenced information exchange by impacting (either positively or 
negatively) on the complexity of the clinical encounter. It was this influence and the dynamics that 
were produced in terms of information exchange between the participants in the ‘triad’, which 
emerged as a theoretical proposition for consideration.   
 
My data analysis led to the theoretical proposition of companions as a persuasive influence on 
information exchange. The substantive theoretical proposition was not specified at the beginning of 
my study but the theory emerged iteratively through discovery and manipulation of themes and 
categories, in an attempt to present a rational view of the phenomena and explain the relationships 
among the cases. Before this theoretical proposition could be used to augment the substantive 
analysis within and across cases, the theme of companion influence had to be described more 
inductively. A significant step in shaping the theoretical proposition is the sharpening or refinement 
of the codes, or constructs as Eisenhardt (1989) preferred to describe them. According to the work of 
Eisenhardt and Graebner, (2007) and Eisenhardt (1989) this a two part process involving: 
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1. Refining the definition of the constructs 
2. Building evidence which measure the constructs in each case 
 
6.3. Refining the definition of the constructs 
6.3.1. Refining the concept of companion  
Throughout this thesis companion has been used to describe the family member, relative or care-
giver. A companion could be defined as any group of persons who are related biologically, emotionally 
or legally (Dokken and Ahmann, 2006). For the purpose of this study I broadly define companion as a 
person with a significant interest and role in the patient’s life who were present during the 
consultation and/or de-brief and/or in-depth interviews. Table 18 summarises the companion 
combinations participating in the study. 
 
Table 18: Companion combinations 
 
Cases Consultation 1 Consultation 2  In-depth interview 
    
Alex Daughter - Ann Daughter - Ann Partner - Agnes 
Ben Daughter - Betty Daughter - Betty  
Celia Brother - Colin Brother - Colin  
Delia Husband - Davie 
Daughter - Diane 
Husband - Davie 
Daughter - Diane 
Husband - Davie 
Eve Son - Eric Son - Eric 
Daughter - Elaine 
Son - Eric 
Son - Ewen 
Flora Husband - Frank 
Daughter - Fiona 
 Husband - Frank 
Gordon Ex-wife Grace Ex-wife - Grace  
 
Within the oncology setting companions are likely to be present at initial visits when the diagnosis is 
being given and treatment options discussed, immediately after cancer recurrence and in the terminal 
phase of the disease (Jansen, van Weert, Wijngaards-de Meij, van Dulmen et al, 2010).  
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 As discussed in chapter 3 there was a substantive amendment to the research proposal submitted to 
the Health Board Ethics Committee, allowing companions to consent to study participation. Original 
submission protocol was designed to capture the information exchange between patients with lung 
cancer and professionals alone. There was recognition that as patients are accompanied by 
companions to clinical consultations, their inclusion in the study was important to capture all data 
pertinent to each case (Street and Gordon, 2008; Ellingson, 2002).  
 
Accompanying companions are predominantly spouses, followed indeterminately by children, parents 
or siblings (Beisecker and Moore, 1994; Labreceque, Blanchard, Ruckdeschel and Blanchard, 1991; 
Adelman, Green and Charon, 1987). My data confirms the literature with companions comprising 
spouses/ex-spouse (cases D, F, G), children (cases A, B, D, E, F) with only Case C accompanied by a 
sibling. 
 
6.3.2. Refining the constructs influenced by companions 
The constructs of controlling influences impacting the communication pathway are central to The 
National Cancer Institute’s Monograph: Patient-centred communication in cancer care: promoting 
healing and reducing suffering (Epstein and Street, 2007). The monograph was a critical synthesis of 
existing literature which focused on optimising communication processes between healthcare 
delivery teams, patients and companions (triads) and not solely the patient-physician dyad (Arora, 
2003). In the monograph’s section appraising communication pathways, of 197 studies referenced 
only 4 directly mentioned patients with lung cancer and none of these were germane to companion 
influence. Within the processes and pathways, from communication to health outcomes, the theme 
which underpinned the work was the influence of Mediators and Moderators.  A mediator or a 
moderator is a third variable that changes the association between an independent variable and an 
outcome variable (Baron and Kenny, 1986). Analysis of mediator and moderator effects may provide 
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more in-depth information about a phenomenon under investigation, with consideration of these 
processes allowing a more precise description of the relationship between the variables (Bennett, 
2000). This process can be identified for my data in the schematic below. 
 
Figure 9: Mediating and Moderating companion influence 
 
In the meta-synthesis describing mediators and moderators, an essential mediator within the 
communication pathway is family and social support, with companions providing instrumental help, 
encouragement and advocacy in gaining access to and effectively utilising health services (Epstein and 
Street, 2007). Companions are seen as mediators providing direct (when present with the 
professional) or indirect (when they suggest topics for the patient to discuss) input into clinical 
conversations to facilitate communication between patient and clinician (Shields, Epstein, Fischella, 
Franks, McCann, McCormick and Mallinger, 2005). Equally, companions (and the social environment) 
were also identified as essential moderators who served to operate at multiple levels, influencing the 
link between communication and health outcomes. Subsequently, the patient’s social environment 
consisting of companions can both mediate and moderate the relationship between patient-
professional communication outcomes (Epstein and Street, 2007).    
 
It was not the intention of my study to investigate or measure health outcomes as a direct result of 
information exchange. What was evident in my data was that information exchange was more 
complex than merely negative and positive companion influences. In addition, the exchange was 
impacted across almost all cases and throughout all a priori codes and at times, entirely companion 
agenda led. A more in-depth analysis will be described in chapter 7. 
Independent variable
•Patients
•Healthcare 
professionals
Mediators/Moderators
•Companion(s)
Outcome variable
•Information exchange
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 The NCI monograph conceptualised the positive and negative influences on information exchange 
within cancer care communication, using the mechanisms of mediating and moderating concepts and 
these rich descriptors seem to have more resonance with my study data (Epstein and Street, 2007). 
Within my findings I considered that the analysis of mediating and moderating companion influences 
could elicit data about how the process of information exchange occurred and was realized. These 
particular conceptual codes could be used to facilitate substantive analysis as they allow a more 
precise description of the companion influence during the clinical encounter. 
 
An essential feature of theory building and refinement is comparison of the emergent proposition 
with the extant literature. Therefore the empirical literature was again investigated utilising Epstein 
and Streets’ themes of mediating and moderating influences on communication pathways and, 
information exchange as an initial theoretical framework to develop analytical codes encompassing 
companion influence, in order to further refine the data constructs. Before companion influence could 
be used to underpin the substantive analysis, the mediating (facilitating) and moderating (controlling) 
constructs had to be refined into a more coherent set of themes (Ryan and Bernard, 2003). As 
previously stated, an essential feature of theory building is comparison of the emergent constructs 
with extant literature (Eisenhardt, 1989).  
 
A literature review was performed to identify analytical sub-constructs relating to companion 
influence. It was conducted using the databases EMBASE, MEDLINE, PubMed, Psych-INFO, CINAHL, 
SCOPUS and Cochrane Library. Clayman and Morris (2013) reported, despite the vast literature on 
patient-physician communication, examination reveals that companion role and influence has been 
sparsely studied. The intention of my review was to permit delineation of the companion role and any 
potential influence and was facilitated by two significant meta-analyses (Laidsaar-Powell et al, 2013; 
Wolff and Roter, 2011).  
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Wolff and Roter (2011) presented a meta-analytical review of family presence in routine medical visits. 
Theirs was the first review of studies investigating the dynamics and consequences of patient 
accompaniment. They reviewed quantitative information describing the medical visit interactions, 
illustrating attributes of accompanied versus unaccompanied patients, medical visit processes and 
outcomes. Electronic data bases PsychInfo and Pubmed were searched 1949-2009. In all, 17 studies 
were identified (10 observational and 7 surveys). Rationale for companion accompaniment was 
identified as both facilitating and controlling and is shown below. Participant perspective of 
companion role was also included in their analysis. 
 
 Facilitating 
• Emotional: providing reassurance 
• Informational: helping patient remember, assisting with recalling symptoms, prompting 
patient to speak and facilitate their questions, providing information to healthcare team 
(clarify patient history), helping patient to understand information and translation if 
necessary 
 Controlling  
• Discouraging: controlling exchange 
• Discussing own agenda 
The systematic review conducted by Laidsaar-Powell et al (2013), essentially built upon the analysis 
by Wolff and Roter, but was more inclusive and not restricted to quantitative research. They explored 
physician - adult patient - adult companion (triadic) communication within medical encounters, 
searching PsycInfo, Medline, Cinahl, Embase and Scopus from 1950 to 2011. Literature synthesis 
resulted in 52 studies for inclusion. In agreement with Wolff and Roter they found that companions 
regularly attended consultations and assumed a variety of roles and influenced the encounter both in 
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a facilitating and controlling manner. In parallel to the previous review they reported that perspectives 
regarding companion accompaniment varied widely. 
 Facilitating 
• Emotional: providing companionship and comfort 
• Informational: clarifying patient history, remembering information, ensuring patient 
understanding 
• Physical: transportation and physical assistance 
 Controlling 
• Companion agenda: discussing own issues 
• Companion control: dominating and controlling exchange 
Based on the empirical literature in the meta-analyses, I theorised mediators and moderators could 
be refined into the sub-constructs shown in figure 10 and used to underpin the substantive theoretical 
proposition. Iterative analysis of my study data identified a further sub-construct (companion as 
expert) which was not revealed within the meta-analyses but which emerged as a significant theme 
for consideration. Equally, although not recognised within the current literature, my data identified a 
third construct NEUTRALITY – with two cases displaying neither a wholly mediating nor moderating 
influence on information exchange. However, as data outliers the construct warranted inclusion and 
the reasons for neutrality merited discussion. 
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Figure 10: Substantive analysis constructs 
 
  
Epstein and Street’s monograph provided a theoretical framework on which to base further analysis 
and on which to both: 
 
1. refine the construct definitions  
2. build evidence to measure the constructs of each case (Eisenhardt, 1989).  
 
6.4. Summation 
This analysis considered the theoretical proposition of companion influence as a mediating and 
moderating impact on information exchange. It recognised patterns of relationships among constructs 
with the opportunity to explore companion presence and influence at the clinical encounter within 
and across cases. The emerging theoretical proposition of companion influence as a mediator or 
moderator, in relation to information exchange within clearly defined constructs, will be the main 
focus of the substantive analysis explored in detail in chapter 7.  
Neutral
Prior 
knowledge & 
experience
Relationships
Moderator
Companion 
control
Companion 
agenda
Companion 
as expert
Mediator
Physical
Emotional
Informational
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Chapter 7: Substantive Analysis 
7.1. Introduction: Substantive replication analysis 
The following section will describe the substantive within and across case replication analysis. 
Companion influence will be demonstrated by describing constructs related to mediating and 
moderating effect. Additionally, as my study data identified, outlier cases showing neutrality as a third 
construct, will be described within the substantive analysis (summarised in table 19). Three case 
summaries will highlight companion influence for each construct. Participant perspective on 
companion presence was identified both in my data and the empirical literature and will be used to 
explore preference for involvement within and across cases. The section will conclude with a synthesis 
of the constructs, leading to the key findings of the substantive analysis. Participant narratives are 
highlighted with Nvivo 9® references (see section 3). 
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Table 19: Mediating, moderating and neutral influences on information 
 
Influences Constructs 
 
Actions Cases 
Mediating (facilitative) 
influence 
Physical 
 
Logistical – provides 
transport 
Physical presence 
C G 
 
A B C D E F G  
 Emotional 
 
Provides reassurance 
 
Seeks reassurance 
 
Being supportive 
 
Physical comfort 
 
A B  
 
D G 
 
G 
 
F (Frank only) 
 Informational 
 
Remembering/ Aid 
memoir 
 
Clarification/seeking 
 
Provides context 
A B C D E F G  
 
 
A C D E F G 
 
A C D E G 
    
Moderating (controlling) 
influence 
Companion control Answers for patient 
 
Interrupts 
 
Dismissive 
 
C E F G 
 
C E F 
 
C F 
 Companion agenda Companion agenda setting 
 
 
 
A C E F G 
 Companion as expert Healthcare profession 
education 
Previous experience in 
cancer 
Learned expertise 
B C F 
 
A D  
 
E 
    
Neutral Prior knowledge & experience  B D 
 Relationships  B D 
    
 
7.2. Mediating companion influence 
Analysis of mediating influences focused on any aspects  of companion involvement which might 
confer a facilitative or positive impact on information exchange, during the clinical encounter, and 
also to an extent during other periods of data collection (de-brief and in-depth interviews). For the 
three main constructs identified physical, emotional and informational, data suggests that within and 
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across all cases, companion mediating influences were witnessed to varying degrees and for divergent 
reasons (table 16). 
 
7.2.1. Physical role and influence 
Despite the majority of the patients having advanced cancer they were identified as good performance 
status (PS). Celia was classified as PS1 but all others were 0 which denoted them as fully independent. 
There were two cases where companions provided logical assistance in the form of transportation. 
Colin provided Celia with a means of getting to the consultation. Celia had attended her breast cancer 
consultations on her own, but was younger and fitter then. She now admitted that despite wanting to 
be unaccompanied, pragmatically she relied on Colin for assistance: 
 
I’ve got a walk. And the walk was telling on me, so it was, because my brother has got the car, he says, “I’ll 
come and get you – it’s no problem.” (In-depth interview/Celia, Ref 1) 
 
However, for Gordon having Grace provide transportation was a significant issue as he commented 
that he felt able to drive himself but because of Grace’s concerns about his physical health she refused 
to let him drive his own car. Although companion influence in Gordon’s case correlates as a mediating 
influence, from Gordon’s perspective it may easily be viewed as moderating as well, as Grace exerts 
her own agenda and control:  
 
Sometimes she nips my heid aboot it, know what I mean? “you’re no driving”. And I’m sitting there and I’m 
going, “Oh.” You know, I’ve got a fifteen thousand pound motor sitting there and I cannae drive it (In-depth 
interview/ Gordon, Ref 7) 
 
There was very little evidence in my data to support that the presence of companions was influential 
in or required for active physical care needs, aside from the logistics of transportation. However, 
notably the data did show that, although not required for direct physical support, companion presence 
at the consultation could theoretically impact on the encounter. Universally across all cases 
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companions provided physical presence. In certain cases companion presence not only provided 
companionship but allowed patients to just listen during the exchange: 
 
For a start I didn’t know what questions to ask you know? But eh, like through listening to them being there, 
through listening to them asking questions and then listening to the answers, I kinda found out more that 
way. If I had been on my own, I wouldnae have asked any questions (In-depth interview/Flo, Ref 2) 
 
7.2.2. Emotional influence 
Data from the study shows that for some cases companion physical presence was closely associated 
to the emotional influence which they exerted. The companion’s role in assisting patients to articulate 
their information needs, whilst expressing concern and offering reassurance and encouragement 
during the exchange of information was identified. Although not prevalent in all cases, there were 
instances where companion influence had a mediating effect on information exchange through their 
use of support and assurance; as witnessed in consultation between Dr Allan, Alex and Ann.  
 
Alex: Aye, the radiotherapy. It’s just the chemo…..I’m actually quite apprehensive about that coz 
the people from what I’ve seen have been very sick 
Dr Allan: Have they? 
Ann:  Dad, I don’t think Auntie Alice was too bad 
Alex:  But she’s still not recovered 
Ann:  Her treatment was a lot longer and her symptoms were much worse 
Alex: Aye, you might be right…I might be strong enough….(Consultation/Alex, Ann, Dr Allan, Ref 
11) 
 
Companions adopted a reassuring and supportive role, often in reply to concerns raised by patients 
and most times answered before the professionals had the opportunity to do so: 
 
 
Ben:  Wonder how that affects you, that. 
Betty:  What? 
Ben:  The vitamins and the injection. 
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Betty:    The vitamins and the injection are just to build up your immune system to reduce the 
possibility of side-effects, and if you went in next week and hadn’t had them, then you 
wouldn’t get it. So we need to make sure that you get them, so you are prepared and strong. 
Ben:  Okay. Yeah. (Consultation/Ben, Betty, Dr Allan, Ref 6) 
 
Information exchanges within the lung cancer setting can be highly emotive and companions may be 
called upon to provide both physical comfort and verbal support in the form of reassurance and 
encouragement for the patient. Within my study there was no opportunity during the consultations 
for me to observe non-verbal behaviour of this nature, such as holding hands, embracing, offering 
tissues etc. Moreover, there was no robust evidence identified from the audio-recordings that 
patients required this level of support. The only case which became emotionally upsetting and 
interrupted data collection was Flo, where during the interview she became too upset to carry on and 
both Frank and I offered her physical contact and support. Prior to becoming upset, Flo and I were 
discussing her diagnosis and she offered that at times exchanging information about it was difficult: 
 
Flo: I know, I know, but it’s just..it’s…I think if I don’t talk about it.. if I don’t discuss it, then it isn’t really 
happening… that I’ll wake and they’ll say ‘we got it wrong…it’s not cancer’ (Flo, in-depth, Ref 10).  
 HERE FLO BREAKS DOWN AND CRIES. 
Frank: It’s alright…you’ve been very good (In-depth interview/Frank, Flo, Ref 10) 
 
In three cases there was no evidence of any emotional influence, in the form of reassurance or 
supportive behaviours (Cases C and E and F). Interestingly, these were the companions who exerted 
a more moderating influence during information exchanges. Data identified that no emotionally 
supportive language was given to either Celia or Eve. Although Flo was given reassurance by her 
husband Frank during the in-depth interview, there was no evidence of this during the clinical 
consultations from her daughter Fiona. 
 
Data indicated that female companions (daughters and partners) offered more supportive language 
or emotional input. This could be explained by the fact that proportionally, females were the 
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predominant accompanying companion (females, n=7; males n= 5). Likewise, although controversial, 
there may be an argument that female companions adopted a nurturing, caring role and were more 
suited to providing this type of reassuring and supportive communication in an emotive consultation.  
As there were such wide-ranging companion characteristics, each with the potential to impact on the 
relationship between patients and companions and ultimately the clinical encounter, there may be 
relevance investigating how these complex features interact.  
 
7.2.3. Informational influence 
Across the three major constructs, companions appeared to demonstrate informational influence 
most appreciably. As information is the basis for discussion regarding diagnosis and is important in 
exchanges concerning treatment decisions, it seems logical that companion influence within this 
construct was so significant.  Within this construct, all cases were affected by companion 
informational influence which included remembering and clarifying/seeking information, both of 
which provided important contextual detail for the exchange. 
 
7.2.3.1. Remembering  
In all cases companions influenced the exchange of information by acting as an aide memoire. They 
recalled medication use, symptom presentation and provided contextual information on health issues: 
  
Don’t forget the anti-depressants (Consultation/Dr Brown, Eve and Eric, Ref 1) 
Likewise, companions contributed a mediating role by encouraging patients to speak about their 
symptoms, especially when patients themselves had not exchanged information on this theme. For 
example: 
 
But sorry, you did comment to me, when we were sitting outside, waiting, you did comment that you had, 
during the past week, you had just once coughed up some blood (Consultation/Dr Anderson/Celia/Colin, Ref 
1) 
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Instances were noted where companions volunteered pertinent information in response to questions 
from professionals and did so before patients could answer for themselves. In the example provided, 
although Grace’s behaviour was mediating, there was also a suggestion of a slightly more moderating 
effect as well, demonstrated by her taking control of the exchange. Mediating and moderating 
influences during a single consultation were not uncommon: 
 
 
Dr Brown: Okay. Good. And how are you in yourself? 
Grace:  I think it’s understandable... 
Gordon:  What can I say? 
Grace:   He’s been eating, sleeping less the last few days. 
Gordon:  Aye. 
Grace:   That’s more about stress than it is….and there’s the coughing  
  (Consultation/Dr Brown/Gordon/Grace, Ref 1) 
 
Analysis using original a priori qualitative data demonstrated that companions, more than patients, 
prompted information exchange about symptoms. Patients may be reluctant to discuss symptoms for 
fear that professionals perceive their disease too advanced for treatment. Analysis showed that 
companions also corroborated in a symptom minimising behaviour. They provided what they thought 
was positive context by offering explanation to justify or even diminish the impact that symptoms had 
on the everyday lives of the patient. The link between symptoms, within the context of daily activities 
and social situation, seemed germane across cases and was evident in Davie describing Delia’s physical 
health and ability to carry on as normal: 
No, no. As she said doctor, she no in any pain, you know. She’s still going aboot doing her day to day activities. 
She’s still walking doon to the nursery to get the grandson. It’s no actually hindered you has it? 
(Consultation/Davie/Dr Allan, Ref 9) 
 
In contrast, in Case C, contextual information regarding symptoms was discussed with the aim of 
escalating the degree of symptoms endured, in order to influence management. Although information 
was provided in two distinct ways, both were still mediating behaviours designed by companions to 
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influence the dialogue on symptom management. Colin appeared determined to convey this 
information as he did so one more than one occasion: 
 
Colin: I do think Celia is much more breathless than even just a few weeks ago. Is oxygen a consideration? 
(Consultation/Colin/Celia/Dr Anderson, Ref 1) 
And 
 
Colin: This is the problem, the stairs and her breathing. Celia would need carrying up all those stairs in one 
of the wee chairs; she’s just too breathless now to manage on her own   (Consultation/Colin/Celia/Dr 
Allan, Ref 3) 
 
 
Symptom information is essential to inform diagnosis, symptom control and dictate treatment 
planning. Chapter five discussed information relating to symptoms and highlighted that information 
on this specific code was not well exchanged during this study. This study was a ‘snap shot’ of the 
patient care pathway and symptoms may have been discussed in more depth when patients first 
presented to the team at the referral stage. 
 
7.2.3.2. Clarifying/seeking information 
The majority of companions engaged in question asking behaviour for this construct with only Cases 
B and D not engaging in this type of activity. The reasons for this neutrality will be discussed later. 
Within this construct, companions demonstrated various mediating influences. They supplied 
additional information regarding comorbidities and past illnesses and contributed important 
information to the exchange. Data suggested that when companions clarified information on past 
medical history, they alerted medical staff to previous ill health and treatments which had the 
potential to impact on current therapies: 
 
Dr Anderson: Radiotherapy, which is strong x-rays shone at the local area – that’s done at the cancer 
centre 
Ann:  He’s had that before 
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Dr Anderson: Oh yeah, that’s right – was it for the prostate? 
Alex:  Yeah, my prostate 
Dr Anderson: And that brings to mind the prostate business…but it does sounds to me as if this stuff is for 
radiation proctitis (Consultation/Dr Anderson/Alex/Ann, Ref 5) 
 
There were also instances across cases where companions advocated for patients, asking treatment 
related questions with the aim of facilitating patient understanding: 
 
So – I know you’re talking aboot the mediastinoscopy – can he no just do them both? Like the, would it be a 
VATS procedure, would you do the video-assisted thoracotomy or would you do...? (Consultation/Fiona/Flo/Dr 
Boyd, Ref 1) 
 
However, for some, the incentive may have been to gain greater personal understanding of the 
situation. Ann revisited her questions regarding radiotherapy for Alex on a number of occasions 
seeking clarity perhaps more for her own information agenda than his, for example: 
 
Will he definitely need radiotherapy? (Consultation/Dr Allan/Alex/Ann, Ref 7) 
 
Ann’s need for clarity may have been coupled with her understanding and expectation of treatment. 
She commented during the de-brief interview that she hoped treatment would have been a single 
therapy: 
At the start, though, I thought, with Dr Allan, when he was talking about the treatment, I thought he might 
just get away with the chemo – but I realise, now, that you’re going to have to get both of them (De-brief 
interview/Ann, Ref 2) 
During this dialogue Alex did not contribute to the process but data demonstrated he appeared 
satisfied with the content of the information exchange: 
No, that’s fine cos I’ve got everything I want to hear and it’s actually put my confidence right the way it always 
has been, you know what I mean? (Consultation/Alex/Dr Allan, Ref 10) 
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Across cases there was evidence that companions influenced the mediating constructs in diverse 
ways. For the majority of cases there was no data indicating that patients had a negative perspective 
on this mediating influence. The next section will explore perception of companion involvement in 
more depth. 
 
7.2.3.3. Perception of companion accompaniment – mediating influence 
Significantly data analysis illustrated that although patients appreciated companion accompaniment 
and involvement, in some cases the actual preference of the patient would have been to be 
unaccompanied. A key finding in this study indicated that companion accompaniment to the clinic 
consultation was often a negotiated process, with three levels of negotiated entry. Accompaniment 
was shown to have been: 
 
• Never negotiated: a mutual understanding without discussion where companion accompaniment 
was taken as an absolute from either party 
• Partial negotiation/negotiated coercion: a negotiated discussion between patient and 
companions where companion petition prevailed 
• Non-negotiable: where companions did not broker discussion or consent of patient 
 
In Case D, Davie and Delia never discussed Davie or Diana’s presence at the clinic. Theirs was a mutual 
understanding that companions would be present: 
 
No, no, no I woulda wanted them there beside me. And if it had been Davie, the only…if it had been him that 
was in..he would have wanted me and my daughter there. Know what I mean like (In-depth interview/Delia, 
Ref 11) 
 
In other cases, although it was thought that accompaniment was mutually agreed, there was a degree 
of negotiated coercion by companions: 
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Well, when I told her, she [Grace] was one of the first ones I told, do you know what I mean. And eh… no, it 
wasnae a conscious thing, know what I mean? When I says to her, and she says, “right, I’ll just come up to the 
hospital with you. I’ll dae this wi’ you. I’ll dae that wi’ you,” and that kind of stuff, know what I mean? And 
that was it, know what I mean? (In-depth interview/Gordon, Ref 1) 
 
This narrative seemed to imply that Grace did not broker any discussion when she insisted “I’ll dae this 
wi’ you. I’ll dae that wi’ you,” 
 
Celia’s reason for accompaniment did have a strong logistical component. However, data analysis 
showed she would have happily attended the consultations unaccompanied had Colin not been fairly 
insistent about transport and entered into negotiation with her. Alex had also previously attended his 
prostate oncology appointments unaccompanied and was keen to do so for his current diagnosis. In 
Alex’s case, analysis showed that in an attempt to shield his companions from the severity of the 
disease, he would have attended on his own. However when they found out they entered into 
negotiation, with Alex finally agreeing to let them be present: 
 
Plus the fact, I think the reason why my daughter’s coming up a lot now, I don’t tell them everything. I keep a 
lot to myself. It’s the same when I was first thingmied with prostate – I tried my best not to tell them, but 
when we heard it was… how bad it was, then they had to know, coz you don’t know the outcome of it by that 
time. And coz she wanted to come now, coz of the difference in it, that’s how (In-depth interview/Alex, Ref 2) 
Another negotiated case was Ben. He would have been unaccompanied, however at his family’s 
insistence; he acquiesced, albeit it appeared under some duress: 
 
Aye, I’d probably have broke it to them in my own way, coz they would have eventually found out with me 
having to go to the, obviously down to the cancer centre and that, my daughter works there, you know? She’d 
have found out. But the first day that Dr Anderson told me in that old place, broke her heart, and I didn’t think 
it was fair on her, you know? I said, “I told you not to come with me and you did, so what can you do? (In-
depth interview/Ben, Ref 4) 
 
The remaining Cases E and F were non-negotiated. Companions were insistent on Eve and Flo being 
accompanied:  
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We wouldnae let her go up hersel’, coz she would come back and tell us a bunch of lies (In-depth interview/Eric, 
Ref 10) 
 
Another crucial finding to emerge from the data identified that the level of negotiated accompaniment 
appeared to be associated with companion moderating influence on information exchange. This 
feature will be discussed in more detail in chapter 8. 
 
7.2.3.4. Mediating construct summation 
In conclusion, there were examples in every case where companions exerted a mediating influence 
on information exchange. Data demonstrated that mediating influences were identified across three 
constructs, physical, emotional and informational. However, companion mediating effect was not 
consistent across themes and ranged from limited to enhanced influence. Informational influence was 
the most significant construct identified. Companions exerted positive influence acting as an aide 
memoire and also within the role of clarification and information seeking.  
 
The study indicated that there was a diverse mix of companion characteristics [gender, personality 
traits and past experiences], as well as relationship types, within and across cases. Explaining the 
demographic variables of companions was not a requisite of this study. However, evidence emerged 
that such features may, in fact, impact on the inter-connectedness of information exchange and 
patients and companion preference for accompaniment. As such this again was a consideration 
worthy of exploration, especially in light of emerging data, demonstrating that the negotiated 
involvement of companions could theoretically influence the constructs identified. Importantly, from 
a patient perspective, companion presence and involvement was appreciated in the majority of cases, 
particularly in relation to informational constructs. 
 
In one case, Ann, all three mediating constructs were in evidence during the clinical encounter and 
these are summarised in the case summary below.  
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Case summary 1: Mediating companion influence 
 
COMPANION CASE SUMMARY: ANN 
 
Alex was a 71 year old man diagnosed with T4 N0 non-small cell lung cancer. He originally presented to his 
general practitioner with a persistent cough. Despite a history of prostatic cancer for which he had radical 
radiotherapy, he was well with a performance status of 0. He was an ex-smoker, having stopped 10 years ago. 
Alex left school with secondary education qualifications and worked as caulker-burner in the construction 
industry before he retired due to a back injury. Widowed, he lived in an inner-city area of a large urban city. 
Primary treatment was chemotherapy, followed by adjuvant radiotherapy if the cancer responded. Treatment 
intent was considered curative. He attended Study site A with his daughter Ann and together they had 
consultations with a respiratory physician (Dr Andrews), a clinical oncologist (Dr Allan) and the Clinical Nurse 
Specialist (Sr Alcorn). This was the second out-patient appointment Ann had attended. Ann was present only 
during the clinical encounters and not at the in-depth interview. Ann was between 35-45 yrs old, married and 
had school age children. She lived close to Alex. Her mother died of metastatic breast cancer.  
 
Initially in this case the companion role was minimal and very little mediating influence was apparent during the 
first clinical encounter with Dr Anderson. The only mediating construct which was identified was emotional, 
whereby Ann attempted to encourage Alex to see that chemotherapy was not necessarily as negative a 
treatment as he envisioned (Ref 1). This was Ann’s only contribution throughout the encounter. However, at the 
second consultation with the clinical oncologist, there was data to suggest that Ann was more involved and 
active within the exchanges. Her main role firstly was that of aide memoire prompting Alex with medication use 
(Ref 3, 16). Her influence then extended once again into emotional constructs where she urged Alex not to 
compare his present situation with that of family members who had undergone anticancer treatment (Ref 9). 
Ann employed reassurance and encouragement as a mediating influence to support Alex with treatment 
decisions. Additionally, she influenced the exchange by providing information regarding past medical history, 
important for healthcare professionals for verifying facts which might be relevant to current therapies (Ref, 11). 
Extending her role Ann’s influence moved to the dual constructs of clarification and information seeking, 
whereby through a sequence of questions she sought to gain a better understanding of the proposed treatment 
(Ref 3, 4, 5). Ann’s motivation for her informational influence appeared twofold - for clarification and 
reassurance for Alex and primarily for her own understanding. Throughout all exchanges with the professionals, 
Ann used supportive and affirmative language in an effort to encourage and comfort Alex during the 
consultations, referring to both his positive attitude and his general physical fitness (Ref 6, 10, 11, 13). There 
was no data to suggest that Ann had a moderating influence on information exchange during the consultations 
and the de-brief interview. Likewise there was no evidence that Ann was following her own agenda to the 
detriment of Alex’s information needs. There is no data found to show that Alex was unhappy with any aspect 
of Ann’s involvement during the encounter. Indeed her influence was viewed as mediating and positive for him, 
in that the conversation between Ann and the oncologist looked to give him confidence and support his decision 
to undergo therapy (Ref 10). Overall, despite Alex expressing concern regarding companion accompaniment (he 
feared Ann would be burdened and upset by the diagnosis [Ref 3]), and companion presence being negotiated 
in this case, her presence served as a positive and mediating influence in general. 
 
7.3. Moderating companion influence 
Analysis of moderating influences focused on any aspects of companion influence which might impact 
information exchange in a controlling or non-facilitative manner, throughout any encounters where 
communication took place between the participants. The main constructs identified with regards to 
moderating influence were companion control, companion agenda and companion as expert. As with 
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mediating influence, companions were shown to influence information exchange to different extents 
across these constructs and for diverse reasons. These will be considered in this section and are 
summarised in table 16. 
 
7.3.1. Companion control 
Companions were seen to exercise control over the exchange of information in various ways, but 
predominantly by answering patient intended questions and through interruption. Although the 
majority of cases (five overall) exhibited this behaviour, some companions did so consistently 
throughout all encounters with various healthcare professionals, as witnessed in Celia’s case with her 
sibling Colin, whereby he frequently controlled the information exchange and Celia’s answers: 
 
Dr Allan: Is there anything else you think we haven’t talked about that you wanted to ask about, or 
anything you haven’t remembered?  
Colin: No, you spoke to Dr Anderson and the, your about your analgesics to your painkiller 
(Consultation/Dr Allan/Celia/Colin, Ref 14) 
 
 
Despite this behaviour being evident, there was no evidence to suggest that Celia was upset by it. 
Throughout the exchanges she only ever interjected once to correct his answer: 
 
Researcher: Did you speak about your treatment? 
Colin:  Ten treatments, yeah. 
Celia:  Twelve treatments. 
Colin:  Oh, I beg your pardon, aye, twelve, twelve (De-brief interview/Celia, Colin, Ref 17) 
 
Data revealed that companions moderated information exchange and applied control to varying 
degrees. In the most moderating cases (C, E and F) companion control was exhibited throughout the 
clinical consultation or period of data collection. Fiona’s controlling influence was shown in her 
tendency to interrupt and control the content and flow of information in this manner, regardless of 
the clinical encounter: 
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Flo:  I’m just doing my normal day, I don’t feel sick. I’ve had my down days as well, when you…. 
Researcher: Yeah of course, can you say more about this 
Interrupted by Fiona 
Fiona: But we’re going home now and Dad’s got two sisters, so there you go, you’re gonna get nae 
sympathy! (De-brief interview/Flo/Fiona, Ref 1) 
 
Additionally Fiona was seen at times to undermine Flo and her replies suggested a dismissive tone: 
 
Flo: It’d be better if they just say, “right, I’m gonnae bring you in tomorrow and do it.” Not to 
give me time to think about it, if you know what I mean?  
Researcher yes I…… 
 Interrupted by Fiona 
Fiona:  You’ve had enough time to think aboot it! (De-brief/Researcher/Flo/Fiona, Ref 5) 
 
In my study, companion controlling influence which directed information exchanges was subject to 
variability and occurred for different reasons. It could theoretically be linked to many variables both 
of the companion and the patient. As with mediating influences, companions could essentially be 
moderating information to ensure that patient care was not compromised.  
 
Key characteristics impacting control of the informational process could theoretically be companion 
personality type, as well as relational aspects between patients and companions. An exemplar is Colin, 
a retired paramedic and the younger, often vocal brother of Celia, attempting to make sure his elderly 
frail sister received the best possible treatment. Likewise, Fiona a registered nurse who had 
experience in dealing with healthcare teams was outspoken and strong-willed, advocated for her 
mother Flo, who by her own admission never usually asked questions and preferred to leave 
treatment decisions to the medical team.  
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A significant finding in the data was that the moderating constructs appeared to be closely associated; 
with companion control interconnected to companion agenda, which in turn was linked to companion 
as expert. 
7.3.2. Companion agenda 
In the cases where companions used controlling behaviour to moderate information exchange, they 
regulated the clinical content of the exchange by addressing their own information agenda. In certain 
cases there was evidence that companions raised concerns and discussed topics which appeared to 
satisfy their own communication and information needs. Such agenda setting was evident throughout 
the clinical consultations and in one Case (A) also present during the in-depth interviews. The data 
also illustrated that in some cases the companion recognised they were addressing their own agenda: 
 
And we needed to talk, and because we have both got perhaps a different take on, on it...now we can kinda, 
I don’t know, clear things up with the others (Consultation/Dr Boyd/Grace/Gordon Ref 2) 
 
Despite this being Grace’s agenda there was evidence in her narratives that she felt she was raising 
this agenda for Gordon. However, there did not appear to be any concern for patient autonomy and 
self-determination: 
No, because if you don’t hear it, you’re gonnae do it, and I’m not gonnae know, so that’s why I thought, I’m 
gonnae have to. I’ve got a wee checklist of questions, and they’re all about things I know you’re gonnae do! 
And that was the major one, because I know what you’re like…( Consultation/Dr Brown/Grace/Gordon, Ref 
4) 
In case A, Agnes was present at the in-depth interview but absent from the consultation. Data 
demonstrated Agnes had her own information needs agenda and this was manifest by the clinically 
related questions she asked of the researcher, which she did not have the opportunity to do 
previously. Agnes was fully aware of my clinical role of nurse specialist and attempted to capitalise on 
this with numerous questions: 
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Well, it’s only sort of, like, ninety, ninety percent don’t survive it, isn’t it? I mean, that’s the sort of ratio, isn’t 
it? (In-depth interview/Agnes/Alex, Ref 11) 
Whereas the data reflected that Gordon never appeared disgruntled with Grace’s moderating 
influence, in case A there is evidence that Agnes’s direct line of questioning regarding treatment 
outcome and prognosis appeared to make Alex uncomfortable: 
 
Agnes: Now, after the second radiothera…, eh, chemotherapy, if it hasn’t shrunk, is there any other 
type of chemotherapy that he can get that would be a different kind of treatment? 
Researcher: It’s difficult for me to say, because I don’t work for Dr Allan. 
Agnes:  No, uh huh..  
Alex: That’s right – see, that’s how I says to you, it’s getting over the first one and moving on from 
there. That’s the best thing. A lot depends on how much it shrinks (In-depth 
interview/Alex/Agnes, Ref 16) 
 
 
It is unknown if Agnes would have exchanged this type of information had she been present at the 
clinic. However, had she done so the content and direction of the information exchange within the 
consultation for Case A would have certainly altered, as there had been no prognostic information 
exchanged. The evidence demonstrated Agnes’s agenda appeared essentially to satisfy her own need 
for information around this theme. It did not appear to be a protective mechanism borne of the need 
to facilitate information exchange regarding prognosis for Alex, because as the narrative above 
highlighted, he was uncomfortable with the content of the discussion. 
 
The previous section described the controlling influence that Colin showed towards Celia, where he 
moderated the exchange with his own predetermined information agenda. It could be argued his 
control and agenda setting was a protective mechanism designed to shield Celia from the difficulties 
of cancer and its therapy. Equally there is evidence he may have sought to control and influence 
certain aspects of her care. An example of this control was witnessed when Celia was introduced to 
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the clinical trials co-ordinator, who gave her Patient Information Sheets to consider for a national trial. 
Colin took this information with the intention of reading it for Celia: 
 
Colin: Och, a lot of this is just, you know, it’s information sheets – it’s just to give you an idea of what it’s 
about. But it’s just confirming what they’ve already told you, that’s all. It’s just to see if… It’s just to 
tell you what it is. Honestly, I’ll take these papers home, have a wee look through them – there’s no 
point in you having more paperwork than you need. Yeah, it’s just information. There’s nothing that 
has to be filled out. I’ll just hang on to that for you. If you particularly want to look at them, then 
I’ll…(Consultation/Dr Allan/Celia/Colin, Ref 11) 
 
Later, Colin attempted to control and limit researcher access to Celia for the in-depth interview. 
Conceivably his actions may have been protective and an attempt to reduce any stress he perceived 
from too much intervention. However conversely this action could have theoretically also impacted 
Celia’s autonomy and decision making as well as her ability to set her own agenda: 
 
Researcher: What I was going to do is, perhaps, give you a call in the next day or two…  
Celia:  That’s fine, uh huh. 
Colin:  Well, if you’re alright with that? 
Celia:  Aye.  
Colin: Well I hope that’s, bearing in mind Celia was actually saying that she’s desperate to get time 
to herself. She’s had an awful lot of visitors and an awful lot of phone calls, and I know people 
mean well – she’s finding it overwhelming and she went out yesterday and got the bus into 
town just to escape. She talks about, it’s interesting terminology – she uses terms like, “to 
escape, I got the bus into town to escape.” So she wants to escape from the house. Why don’t 
you leave it until next week?  (De-brief interview/Celia/Colin, Ref 3-6) 
 
Corresponding with Case G, the data did not provide evidence that in either case the patients had a 
negative view of their companion’s moderating influence. On the contrary, Celia’s narrative praised 
her brothers (Colin’s twin often accompanied her as well) and their input, despite earlier suggestions 
that she would have happily been unaccompanied: 
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Celia: I’m quite happy for my brothers to be there. We’re quite a close family. They’ve got kind of 
experience of nursing, the ambulance side of it, you know?  (In-depth interview/Celia, Ref 
17)  
 
My data revealed that companion agenda can exert a significant moderating influence both on the 
content and direction of information. In addition, it showed that a predetermined companion agenda 
can moderate the direction and content of the exchange and lead to a totally different discussion. In 
the example highlighted below - Eric and Elaine’s concerns regarding Eve’s smoking led to an exchange 
about prognosis. During the clinical encounter the exchange was animated and could have been 
exacerbated by the family discussing this agenda prior to the consultation and their very differing 
views regarding smoking: 
 
Eric:  The doctor said last week – the smoking has got to stop, and it’s got to stop now because… 
Eve:   Easier said than done. 
Eric:  ……of the  treatment (Consultation/Dr Brown/Eve/Eric, Ref 4) 
 
And 
 
Dr Brown: Ok, right. Hmm. Ok, good. Right, so I think, I understand that you’ve probably been lectured 
about the smoking. He’s right, yeah. The side-effects will be much worse. 
Eric:   Yeah, as soon as the treatment starts the smoking has to stop… 
Dr Brown: And the chances of curing you will be cut. The chance of curing you is very small, but you’re 
going to make it very, very small. So I don’t want to lecture you, but I just want to confirm 
what Dr Boyd said (Consultation/Dr Brown/Eve/Eric, Ref 6) 
 
Dr Brown introduced the theme of treatment side-effects and outcome to highlight that smoking 
cessation will impact positively on both these aspects of therapy. However, this served to lead the 
companions to another agenda, which Eve had not noticed: 
 
Eric:  She says there that ‘the chances of curing you are small’.   
Elaine: So it’s pretty bad, then? 
Dr Brown: Em… In what sense is that? 
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Elaine: You’ve just said there, the chances of curing her are small but the chances of curing her if 
she’s smoking is even smaller. 
Dr Brown: Yes, so the chance of, I mean, what do you think the chances of cure are for this? 
Elaine:    We’re hoping that it’s a good percentage. 
Dr Brown: What would you think is a good percentage? 
Elaine:  I don’t know. 80/20. 
Dr Brown: (Laughing.) No. 
Elaine:  No, 50/50? 
Dr Brown: It’s more 20% chance of cure and 80% chance not. 
Eve:  So, you mean that’s whether I smoke or whether I don’t smoke? 
Dr Brown: No, if you smoke it will be a lot less than that. 
Eric:  So you’ve got to stop smoking to gie yourself the best chance (Consultation/Dr 
Brown/Eve/Eric Ref 7) 
 
This case appears to highlight the complex narrative that develops during exchanges of information 
between patient and clinician, when the content and direction of information is impacted by the 
influence of other participants, namely Eve’s children. The exchange began as a discussion on smoking 
and therapy outcome, and despite Dr Brown providing data that the chance of cure were small and 
continuation of smoking would lessen the chance further, Eve either never heard this crucial piece of 
information, or she knowingly chose not to pursue this line of information directly. If the latter 
proposition was evident, then Eve and Dr Brown could be determined to be complicit in their collusion 
where neither of them pursued communication regarding the often difficult subject of prognostic 
outcome. Collusion relating to prognostic information was evident elsewhere.  
 
In Case B, Ben was reluctant to exchange information about several aspects of his management, 
particularly outcome, during his clinical encounters: 
 
Well, I’m never going to ask ‘how long am I going to live’. No, no, no….I wouldn’t annoy anybody with 
questions like that. I don’t see a point to it (Consultation/Dr Anderson/Ben/Ref 3) 
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Moreover, both clinicians where complicit in the collusion actively avoiding prognostic information 
exchange, with both offering justification for this stance, based on ideals of following patient agenda 
and being respectful of patient-centred care: 
 
So that’s…he’s very, he’s very down to earth. He didn’t want to discuss the prognosis and he really didn’t want 
to go over things again. So I was led by his agenda (De-brief interview/Dr Anderson/Ben/Ref 1) 
 
Yes, I mean from previous discussions, I knew what his expectations were likely to be. He didn’t particularly 
want to talk about prognosis and therefore we didn’t focus on that specifically – but that was his, that was 
the way he wanted the conversation to go (De-brief interview/Dr Allen/Ben/ Ref 1) 
 
The very obvious difference in these two cases was that Ben’s companion adopted a neutral influence 
during the information exchanges and did not impact or control any aspect of this particular 
encounter. Contrastingly, Eve’s companions adopted a different perspective and chose to question 
aspects of the information given by the oncologist, thus influencing the content and direction of the 
exchange. Significant influence was consequently exerted within the prognostic information domain, 
with the oncologist compelled to justify her rationales.  
 
Companion influence in Case E could essentially be viewed as moderating. Companions controlled and 
moderated the content and direction of the exchange and as they picked up on prognostic information 
in advance of Eve, they did so without her initial consent and theoretically against her wish to collude 
with medical staff to avoid precise information about outlook. Equally in this case companion 
influence could also confer a mediating role whereby the actions of the family lead to a more in-depth 
discussion and analysis of prognostic indictors which would otherwise have been missed by Eve and 
ignored by Dr Brown. 
 
In three of the five Cases (C, E and F) where moderation was evident in relation to companion control 
and companion agenda, there was also persuasive links with the third construct of companions as 
experts.  
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7.3.3. Companion as expert 
In this study expert companion was conceptualised within a broad categorisation and ranged from 
companions who had a healthcare background (Betty, Colin and Fiona) to those with previous 
knowledge and experience of caring for someone with the illness (Agnes, and Davie). Importantly 
there was also evidence that in some cases (Eric), companions became ‘expert’ through reading and 
familiarisation around the subject matter. Colin, a retired paramedic, was a compelling example of a 
companion with a healthcare background who moderated the content and direction of information 
by utilising his knowledge of breathlessness management: 
 
Dr Anderson: Is there anything that I’ve not made clear that you’d like to ask me at all? 
Colin: No, well, I don’t know if this is your department, or if it would be this other fellow – but I 
think there’s just a few wee things. Sorry, I don’t mean to be rude by writing things down. 
Yeah, I do think Celia is much more breathless than even just a week ago. Is oxygen therapy 
a consideration? 
Dr Anderson: I think it’s unlikely. I can measure the oxygen level in her blood quickly with a wee machine, 
so I’ll do that in two minutes. I think that’s unlikely to be necessary, but it’s certainly 
something that I’ll check just now. 
Colin:  Or a nebuliser of some kind (Consultation/Dr Anderson/Celia/Colin, Ref 1) 
 
 
In his attempts to improve Celia’s health status Colin’s moderating ‘expert’ knowledge and 
information agenda could have impacted negatively on her care. He failed to take full account of her 
current contextual situation - Celia continued to smoke: 
 
Dr Anderson: You’ve stopped smoking then, haven’t you? 
Celia: Not really, no, doctor 
Dr Anderson: Well, there’s no question of oxygen on someone who still smokes 
Celia: I had heard that doctor. Is that for health and safety doctor? 
Dr Anderson: It’s health and safety and there’s no benefit from oxygen if people go on smoking 
Colin: But em…Oh right. (Consultation/Dr Anderson/Celia/Colin, Ref 8) 
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In other cases companions did not recommend therapy. Applying control with expert knowledge to 
moderate the content and direction of the exchange was evidenced by monopolising the conversation 
with the consultant: 
 
Fiona: Cos obviously, d’you know what I mean, I’d like... just to know, like...the bronch was…Cos 
the bronch was inconclusive, you know, the...  
Dr Boyd: All the tests that are inconclusive are good. Yeah. 
Fiona:  mmm...d’you know what I mean, it’s all looking good. I know it’s all looking good, but it’s 
still, like, and I know you’re never gonnae know until you go in and look, but... 
Dr Boyd: What we want to avoid is surgery that is done for the wrong reasons and is basically not 
achieving its target, which is to cure (Consultation/Dr Boyd/Flo/Fiona, Ref 3) 
 
In Eve’s case, Eric did not have a healthcare education, but his moderating expert influence was 
evidenced by him becoming a knowledgeable companion through research and studying the written 
information supplied: 
 
Eric:   Yeah, I read it over, like. It’s 230 patients or something just now. She actually read the 
booklet herself, last week, and what put her aff was the side-effects – but it doesnae matter. 
I said to her, it doesnae matter what you have, you’re still gonna get the side-effects. Is it 
just a case of if she takes both treatments at the same time it’d be quicker? 
Dr Brown: It doesn’t make any difference. 
Eric:   Does that not make any difference? 
Dr Brown: So do you have any questions about it? 
Eric:   No. I just like to know how far on this cancer is (Consultation/Dr Brown/Eve/Eric, Ref 11) 
 
 
Eric skilfully shifted between his understanding and knowledge of the trial literature to moderating 
the information flow and content to suit his own information needs and agenda concerning Eve’s 
prognosis. 
 
In all other companion Cases (A, D and G) there was no significant evidence of companions as experts. 
Yet prior knowledge regarding the experience of cancer, such as caring for someone previously with 
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the illness, could also imply a level of ‘expertise’ which might subsequently influence the process. In 
Case A, Agnes expressed an opinion regarding outlook, based on Alex’s experience of prostate cancer. 
Agnes projected that the outlook from lung cancer would be similar to that of his previous cancer and 
this prior knowledge and experience (as incorrect as it was), allowed her to adopt a moderating 
influence on her current opinion and viewpoint: 
Well, I feel as if, because he responded so well with the prostate, (yeah) you know, from such an aggressive 
one that he had and he beat it…that he will be the same here (In-depth interview/Alex/Agnes, Ref 12) 
 
Data suggests that, although companions moderated across the three main constructs to differing 
degrees, aside from minimal comments from Alec and Gordon, no other patient expressed their 
discontent at the influence of companion presence. However, perspective on companion moderating 
influence was evidenced, not from patient perception but from that of professionals and the next 
section will explore perception of companion involvement in more depth. 
 
7.3.4. Perception of companion accompaniment – moderating influence 
Within the mediating influence construct, patients expressed positive opinions regarding companion 
impact on information exchange. But, professional perspective was absent for this domain. However, 
the reverse was identified for moderating influence. Despite evidence that companions influenced 
information exchange in a moderating fashion, overall patient perspective was not critical of this 
effect. Professionals were more vocal for this domain and study data illustrated that, for some cases, 
there was a negative perception noted regarding companion accompaniment. 
 
Professionals’ views were elicited directly after the consultation to capture the immediacy of their 
opinions.  Analysis of de-brief interview data showed for most cases, the professionals responded to 
the questions in the affirmative, stating they had covered the pertinent areas which they had intended 
to. Some professionals commented that they tended to follow the patient’s agenda: 
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Well, the answer to that is yes, I hope so, but I don’t always follow my agenda, I follow the patient’s agenda 
(Consultation/Dr Anderson/Alex, Ref 1) 
 
Whereas professionals confirmed they exchanged the amount and type of information which they 
hoped to during the consultation, they also identified that at times there was large volumes of 
information to communicate to patients and their companions: 
 
But... no, it’s quite, they’ve had a bit of a rollercoaster. It’s funny that... sometimes there’s an advantage in 
seeing patients quickly. But sometimes....It’s too, too much. Too much time, too much information 
(Consultation/Dr Brown/Gordon, Ref 3) 
 
In only one case (Case E) did the oncologist feel that the content of the information she provided was 
inadequate: 
 
No. I think what I wanted, what I would normally have done, also, is gone through the actual chemotherapy 
treatment. Sometimes, I mention the drugs and …explain to patients that it’s given over three weeks, and that 
they receive four cycles. I didn’t really get the opportunity to do that. Most of the consultation was dominated 
by her stress, regarding smoking. …and I mentioned that it’d be four treatments. But I would have liked to 
have gone through that, because, obviously, there’s neutropenia sepsis, …which you want to warn the patient 
of…so that is something that I’m gonna have to follow up on (Consultation/Dr Brown/ Eve, Ref 1). 
 
Significantly, without being asked directly, professionals made unsolicited comments regarding the 
accompanying companions as evidenced with these exemplars: 
 
The brother is a bit intense, actually – he got a bit wearing (De-brief interview/Dr Anderson/Colin, Ref 1) 
 
There seems to be a lot of antagonism between her and the son…and is nagging her …regarding smoking…and 
harassing her, and she’s feeling very stressed with that. So the consultation was interrupted about three times 
just for that (De-brief interview/Dr Brown/Eric, Ref 2) 
 
They had a daughter here that I had not met before, so we had to go over everything again. The daughter 
seemed well-informed, was mentioning VATS procedures and things like that, so...It was more the relative 
189 
 
that wanted to know stuff and not the patient. She didn’t think of much (De-brief interview/Dr Boyd/Fiona, 
Ref 2) 
 
In the data there is association shown between the companions who influenced the exchange of 
information in a moderating manner and whom professionals chose to comment, particularly, Colin, 
Eric and Fiona. There is no indication from the medical staff that the presence of the companions was 
so moderating that it made information exchange untenable. Yet, companions altered the content 
and direction of the exchange to suit their information agenda. Professionals mentioned certain 
companions spontaneously but not necessarily in a positive light. The unsolicited nature of their 
comments appeared to confirm that the data accurately assessed these companions as persuasive 
moderators of information exchange. Importantly, data revealed that the most vocal and moderating 
companions did not negotiate their accompaniment but insisted on their presence at the 
consultations.  
 
7.3.5. Moderating construct summation 
The negotiated presence of companions and more importantly, the moderating role of non-
negotiated companions, emerged as a major finding in the data. A moderating influence was shown 
in five of the seven cases and could be categorised into three main sub-themes of controlling 
companion, companion agenda and companion as expert.  Evidence also showed the sub-themes were 
linked with recurring patterns, demonstrated across all three constructs. The more controlling the 
companion, the more they influenced the information exchange process with their own information 
agenda. This was particularly so when the companion may have a perceived expert companion role. 
Conversely, companions did not need to have a healthcare background to exert their own agenda, 
only a persuasive desire to have their questions answered. Moderating influence was thought to be 
partly driven by companions desire to enhance their loved one’s care and not solely for their own 
advantage.  
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Iterative data analysis also revealed that professionals and patients held views and attitudes about 
companion moderating influence, which warranted analysis and exploration. There were no negative 
comments elicited from patients regarding companion influence within this construct. Although 
narratives indicated patient disquiet in two cases (A and G), professionals commented more 
specifically about the most moderating companions.  
 
Similar to mediating influence, diverse companion demographic characteristics [gender, personality 
traits and past experiences] as well as relationship types within and across cases (shown in table 16) 
may have had a significant role to play in the information exchange process for moderating constructs.  
 
Case summary 2 described below, illustrates all three moderating constructs which were evident 
during the clinical consultation for Case F. 
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Case summary 2: Moderating companion influence 
 
COMPANION CASE SUMMARY: FIONA 
 
Flo was a 67 year old lady diagnosed with T2 N0 non-small cell lung cancer. Her cancer was diagnosed following 
investigation of recurrent chest infections. She had no significant past medical history and stopped smoking over 
20 years ago. Performance status was recorded as 0. Since leaving school with secondary school qualifications, 
Flo worked as a clerical assistant until she retired. She was married and lived with her husband in a large urban 
suburb. The treatment modality was surgical resection with a curative intent. Flo was diagnosed at Study site B 
and attended consultations there with Dr Boyd and Sr Baxter. She was accompanied by her husband Frank and 
daughter Fiona. Fiona was present only during the clinical encounters and not at the in-depth interview. Fiona 
was aged 35-45 yrs, married with no children. She lived in the USA and was a registered nurse, practising abroad 
and had flown home specifically to be present when Flo was given her results and proposed treatment plan. 
 
At the outset of the consultation, in this case the companion was quiet and did not exchange any information 
with Dr Boyd whilst he explained specifics relating to the cancer type and stage. Approximately half way through 
the consultation, data showed that Fiona began to engage in the exchange and became more involved exerting 
a strong moderator influence throughout the communication process in the second half of the discussion. Her 
influence was evident through all three moderating constructs (control, agenda and expert). Data identified that 
Fiona controlled the exchange of information by employing the three sub-constructs of companion control. She 
spoke directly to Dr Boyd throughout the exchange, with no attempt to engage Flo in the discussion between 
them, either with prompting or asking her questions or seeking her opinion. Likewise, Fiona exerted a strong 
control over elements of the exchange, often interrupting the dialogue to interject (Ref 5) or answering for her 
mother unsolicited (Ref 1).  There was data to suggest that Fiona used a moderating influence to marginalise 
Flo, which included use of the third person, with Fiona referring to her mum as ‘she’ (Ref 2) and her tone 
appeared dismissive at times during the exchanges (Ref 1). Extending her moderating behaviour, Fiona 
controlled the exchange by direct questioning of the physician. Her line of candid questioning suggested a 
companion agenda devolved of an enhancing or protective behaviour towards Flo (Ref 8). A further moderating 
or inhibiting effect was Fiona’s use of her expert knowledge often displayed in the language used. As a nurse she 
asked direct medicalised questions (Ref 6), and her language further prohibited the inclusion of Flo and Frank 
from the exchange as it often included terminology that they would have been unfamiliar with i.e. 
mediastinoscopy and VATS (ref 4), ‘bronchoscopy was inconclusive’ (Ref 3).Despite Fiona’s moderating 
influence, this style of exchange appeared to suit Flo. It fitted with her desire not to ask direct questions herself 
and to allow Fiona to control the content and direction of the information (Ref 2). Although her moderating 
influence did not render the consultation difficult and information exchange untenable, and despite Flo 
appearing content with Fiona’s presence, Dr Boyd mentioned her role  when questioned at the de-brief (Ref #). 
Aside from being a physical presence there was no data indicating that Fiona exhibited any other mediating 
influences within this case. Additionally, Fiona’s accompaniment to the clinical encounters was non-negotiable. 
She had taken leave from work in America and had a specified time to accompany her mother to the 
consultations.  
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7.4. Neutral companion influence 
The previous sections explored the data relating to both mediating and moderating companion 
influence. However, analysis identified a more non-aligned influence in two cases (Case B and D). Aside 
from acting as a physical presence and memory aid, these companions appeared to have so little 
influence on the information exchange that their input could be regarded as neutral. Analysis of 
neutral influences focused on any aspects of companion influence, which could explain the rationale 
for why, in these two cases specifically, there was neither a significant mediating not moderating 
influence. Two main constructs were identified which could theoretically explain the influence; past 
experience and knowledge and relationships. 
 
7.4.1. Past experience and knowledge 
These two cases were completely dissimilar in terms of companion characteristics relating to 
experience and knowledge. Ben’s daughter Betty was his accompanying companion. A registered 
oncology nurse she had a minimal mediating influence on the exchange when she acted as an aide 
memoire, only reminding Ben which medications he took. Likewise Betty then had a minimal 
moderator effect on the discussion when she answered a question about Ben’s understanding of his 
condition and used the word mesothelioma when he struggled to pronounce it. Aside from minor 
interjections, Betty appeared to keep her counsel and remained neutral for significant amounts of 
time, with Ben predominantly exchanging information with both professionals. When invited to ask 
questions she declined (Dr Anderson, Ben, Betty, Ref 3). Her reasons for adopting a more impartial 
role are unclear. However, it could be proposed that Betty as an experienced cancer nurse already 
knew the treatment pathway, expected treatment side-effects and potential prognostic outcome and 
did not need to engage in an exchange for more information.  
 
Delia was accompanied to her consultations by Davie her husband of thirty years and their daughter 
Diane. Davie was also present at the in-depth interview. Davie had no healthcare education but had 
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personal experience of lung cancer with his mother, who subsequently died of the condition. The 
couple also experienced the death of their son. Davie conferred a mediating influence by his physical 
presence and had a further mediating role as an aide memoire. Similar to Betty, Davie seldom asked 
direct questions. Feasibly, he may already have understood the proposed treatment plan and 
potential side-effects from past experience.   
 
7.4.2. Relationships 
In both cases, relationship factors may have been a significant influence.  It is possible that Betty 
maintained the role of daughter, setting aside her nursing experience, and taking the lead from her 
father. Ben was reluctant to ask too many questions, especially in relation to the themes of treatment 
and treatment outlook, and Betty may have thought it inappropriate to discuss these subjects in his 
presence. In case D, Davie and Delia’s long-standing marital relationship may have provided the easy 
and relaxed communication between them, witnessed even in the cancer setting. 
 
A case summary 3 describing the dual constructs of past experience and relationships of Case D is 
summarised below. 
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Case summary 3: Neutral companion influence 
 
COMPANION CASE SUMMARY: DAVIE 
Diagnosed with T4 N2 non-small cell lung cancer, Delia was a 55 year old woman who presented with pleuritic 
chest pain. This was a new symptom on a background of severe Chronic Obstructive Pulmonary disease (COPD). 
Delia was unemployed due to ill-health as a result of her airways disease but worked as a cleaner and car valet 
previously. She left school with secondary school qualifications. She was married and lived with her husband in 
an inner city area and her performance status was described as 0. At the time of data collection Delia was a 
smoker. Treatment regimen was chemotherapy, with the intent being symptom control and palliation. The 
patient attended clinic consultations at Study site A and was reviewed by Dr Andrews, Dr Allan and the Clinical 
Trials Nurse. Delia was accompanied by her husband Davie to both clinic consultations and he was present when 
the in-depth interview was conducted. Davie and Delia had been married for 30 years. They had two adult 
children. Their daughter Diane, a mother of two, was present during the consultation with Dr Andrews. Diane’s 
only exchange of information was to ask if the situation was ‘hopeless’ (Ref #). Their son died 13 years ago from 
an unintentional overdose of Ecstasy tablets at a rave. They spoke of him frequently throughout the in-depth 
interview, especially in relation to avoidance of companions and avoidance of communication. The family had 
experienced loss from their son’s death and Davie’s mother died of lung cancer (she was under the care of the 
same healthcare team that was currently caring for Delia). As a couple they both exchanged information 
throughout all information exchange encounters (consultations, de-brief and in-depth interviews).  
 
Davie never exerted control over Delia and never answered questions intended for her. He rarely asked any 
questions, preferring instead to make statements (Ref 3, 4, 6). Data showed that as a couple Delia and Davie had 
a very easy-going communication style, often completing sentences for each other (Ref 10). There was no 
dismissive tone adopted and Davie never seemed to be controlling the information exchange with his own 
agenda. Field notes and researcher observations noted Davie adopted a fairly relaxed, laid back stance, and his 
exchanges were almost conversational. His calm composed manner seemed at odds with the gravity and 
emotive nature of the situation. Across all cases he was the only companion who constantly thanked the staff 
and he praised them repeatedly (Ref 9).  
 
This style of communication could be related to many variables including personality trait, strength and longevity 
of relationship and also prior experience of cancer with Davie’s mother. In this case Delia appeared comfortable 
with Davie’s influence (neither mediating nor moderating) and commented that she needed his accompaniment 
at the information exchanges (Ref 2). 
 
 
 
7.4.3. Neutral construct summation 
Specific conclusions for the reasons for a more passive stance within these two cases could not be 
determined from the data. Data did identify a broad spectrum of features which could effectively 
impact neutrality. Comparing data within and across the two cases, there is an assertion that the 
recurring sub-constructs found related to prior knowledge and experience. Betty was an oncology 
nurse and Davie had past experience with his mother’s lung cancer and son’s death. Within the 
relationship sub-construct Betty’s deferential role as daughter and Davie and Delia’s long and 
comfortable marriage, were identified as central tenets (see table 16). 
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There is no evidence that companions in cases B and D significantly influenced the exchange of 
information between patients and professionals. Nevertheless, their actual physical presence at the 
clinic may have impacted positively as a source of emotional support and this is borne out in Delia’s 
narrative (Ref 2). 
 
7.5. Comparison across all constructs 
Across the three major constructs of mediating, moderating and neutral influences, further sub-
construct analysis has been presented, both within and across the cases. Whilst it is recognised 
empirically that companions influenced information exchange along similar broad constructs 
(Laidssar-Powell et al, 2013; Wolff and Roter, 2011), there was no meaningful evidence to inform 
which constructs were more influential than others or why and how companions did indeed mediate 
or moderate within each specific domain. 
 
This study recognised that all companions displayed mediating influences, primarily and significantly 
across the informational construct. They provided clarification, context and vitally recalled 
information to enable professionals to provide care based on current communication and knowledge. 
Whilst a physical role was not relevant in this study, all companions were recognised as providing a 
physical presence and a sense of ‘being there’ for the patient. Whereas physical presence was 
associated with emotional support, not all companions offered reassurance and encouragement in 
this study. The data illustrated, within this construct that companion variables, including personality 
traits and relationship alliances, may account for the way that companions as individuals and as a 
collective, influence the information process. 
 
In relation to moderating constructs, evidence suggested that although all companions regulated 
information exchange to some extent, certain cases did so across all three sub-constructs. Evidence 
further demonstrated that companion control, companion agenda and companion as an expert were 
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correlated and inter-connected. The evidence also indicated that companion personality traits may 
significantly influence which cases displayed more moderating behaviours. The interaction of 
relationship variables, as well as knowledge and past experience, were also illustrated as prominent 
explanations why certain companions adopted a more neutral influence on the process. 
 
There was clear evidence that companion accompaniment to the clinical consultations was a 
negotiated process. Companions who exerted a more moderating influence appeared to be placed in 
the non-negotiable end of the spectrum, with patient preference receiving little consideration. Across 
all cases, the evidence showed that patients valued companion involvement even when it was shown 
to moderate the information content and exchange. Professionals did not voice opinion regarding any 
mediating companion influence but were vocal about moderating companion behaviour. 
 
Policy initiatives dictate that companion accompaniment is recommended at consultations. 
Recognising what constructs relating to information exchange are influenced by companions within 
clinical consultations is essential for informing information exchange between patients, companions 
and professionals. Subsequently, identifying what characteristics impact on preference for companion 
accompaniment is important; as is an understanding of the reasons for particular companion 
presence. There is also a requirement to investigate the impact of participant perspective on 
companion accompaniment and the implications this has on clinical practice. These key findings will 
be discussed in the following sections. 
 
From this analysis key findings have emerged from construct synthesis which requires further analysis 
and exploration: 
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 What specific constructs relating to information exchange in lung cancer are influenced by 
companion presence? And how is it impacted by characteristics (both patient and companion) 
and relationships?  
 What is the preference for companion accompaniment and how is it impacted by patient and 
companion characteristics and relationships? 
 What is the participant perspective of companion presence and are there implications for 
clinical practice? 
 
This study has used within and across case analysis of the mediating, moderating and neutral 
constructs and associated sub-constructs to explain the influence of companions on information 
exchange. Additionally companion and patient characteristics are described in conjunction with 
participant perspective. These are summarised in table 20. 
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Table 20: Associated constructs & characteristics 
Case Patient variables Companion  
relationship 
Companion variables & attitude Preference for 
accompaniment 
Influence Constructs influenced Participant perspective on 
accompaniment 
        
A Independent man. 
Living with prostate cancer. 
Did not want to burden companions with 
his cancer. Did not want specific 
information (i.e. prognostic info). Would 
have attended alone.  
Daughter 
 
 
 
 
 
 
Partner 
One of 2 siblings (brother was a drug addict). 
Married with young children. 30-40 yrs old. 
Some previous cancer experience as mother 
died of cancer + Alex had prostatic CA. Fairly 
quiet and appeared respectful during 
exchange. No obvious agenda noted 
 
In relationship with Alex for 12 years. Age 
between 65-75 yrs. Experience of looking after 
Alex with prostatic CA. Was not present at clinic 
and had an informational agenda at in-depth 
interview. Vocal and strong personality 
Negotiated 
 
 
 
 
 
 
Negotiated 
 
Mediating 
 
 
 
 
 
 
Moderating 
Physical - presence 
Emotional -  reassurance 
Informational - aide memoire, 
seeks clarification 
 
 
 
Companion agenda setting 
Expert companion -  past 
experience 
Patient content 
Professional no comment 
 
 
 
 
 
Patient displayed some disquiet 
but overall content 
Professional no comment 
B Independent man. 
No past history of cancer and was still 
grieving for his wife who died in the past 
year. 
Did not want to burden companions with 
his cancer. Adamant he did not want to 
know too much and did not want specific 
information (i.e. prognostic info).  
Would have attended alone. 
Daughter One of 3 siblings. Married with 2 young 
children. 30 - 40yrs old. Registered oncology 
nurse. Fairly quiet and appeared respectful 
during exchange 
Negotiated 
 
Neutral Prior knowledge and experience 
Relationships 
Physical - presence 
 
 
 
 
 
  
Patient content 
Professional no comment 
C Fairly frail elderly lady.  
Past experience of breast cancer and good 
grasp of information. Would have 
attended alone but brother was 
persuasive and she logistically needed 
transport 
Brother One of 2 of Celia’s younger brothers. A retired 
para-medic with some healthcare knowledge. 
65-75 yrs. old. Vocal and strong personality 
Partially  
negotiated 
 
Moderating Physical  - logistical, presence 
Informational - aide memoire, 
seeks clarification, provides 
context 
Companion control - answers for 
patient, interrupts, dismissive 
Companion agenda  
Expert companion – education 
Patient content 
Professional mentioned 
moderating influence 
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D Independent lady.  
Past experience of cancer and family 
bereavement.  
Never gave thought to attending alone or 
negotiate companion presence 
 
Husband 
 
 
 
Daughter 
Married to Delia for > 25 years. Previous 
experience of cancer with his mother. Age 55-
65 yrs. Never vocal or opinionated during 
exchange. 
One of 2 siblings (brother died of OD). Married 
with 2 young children. 25-35 years old. 
Previous experience of cancer with her 
grandmother. No obvious agenda and fairly 
quiet and respectful throughout exchange 
No discussion 
 
 
 
No discussion 
Neutral 
 
 
 
Mediating 
Prior knowledge & experience 
Relationships 
 
 
Physical- presence 
Emotional -  seeks reassurance 
Informational – seeks 
clarification, provides context 
Patient content 
Professional no comment 
 
 
Patient content 
Professional no comment 
E Independent lady. 
Some experience of friends with cancer. 
Strong personality and recovering 
alcoholic. Argumentative and strong 
personality. 
Family did not appear to give option of 
attending alone. 
Son 
 
 
 
 
 
Daughter 
One of 3 siblings. Age 30-40 yrs. No previous 
family history of cancer but gained insight into 
the condition, treatment and trial data. Vocal 
and strong personality. Argued with Eve during 
consultations 
 
One of 3 siblings. Age 30-40 yrs.  No previous 
family history of cancer and was not as versed 
as her brother about condition and treatment.  
Vocal and strong personality. Argued with Eve 
during consultations 
No negotiation 
 
 
 
 
 
No negotiation 
Moderating 
 
 
 
 
 
Moderating 
Physical  - presence 
Informational - aide memoire, 
seeks clarification, provides 
context 
Companion control - answers for 
patient, interrupts, dismissive 
Companion agenda - agenda 
setting 
Expert companion - learned  
Patient and companion argue 
but overall content 
Professional mentioned 
moderating influence 
F Independent lady. 
Cancer found co-incidentally and she 
appeared to be still coming to terms with 
diagnosis. Did not like to use the word 
cancer and never asked questions of 
healthcare professionals. 
Family did not appear to give option of 
attending alone. 
Husband 
 
 
 
Daughter 
Married to Flo for > 30 years. Retired. Age 65-
75 yrs. Did not comment much during clinics. 
Quiet with no obvious agenda.  
 
One of 2 siblings (brother lived in London). 
Fiona lived and worked as a RGN in the USA. 
Age 30-40 yrs. Vocal and strong personality 
No negotiation 
 
 
 
No negotiation 
Mediating 
 
 
 
Moderating 
Physical – presence 
Emotional – physical comfort 
 
 
Physical – presence 
Informational – aide memoire, 
seeks clarification 
Companion control - answers for 
patient, interrupts, dismissive 
Patient content 
Professional no comment 
 
 
 
Professional mentioned 
moderating influence 
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Companion agenda  - agenda 
setting 
Expert companion  - education 
G Independent man. 
Worked as a carer and looked after his 
father who died of upper GI cancer. 
Did not want many family members to 
know about diagnosis. 
Companion appeared persuasive re 
accompaniment 
Ex-wife Divorced from Gordon, but still friends. They 
have a son. Age 45-55 yrs. No past experience 
of cancer. Had informational agenda, vocal but 
not overly so. Strong personality. 
Partially 
negotiated 
Moderating Physical – presence 
Emotional - seeks reassurance 
Informational - aide memoire, 
seeks clarification, provides 
context 
Companion control - answers for 
patient 
Companion agenda  - agenda 
setting 
Patient displayed some 
disquiet, but overall content 
Professional no comment 
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7.6. Constructs influenced by companion presence 
Data from the study illustrated that, across cases, companion presence at clinical consultations is 
universal. Inherently the presence of another individual alters the dynamics, focus and exchanges that 
take place within non-dyad or triad consultations. This is not disputed in either my study data or the 
empirical literature. What was more equivocal was the influence that companion accompaniment had 
on information exchange, specifically within lung cancer consultations. Exploring the 
interconnectedness of companion influence on information exchange and the implications this has on 
clinical practice, was relevant and appropriate as there was a paucity of data within this arena.  
 
Although my data did not find persuasive evidence that practical, physical influence was significant, 
there were incidences (Cases C and G) where companions fulfilled a logistical role by transporting 
patients to consultations. In this study patients were more robust and younger than the ‘typical’ lung 
cancer patient. For all cases performance status was 0 or 1 and this may reflect the stage of the illness 
when patients were not encumbered by treatment and its related side-effects and therefore less 
reliant on companions for physical support. More notably, my data indicated actual companion 
physical presence or ‘being there’ inferred a more significant mediating influence and in my study, 
evidence revealed this was closely connected to the second construct of emotional support. Even 
when companions did not exchange significant amounts of information their company and 
companionship provided reassurance and emotional support and an overall mediating effect. 
Companion presence gave patients the confidence to attend an emotionally laden consultation. 
Conversely, physical presence was also identified in the study as a moderating influence. In case E, 
argumentative exchanges regarding smoking diverted the discussion from clinically important 
information exchange regarding treatment and potentially life-limiting side-effects.  
 
Study data revealed that companions exerted the most influence within the informational construct. 
Across all cases companions aided memory recall, with the exception of Case B, all sought clarification 
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of information and every case, except Cases B and F, provided the healthcare team with contextual 
information. The impact that the provision of pertinent information from companions regarding 
current symptoms, past medical history and the social/situational context has on patient care and 
management, can be significant. In Case A cough was alleviated, Case B pain control was tackled and 
Case C, breathlessness and anorexia were addressed. Noticeably, data from the study suggested that 
patients themselves seldom highlight their own symptoms or social context. Therefore, companion 
influence within this construct can be influential in assisting in overall patient management.  
 
Although the majority of companions influenced the physical/emotional and informational constructs, 
some were more involved in information exchange than others. One hypothesis for this difference 
was the actual range and diversity of companion characteristics. Data illustrated that companion 
characteristics such as confidence level and life experience, may have an impact on information 
exchange within the consultation.   
 
More notably patient/companion relationship may have a significant influential role within mediating 
influences. As table 18 summarised, there were a wide range of companions represented with more 
female companions accompanying patients. Evidence suggested within the sub-constructs of 
emotional and informational domains, the majority of companions influencing the exchanges were 
daughters or spouses and these and other relationship traits inform the second key finding and will 
be discussed within section 7.7. When companions did mediate within the physical/emotional and 
informational sub-constructs, data indicated that their influence was intended to enhance patient 
health status. The provision of current, contextual health details added to the clinical picture and 
provided improved knowledge for professional, enhancing care for the patient.  
 
In contrast, when companions were seen to moderate the information exchange process, there was 
the potential for patient care to be compromised. Data demonstrated that the majority of companions 
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moderated information within three main constructs and sub-constructs with evidence identifying 
that it was difficult to isolate companion control, companion agenda and companion as expert. Each 
construct appeared interconnected. Whereas five companion cases demonstrated moderating 
influence in relation to information exchange via a combination of the constructs, three cases were 
identified where there was significant moderating influence seen throughout all three domains, with 
constructs inter-dependant.  
 
In the three most principal moderating cases (C, E and F) data demonstrated the exchange of 
information was primarily regulated during the consultations by companions exercising control. 
Control was implied through companions answering for the patient, interrupting discussions and at 
times by dismissive behaviours (Cases C, E and F). Although conceivably not intended, such companion 
control could be seen to side-line patient control of information exchange. In turn this then has the 
potential to diminish patient autonomy and decision-making capabilities. Study data showed across 
these three cases companions used control and agenda setting to moderate the direction and content 
of information exchange. 
 
There is further evidence that other companions also employed information agenda setting 
effectively. In Case A, companion agenda centred on treatment outcome and prognostic information, 
with manipulation of the discussion focusing on this aspect of communication. Equally throughout 
both consultations, Case G’s companion effectively constructed her own agenda of symptoms and 
contextual information (working and driving) into the discussions. Notably in all five cases patients did 
not raise these issues independently and thus data showed the respective companions choose their 
own schedule and moderated the content and flow of the information to suit their own and not 
necessarily the patient agenda. 
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Of the five most moderating companions there was evidence, in certain cases, that control and agenda 
setting were associated with and impacted by companions as experts. This construct comprised three 
sub-constructs which the majority of cases fitted; health education background (Cases B, C and F), past 
experience (Case A and D) and learned/self-taught expert (Case F). My study indicated that 
companions with a healthcare education moderated information exchange more appreciably. Case C 
and F appeared to take advantage of their professional education to control information content, with 
the data showing they often monopolised the discussion. Further indications were that expertise can 
be taught and Case E was able to control information exchange through his learned knowledge of lung 
cancer and proposed therapies. Experiential knowledge, although shown to moderate the exchange 
in Case A, was not a moderating feature in Case D, with theoretically, relationship characteristics 
explaining the difference in this sub-construct. Data analysis highlighted that Case B was an 
incongruous case within this construct. Here the companion had more knowledge of oncology, 
practising as a senior nurse within the field, yet had no moderating effect on information exchange, 
aside from minor corrections of the diagnostic terminology. Consistent with Cases A and D, 
relationship traits may explain this variance.  
 
As with mediating influences, patient and companion characteristics, as well as relationship types, 
should be considered as having a significant and persuasive impact on information exchange within 
moderating constructs. Companions who moderated information exchange were vocal and confident 
in their relationships with other members of the triad. In order to control and at times direct the 
information agenda companions exercised strong personality characteristics. Likewise due 
consideration of the family relationships is warranted; this identified that adult children and siblings 
were more moderating than spouses.   
 
In contrast to mediating influence, data analysis revealed when information exchange was moderated 
by companions, it had the potential to impact adversely on patient care, by diverting from clinically 
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relevant information. During consultations where companions controlled information content with 
their own agenda, there was evidence that professionals did not discuss information pertinent to 
treatment and side-effects, both potentially life limiting scenarios (Case E). Similarly as in case C, the 
professional was forced to discuss inappropriate therapy which would not have been beneficial to the 
patient or indeed the patient may have been distressed and upset by the topic under discussion (Cases 
A – prognosis, Case G, activity limiting discussion).  
 
However, moderating influence could also be perceived as a protective mechanism whereby 
companions attempted to engage with professionals to ensure patients had enhanced care. By leading 
and controlling the information exchanges relating to treatment modalities and treatment outcome, 
companions could theoretically be looking to push for the most beneficial therapy for their loved one. 
Companions may notionally be acting as an advocate for the patient exchanging information with 
healthcare professionals on many aspects of the disease process, including symptomology, as well as, 
therapy options and treatment outcomes. An important core feature of this companion advocacy role 
was identified as collusion reduction, where companions recognised that patients either failed to 
discern important information relating to key discussions such as prognostic communication or they 
in fact engaged in complicity with their healthcare professional preferring to avoid difficult to discuss 
subjects.  
 
This study provided new evidence that companions mediated and moderated information exchange 
within and across six major constructs. It further identified and synthesised new knowledge relating 
to which specific sub-constructs were more impacted by companions within lung cancer consultations. 
Additionally, data explored in the substantive analysis reflected that there was a wealth of 
characteristic variables (companion and patient) which might impact this influence across the major 
constructs. This in turn might theoretically impact the preference for companion accompaniment. This 
was the second key finding to emerge from synthesis and is explored in section 7.7.  
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7.7. Preference for companion accompaniment 
Although companion presence was universal, data revealed that companion accompaniment was not 
an absolute certainty. A key, innovative finding was that companion accompaniment occurred along 
a continuum, from negotiated to non-negotiated. In two Cases A and B, patients would have preferred 
to have been unaccompanied to the consultations. Reasons cited for preferring to be unaccompanied 
were; to protect companions from the diagnosis and believing any information was their private 
business. However, within these cases, even when patients expressed a desire to be unaccompanied, 
companions appeared to negotiate with them and secured their attendance. As summarised in table 
20 another level of negotiation was identified as partial negotiation.  
 
Data for Cases C and G identified a mix of pragmatism and logistical need (i.e. transportation), some 
negotiation and ultimately companion presence, which was not fully consensual from the patient 
viewpoint (Case C) and slightly coerced (Case G). Atypically, in Case D, data showed there was no 
debate about accompaniment. This patient and her companions attended all consultations as a family 
unit and gave no consideration to the situation being otherwise. Across the remaining cases there was 
neither discussion nor negotiation. Companions did not give patients the option of their presence. 
Data showed there was direct association between non-negotiated accompaniment and moderating 
influence. In cases where companion presence was non-negotiable (E and F and to a lesser extent C) 
companions appeared to exert a moderating influence on information exchange. These three cases 
exercised important influence throughout the three constructs, controlling information exchange, 
following their own information agenda and applying expert knowledge. A common justification for 
accompaniment from companions was patients would not tell them all the information (case E) or 
would not ask for any information during the consultation (case F). Research demonstrated patient 
preference for accompaniment appeared to be compromised by vocal companions, with strong 
personal characteristic traits which did not allow patients to broker objection regarding 
accompaniment.  
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 As substantive analysis occurred after the completion of data collection, with data explored 
retrospectively, I was unable to adapt my data collection to gather prospective evidence to inform 
patient selection/preference of companion for accompaniment. However, within the data there is 
evidence to suggest that the companions who were present may have influenced information 
exchange because of the very nature of their relationship with patients, in addition to defining 
characteristics of both patients and companions.  
 
7.7.1. Patient and companion characteristics 
Analysis of the data hypothesised that certain aspects of personal characteristics render some 
companions more mediating, moderating or neutral than others. Across cases there were 5 
moderating companions (3 women and 2 men). Of this number, 3 were identified as more influential 
moderators (1 woman and 2 men). As case study numbers were small it is important to note that no 
one gender appeared more significantly moderating than another. Of more significance was that all 
moderating companions were very vocal throughout the information exchange process, with strong 
opinions and forceful personalities, with an ability to control information content and direction. 
Likewise, where mediating or neutral influence was noticed, companions tended to be from both 
genders and from different age groups.  In contrast, when they exchanged information they did so 
less frequently and used more supportive behaviours with little or no attempt to control the exchange 
process.  
It is unknown how much of an impact educational level had on the mediating or moderating 
companion influence, but professional status showed mixed effect. There was an identified 
association between companions with expert knowledge (Colin a retired paramedic and Fiona, a 
registered nurse) and moderating influence. Yet, the companion with the most oncology professional 
knowledge (Betty) adopted a wholly neutral influence. On reflection it could be considered that Betty’s 
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neutrality stemmed more from relationship influence than professional knowledge as highlighted in 
section 7.4.2. 
 
The data did not suggest that specific patient variables were strongly influential across the six 
constructs. Overall, patients were neither elderly, of poorer health or performance status nor 
cognitively impaired by disease processes.  Likewise there were no discerning or segregating features 
relating to educational level or socio-demographic status, which could be seen to differentiate the 
patients along identifiable demographic differences. The majority of patients had some prior 
experience of cancer or ill health. Equally, few of the patients were overly passive recipients of their 
own care. Despite Celia being older and frailer than the other cases, she exchanged information and 
participated in the dialogue. Similarly, data showed that Eve was very vocal herself, appeared to have 
a volatile relationship with her companions and often argued during consultations. Of the three cases 
where significant moderating influence was dominant, Flo exhibited the most passivity. Her 
personality might explain this reticence, as she never historically exchanged information with the 
healthcare team and, fundamentally, she was reluctant to speak about her cancer. A notable feature, 
but of questionable significance, was the fact that of the three most moderating companion cases, 
patients were female.  
7.7.2. Patient and companion relationships 
Patients were never accompanied by more than two companions throughout data collection. 
Theoretically, there may have been some type (however negotiated) of selection from a wider group 
of companions, but the opportunity to explore patient preference for companion selection in greater 
detail was not capitalised. Patients were never explicitly questioned about the nature of the 
relationship with their companions. They were asked during the in-depth interview under the heading 
of support at clinic if there was a conscious decision taken pre consultation to take a companion to 
the clinic and also questioned on the rationale for this decision. As negotiated accompaniment was 
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not an original consideration of the thesis this line of enquiry was not investigated extensively at this 
point in data collection. However, in some cases patients commented that their original preference 
would have been to be un-accompanied. In hindsight exploring the concept of patient preference for 
specific companion accompaniment and deeper exploration of the familial relationship and domestic 
affiliations between the patients and their companions could perhaps have allowed a deeper 
understanding of the reasons why certain patients wished to attend clinics alone and why for others 
the thought of being unaccompanied never entered their thoughts.   
 
 In addition, the study did not take the opportunity to consider patient perception of the roles they 
believed their companions should play during the consultation. This was principally because the study 
did not primarily set out to explore this domain and instead the influential roles and constructs 
influenced by companions only emerged as a theoretical proposition as the study unfolded and the 
data was analysed in-depth.  
 
Data illustrated when patients had a spouse or partner (Cases A, D and F), or ex-partner (Case G) these 
appear to be the preferred companion. Other accompanying companions comprised adult children 
(Cases A, B, D and F) or as in case C a sibling.  
 
Two of the most moderating companions were adult children. These companions appeared to be 
more controlling of the content and direction of information exchange and their recorded interactions 
revealed they used moderating behaviours which often interrupted and at times side-lined patients. 
Data does not suggest that these companions were not caring towards the patients, as their presence 
at the consultation may in itself signify, concern and consideration. Nonetheless, data demonstrated 
that their behaviours contrasted to other accompanying adult children (Cases A and B) who appeared 
to show different levels of respect and deference to their parents. Additionally, in relation to three of 
the accompanying daughters, data indicated that notable differences were seen in both their 
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relationships with the patients and their effect on information exchange process. Case A (Ann) was 
respectful and exerted a significant mediating influence on information exchange. Case B (Betty) was 
deferential and shown to be more neutral, whereas Case F (Fiona) was a strong moderator of 
information, often controlling both content and direction of the exchange. Reasons for such 
contrasting influences could be explained, in part, by companion-patient relationships and also 
companion-patient characteristics. 
 
Spousal/partner companions were present in Cases A, D, F and G. Consistent with children relationship 
effect, data showed that spousal/partner/patient relationship appeared to impact differently on 
information exchange. Partner companions A and G both displayed moderating influence on 
information, but data suggested to a lesser extent than other moderating cases and not across all 
constructs and although they followed their own information agenda there was less controlling 
dismissive influence. By contrast in Case D, companion influence was neutral with no moderating 
behaviour witnessed. In Case F, Flo’s husband would have been considered a neutral influence had he 
not exhibited a more mediating, emotionally supportive role. It is conceivable that divergent 
influences across these cases could be explained by relationship dynamics. In Case A, the couple had 
never married and lived separately. Equally in Case G the couple had divorced and lived apart and 
therefore their relationship characteristics may not mirror that of married couples (Cases D and F) 
with marriage longevity and different attitudes to their relationship. Additionally, although not fully 
understood, female partners appeared to have a more moderating influence on the exchange. 
Attitudinal influence can only be hypothesised from data analysis in certain cases, as patients and, 
more importantly, companions were never directly questioned regarding these constructs. Although 
conjecture, a reason for moderating influence could have been that companions felt that, as 
immediate and close family members it was their ‘place’ to advocate for the patient, ensuring 
symptoms were detailed (Case C), or contextual information given regarding smoking behaviour (Case 
E) and clarification sought regarding surgery [Ref 6] (Case F). Likewise, companions may have assumed 
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that a level of patient passivity allowed them to be vocal and speak on patient behalf. In Case C the 
companion may have viewed the patient, as elderly and frail and unable to make autonomous 
decisions. Hence the reasons he was controlling the information exchange and his rationale for taking 
away her right to see patient information regarding clinical trials. Equally, in Case F, companion 
dominance of the exchange; may have been mitigated by her knowledge that the patient historically 
displayed avoidance behaviour in order to escape discussing her cancer diagnosis with the healthcare 
team. 
 
Data illustrated that companions and patients are complex yet individual humans with differing 
opinions, personalities and attitudes about their relationships. Consequently, they interact with 
others in complex and different ways which consequently impacts information exchange processes. 
The evidence did not specify categorically, what specific companion and patient characteristics were 
more influential than others across the constructs, but considered the rationale for their interaction 
across cases.  Importantly, the study contributed new evidence of the association between 
companions who were significant moderators of information exchange and their level of negotiated 
presence at clinical consultations. Evidence showed these companions to be opinionated and vocal, 
controlling information via their own agenda by utilising their expert knowledge.  
 
Such companion influence has the potential to influence important constructs of the information 
process. Therefore, exploring companion accompaniment and influence from the perspective of 
patients and healthcare professionals appeared to be the next logical step within data synthesis and 
this emerged as the third key finding. 
 
7.7.3. Perspective and implications of companion presence 
The interview schedule for patients asked if it was a conscious decision to have a companion present 
during the consultations. There is evidence that some cases would have preferred to have been 
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unaccompanied and in the narratives, there is further evidence that patients felt uneasy with the 
informational content that companion agenda discussed. Yet, pertinently, there was no data analysed 
which showed that any of the cases were profoundly dissatisfied with companion presence.  Notably 
data showed that patients only commented on companion mediating influences, using affirming 
language to reinforce the positive aspects of their accompaniment. Even when companions did not 
negotiate their presence and moderated the exchange of information with controlling behaviour, 
patients did not raise any issues with the level of moderation. 
 
Conversely, data demonstrated that healthcare professionals were cognisant of companion presence 
and offered their perspective on accompaniment in certain cases. Significantly, healthcare 
professionals who did express their view on companion presence only did so when the influence 
displayed was moderation. Additionally, professionals offered their perspective at the de-brief 
interviews, unsolicited. In Case E the oncologist expressed concern that companion agenda distracted 
from clinically relevant information exchange and could potentially have life-limiting consequences, if 
the opportunity was lost to redress the imbalance. In other cases, professionals were aware that 
companion agenda was controlling the exchange of information (Case F), or that companion control 
was wearisome (Case C). Despite comments from professionals regarding companion influence, there 
was no evidence from the narratives to suggest that moderating behaviour made information 
exchange untenable. 
 
On this third key finding, data suggested there was a clinical impasse between patient and professional 
perspective on companion accompaniment. In certain cases, professionals thought moderating 
behaviour had a negative influence on information exchange during the consultation. However, from 
a patient perspective, data did not identify this moderating influence as significantly impacting the 
exchange. Data could not offer specific explanation as to why there should be disparity between 
patients and healthcare professionals on this unique finding.  
214 
 
It can be theorised that, at this emotive type of clinic consultation, patients were less conscious of the 
moderating, mediating or neutral influence of their companions. Although never questioned 
prospectively regarding their perspective of companion role, there was evidence from the narrative 
data, that patients did not view moderating behaviour as impacting on their care. Even Eve did not 
mention the heated debate she had with her companions regarding her smoking habit and how this 
led onto a sensitive discussion regarding her prognostic outlook. It may not have fundamentally 
mattered to her. The information was now there and she was dealing with it.  Conceivably, patients 
may just be accepting of their own particular family traits, even if that includes moderating 
behaviours. Equally, patients may just be grateful to have someone there with them throughout this 
time and as such, are prepared to tolerate moderating behaviour. 
 
Although not able to draw any robust conclusions from the data, the study has highlighted the emotive 
nature of lung cancer care, the poor prognostic outlook and the fear and uncertainty in which patients 
live their lives. It might be theorised that the severity of certain conditions and the poor outcome of 
specific diseases mitigates against patients being too unhappy with any influence which companions 
exercised. 
 
Impasse between patients and professionals could signal an important deficiency in patient clinical 
care (Epstein et al, 1985). For communication and information exchange to be effective, the 
professional must gain an understanding of the patient’s perspective, with values and preferences 
explored (Teutsch, 2003). The empirical literature and national policy directives recommend that 
professionals suggest to patients that they should be accompanied to clinic consultations by a 
companion, based on evidence which has shown the positive, mediating influence they exert on the 
exchange. Significantly, my data now challenges the clinical assumption that companion 
accompaniment should be recommended universally. Additionally, my findings also highlight that 
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companion accompaniment is not only a source of mediating influence within the clinical encounter, 
but needs to be considered from moderating and neutral constructs simultaneously.  
 
7.8. Summation 
Substantive data analysis could be described through three distinct stages in my study. 
 
1. The first stage refined the substantive analysis constructs relating to companion influence, 
naming mediating, moderating and neutral constructs 
2. In stage two the influences of the substantive within and across case analysis related to the 
three major constructs and their associated sub-constructs were described 
3. The third stage identified the key findings which emerged from construct synthesis 
 
Data was analysed between all constructs, in an attempt to synthesize the key components of the 
domains and describe the influence that companions exert within and across each construct. Analysis 
illustrated that patient, and more significantly companion, characteristics and relationships may have 
been instrumental in further influencing information exchange.  The data could not claim to have 
categorically investigated all such variables. However, within the constraints of small case numbers, 
the evidence demonstrated that both personality traits and relationship alliances appeared to 
influence the information exchange process. Also, although this is important data in itself, and an area 
which also warrants future investigation, it primarily underpins the innovative finding of negotiated 
accompaniment. 
 
The study generated new knowledge, identifying the association between preference for companion 
accompaniment and negotiated presence at the clinical encounter. Pertinently, data illustrated that 
companions with a non-negotiated accompaniment to the consultation subsequently exerted a 
significant moderating influence on the information exchange process, which had the propensity for 
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both negative and positive outcome. Consistent with influencing factors within the construct domains, 
personal characteristics and relationships could theoretically impact preference for accompaniment 
as well. Companion accompaniment is universally recommended and accepted at the clinical 
encounter. Therefore, focusing on understanding the perceptions of all participants seems both timely 
and germane. 
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Chapter 8. Discussion 
8.1. Introduction 
My study has generated new and original knowledge related to negotiated and more specifically non-
negotiated companion accompaniment at the clinical encounter. This thesis described information 
which was exchanged or not exchanged between patients with lung cancer, the companions who 
accompanied them to clinic consultations and the professionals with whom they consulted. The 
principal finding to emerge from the data, illustrated the influential role of accompanying companions, 
especially those with a non-negotiated presence who were identified as influential and expert with a 
moderating influence on the information exchange process. Secondary study data also suggested that 
preference for accompaniment was impacted by a variety of factors, such as patient and companion 
characteristics as well as relationship alliances. Perceptions of companion accompaniment also was a 
significant aspect of secondary data worthy of consideration, especially as my data highlighted that 
patient-professional perspective on companion accompaniment and influence on information 
exchange were both inconsistent.  
 
This chapter considers explanations for these findings with reference to the wider corroborating or 
contradictory literature. The chapter will begin with an analysis of the study’s strengths and 
limitations.  
 
8.2. Strengths of the research 
To my knowledge this study is one of the first to investigate information exchange between patients 
with lung cancer, their companions and professionals at clinic consultations.  The study explored a 
previously under-researched subject, describing in detail the content and type of information 
important and relevant to each participant within triadic clinical consultations. This research 
identified, for the first time, the influential role that companions played in negotiating their presence 
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at clinical encounters and the subsequent impact accompaniment has on the information exchange 
process.   
 
It was the absence of empirical evidence on information exchange within the lung cancer context that 
primarily guided the use of a case study design. The strength of this method allowed exploration of 
the richness of the phenomenon and the extensiveness of the real-life context (Yin, 2009, p2). One of 
the key strengths was the decision to employ a research method which allowed an in-depth 
understanding of the specific and contemporary topic of information exchange. The study was 
concerned about information exchanges between the participants and all relevant behaviours, but as 
it was not motivated with manipulating either behaviours or variables, adopting a case study method 
added to the strength of the research design and the ability to answer the research questions. 
Demonstrating the experience of information exchange from the insider’s perspective was an integral 
element of the research and another key strength of the study was the use of multiple methods of 
data collection techniques (detailed in chapters 3 and 4). 
 
The decision to audio-tape all clinical consultations and interviews was both considered and 
pragmatic. Capturing all information exchanges precisely and truthfully promoted rigor and 
trustworthiness of data and provided an accurate unbiased record of events which did not rely 
exclusively on retrospective participant recall (Coleman, 2000). An added strength of utilising multiple 
methods of data collection in the study, specifically debrief and in-depth interviews, allowed focus on 
participant perspective. The effect of this was twofold in that de-brief interviews captured the 
immediacy of participants perceptions and semi-structured interviews permitted the individual to 
explore their experience of the information exchange process from their own personal perspective, 
whilst standardisation of at least some questions increased data reliability and replication across 
cases. The overriding strength of the study was the multiplicity of participant perspectives and 
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triangulation of data which allowed an in-depth and extensive exploration of the information 
exchange process. 
 
8.3. Limitations of the research 
One limitation related to sample size. Yin (2009) stated that one replication can support analytical 
generalisation and Eisenhardt (1989) specified each case serves as a distinct experiment that stands 
on its own as an analytical unit. Although each of the seven case studies in my research emphasized 
the rich, real-world context in which information exchange and companion influence occurred, case 
size was limited and, although innovative, the findings must be considered judiciously. 
 
A second limitation of the study was the number of patients who were younger and in better health 
recruited to the study. Case selection bias by professionals could have contributed this limitation. 
Although overall cases were a heterogeneous group in terms of gender, cell type, treatment options 
and potential survival outcomes, data analysis showed that patients with advanced cancer could have 
been excluded from the study because their physicians believed it is not in their interest to participate 
or that they were too frail to do so. Professionals are frequent gatekeepers during recruitment and 
wish to protect the more vulnerable, frail and elderly patient population (Holloway and Wheeler, 
2002; Polit et al, 2001). This was evidenced in the current study and cited as a common justification 
for not approaching certain patients. Professionals often face dilemmas when recruiting patients with 
life-threatening illness to research studies and although supportive of the research process have 
concerns about exacerbating anxiety at such a sensitive time in the illness journey (Ewing, Rogers, 
Barclay, McCabe et al, 2004). Such challenges with recruitment resulted in a less than typical case 
selection for this research with the overall effect that the study was unable to present evidence 
regarding both information exchange and companion influence and roles in patients who were elderly 
and with poorer performance status. 
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The final limitation concerned collection of companion demographic data. Both companion 
demographic information and data exploring their perception of the interaction was never requested 
formally. Some companion data was collated retrospectively from transcription narratives and 
researcher field notes. Collection of additional demographic data such as age, professional 
background and educational status would have been valuable when analysing companion 
demographic effect on preference for accompaniment and companion influence on information 
exchange and consequent roles. However, this reflects in part, the true nature of case study research, 
that the true significance of negotiated companion accompaniment and subsequent companion role 
and influence were only identified during the substantive analysis period when emerging theoretical 
propositions were inductively identified. 
 
8.4. Negotiated accompaniment  
This study generated new knowledge regarding the concept of negotiated companion accompaniment 
prior to clinical encounters. Whilst exploring the information exchange process between patients, 
companions and professionals, the study found that companions exerted an influential role on many 
constructs of information exchange. Those companions with a non-negotiated accompaniment to the 
consultation were shown to exert the most significant moderating influence. Within the study patient: 
companion negotiation divided into three distinct categories:  
 
•     Reciprocal: accompaniment was mutually agreed by both participants 
•     Partial: accompaniment partially coerced following companion petition 
•     Non-negotiable: accompaniment was immutable where companions did not broker discussion 
or consent. 
 
My findings indicated when accompaniment was reciprocal or partially negotiated; companions 
predominantly demonstrated a mediating or enhancing influence on information exchange. 
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Conversely non-negotiated accompaniment was associated with vocal and expert companions with a 
significant moderating and controlling influence on information exchange.  
 
Effective negotiation enhances the prospect of purposeful and meaningful communication.  
Conversely, ineffectual or non-negotiation is associated with conflicts and adversarial relationships 
which restrict the full potential of communication and information (Botelho, 1992). Although my data 
could not be informed by empirical evidence on negotiation between patients and companions prior 
to the consultation, investigation of the wider negotiation literature, although limited, demonstrated 
that companion negotiation can increase the dynamics and complexity of both information exchange 
and clinical care in other contexts. Rosenthal, Marshall, MacPherson and French (1980) emphasised 
the problems of both conflict and control, in the negotiated relationship between all care participants 
(patients, companions and nurses) or triads. Patients, companions and professionals came from 
different worlds, brought individual definitions of the clinical situation, as well as various goals. 
Professionals seek to control the clinical conditions of their work, whereas patients and companions 
seek to control the conditions of the clinical experience. Negotiation of control takes place in a 
situation of unequal power between the participants, with professionals operating from the most 
dominant position. In order to control companions within the clinical setting professionals cast them 
into three roles.  
 
•     Visitor: the preferred role as it is the least threatening to professionals 
• Worker: companions adopting a more involved but still subordinate role  
•     Expert: orientated to patient care needs and as a consequence their actions could lead them 
to disrupt the fundamental features of ward clinical work 
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My research correspondingly identified the ‘expert’ role of non-negotiated companions who 
moderated and consequently altered the fundamental features of the information exchange process. 
The companions in my study adopted the role of expert, independent of any other individual, in direct 
contrast to Rosenthal and colleagues’ findings that professionals cast companions in the expert role. 
My research showed that expertise was often conferred through a companion’s established 
relationship and intimate health knowledge of the patient (Allen, 2000); past experience, healthcare 
training and the self-development of disease and treatment related knowledge (Nolan, Grant and 
Keady 1996). All factors which could theoretically have been instrumental in determining the 
moderating companion’s decision not to negotiate their presence at clinic in the first place.  
 
There was no indication in my study these expert companions felt subordinated, with a need to 
negotiate or relinquish control to other members of the triad. Companions came to the clinical 
encounter without negotiating their presence and guided their own information agenda by directing 
and controlling information exchanges. Importantly, they did so independently of any other member 
of the triad. Study evidence suggested that as singular individuals, they were both confident and 
influential in their own right to control the information exchange process, independent of coalition 
formation.  
 
Coalitions occur when two individuals in a triad adopt a common strategy to achieve a mutually-
desired decision despite the active or passive resistance of the third individual (Coe and Prendergast, 
1985). Coe and Prendergast’s analysis of interactions among physicians, elderly patients and their 
companions revealed each encounter involved several coalitions, where the majority of companions 
made efforts to form coalitions with physicians. Physicians are viewed as an important ally for 
companions because of their power and status within the triad. This is contrary to my study data which 
demonstrated that companions seemed unconcerned about the amount of power and expertise held 
by other individuals, relying instead on their own perceived expert status within the triad. 
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In a study exploring ways in which nurses, patients and companions negotiated care and the division 
of labour when patients were in medical wards in the UK, expert companions were found to constitute 
a special case in the understanding of negotiated care (Allen, 2000). Drawing on the three companion 
roles defined by Rosenthal et al (1980), Allen found that expert companions posed challenges to the 
basic features of the social organisation of the clinical work. Fundamentally the negotiation and 
subsequent integration of expert companions was described as problematic because companions 
perceived they were negotiating and delegating care for the patient and subsequently relinquishing 
control to professionals. Companion roles within the triad were identified as the third member and 
stated they were:  
•     mediator (negotiating equally and impartially between the other two) 
• exploiter (seeking to turn a disagreement between the other two to their own advantage) 
•     oppressor (using a divide and conquer process, creating conflict to achieve their own ends). 
  
My data showed, in contrast to Allen (2000), the expert companions in my study portrayed none of 
these roles. Likewise there was no indication of negotiation within the triad at the oncology out-
patient consultation. Clinical context may be an important consideration for negotiating and 
relinquishing control. Allen’s study was in-patient based where triadic exchanges could be more 
prolonged (over days and weeks). Within this clinical context, companions may recognise the severity 
of the patient’s condition and the nature of continual care renders the patient particularly dependent 
on other members of the triad. Subsequently companion expert role is less defined.  
 
My data was consistent with the findings of Hasselkus (1992) whereby companions have moved 
beyond viewing themselves merely as fonts of medical information and historical details, content with 
either forming coalitions with or relinquishing control to other triad participants. In her study 
Hasselkus analysed topical themes and exchanges of meaning between physicians, older patients and 
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family caregivers during medical appointments. Unexpectedly, she found that caregivers contributed 
to traditional physician domains of care such as diagnosis, interpretation of symptoms and treatment 
recommendations much more than anticipated. In line with my findings, companions exchanged 
information around medical aspects of care whilst bringing very little social context to the exchange. 
Companions viewed themselves as integral primary healthcare providers, with their long-term 
experience in monitoring symptoms, controlling medication and taking an active role in the health of 
the patient. This presentation of their role and place within the clinical consultation differs markedly 
from the model of coalitions (Coe and Prendergast, 1985).  
 
Correspondingly, in my study companions acted more as independent practitioners, often as an expert 
and vocal individual for the purpose of fostering their own information agenda rather than in 
contention or even negotiation with the other members of the triad. In her study Hasselkus’s sample 
was derived from an elderly population and it could be considered that companions would be more 
engaged in care activities requiring a high level of involvement when patients were both elderly and 
of poorer health status (Wolff and Roter, 2008). The clinical context within which negotiation 
transpires is an under-researched area and one worthy of further consideration. 
 
My findings of the expert, controlling and non-negotiating companion were distinct to research 
undertaken by Morris and Thomas (2001). The overreaching aim of their qualitative study which 
interviewed 79 carers and patients was to obtain an account of the cancer experience from the carer’s 
perspective. The research primarily focused on how carers negotiated their relationship within the 
medical setting. Unlike my research there was no indication that patients and companions negotiated 
companion presence pre-consultation. Also in direct contrast to the non-negotiated accompaniment 
found within my study, companions in this work were diffident about their place at the consultation 
and required to be ‘invited in’ both by the patient and the professional. Morris and Thomas found 
carers were reticent of entering the consultation, ‘stood back’ without contributing to the exchange, 
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were uncertain of their role and reserved about disturbing the privilege of the doctor-patient 
relationship. Carer diffidence about their role and accompaniment was due to concern about issues 
of confidentiality as well as maintaining a sense of independence for the patient. In my research even 
when companions displayed more neutral influence (Cases B and D) they still contributed to 
information exchange within the clinical encounter, although there was a greater sense of deference 
to the patient rather than diffidence. However, this respect for patient self-determination found in 
the neutral cases in my study was not evident in the replication analysis of some of the mediating 
cases and appeared to be absent in the moderating cases.  
 
Although the primary focus of my study was not on exploring the carer’s place within the clinical 
consultation, my data did not identify with any of the concerns of negotiated identity, support and 
sharing, among the moderating companions, recognised in the research by Morris and Thomas (2001). 
There is no immediate explanation as to why companions in my study were different to those of Morris 
and Thomas (especially as their sample included 10 patients with various stages of a lung cancer 
diagnosis). I have previously hypothesised that both personal characteristics and relationship alliances 
may have a significant influence within my study and the contrast between the two studies points to 
such variables.  
 
My research data also illustrated an important consideration of moderating companion role, namely 
that of reducing collusion between patient and healthcare professionals, especially in relation to 
dialogue surrounding prognostic information. Within my study I viewed collusion in the terms and 
definition postulated by Helft (2005) whereby faced with a sensitive and uncomfortable situation (i.e. 
prognostic information exchange) patients and their clinicians often come to a tacit or explicit 
avoidance of dialogue.  Within my study certain companions recognised this situation and altered 
information content and direction accordingly. Moderating companions were identified as patient 
advocates or surrogates, ‘speaking-for’ their loved one on a sensitive and emotive subject. Mazer, 
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Cameron, DeLuca, Mohile and Epstein (2014) examined pseudo-surrogacy among 46 companions 
accompanying patients with life-limiting cancer to clinical encounters where treatment options and 
outcomes were discussed. They identified a range of companion roles from pseudo-surrogacy 
(companions speaking as if the patient were unable to speak for himself), hearsay, and conflation of 
thoughts to co-experiencing and facilitation. In line with previous research that suggested companion 
role can be both influential but also dominant during clinical encounters (Karnieli-Miller, Werne, 
Neufeld-Kroszynski and Eidleman, 2012), Mazer et al found that companions often advocated and 
spoke on behalf of patients even when the patient was capable of engaging in the exchange. This 
companion role could be seen to either inhibit or enhance patient-centred care (Shepherd, Tattershall 
and Butow, 2008). Mazer et al (2014) warn that such moderating companion influence and 
perspective might sometimes allow him/her to communicate patient held values and concerns often 
more articulately than the patient. At other times is can be unclear whether it is the patient’s or 
companions perspective that is being expressed.    
 
The principle finding which emerged from my data was non-negotiated accompaniment was 
undertaken by expert, moderating companions with the ability to influence meaningful information 
exchange. Within my study, moderating companions often followed their own agenda to achieve their 
individual informational needs independent of other members of the triad. Also study data, in 
agreement with empirical research, demonstrated that companions had both expert knowledge of 
the patient and the healthcare context and viewed themselves equal partners in the information 
exchange process. In contrast to empirical data, moderating companions influenced information 
exchange without forming coalitions with or appearing subordinate to professionals and as referenced 
above, often felt confident to confront collusive situations. 
 
Study findings revealed there may be other factors influential in shaping non-negotiated companion 
accompaniment. In particular, the clinical context appeared germane, as was the timing of 
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information, i.e. around the time of diagnosis and treatment. Within my analysis participants’ 
characteristics, attitudes and interpersonal relationships with each other were further shown to be 
considerations relating to information exchange and companion presence during consultations. 
Consequently, there is an identified need for ongoing research focusing on negotiation within both 
the cancer and non-cancer context, at various stages of the patient journey and with all participants 
involved.  
 
8.5. Factors impacting preference for accompaniment 
The evidence presented in chapter 6 indicated that there were three distinct levels of negotiated 
accompaniment prior to the clinical consultation. There is further evidence that the level of negotiated 
accompaniment was associated with companion influence and impacted on the constructs of 
information exchange within the clinical encounter. My data analysis indicated the level of negotiated 
companion presence may be affected by other considerations namely, participant characteristics and 
interpersonal relationships which exist between them and these will be considered in the next three 
sections.  
  
8.5.1. Patient characteristics impacting companion accompaniment 
Although tentative, a key finding in my data is that although patient demographic characteristics are 
important and worthy of consideration, their companions are still likely to accompany them to the 
consultation irrespective of patient attributes or functional status. A significant difference between 
my data and empirical evidence is the influence that patient demographic characteristics have on 
companion accompaniment to clinical encounters. Although evidence in the literature is inconsistent, 
results from some studies indicate that accompanied patients are more likely to be older, female, less 
educated and in worse physical health (Wolff and Roter, 2008; Schilling et al, 2002; Glasser, Prohaska 
and Gravdal, 2001). My data contradicts these findings especially in relation to age, gender and 
physical functioning.  
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 8.5.1.1. Accompaniment rate: clinical context and age 
Companion accompaniment rate in my study was high (100%). Theoretically there could be a number 
of justifications for such universal accompaniment. The majority of acute teaching hospitals 
throughout the United Kingdom adhere to national cancer guidelines recommending patients are 
accompanied to clinical consultations when information concerning the diagnosis and treatment will 
be exchanged (BTS, SIGN, NICE). Evidence from my study demonstrated that patients may need their 
companion to be present primarily as the diagnosis is cancer, regardless of age and physical 
functioning or because it was recommended.  
 
Wide variation in the rate of accompaniment has been demonstrated according to clinical context and 
population studied. Low rates of accompaniment are found in studies when adult patients attended 
primary care or out-patient clinics (Schilling et al, 2002; Brown, Brett, Stewart and Marshall, 1998; 
Bothelo, Lue and Fiscella, 1996). Accompaniment rate was reported to rise when older patients (> 60 
years of age) visited primary care or care of the elderly clinics (Ishikawa, Roter, Yamazaki and 
Takayama, 2005; Glasser et al, 2001). Accompaniment rate increased within oncology encounters 
(Street and Gordon, 2008) and more so when diagnosis was disclosed (Eggly, Harper, Penner, Gleason, 
Foster and Albrecht, 2011).  
 
In an observational study by Brown et al (1998) to determine the proportion of accompanied patients 
and demographic characteristics, approximately a third of patients were accompanied to family 
practice visits. Children and patients over the age of 75 years were the most frequently 
accompanied.  Adelman, Green and Ory (2000) commented that the one major characteristic that 
distinguished the geriatric medical visit from many other encounters was that often the older patient 
is accompanied by a third person. Accompaniment in this age group is associated with additional 
difficulties encountered by patients such as sensory deficits, cognitive impairment and functional 
limitations (Ishikawa et al, 2005; Wolff and Roter, 2008). Despite two of the patients in my study being 
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over 70 years there was no indication of any significant functional deficits requiring physical assistance 
aside from transport (Adelman et al, 2000). 
 
In a study carried out by Street and Gordon (2008) 64% of newly diagnosed lung cancer patients were 
accompanied to Veterans Affairs medical centre consultations. This figure is markedly lower than the 
accompaniment rate in my study, but may in part be explained by the fact that Street and Gordon 
recruited mainly male Veterans from culturally diverse backgrounds. A small but not insignificant 
number of their sample was African-American men who are less likely to bring a companion to cancer 
consultations (Eggly et al, 2011; Gordon et al, 2006).  
 
Importantly my study demonstrated there was no difference in accompaniment rates with respect to 
age, underpinning the findings by Street and Gordon (2008) who also demonstrated this. My data, 
although comparable with Street and Gordon consisted of a younger group of patients with lung 
cancer (median age = 64 years).  It is not possible from the evidence presented here to state 
categorically why the cases in my study were younger (but selection bias at recruitment may be a 
factor), but age was not a significant influence impacting the rate of companion accompaniment. 
 
8.5.1.2. Accompaniment rate: gender 
Gender did not influence the rate of accompaniment in my study. However my data was based on 
small case numbers and did not reflect the power differentials seen for gender influence in other larger 
studies. There are also inconsistencies highlighted regarding gender within the empirical data. In the 
systematic review conducted by Laidsaar-Powell et al (2013) two studies found that accompanied 
patients were more likely to be female (Glasser et al, 2001). Brown et al (1998) concurred with this 
finding that female patients were more likely to be accompanied to family practice visits. 
Nevertheless, in the Brown study, accompanied females were often elderly and accompanied by 
elderly female siblings. Equally, gender was found to have no bearing on rate of accompaniment in 
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other studies (Eggly et al, 2011; Ishikawa et al, 2005; Labrecquel Blanchard, Ruckdeschel and 
Blanchard, 1991). Ishikawa et al (2005) reported male patients were frequently accompanied more 
than their female counterparts. However, cultural differences and the collectivist culture in Japan may 
have influenced male accompaniment rate in this study where, out of elder respect, it may be the 
norm for elderly males to be accompanied. Further research is required to determine if demographic 
variables, influential in some international studies, reflect cultural and historic practices (Andrades, 
Kauser and Ambreen, 2013; Ishikawa et al, 2005).  
 
  
8.5.1.3. Accompaniment rate: educational status 
My findings suggested educational status to have little influence on accompaniment as across cases 
there was homogeneity within this domain (i.e. the majority of cases had secondary school education). 
Empirically it has been shown that patients with less educational status are most frequently 
accompanied to clinical encounters (Ishikawa et al, 2005; Wolff and Roter, 2008; Schilling et al, 2002). 
Of relevance to my data is that two of three studies which showed no influence by educational level 
were conducted in the oncology setting. My findings paralleled those of Street and Gordon (2008) 
who failed to identify any relationship between educational status and companion accompaniment in 
a lung cancer setting. 
 
8.4.1.4. Accompaniment rate: disease and physical status 
Two key findings emerged from my research concerning physical status and accompaniment. Firstly, 
the majority of patients (n=5) in my research were diagnosed with advanced disease with treatment 
intent palliative. Uncharacteristically, despite advanced disease, all of the cases had good 
performance status and functional ability. Disease classification and poorer health status are two of 
the most significant factors influencing the frequency of companion accompaniment to clinical 
encounters (Street and Gordon, 2008). Contrary to existing research although all patients in my study 
experienced good health and physical function, they were all accompanied to all of their consultations.  
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 Secondly, despite awareness that information exchange within the clinical encounter would involve 
discussion concerning complex therapies and treatment outcomes, some patients did not wish to be 
accompanied to the consultation. This finding contradicted literature which suggested when patients 
are faced with uncertainty and anxiety they seek companion presence at consultations (Labrecque et 
al, 1991) and companion presence at oncology consultations is seen as normative among cancer 
patients (Beisecker and Moore, 1994). The negotiated nature of accompaniment identified in my study 
indicates this is not universally the case for all patients within this clinical context.   
 
In conclusion, my analysis revealed that despite advanced disease and uniformly poor prognostic 
outlook, none of the patients had poor functional ability, yet there was universal accompaniment. By 
contrast other research showed patients are more likely to be accompanied to consultations when 
they have worse physical health and poorer functional status (Wolff and Roter, 2008; Ishikawa et al, 
2005; Schilling et al, 2002; Labrecque et al, 1991). I consider that the nature of the disease itself is a 
key feature of accompaniment even in the absence of poor health status. Data analysis would suggest 
that of patient related characteristics, health status and more pertinently the nature of the disease 
are the principal variables influencing companion accompaniment, as there is no overall effect noted 
from the other variables discussed above. Even when patients are functionally well and wish to be 
unaccompanied, companion presence still prevailed.  
 
8.5.1.5. Companion characteristics and interpersonal relationships impacting accompaniment 
Although my data did not demonstrate patient characteristics as a major influence on negotiated 
accompaniment, companion characteristics and interpersonal relationships between patients and 
companions appeared to have been a more persuasive influence on companion presence. My findings 
corresponded with recent literature in terms of companion gender but contrasted with relationship 
characteristics. Wolff and Roter (2011) in their meta-analytical review of 17 quantitative studies 
investigating the dynamics and consequences of patient accompaniment found that companions were 
232 
 
on average 63 years of age and predominantly female (79.4%). Patients were accompanied in 54.7% 
of cases by spouses followed by adult children (32.2%). Systematic review of mixed method research 
also identified the same companion demographics and interpersonal relationships internationally 
(Laidsaar-Powell et al, 2013). 
 
A higher accompaniment by adult children in my research may have reflected both divorce and 
widowed status. In my study only two of the cases were currently married (Case D and F) and they 
were accompanied by their spouses. Case G was accompanied by his ex-wife. The remaining cases 
were either widowed (Cases A, B and C) or divorced (Case E). Theoretically these cases may have been 
accompanied by spouses under different circumstances. Instead adult children and a sibling fulfilled 
the role of accompanying companion, with information exchange ultimately impacted by 
accompanying companion composition and moderating behaviour.  
 
Of the three cases in my study with the most moderating companions with non-negotiated presence, 
two were males (an adult son [Case E] and a brother [Case C]) and two were females (adult daughters 
[Cases E and F]). Likewise my data analysis showed that in other cases where moderating behaviour 
was demonstrated and presence was partially negotiated (Case A – Agnes and Case G, Grace) female 
companions were more verbally dominant. This is consistent with other studies which demonstrated 
that female companions tend to be more assertive and dominant than men when interacting at 
consultations (Glasser et al, 2001). Contrary to research which suggested that verbally dominant 
companions facilitated patient involvement in the medical visit by prompting patients to ask questions 
and interact in dialogue, subsequently promoting patient autonomy; among the most moderating 
companions in my study there was no indication that patient autonomy guided the agenda (Clayman 
et al, 2005).   
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Substantive data analysis allowed significant themes to emerge inductively which showed some 
companion personalities as expert, controlling and moderating. Identification of these companion 
personality traits allowed my research to illustrate behaviours had significant influence on negotiated 
or more pertinently non-negotiated accompaniment and consequent information exchange. Data 
demonstrated these companions were vocal and often opinionated even in clinical encounters with 
experienced professionals. Despite widespread agreement regarding the importance of companion 
involvement and support in the context of cancer consultations, a review of the literature discloses a 
relative dearth of research investigating the personality traits and behaviour of companions during 
clinical consultations (Eggly, Harper, Penner, Gleason et al, 2011). Despite recognition that companion 
behaviour affects the dynamics of all stages of the triadic interaction, where even in a single visit, 
companions may range from facilitative and supportive to argumentative and controlling (Albrecht, 
Eggly and Ruckdeschel, 2010), research has focused less on companion personality traits and more on 
demographics such as race and age (Street and Gordon, 2008). 
 
My findings appear to correspond with the perspective of earlier researchers who presented ideas on 
the nature of both negotiation and triad behaviour whereby interactions may change depending on a 
variety of factors, not least the characteristics and relationships of its members (Kleinman, 1979). My 
analysis indicated that both negotiated accompaniment and the information exchange process was 
more moderated when the patient was female and the accompanying companion was an adult child 
(of either gender) or a male sibling. Yet as discussed in chapter 6, none of the female patients with 
moderating companions were passive recipients of care, in poorer health or elderly. My data failed to 
highlight specific patient characteristics which could account for such moderating influence from 
companions.  
 
Therefore, it could be suggested that the interpersonal relationships between these three patients 
and companions influenced accompaniment. Relationships co-existed or ‘fitted’ without negotiation 
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of their mutual relationships, but were also persuasively governed by strong, expert companions who 
were likely to attend the consultations as a direct result of their own personalities and agendas, 
irrespective of patient preference or characteristics. 
 
Co-existence and negotiated care were themes identified when Coeling, Biordi and Theis (2003) 
described the ways in which companions and patients negotiated the rules that influence the care 
experience. Their qualitative study was part of a larger examination of 60 care dyads and their use of 
respite care in the Midwestern United States. Using content analysis they analysed the data from 
interviews conducted between caregivers and care-receivers to suggest how the care experience ‘fits’ 
into their lives. They constructed the theory of caregiver and care-receiver dyadic identity, which was 
mutually agreed upon when both parties negotiated a set of rules about their conduct together and 
their relationship.  Importantly, the rules which govern the relationship can be consciously decided or 
implicit and taken for granted (Botelho, 1992).  In comparison with my findings, Coeling et al found 
that relationships can co-exist regardless of whether the contributions from each member are equal. 
Conceptually, one party can be more controlling and give more than the other. Dyadic negotiation and 
relationships take place within an important social context, with its attendant conditions, which 
include both individual perceptions of the relationship and the issues which are important to each 
individual (Morley, 1986).  
 
Although Coeling et al (2003) advanced the theory of both dyadic negotiation and the influences on 
care processes and outcomes; they failed to investigate the ways that processes are influenced by age, 
gender, ethnicity and other demographic and relationship variables. Like other empirical studies and 
my own research, the opportunity was lost to capitalise on this significant area of research. What my 
study provided was an important opportunity to identify moderating companions and the influence 
of their behaviours on both negotiated-non-negotiated accompaniment and information exchange 
within the triad encounter. Future research should focus specifically on what aspects of companion 
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demographic variables and patient-companion relationship alliances impact on dyad negotiation 
relating to companion accompaniment. 
 
8.6. Perception of companion accompaniment 
This study provided an important opportunity to advance the understanding of companion 
accompaniment at clinical consultations and their subsequent influence on information exchange. It 
specifically identified six constructs which were moderated and mediated by companions within 
triadic encounters. Additionally, the opportunity to understand the perception of patients and 
professionals regarding companion accompaniment and influence was afforded during this research. 
There has been little research exploring triadic relationships and what evidence there is historically 
focused on encounters involving care of the elderly (Haug, 1994). The patient-physician-companion 
interaction at consultations is complex. Each member of the triad brings different perspectives to the 
encounter (Quinn, Clare, McGuinness and Woods, 2012). My study demonstrates the divergent 
viewpoints of patients and professionals and provides new knowledge relating to triadic perception 
within the oncology context. 
  
8.6.1. Patient perception 
In my study there was no indication that patients perceived companion accompaniment negatively. 
Even when companions moderated the information exchange process there was no suggestion that 
patients were dissatisfied with companion input. Equally in cases where companions either negotiated 
their presence (Cases A, B and G) or where accompaniment was non-negotiated (Cases C, E and F), 
patients appeared content with companion level of involvement. 
 
Analysis revealed that Cases A and B wanted to attend the clinical consultation on their own. Both 
men viewed accompaniment as an additional burden for companions. They felt strongly about the 
avoidance of companion burden. Self-perceived burden is an important issue faced by patients with 
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cancer, with over 70% of patients with advanced cancer reporting mild to extreme levels (McPherson, 
Wilson and Murray, 2007). Posing a burden to companions has emerged consistently in qualitative 
research as a domain relevant to quality care at end of life (Singer, Douglas, Martin and Kelner, 1999); 
the maintenance of dignity and is an important consideration in actual treatment related decisions 
(Ashby, Kellehear and Stoffell, 2005). 
 
However, despite strong feelings regarding non-accompaniment and following negotiation with 
companions, both cases acceded to companion presence. This finding was in contrast to Beisecker and 
Moore (1994) who found that although patients generally preferred accompaniment, they also 
believed they should be the one who decided whether companions attend. Additionally Case B 
strongly believed he alone should have autonomous ownership of information exchanged about his 
diagnosis and treatment with the inclusion of family members at his discretion.  
 
Benson and Britton (1996) found that overwhelmingly patients opposed companions influencing 
information that was provided to them, with notions of ownership of body, illness and information 
mentioned by over 60% of the patients they surveyed. Acknowledgement of the needs and wishes of 
their loved ones was the reason for A and B finally acquiescing and agreeing to accompaniment.  
 
Allowing for different levels of negotiated accompaniment in my study, overall patients commented 
favourably on companion involvement across cases. Patients appreciated companion involvement in 
information seeking, clarification and retention. This is consistent with the existing literature 
examining patient preference for companion involvement in consultations which also demonstrated 
that companion participation is generally accepted and welcomed (Repetto, Piselli, Raffaele and 
Locatelli, 2009). Patients in my study commented that emotional support or being present were also 
important companion roles and again this finding is illustrated empirically (Repetto et al, 2009; 
Kimberlin, Brushwood, Allen, Radson and Wilson, 2004).  
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Notably none of the patients in my study reported that companion accompaniment impacted 
negatively on any aspect of information exchange. Similarly, none of them wished in hindsight to be 
unaccompanied, even in the most moderating and non-negotiated cases. My findings reflect those of 
Schilling et al (2002) who found 84% of patients attending primary care consultations stated 
companion presence very helpful. Of the patients who were unaccompanied, 16% regretted their 
decision and thought in hindsight having a companion would have been beneficial (Schiling et al, 
2002). Data described in section 7 noted that even in the most moderating of information exchanges; 
patients did not comment that the process was made untenable by companion influence. However, 
several other studies have shown companion presence and role within the consultation can impact 
negatively on information exchange (Brown et al, 1998; Hasselkus, 1992; Labrecque et al, 1991). 
Companion involvement can reduce direct interaction between patient and professionals; with 
patients in accompanied visits found to be excluded from companion-professional conversations and 
ultimately less involved in joint decision-making (Greene, Adelman, Friedman and Charon, 1994).  
Within my study there seemed to be an implicit acceptance of moderating companions and as 
illustrated this may be a direct consequence of patient-companion established relationships. Exploring 
the association between patients’ expectations regarding the communication role of companions, it 
was found that while patients varied in their ratings of companion helpfulness, few reported any 
disadvantage to having a companion present (Ishikawa, Roter, Yamazaki, Hashimoto and Yano, 2006). 
A caveat of the Ishikawa and co-workers’ study is that the setting was a Japanese geriatric clinic where 
cultural and traditional deferential views of relationships may strongly influence outcomes. That said, 
reflecting my data, these same relationship factors may account for the fact that patients are often 
routinely accompanied to their hospital visits by companions where relationship bonds are firmly 
established and the interplay of family relationships and individual personality ‘quirks’ and traits are 
well known to both patient and family (Ishikawa et al, 2006).  
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 Within my research there appeared to be an implicit acceptance and understanding of companion 
dynamics and relationships. Difficulties and strategies of involving family members with dysfunctional 
dynamics in cancer care was a theme explored by Speice et al (2000). They found while companions 
are an integral part of patient care, they bring with them a range of emotional reactions, interpersonal 
dynamics and expectations. Often these dynamics exist prior to the diagnosis and frequently become 
exacerbated by it. However, as disruptive and dysfunctional as companion personality traits and family 
relationships are, they are often interconnected and more likely accepted by patients. Patients are 
used to dealing with their own family dynamics and any chaotic responses and behaviours (Speice et 
al, 2000).   
 
My data analysis indicated even when companions exhibited moderating influences within the 
consultation; this may be their usual dynamic. Consequently patients accepted and allowed without 
complaint moderating behaviour and its subsequent effect on accompaniment and information 
exchange.  
 
8.6.2. Professional perception 
A central finding in my data analysis was the difference between the patient and professional’s 
perception of companion accompaniment. Analysis showed whereas patients were accepting of 
companion accompaniment and influence on information exchange, professionals appeared less so. 
Three professionals gave unsolicited opinion concerning the most moderating behaviours of 
companions, explicitly Cases C, E and F, the three non-negotiated accompanying companions 
identified in the study. My data demonstrated patient and professional perception of companion 
accompaniment were polarised. Essentially, patients remarked only on mediating and supportive 
influence, whereas professionals expressed opinion exclusively on moderating behaviours.  
 
239 
 
Companion expertise, control and agenda were identified as the three principal influences inextricably 
linked and affecting the dynamics of information exchange within the current study. Analysis 
demonstrated professionals also perceived companions used control and their own agenda to 
moderate and influence the direction and content of information. Companions within my study were 
shown to promote their own information agenda, which at times appeared different to that of the 
patient’s and the professional’s. Agenda setting and the companion as an expert practitioner are 
issues identified as potentially problematic both in my data and elsewhere in the literature.  
 
Hasselkus (1992) explored family caregiver-professional relationships in the medical setting when the 
patient was elderly. In line with my findings Hasselkus’s data showed whereas companions believed 
they acted as primary care givers interacting as a second practitioner with the professional, physicians 
viewed the companion as a patient substitute and an alternate source of information. Similarly, my 
results showed companions acted as independent practitioners to further their own information 
agenda. Also the more attention given to companion information agenda the less consideration was 
given to patient and professional agenda.  
 
My data showed that departure from professional clinical agendas can cause discord with physicians 
who perceived that clinical information was neglected in pursuit of a different agenda by 
companions.  The relationship between agendas and physician stress was noted in a study by Yaffe 
and Klvana (2002). Exploring family physician attitudes to interfacing with family caregivers, they 
found that although most family doctors believed it was their responsibility to address companion 
concerns within triadic encounters, 81% found this activity stressful. A significant cause of stress was 
different agendas or conflicting responses from patients and companions. Differing care needs 
between the two was a cause of much concern for doctors which created additional complex 
challenges as companion agenda took precedent over those of the patient (Yaffe and Klvana, 2002). 
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Companion agenda was a significant construct identified in my data and comparable to research by 
Schilling et al (2002). These authors discovered that whilst companion accompaniment favourably 
influenced patient and physician understanding, it could also add greater social and medical 
complexity. Echoing earlier studies, my research identified companions discussed their own agendas, 
and influenced the encounter with moderating or controlling behaviours towards the patient 
(Labrecque et al, 1991).  
 
There was no evidence of stress among professionals in my study. However companion presence 
appeared to increase the complexity and dynamics of the consultation resulting in moderating and 
controlling influences which altered the content and direction of the encounter. Although data 
showed that companions were vocal and influential and pursued their own information agendas, 
there was no evidence in my research that companion accompaniment rendered information 
exchange untenable.  
 
Still, Greene et al (1994) cautioned that the presence of a companion can impact on clinical practice 
significantly. Investigating the effects of the presence of a third person on the physician-older patient 
medical interview, these researchers concluded companion presence can limit the exchange of 
information and the establishment of good rapport between patients and physicians. Green et al also 
found that patients often raised fewer issues and are less assertive in the presence of a companion, 
thus potentially failing to address their own agenda. Importantly when companions do raise concerns 
they may not reflect the patient’s needs and current concerns. In accord with my data these 
researchers concluded that patients and companions may attend the consultation with very different 
agendas and the presence of a companion could undermine the development of a trusting patient-
physician relationship which consequently compromises patient care (Greene et al, 1994). 
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8.7. Patient – professional discordance  
My analysis revealed a measure of patient and professional discordance as a consequence of differing 
perceptions of companion accompaniment. Results showed that patients and professionals had 
polarised perspectives especially pertaining to moderating companion behaviours. Importantly 
patients did not voice any concerns regarding moderating behaviours such as companion control or 
more specifically companion agenda, which influenced both accompaniment and the information 
exchange process. In contrast, in some cases professionals expressed opinions on moderating 
behaviours which impacted the content and direction of the consultation information exchange. 
Recognising the negative impact of moderating behaviour, one professional within my study also 
recognised the potential impact on clinical patient care. Understanding patient healthcare beliefs, 
values and preferences is a fundamental feature of patient-centred care (Epstein and Street, 2007); 
with any lack of agreement or impasse potentially signalling a deficiency in patient clinical care 
(Epstein and Peters, 2009).  
 
Current evidence indicates that professionals often have a poor understanding of patient perspective 
and little insight into the patient as person, including prior behaviour or family involvement (Duggan, 
Geller, Cooper and Beach, 2006). Street and Haidet (2011) explored factors affecting physician 
understanding of patient health beliefs using a cross sectional, observational method of 207 patients 
and 29 primary care physicians. They determined that the physician’s perceptions of health beliefs 
differed significantly from patients. Similar to my data, physicians had a relatively poor understanding 
of patient perception of health beliefs; believing patient beliefs mirrored theirs with a level of shared 
understanding. Additionally, physicians perceive the quality of their interactions with patients 
differently from patients with a tendency to under-estimate patient desire for information (Willems, 
De Maesshalck, Deveugele, Derese and De Maeseneer, 2005) and shared decision-making (Bruera, 
Sweeney, Calder, Palmer et al, 2001).  
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 However, in parallel with my findings, there was a recognised discord between physicians and patients 
not just on the outcome of the medical encounter but also the nature of the health condition being 
addressed. Street and Haidet (2011) suggested physicians may misperceive how patients understand 
medical issues and point to the need for both parties to develop shared understanding within clinical 
encounters. This would seem especially relevant within the oncology context where complex 
information is exchanged at triadic encounters. 
  
8.8. Summation 
Within lung cancer management this study made a new contribution to the body of evidence by 
exploring information exchange between patient, companions and professionals. The findings 
discussed in the sections above suggest that companion accompaniment to lung cancer consultations 
is often a negotiated process. When the accompaniment is identified as non-negotiated it is 
predominantly by companions who moderate the information exchange process. Persuasive 
influences shaped negotiated accompaniment and are summarised as (i) factors impacting preference 
for accompaniment (ii) perception of companion’s accompaniment and (iii) patient-professional 
discordance. Having identified these influences and discussed them in relation to the wider literature 
each of these will be explored in relation to implications clinical practice and future research in the 
concluding chapter. 
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Chapter 9. Conclusions and recommendations clinical practice and future 
research  
9.1. Introduction 
The aim of the final chapter is to summarise the key findings and relate them to implications for clinical 
practice. The chapter will conclude with my recommendations for future research.  
 
The research used a multiple case study design, informed by a constructivist paradigm, to explore the 
exchange of information between patients, companions and professionals at lung cancer 
consultations. It is a design appropriate to investigating new subject areas, when resultant theory is 
often novel and empirically valid and this approach to lung cancer management had not been reported 
previously in the literature.   
 
9.2. Conclusion of the thesis and key findings 
Findings in the preceding chapters suggest that, whilst exploring the original concept of information 
exchange between study participants during lung cancer consultations, new emerging theoretical 
propositions were identified in relation to influential factors impacting the information process during 
these clinical encounters. Information content (what information was exchanged and not exchanged) 
was an important consideration, but across cases, was carried out to a level which appeared to have 
utility for all triad participants. Data showed there may have been other contextual factors influencing 
the content and direction of information exchange. Results from the analysis demonstrated that 
accompanying companions emerged as an influential factor during the clinical encounter. 
 
The findings provided new insight into companion presence during cancer consultations as mediating, 
moderating or neutral influences, adding to an existing knowledge base regarding the specific 
constructs impacted. However, in terms of emerging theory my study further conceptualised and 
refined these constructs to specify the distinctive role companions of patients with lung cancer 
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assumed. Data analysis showed that in some cases companion presence at lung cancer consultations 
was found to be a non-negotiated accompaniment.    
 
Significant interrelating factors influencing non-negotiated companion accompaniment emerged from 
my research and I considered these emerging concepts to have clinical relevance in terms of 
contemporary cancer practice. 
 
9.3. Summary of key findings 
1. Content 
Recognising the influence companions have on the content and direction of the information exchange 
process, as conceptualised by Charles et al (1999), was crucial. The positive influence of accompanying 
companions, identified in the literature, on patient-professional interactions supports the value of 
companions being present during consultations. Equally useful is identifying when the role is non-
supportive and challenging to both patient and professional information exchanges and deviates from 
important clinical interactions, as was the situation in the most moderating of cases in my study. 
 
2. Demographic characteristics 
There was universal accompaniment to consultations. Although accompaniment to consultations 
appears to be unanimously accepted, some patients would prefer to be unaccompanied to the clinic 
encounter. Accompaniment occurs via a process of negotiation. Non-negotiated companion presence 
is associated with expert companions who moderate the information exchange processes with skilful 
use of their own information agenda. Importantly companion presence was determined by a range of 
variables connected to levels of negotiation and characteristics of patients and companions. The 
breadth of studies in triadic clinical encounters addressing negotiation is narrow, unreported in the 
out-patient oncology setting and rarely concentrates on the demographic variables of all participants. 
However, it was specifically companion attributes as well as interpersonal relationships which 
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appeared to determine the level of both negotiated presence and moderating companion behaviour. 
Of particular interest is that healthcare teams recommend to patients with lung cancer that they are 
accompanied to clinical consultations. Such recommendations are endorsed in national policy 
directives (BTS, 2013; NICE, 2005; SIGN, 2005).  
 
3. Preference for and perspective of accompaniment 
Despite the dynamics and complexities of the consultation being moderated by companions, there 
was no evidence to demonstrate that patients found companion presence and subsequent influence 
untenable. Even among those patients who stated their original preference was for an unaccompanied 
consultation, moderating companion presence was accepted. However, within the study professional 
perceptions of moderating influence conflicted dramatically, with recognition that the complexity and 
direction of clinical information could be compromised by companion presence. 
 
4. Discordance 
 Discordance between patient and professional perception of the utility of companion accompaniment 
was evidenced during this study. In some encounters incongruence was manifest between the 
perceptions of two key members of triad, with a potential to impact clinical care at a fundamental 
level. Such discordance identified within my data may well illustrate that patients and professionals 
assess the clinical encounter and the component parts of it, differently, ultimately leading to divergent 
perceptions and goals during the consultation and process of information exchange.  
 
9.4. Implications for practice 
The results of this study have clinical implications for practitioners involved in the informational and 
care needs of patients and companions within the oncology setting. Although companions are often 
perceived as helpful within the consultation and their presence can result in perceived benefits such 
as increased patient understanding and improved quality and quantity of information, based on the 
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findings of my study there needs to be a greater understanding among professionals of the ways in 
which information exchange can be influenced by companions. 
 
The emerging theory suggested that expert companions adopted a significant moderating role and 
controlled many aspects of informational content. Findings suggest that professionals should be 
aware of and respect patient preference regarding companion involvement. This in some ways 
contradicts policy initiatives which recommend, often universally, that patients should be actively 
encouraged be accompanied to the clinical encounter (BTS, 2013, NICE, 2005, SIGN 2005), when in 
fact unwanted accompaniment may result in negative outcomes for patients. 
 
The following key points are drawn from the findings of the substantive analysis of the emerging 
theoretical proposition: 
 
o Professionals may find it worthwhile to seek clarification of companion role and purpose of 
accompaniment at the outset of the consultation. Ascertain from the patient and/or the 
companion why the companion has accompanied the patient to the clinic encounter, 
especially as there may be discordance between the patient and companion perception of 
accompaniment 
o Be aware and respect patient preference for accompaniment – if patient preference is to 
retain control over the informational content and decision-making role then this should be 
respected. Professionals should be cognisant that companion accompaniment is often non-
negotiated and has the express aim of satisfying companion and not patient agenda.  
o If companion led agenda is evident, it may be useful to highlight helpful companion behaviours 
and discuss the various supportive roles companions can adopt 
o Reflect upon your own practice, recognising where discord may be apparent and 
communication blocking techniques may be employed 
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o Consider national guidance which recommends almost universal accompaniment to 
consultations and respect patient preference for accompaniment. 
 
9.5. Recommendations for future research 
Several implications for future research were identified. They come with the caveat that the sample 
size in my study was small. 
 
1. The clinical and social context of the disease process and the stage of the care pathway is 
worthy of further investigation. For example, are companions more involved and influential 
in the diagnostic phase of the disease process or does moderating influence continue into 
post-therapy follow up and survivorship stages of the continuum?   
2. Companion roles appear to vary considerably and do so depending on perceived need of 
individual patients. Other characteristics and variables, such as companion personality and 
demographic attributes, as well as relationship alliances, may also influence information 
exchange. These require further assessment. 
3. There is little contemporary evidence to inform both the role and impact of negotiated 
companion accompaniment at out-patient clinical encounters. This needs to be studied 
further. 
4. A study documenting the characteristic attributes and preferences of patients who prefer to 
attend consultations unaccompanied would be recommended. A clearer understanding is 
required of how the specific needs and characteristics of patients influence companion 
accompaniment.  
5. There is a paucity of data within oncology settings relating to the impact of patient-
professional discordance and its effect on information exchange and clinical care processes. 
As discordance has the potential to negatively impact clinical care further research in this vital 
area would be valuable. 
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Gentle reminder to patients about their immediate debriefs interview answers. 
Clinic consultation 
Main topic question 
Generally looking back over your clinic visit(s) how do you think they went? 
Prompts & supplementary questions 
Is that what you expected? 
Who did you see? 
Support for you at clinic 
Main topic question 
Was it a conscious decision to take …companion to clinic? 
Prompts & supplementary questions 
Can you tell me why this was the way you did it? 
Was that the right decision to attend in this manner? 
Information which the healthcare professional gave to or withheld from you 
Main topic question 
Can you remember what things you spoke about? 
Prompts & supplementary questions 
Was the hcp more interested in physical problems (such as breathing or pain)? 
Did they discuss other concerns i.e. emotional matters, psychosocial concerns, and financial problems? 
Is this really what you expected to be discussed? 
Thinking back to the visit do you think the healthcare professional(s) gave you as much information as 
you would have liked? 
Was there too much or too little information? 
Do you remember what information you did receive? 
Was there information, which you were expecting to get that perhaps you, didn’t (can you give me any 
examples?). 
Did you ever experience a sense that they were holding back from you? 
Can you please give me any sense in what way this was apparent? 
How did this make you feel? 
Appendix 1. Interview Guide
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Information which you gave to or withheld from the healthcare professionals 
Main topic question 
Can you tell me if you covered all the points you wanted to on the day? 
Prompts & supplementary questions 
Was there information you knew you had to tell the hcp and why it was important? 
Was it more important for you to discuss the physical/psychosocial aspects of your illness? 
Did you feel you held back telling them everything? And if this was the case why did you do so? 
A week or two down the line do you wish you had given them this information? 
Effect if any of withholding information 
Main topic question 
If you have felt that information has been withheld on both sides; is it possible for you to say if 
withholding any information has in anyway had an impact (positive or negative) on your care?  
Prompts & supplementary questions 
Do you for example think you could have had your concerns/needs discussed and addressed properly if 
there had been a fair exchange of info? 
Do you think it would have led to you making different decisions regarding treatment or your care in 
general? 
Interacting with clinicians 
Main topic question 
For you personally is interacting and exchanging information with your clinician important to you 
Can you explain your answer please? 
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cancer 
09/50703/106 
Committee reviewed the above 
you for attending to discuss the 
committee discussed at length and had several 
which were to their satisfaction namely: 
a) of the numbers in each group.
at the 
the 
b) Is each site/clinic involved in the tape recording. Are going to tape whole 
consultation?
c) Are they comparing like with like?
d) Has the researcher got some back-up in case of upset?
e) Are they going to provide a copy of the tape recording of the consultations to the
participants if requested?
f) How are healthcare professionals being approached?
on 
g) The committee thought that the interviews with healthcare professionals would last more
than 5 minutes?
h) Question 6.2 - how many sites involved?
i) The committee wondered why men are not being included?
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NHS sites 
from 
study (see "Conditions of the favourable opinion" below). 
opinion is subject to the following conditions met to 
Management permission or approval must be obtained from each host organisation prior to 
the start of the study at the site concerned. 
For NHS research sites only, management permission for research ("R&D approval'? should 
be from the relevant care organisation(s) in accordance with NHS research 
governance arrangements. Guidance on applying for NHS permission for research is 
available in the Integrated Research Application System or at http://www.rdforum.nhs.uk. 
Where the only involvement of the NHS organisation is as a Participant Identification 
Centre, management permission for research is not required but the R&D office should be 
notified of the study. Guidance should be sought from the R&D office where necessary. 
Sponsors are not required to notify the Committee of approvals from host organisations. 
Other conditions specified by the REC 
The committee require the undernoted minor clarifications/amendments to both the Study 
Design and Information Sheets 
Study Design: 
a1 Question A71-2 should read 2 sties - not 1. 
o) Data should be stored for longer than 3 months.
o, Do patients know that the researcher is getting information about them from their
consultant?
d) The committee noted that the Insurance Certificate is out of date.
Information Sheets for Healthcare workers. 
,.;1) Participants should be informed whether they will be using own time or work tlme for this 
research. 
b) Section "Who has reviewed this Study"- delete any reference to the "IRAS system and·
a!ily reference to the "Ethics committee at th " etc (there is no Ethics 
.committee at the Golden Jubilee). The wordi ct of Ethics Committee should read 
"This study has been reviewed by the' (1) REC". Any reference to
"Trust" should read "Board". 
Information Sheet for Patients: 
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to the 
"Who has reviewed this study" - amend as 
9) Patients should be of the exchange of information between 
'professional and the researcher. 
Consent Form for Patients: 
a) A further box should be added in respect of their agreeing to the exchange their
information between healthcare professional and researcher.
It responsibility of the sponsor to ensure that all are with 
before the start of the study or its initiation at a particular site (as 
Approved documents 
documents reviewed and approved at the meeting were: 
Document Version Date 
Covering Letter 07 September 2009 
REC application 07 September 2009 
Protocol 07 September 2009 
Investigator CV 20 August 2009 
Participant Information Sheet: Healthcare Professional 4 24 August 2009 
Participant Information Sheet: Patients 4 24 August 2009 
Participant Consent Form: Healthcare Professionals 4 24 August 2009 
I Participant Consent Form: Patients 4 24 August 2009 
Letter of invitation to participant Healthcare 24 August 2009 
Professional 
s V4 
GP/Consultant Information Sheets 4 24 August 2009 
Evidence of insurance or indemnity 01 May 2009 
Letter from Sponsor 01 May 2009 
Interview Schedules/Topic Guides 4 01 May 2009 
Letter of invitation - Patients 4 124 August 2009 
CV for supervisor 4 25 August 2009 
Membership of the Committee 
The members of the Ethics Committee who were present at the meeting are listed on the 
attached sheet. 
Statement of compliance 
The Committee is constituted in accordance with the Governance Arrangements for 
Research Ethics Committees (July 2001) and complies fully with the Standard Operating 
Procedures for Research Ethics Committees in the UK. 
After ethical review 
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ethical review - guidance for 
on reporting requirements for studies with a favourable opinion, 
• Notifying substantial amendments
• new and 
• Progress safety reports 
• Notifying the the study 
NRES website also provides guidance on these topics, 
changes in reporting requirements or procedures. 
is in the light of 
We would also like to inform you that we consult regularly with stakeholders improve our 
service. If you would like to join our Reference Group please email 
I 09/50703/106 ______ _____ P_ le_ a_ s_ e�q_u _ot_e _  t_h_is _n_ u_m_b_ e_ r_ o_ n_a _l l_c_o_r _re_s�p_o_n_d_e _n_c_e_,/ 
With the Committee's best wishes for the success of this project 
Enclosures: 
Copy to: 
List of names and professions of members who were present at 
meeting and those who submitted written comments 
"After ethical review - guidance for researchers" 
Carol Johnstone, 
Business Development Manager 
University of Stirling 
Stirling FK9 4LA 
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Our Ref: 
Enquiries to: 
Direct Line: 
e-mail:
EP/LR 
26th Jan 2010 
Gl2 0YN 
Dear Ms 
R&D Reference: GN090N3 71 
REC Ref: 09/S0703/106 
between women with lung cancer and healthcare 
professional at diverse clinic consultations. 
I am pleased to is now able to grant 
Management Approval for the above study. 
As a condition of this approval the following information is required during the lifespan of 
the project: 
1. SAES/SUSARS - ff the study is a Clinical Trial as defined by the Medicines
for Human Use Clinical Trial Regulations, 2004 (CTIMP only)
2. Recruitment Numbers on a quarterly basis (not required for commercial trials)
3. Any change of Staff working on the project named on the ethics form
4. Change of CI
5. Amendments - Protocol/CRF etc
6. Notification of when the Trial I study has ended
7. Final Repo1i
8. Copies of Publications & Abstracts
Please add this approval to your study file as this letter may be subject to audit and 
monitoring. 
Yours sincerely 
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Dear Mrs Smith, 
Manageme�t Approval for a non-eommerdal research project 
I am P.1. eased t.o tell you tha.t y. ou n.ow have Manag.ement Approval. 6. or. the .resear. 
ch _project
entitleii: Intormation exchange between women with lung cancer and healthcare 
professionals at diverse clinicaf consultations. I acknowledge that: 
, The proj�t is sponsored bythe U.nivenityof Stirling. .. . .. .. _ . _ .. 
• Researc.ih· .. Ethics �pr. oval for the. project. 
has b
. 
ee.n obtai.
ned from the West of Scotland
Rese,arch Ethics Committee 1 (reference number: 09/80703/106). 
• The Sitf Spec we form for this project has been reviewed and there_ is no objection to it
pm� lllg at _this$1le. .· <:, ,. . i _ .. 
The followin1; conditions apply: 
• � study will be subject !O ongo� monitoring for Research Governance purwses and may be
audited to. ensure comphance with. t9e Research Governance Framework for Health and
_ Gonun�_Care in�Setltlao.d(20U6,2 �EditiOOh lwwexer ,PooovrJtteni1o.ticepf .audit.will.�
given. .. . _ : __ ..... _ - _, , _ 
·- .• - _ ,,, - _ - :- .... _ 
� ��v�!!J�ei�e'fJ{W&l�� . 'fRc��v·��P�rJ?-t�e�·!e�at. a�pfrct!J
da�-
approval letter. 
Please report the information detailed above, or any other changes in resources used, or staff involved in 
the P,roject, to th� Navona( Wai,ting Times Centre Board Research Manager, Dr Catlierine Sinclair (0 l 41 
951 5�0, cathenne.smclair@ginh.scot.nhs.uk). 
Further information about research at the National Waiting Times Centre Board can be found at the 
following website: www.nhsgoldeniubilee.eo.uk/home/research.php. 
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Appendix 5: Healthcare Professional Introduction Letter 
Dear Dr 
Information exchange between patients with lung cancer and healthcare professionals at clinic 
consultations. 
You are invited to participate in a study to explore the exchange of information between patients with 
lung cancer and healthcare professionals at clinic consultations. The researcher is a lung cancer clinical 
nurse specialist currently undertaking a clinical doctorate at the University of Stirling investigating the 
research title listed above. 
You and your colleagues have been identified as being involved in the specialised management of 
patients with lung cancer within Glasgow and as such are in an ideal environment to assist with this 
research study. 
For your information I have enclosed a Healthcare Professional Information Sheet, which incorporates 
the purpose of the study, as well as the methodological design to be used. Once you have had the 
opportunity to read and consider all the information, I would like to invite you to take part in the study. I 
have also enclosed a Consent Form, so that you can tell me whether or not you wish to participate in 
the study 
If you have any questions about the research study you can contact me by telephone or email at the 
above listed numbers and addresses. I would be happy to visit your department to discuss the study in 
more detail personally. 
The study and all relevant documentation have been reviewed by the West of Scotland (1) Research and 
Ethics Committee. 
Thank you for your attention and with your permission I look forward to undertaking my research within 
your department. 
Yours sincerely 
Allison Smith.  
Doctoral Student. 
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Appendix 6: Healthcare Professional Information Sheet 
Project title 
Information exchange between patients with lung cancer and healthcare 
professionals at clinic consultations. 
Introduction 
I would like to invite you to participate in a research study, which aims to explore the exchange of information 
between patients with lung cancer and healthcare professionals at clinic consultations. You and your clinical 
colleagues have been identified as health professionals who are involved in the management of people with lung 
cancer and are thus best qualified to take part in this study.  
You should only participate if you want to. Choosing not to take part will not disadvantage you in any way. Before 
you make your decision it is important for you to understand why the research study is being carried out and what 
it will involve. Please take time to read the following information carefully and discuss it with other people, 
including your colleagues. Please get in touch if there are any areas you feel need clarified. 
Thank you for reading this. 
What is the purpose of the study? 
The aim of the research study is to explore how patients with lung cancer and healthcare professionals exchange 
information in the clinical consultation setting. The research will focus on what information is exchanged between 
patients and healthcare professionals and what information is not exchanged 
Why have I been asked to take part? 
You have been asked to take part in the research because you are a health professional involved in the speciality of 
lung cancer.  
Do you have to take part? 
It is up to you to decide whether or not to take part. If you do decide to take part you will be given this information 
sheet to keep and asked to sign and return the consent form enclosed. If you decide to take part you are still free 
to withdraw at any time and without giving a reason. A decision to withdraw at any time, or a decision not to take 
part, will remain confidential. 
What will happen to me if I take part? 
If you decide to take part, you will be asked to take part in the audio taping of your clinic consultation with 
patients with lung cancer. You will also will be asked to take part in a short (5 minute) debrief interview, with the 
researcher, following the clinic consultation. During this interview you will be asked about the information you 
gave to the patient during the consultation and whether or not you felt you may have withheld certain types of 
information and if so, what type of information and why.  
With your permission, the interview will be tape-recorded. 
The researcher may also ask for some demographic information about the patient with lung cancer who will also 
be taking part in the study. 
Participation in consenting to the study and any data collection will take part within the normal working day and 
you will not be asked to participate in any part of the study in your own time. 
The researcher will securely store all data. Electronic data will be stored in a password-protected computer and 
written transcripts will be secured in a locked drawer within a locked office. The researcher and her supervisor will 
be the only people with access to the data. Your identity will be coded and anonymised. 
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What are the possible benefits of taking part in the research study? 
You may not benefit personally from taking part in this research. However, with your assistance and participation 
in this study, you will be able to contribute, as a professional, in a research project examining the information 
exchange between patients with lung cancer and healthcare professionals. Your involvement may assist the 
research to identify areas in patient care that can be improved for the future management of this patient group. 
What are the possible disadvantages of taking part in the research study? 
The disadvantages are that there may be the inconvenience of having your consultations with patient’s audiotaped 
and the time (no longer than 5 minutes) taken to participate in a debrief interview with the researcher after the 
clinic consultation. 
What will happen to information about me? 
All of the information/data generated at clinic consultation and debrief interview will be anonymised. Neither you 
nor the patients will be identified in any publication.  
Who is funding the research study? 
The research is part of a doctoral study, self-funded by the researcher. 
Who has reviewed the research study proposal? 
This study has been reviewed by the West of Scotland (1) Research and Ethics Committee. 
If you do wish to take part, please sign and return the consent form and return it to the researcher in the stamped 
addressed envelope provided. 
Thank you. 
Contacts for further information 
 Should you wish to talk to someone or have the researcher visit you in person to go over any aspect of the study, 
please contact  
 Allison Smith. Doctoral Student. 
C/O Gartnavel General Hospital. 1053 Great Western Road. Glasgow G12 0YN 
0141 211 0182 or 0777 198 2110 
allison.smith@ggc.scot.nhs.uk 
 Should you wish to contact someone other than the researcher, please contact the research supervisor: 
Dr Carol Bugge. Senior Lecturer.  
Department of Nursing & Midwifery. University of Stirling. Stirling. FK9 4LA 
01786 466109 
carol.bugge@stir.ac.uk 
 Should you wish to raise a concern about the study with someone who is independent from the research team, 
please contact the Head of Department: 
 Professor William Lauder 
Department of Nursing & Midwifery. University of Stirling. Stirling. FK9 4LA 
01786 46 6345 
william.lauder@stir.ac.uk 
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Appendix 7: Healthcare Professional Consent Form 
Title of project 
Information exchange between patients with lung cancer and 
healthcare professionals at clinic consultations. 
Researcher 
Allison Smith 
Doctoral Student 
 Please initial box 
1. I confirm that I have read and understand the information sheet
for the above study.
2. I confirm that I have discussed the study with those people whom
I regard as appropriate and have had the opportunity to ask questions.
3. I understand that my participation is voluntary and that I am free to
withdraw at any time, without giving any reason.
4. I agree to the clinic consultation and the debrief interview being audio
taped. It has been explained to me that disks and transcriptions will
be stored securely and that I will not be identified by anyone outside
the research team.
5. I agree to the use of anonymised quotes in reports and publications
________________ _______ ___________ 
Name of Participant Date Signature 
__________________ _______ ___________ 
Name of Researcher Date Signature 
For further information please contact 
Allison Smith, Doctoral Student.  
Gartnavel General Hospital. 1053 Great Western Road. Glasgow G12 0YN. 
Telephone: 0141 211 0182 or 0777 198 2110 
Email: allison.smith@ggc.scot.nhs.uk 
1 copy for participant 
1 copy for researcher 
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Appendix 8. Patient Introduction Letter 
Dear 
Information exchange between patients with lung cancer and healthcare professionals at clinic 
consultations. 
I am a clinical nurse specialist currently undertaking a clinical doctorate at the University of Stirling. You 
are invited to take part in a research study exploring the exchange of information between patients with 
lung cancer and healthcare professionals at different clinic consultations. 
As you have been receiving care from a team of health professionals specialising in lung cancer care you 
have been identified as eligible to take part in this study. 
I have sent you the study Patient Information Pack. It contains this letter, as well as a Patient 
Information Sheet, which has more details about the study. The information sheet explains exactly what 
you would be required to do if you decide to take part in the study.  
Once you have had the opportunity to read and consider all the information, I would like to invite you to 
take part in the study. The research is interested in how patients and health professionals (such as 
doctors and nurses) exchange information when they meet at the outpatient clinic consultation. 
Your doctor or nurse will have asked for your permission for me to contact you by telephone, which I 
will do 48 hours after you receive the Pack. This will to allow you time to consider the information and 
discuss the study with your family and friends if you would like to. When I phone we can discuss any 
questions about the research study you may have. 
You can contact me by telephone or email at the above listed numbers and addresses if you or your 
family and friends have any questions in the meantime. 
I look forward to speaking with you. 
Yours sincerely 
Allison Smith 
Doctoral Student 
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Appendix 9: Patient Information Sheet 
Project title 
Information exchange between patients with lung cancer and healthcare professionals at clinic 
consultations. 
Introduction 
I would like to invite you to take part in a research study, which aims to explore the exchange of 
information between patients with lung cancer and health professionals at outpatient clinic 
consultations.  
You should only take part if you want to. Choosing not to take part will not disadvantage you in any way. 
Before you make your decision it is important for you to understand why the research study is being 
carried out and what it will involve. Please take time to read the following information carefully and 
discuss it with other people, including your hospital doctors and nurses and your own GP. 
Please ask me if there is anything that is not clear or if you would like more information. 
Take time to decide whether or not you wish to take part in the study. 
Thank you for reading this. 
What is the purpose of the study? 
The aim of the study is to look at what information patients with lung cancer and healthcare 
professionals exchange with each other at the outpatient clinic consultation. The study plans to describe 
the information they DO give and the information that they DO NOT give. 
Why have I been asked to take part? 
You have been asked to take part in the research because you are a patient affected by lung cancer, who 
is attending outpatient clinic consultations. We want to gather your views on your experience of the 
clinic consultations and your thoughts and opinions on the information that is given to you by health 
professionals and the information that you give in return to them. 
Do I have to take part? 
No. It is up to you to decide whether or not to take part. The decision you make (to take part or not) will 
in no way affect any care you receive. If you do decide to take part you will be asked to sign a form 
giving your consent. You will be given a copy of this information sheet and your signed consent form to 
keep. You are free to stop taking part at any time during the study, without giving a reason. Please ask 
your own General Practitioner and your care team at the hospital for their advice if you need it 
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What will happen to me if I take part? 
If you might be interested in taking part, the researcher will tell you more about the study. You can 
contact the researcher by telephone (the number is on this letter) and arrange to have the researcher 
call you back for a telephone discussion, or if you prefer arrange, for the researcher to visit you at home. 
If you do agree to take part you will meet with the researcher when you attend the outpatient clinic on 
your next visit. At this time the researcher will discuss the Consent Form with you and if you are still 
willing to take part in the research ask you to sign the form at this time. The consultation you have with 
the doctors and nurses at this clinic visit and any other clinic consultations relating to your condition will 
be tape recorded, with your permission. 
The researcher will NOT be present when you are having your consultation with your medical and 
nursing team. 
After the consultation, the researcher will ask you to take part in a 5 minute debrief interview. If you do 
not feel up to this debrief interview after your consultation, this can be arranged to be done at another 
time, if you prefer. With your permission this short interview will be tape-recorded as well. 
On the day of your consultation, the researcher will arrange with you a date, time and convenient 
location for a more in-depth interview, which will discuss the consultation in more detail and, which will 
last approximately 30-60 minutes. With your permission this interview will be tape-recorded. 
Any clinic visits you have after the in-depth interview with the researcher will no longer be part of the 
research study and will therefore not be tape-recorded. 
The researcher may ask your healthcare professional for health-related information about you, such as 
details about your illness, the expected treatment plan, as well as your age and place of residence. All 
recorded information will be stored securely. Electronic data will be stored in a password-protected 
computer and written transcripts will be secured in a locked drawer within a locked office. The 
researcher and her supervisors will be the only people with access to the data. Your identity will be 
anonymised and your confidentiality will be guaranteed at all times.  
What are the possible benefits of taking part in the research study? 
This study may not benefit you personally, but the information we get might help other patients with 
lung cancer in the future by letting us understand what people need in terms of the information that is 
exchanged between them and their health professionals. It will also give you the chance to say what you 
think about information that is exchanged and how it exchanged and what things affect it in your 
opinion and we will listen to your views. 
What are the possible disadvantages of taking part in the research study? 
You will have your conversations with your health professionals tape-recorded. It is possible you may 
find this intrusive. If you feel it is affecting your consultation in anyway, the recording can be stopped at 
anytime.   
You may find you feel anxious about discussing your care and if this is the case you can stop the 
interview with the researcher at any stage and you can withdraw from the study if you are unhappy with 
any aspect of it. However, some people find it helpful to discuss their opinions and feelings. 
There are no other disadvantages to the study foreseen. 
Will my details be kept private if I take part? Will anyone else know I’m doing this? 
If you consent to take part in the study, all information about you and all information that you give will 
be anonymised and will be kept strictly confidential. No one will be able to recognise you from any 
report about the study – your name and anything, which could lead to anyone being able to recognise 
you, will be removed. Any quotes used in reports and publications will be anonymised and referenced 
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using a confidential coding system. All recorded data is stored securely and is destroyed following strict 
NHS guidelines after a suitable time period. 
What will happen to the results of the project? 
A summary of the findings can be sent out to you if you wish to see them. The researcher will also be 
preparing a manuscript for publication in academic and scientific journals and all participants in the 
study can read this. You will not be identified in any report or publication. 
Who is funding the research study? 
This research is part of a doctoral study, self-funded by the researcher. 
Who has reviewed the research study proposal? 
This study has been reviewed by the West of Scotland (1) Research and Ethics Committee. 
Thank you once again for taking the time to read this. 
Contacts for further information 
 Should you wish to talk to someone before deciding to take part, or at any time during the study you 
can contact  
Allison Smith. Doctoral Student. 
C/O Gartnavel General Hospital. 1053 Great Western Road. Glasgow G12 0YN 
0141 211 0182 or 0777 198 2110 
allison.smith@ggc.scot.nhs.uk 
 Should you wish to contact someone other than the researcher, please contact the research 
supervisor: 
Dr Carol Bugge. Senior Lecturer.  
Department of Nursing & Midwifery. University of Stirling. Stirling. FK9 4LA 
01786 466 109 
carol.bugge@stir.ac.uk 
 Should you wish to raise a concern about the study with someone who is independent from the 
research team, please contact the Head of Department: 
Professor William Lauder 
Department of Nursing & Midwifery. University of Stirling. Stirling. FK9 4LA 
01786 46 6345 
william.lauder@stir.ac.uk 
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Appendix 10: Patient Consent Form 
Title of project 
Information exchange between patients with lung cancer and healthcare 
professionals at clinic consultations. 
Researcher 
Allison Smith 
Doctoral Student 
     Please initial box 
1. I confirm that I have read and understand the information sheet
for the above study. I have had the
opportunity to consider the information, ask questions and have had
these answered satisfactorily.
2. I understand that my participation is voluntary and that I am free to
withdraw at any time without giving any reason, without my medical
care or legal rights being affected.
3. I agree to my GP being informed of my participation in the study.
4. I agree to take part in the above study.
5. I agree to the clinic consultation(s), the debrief interview and the in-depth
interview being audiotaped. It has been explained to me that disks and
transcriptions will be stored securely and that I will not be identified by anyone
outside the research team.
6. I agree to my healthcare professional exchanging health-related information
about me to the researcher
__________________ _______ ___________ 
Name of Participant Date Signature 
__________________ _______ ___________ 
Name of Researcher Date Signature 
For further information please contact 
Allison Smith, Doctoral Student.  
Gartnavel General Hospital. 1053 Great Western Road. Glasgow G12 0YN. 
Telephone: 0141 211 0182 or 0777 198 2110 
Email: allison.smith@ggc.scot.nhs.uk 
1 copy for participant 
1 copy for researcher 
1 copy for case notes 
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Appendix 11: Companion Introduction Letter 
Dear [carer’s name inserted] 
Information exchange between patients with lung cancer and healthcare professionals at clinic 
consultations. 
I am a clinical nurse specialist currently undertaking a clinical doctorate at the University of Stirling. 
You are invited to take part in a research study exploring the exchange of information between 
patients with lung cancer and healthcare professionals at clinic consultations. 
As you have been recognized as a carer, who is likely to attend clinic consultations with a patient 
receiving care from a team of health professionals specialising in lung cancer care you have been 
identified as eligible to take part in this study. 
I have sent you a Companion Information Pack. It contains this letter, as well as an Information 
Sheet, which has more details about the study. The information sheet explains exactly what you 
would be required to do if you decide to take part in the study.  
Once you have had the opportunity to read and consider all the information, I would like to invite you 
to take part in the study. The research is interested in how patients and health professionals (such as 
doctors and nurses) exchange information when they meet at the outpatient clinic consultation. As 
you may be present with a friend or relative at these consultations it is important that you are aware 
of the study and if you are part of the consultation it is important that you have all the relevant 
information and that you give your consent to take part in the study. 
The hospital doctor or nurse looking after your friend or relative will have asked for their permission 
for me to contact them by telephone, which I will do 48 hours after they receive The Patient 
Information Pack. Therefore I also wanted to send you details of the study as you may be with the 
patient on the day of clinic. This will to allow you time to consider the information and discuss the 
study with your friend or relative, or anyone else you like. When I phone we can discuss any questions 
about the research study you may have. 
You can contact me by telephone or email at the above listed numbers and addresses if you or your 
family and friends have any questions in the meantime. 
I look forward to speaking with you. 
Yours sincerely 
Allison Smith. 
Doctoral Student 
Highland Campus: Stirling Campus: Western Isles Campus: 
Centre for Health Science Stirling Western Isles Hospital 
Old Perth Road FK9 4LA MacAulay Road 
Inverness   IV2 3JH Stornoway    Isle of Lewis  
HS1 2AF 
Tel:  +44 (0) 1463 255655 Tel: +44 (0) 1786 466340 Tel:  +44 (0) 1851 708243 
Fax:  +44 (0) 1463 255654 Fax: +44 (0) 1786 466333 Fax:  +44 (0) 1851 
706070 
292
1 
Appendix 12: Companion Information Sheet 
Project title 
Information exchange between patients with lung cancer and healthcare professionals at clinic 
consultations. 
Introduction 
I would like to invite you to take part in a research study, which aims to explore the exchange of 
information between patients with lung cancer and health professionals at outpatient clinic 
consultations.  
You should only take part if you want to. Choosing not to take part will not disadvantage you or your 
friend or relative in any way. Before you make your decision it is important for you to understand why 
the research study is being carried out and what it will involve. Please take time to read the following 
information carefully and discuss it with other people, including the hospital doctors and nurses or 
anyone else. 
Please ask me if there is anything that is not clear or if you would like more information. 
Take time to decide whether or not you wish to take part in the study. 
Thank you for reading this. 
What is the purpose of the study? 
The aim of the study is to look at what information patients with lung cancer and healthcare 
professionals exchange with each other at the outpatient clinic consultation. The study plans to 
describe the information they DO give and the information that they DO NOT give.  
Why have I been asked to take part? 
You have been asked to take part in the research because you may be attending the clinic 
consultation with a friend or relative who is affected by lung cancer. Sometimes other people present 
influence the exchange of information between the patient and the healthcare professional, 
therefore it is important that your participation in the consultation is recognised. 
Do I have to take part? 
No. It is up to you to decide whether or not to take part. The decision you make (to take part or not) 
will in no way affect any care your friend or relative receives. If you do decide to take part you will be 
asked to sign a form giving your consent. You will be given a copy of this information sheet and your 
signed consent form to keep. You are free to stop taking part at any time during the study, without 
giving a reason. Please ask the care team at the hospital for their advice if you need it 
What will happen to me if I take part? 
If you might be interested in taking part, the researcher will tell you more about the study. You can 
contact the researcher by telephone (the number is on this letter) and arrange to have the researcher 
call you back for a telephone discussion, or if you prefer arrange, for the researcher to visit you at 
home. 
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If you do agree to take part you will meet with the researcher when you attend the outpatient clinic 
with your friend or relative at their next visit. At this time the researcher will discuss the Consent 
Form with you and if you are still willing to take part in the research ask you to sign the form at this 
time. The consultation your friend or relative has with the doctors and nurses at this clinic visit and 
any other clinic consultations relating to their condition will be tape recorded, with theirs and your 
permission. 
The researcher will NOT be present during the actual consultation with the medical and nursing team. 
After the consultation, the researcher will ask your friend or relative to take part in a 5 minute debrief 
interview. If you are there after the consultation you may be part of the de-brief interview and 
therefore your permission will be asked to tape-record this short interview alongside your friend or 
relative. If either the patient or you do not feel up to this de-brief interview after the consultation, 
this can be arranged to be done at another time.  
On the day of the consultation, the researcher will arrange with your friend or relative a date, time 
and convenient location for a more in-depth interview, which will discuss the consultation in more 
detail and, which will last approximately 30-60 minutes. You may be present at this interview and 
with your permission this interview will be tape-recorded. 
Any clinic visits which you have with your friend or relative after the in-depth interview with the 
researcher will no longer be part of the research study and will therefore not be tape-recorded. 
All recorded information will be stored securely. Electronic data will be stored in a password-
protected computer and written transcripts will be secured in a locked drawer within a locked office. 
The researcher and her supervisors will be the only people with access to the data. Your identity will 
be anonymised and your confidentiality will be guaranteed at all times.  
What are the possible benefits of taking part in the research study? 
This study may not benefit you personally, but the information we get might help other patients with 
lung cancer and their carers in the future by letting us understand what people need in terms of the 
information that is exchanged between them, their carers and their health professionals. It will also 
give you the chance to say what you think about information that is exchanged and how it exchanged 
and what things affect it in your opinion and we will listen to your views. 
What are the possible disadvantages of taking part in the research study? 
The conversations between the patient, you and the health professionals will be tape-recorded. It is 
possible you may find this intrusive. If you feel it is affecting your consultation in anyway, the 
recording can be stopped at anytime.   
You may find you feel anxious about discussing your friend or relative’s care and if this is the case you 
can stop the interview with the researcher at any stage and you can withdraw from the study if you 
are unhappy with any aspect of it. However, some people find it helpful to discuss their opinions and 
feelings. 
There are no other disadvantages to the study foreseen. 
Will my details be kept private if I take part? Will anyone else know I’m doing this? 
If you consent to take part in the study, all information about you and all information that you give 
will be anonymised and will be kept strictly confidential. No one will be able to recognise you from 
any report about the study – your name and anything, which could lead to anyone being able to 
recognise you, will be removed. Any quotes used in reports and publications will be anonymised and 
referenced using a confidential coding system. All recorded data is stored securely and is destroyed 
following strict NHS guidelines after a suitable time period. 
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What will happen to the results of the project? 
A summary of the findings can be sent out to you if you wish to see them. The researcher will also be 
preparing a manuscript for publication in academic and scientific journals and all participants in the 
study can read this. You will not be identified in any report or publication. 
Who is funding the research study? 
This research is part of a doctoral study, self-funded by the researcher. 
Who has reviewed the research study proposal? 
This study has been reviewed by the West of Scotland (1) Research and Ethics Committee. 
Thank you once again for taking the time to read this. 
Contacts for further information 
 Should you wish to talk to someone before deciding to take part, or at any time during the study 
you can contact  
Allison Smith. Doctoral Student. 
C/O Gartnavel General Hospital. 1053 Great Western Road. Glasgow G12 0YN 
0141 211 0182 or 0777 198 2110 
allison.smith@ggc.scot.nhs.uk 
 Should you wish to contact someone other than the researcher, please contact the research 
supervisor: 
Dr Carol Bugge. Senior Lecturer.  
Department of Nursing & Midwifery. University of Stirling. Stirling. FK9 4LA 
01786 466 109 
carol.bugge@stir.ac.uk 
 Should you wish to raise a concern about the study with someone who is independent from the 
research team, please contact the Head of Department: 
Professor William Lauder 
Department of Nursing & Midwifery. University of Stirling. Stirling. FK9 4LA 
01786 46 6345 
william.lauder@stir.ac.uk 
295
Appendix 13: Companion Consent Form 
Title of project 
Information exchange between patients with lung cancer and healthcare 
professionals at clinic consultations. 
Researcher 
Allison Smith 
Doctoral Student 
     Please initial box 
1. I confirm that I have read and understand the Companion Information Sheet
dated for the above study. I have had the
opportunity to consider the information, ask questions and have had
these answered satisfactorily.
2. I understand that my participation is voluntary and that I am free to
withdraw at any time without giving any reason, without my legal rights being
affected
3. I agree to the clinic consultation(s), the debrief interview and the in-depth
interview being audiotaped. It has been explained to me that disks and
transcriptions will be stored securely and that I will not be identified by anyone
outside the research team.
4. I agree to take part in the above study.
__________________ _______  ___________ 
Name of Participant Date Signature 
__________________ _______  ___________ 
Name of Researcher Date Signature 
For further information please contact 
Allison Smith, Doctoral Student.  
Gartnavel General Hospital. 1053 Great Western Road. Glasgow G12 0YN. 
Telephone: 0141 211 0182. or 0777 198 2110 
Email: allison.smith@ggc.scot.nhs.uk 
1 copy for participant 
1 copy for researcher 
1 copy for patient case notes 
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Appendix 14: Potential Participants Data Sheet 
Log of Potential Participants 
Patient ID CODE 
Performance Status    Disease stage   
Gender      5 Digit post code 
Q1 Treatment regimen 
Surgical resection  Surgery & CT  Surgery & radiotherapy 
Radiotherapy     RT & CT 
Chemotherapy     & RT 
 Treatment intent: Curative 
Best supportive care  Palliative 
Q2. Age (years old) 
18-25  56 -65 
26- 35  66 - 75 
36-45  Over 75 
46 – 55  No reply 
Q3. Reason for not participating 
297
Highland Campus: Stirling Campus: Western Isles Campus: 
Centre for Health Science Stirling Western Isles Hospital 
Old Perth Road FK9 4LA MacAulay Road 
Inverness   IV2 3JH Stornoway    Isle of Lewis   HS1 2AF 
Tel:  +44 (0) 1463 255655 Tel: +44 (0) 1786 466340 Tel:  +44 (0) 1851 708243 
Fax:  +44 (0) 1463 255654 Fax: +44 (0) 1786 466333 Fax:  +44 (0) 1851 706070 
The University of Stirling is recognised as a Scottish Charity with number SC 011159 
Appendix 15: Patient Debrief Interview Guide 
1. Can you tell me what you talked about today?
2. Did you mention everything you wanted to?
3. Do you feel that there was any information that you held back
4. Can you say why?
5. Do you think the healthcare professional covered all the main points that
you expected they would?
6. Was there anything you hoped they would talk about but didn’t?
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Appendix 16: Healthcare Professional Debrief Interview Guide 
1. Can you tell me the main things you discussed today?
2. Did you tell the patient everything you had intended?
3. If not – why not?
4. Did you feel the patient gave you all the information you would have
expected them to on this visit?
5. If not can you say why they may not have?
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Appendix 17: Case summary E 
Pseudonym: Eve 
Demographics: 
Case E - Eve 
Code/Gender GR05/E 
PS 0 
Symptoms L sided chest discomfort, increasing 
dyspnoea 
Disease stage Limited stage 
Histological type Small cell lung cancer (L upper lobe) 
Treatment intent Palliative, concurrent chemo-radiotherapy 
Age 63 
Employment Retired engineering plant worker 
Residence City. Usually lives along. Son staying at 
present 
Marital status Divorced but newly engaged to her partner 
Educational status Secondary school education 
Smoking status Current smoker 
Field Note Summation (1): Consultation 1 
Location: Study site B Resp clinic 
People present: Eve & companion (son - Eric) 
Patient & companion demeanour: They were both very relaxed and patient was making jokes 
throughout time at clinic (she got her hair done to impress the doctor). ? Coping mechanism. Eve’s 
partner did not come into clinic – he was too anxious. Patient had already been informed of 
diagnosis – was returning for histology and provisional treatment plan. 
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Listening to the tapes post clinic: patient did appear to be given sound relevant clinical information 
and Dr Boyd did spend time (20-30 mins) discussing all the issues with the patient and her son. 
Chemotherapy given in the context of curative therapy (despite small cell lung cancer).  
Son initiated conversations, asked frequent questions, answered questions for Eve. Son seemed to 
have his own agenda re smoking and almost bullying his mother into stopping. Treatment outcome 
seemed the most important subject for companion. Atmosphere was volatile (?) at times 
De-brief summations: 
 Dr Boyd described Eve as ‘flighty’ but felt she was happy with level and content of
information exchanged as was he.
 Sr Baxter confirmed she had exchanged the information she felt was required and patient
was given written information on clinical trials.
Emerging themes: 
Information discussed around a priori categories  
No obvious disquiet at content, flow or direction of information from any participant 
Companion role 
Field Note Summation (2): Consultation 2 
Location: Study site B – oncology clinic 
People present: Eve, Eric and Elaine (daughter) 
Patient and companion demeanour: A second companion was present this week. There was a 
somewhat tense atmosphere between the 3, as they had been arguing about patient’s smoking 
habits and I think they had fallen out over certain things. Eve continued to make jokes but I felt she 
was more anxious this week. Consultation aim was to discuss therapy with oncologist and it had 
been a week since they last attended. 
Listening to tapes post clinic: Patient and her family had read the written information and did ask 
viable questions, even quoting stats! Dr Brown spent time (approx. 30 mins) going over and building 
on info re trial. First mention that treatment has no ‘guarantees’. Content, flow and direction of 
consultation and information exchange influenced significantly by companion agenda, asking 
questions (specifically about treatment outcome). Specific a priori categories becoming more 
relevant - treatment outcome 
De-brief summations: 
 Sr Baxter stated she had exchanged the information she intended and thought she pretty
detailed info and the opportunity to ask questions – but all declined. Backed up verbal info
with written information. Felt she had covered all aspects of therapy and that son did most
of talking at this time, as patient declined to ask too much.
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 In contrast, Dr Brown stated there were topics she did not cover (ie clinical aspects of
chemotherapy) as family argued and dominated consultation with smoking and prognosis
agenda. Normally she would prefer to discuss chemo s/e in more depth.
 Patient shocked to learn she had ‘fast track cancer’
 Companions comment that tone of discussion had changed from positive, with a chance of
cure (they thought in terms of 80:20) to negative (20:80) in the space of 1 week.
Family were very vocal and led and controlled exchanges the majority of the time. Their agendas 
concerning smoking and prognosis dominated. Atmosphere was tense and son walked out of 
consultation at one point.  
Emerging themes: 
 Strong, dominant role of companions
 Companion led agenda (smoking and prognosis) – not patient agenda
 Companion knowledgeable re aspects of trial and chemotherapy
 A priori categories were covered to participants required level
Field Note Summation (3): In-depth interview 
Location: Eve’s home 
People present: Eve, Eric (and Ewen, 2nd son later) 
Overview: Family dynamics play a significant role in the interactions of this family. Arguments and 
antagonism are evident but appear to be part of their family dynamics. No negative comments from 
companion re the significant companion led agenda witnessed at clinic. Eve originally said she would 
prefer to be unaccompanied to clinics but then admitted she would forget things, so needed 
companion presence. 
Despite dynamics witnessed at clinic, patient and companion felt well informed – felt the level of 
information exchange suited them – felt they were given all relevant information and gave 
information in return. 
Tone of information and the impact of the news re prognosis was apparent and left the family 
‘shocked’. 
New emerging themes 
 Exchange of information (content of a priori categories overall) appeared to suit participants
 Content controlled by vocal companions
 Family dynamics
 Original reticence by patient to be accompanied to consultation
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Information exchanged 
Diagnosis Lung 
cancer 
Small cell CT shown Limited stage ‘Nasty 
cancer’ 
Symptoms pain breathlessness headaches 
Treatment Depends 
on cell 
type 
Trial discussion Rationale Cisplatin/Etoposide Eve does not 
want surgery 
as it ‘spreads’ 
cancer 
Treatment side-
effects 
Nausea Hair loss Tired Reduced immunity 
Treatment outcome Chance of 
cure 
Difficult to cure Likely to 
respond to 
chemo 
Companions 
initiate discussion 
and ask prognosis  
Prognostic 
information 
change dover 
the course of 
1 week 
Miscellaneous Family 
history 
Employment Social input Physical exam SMOKING! 
Information not exchanged 
Diagnosis Eve stated she originally did not want 
companions present at diagnosis 
Eve originally wanted only her son to 
have information about her 
diagnosis 
Symptoms Not discussed 
Treatment Dr Brown disappointed with her 
exchange of information about 
chemotherapy 
Opportunity to discuss issues not 
given as companions changed flow, 
content and direction of exchange 
with their own agenda  
Treatment side-
effects 
Dr Brown disappointed with her 
exchange of information about 
chemotherapy side-effects 
Opportunity to discuss issues not 
given as companions changed flow, 
content and direction of exchange 
with their own agenda 
Treatment outcome Specific focus on outcome altered 
the dynamics of the exchange 
significantly 
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Appendix 18. Patient Demographic Sheet 
Patient ID CODE  Gender 
Performance Status       Disease stage      Histological Cell Type 
Q1 Treatment regimen 
Surgical resection           Surgery & CT  Surgery & radiotherapy 
Radiotherapy        RT & CT 
Chemotherapy         & RT 
 Treatment intent: Curative 
Best supportive care        Palliative 
Q2. Age (years old) 
18-25    56 -65 
26- 35  66 - 75 
36-45   Over 75 
46 – 55       No reply    
Q3. Employment 
Works F/T      Unemployed       Retired 
Works P/T          On sick leave             No reply 
Q4. Residence 
A town/city              Other (please state) 
Village/rural        Postcode 
Q5. Marital status 
Married       Divorced 
Living with a partner  Widowed 
Single        Other 
Prefer not to say 
Q6. Educational status 
Secondary school education             Other 
College or university education             Prefer not to say 
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Appendix 19: WHO Performance status 
Grade Explanation of activity 
0 Fully active, able to carry on all pre-disease performance without restriction 
1 Restricted in physically strenuous activity but ambulatory and able to carry 
out work of a light or sedentary nature, e.g., light house work, office work 
2 Ambulatory and capable of all selfcare but unable to carry out any work 
activities. Up and about more than 50% of waking hours 
3 Capable of only limited selfcare, confined to bed or chair more than 50% of 
waking hours 
4 Completely disabled. Cannot carry on any selfcare. Totally confined to bed or 
chair 
5 Dead 
305
1 
Appendix 20: Article for submission 
Title 
Non-negotiated companion influence on information exchange at lung cancer clinic consultations 
ABSTRACT 
Aim: To investigate information exchange processes during lung cancer consultations 
Background: Effective information exchange is an asset to effective cancer care. The way in which a 
professional relates to and exchanges information with patients can be impacted by wide-ranging, 
external factors, including the presence of an accompanying companion. Patients with cancer are 
frequently accompanied to the clinical consultation by companions. Their potential to influence the 
exchange, either in a facilitative or non-facilitative manner warrants further investigation.  
Design: Qualitative, multiple case study design 
Methods: A case centred on a patient with lung cancer.  Within the case were the patients, the 
health professionals they consulted with and anyone else who was present within the consultation.  
Seven cases were recruited, which included 12 companions. Data were collected in outpatient clinics 
between 2010 and 2011. Data were digital recordings of consultations, debrief interviews 
immediately post-consultation and later in-depth patient interviews. All interviews and audio-
recordings were transcribed and analysed for pattern matching and coding. 
Findings: All patients took at least one companion to a consultation. Three levels of negotiated 
companion accompaniment were identified. Companions mediated and moderated information 
exchange within and across six major constructs. Companions who did not negotiate their presence 
at the clinic were powerful and expert companions who significantly moderated the content, 
direction and flow of information exchange, using the constructs of companion control, companion 
agenda and companion as expert. 
Conclusions: The level of negotiated companion presence at lung cancer clinics has direct 
implications for clinic care. There needs to be greater understanding among professionals of ways in 
which information exchange can be influenced by companions.  
Key words: lung cancer, information exchange, patient-professional-companion interaction, 
negotiated accompaniment, mediating and moderating influence 
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Introduction 
Effective communication is an asset to effective cancer care (Thorne, Bultz and Baile, 2005). 
Communication between patients and professionals can impact the effectiveness of the clinical 
encounter and influence quality of care and clinical outcomes for patients with cancer (Aiello 
Bowles, Tuzzio and Wise, 2008). Clinical communication can be defined as the dynamic, 
interpersonal process of mutual influence that occurs during the exchange of verbal and non-verbal 
messages between patients and healthcare professionals (Albrecht, Penner, Cline, Eggly and 
Ruckdeschel, 2009). A seminal review (Ong et al, 1995) signalled the scope of this influence and 
noted three basic communication functions in the cancer context, creating effective interpersonal 
processes, exchanging information and facilitating appropriate treatment decisions. This paper is 
concerned with one of these functions: information exchange.  
The evidence suggests the way in which a professional relates to and exchanges information with 
patients can be profoundly impacted by wide-ranging, external factors (Edwards et al, 2009).  One 
significant influence on information exchange at the clinical encounter is the presence of patient 
companion(s).  As overwhelmingly patients with cancer are accompanied to the clinical consultation 
by companions (Shepherd et al, 2008), their potential to influence the exchange, either in a 
facilitative or non-facilitative manner warrants further analysis.  
Background 
Lung cancer is one of the main causes of cancer death in the Western world. It is associated with 
significant morbidity and in 80% of patients with lung cancer the disease is inoperable due to 
advanced stage at presentation (Tod et al, 2007). Receiving such a diagnosis will be, for most 
patients, an overwhelming experience. In these circumstances, the provision and exchange of 
appropriate and understandable information is important. 
A key component of healthcare delivery is the patient-healthcare professional encounter and the 
exchange of information which takes place therein. Information exchange accounts for a large 
percentage of time within the clinical consultation, at which patients with cancer, seek information 
about their diagnosis, treatment and prognosis (Epstein and Street, 2008). 
Traditional models of human interaction suggest that communication occurs on content [i.e. transfer 
of information] and that information content is important (Albrecht et al, 2008). Clinicians required 
contextual information from patients about past medical history, presenting symptoms as well as 
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previous experience and current expectations to formulate a diagnosis and treatment plan. Likewise 
patients needed information regarding all available therapies, potential side-effects and expected 
outcomes to make informed choices.  
Examination of the contemporary literature on information exchange found research has primarily 
focused on professional–patient exchanges, leaving the influence of companions relatively 
unexplored (Arora, 2007). Despite this, a diverse, albeit disjointed research base has begun to 
highlight the potential role companions may play during clinical consultations. The major problem 
with existing literature is there has been little synthesis of data in this area, potentially due to 
diverse disciplines investigating the subject matter (medicine, linguistics, sociology, psychology) as 
well as the range of consultations under investigation (care of the elderly medicine, primary care, 
diabetes) (Laidsaar-Powell et al, 2013). The current pool of literature informing companion influence 
in the cancer care context is small with only a few in-depth studies. None have focused specifically 
on the information exchange process or, more pertinently, have studied the influence of 
companions within the context of lung cancer care.  
The professional-patient interaction is frequently situated in a triadic relationship consisting of the 
healthcare professional, the patient and a third party, usually at least one key family member or 
companion (Blanchard et al, 2000). A companion could be defined as any group of persons who are 
related biologically, emotionally or legally (Dokken and Ahmann, 2006). Within the oncology setting 
companions are likely to be present at varying stages of the care pathway, at initial visits when the 
diagnosis is being given and treatment options discussed, and immediately after cancer recurrence 
and in the terminal phase of the disease (Jansen et al, 2010).  
The National Cancer Institute’s monograph (Esptein & Street, 2007) is a critical synthesis of existing 
literature focussing on optimising communication processes between healthcare delivery teams, 
patients and companions (triads) and not solely the patient-physician dyad (Arora, 2007). 
Communication pathways are appraised (Esptein & Street, 2007), but of 197 studies only 4 directly 
mentioned patients with lung cancer and none of these were germane to companion influence.  
The monograph used the concepts of Mediator and Moderator to explain links between 
communication and health outcomes.  A mediator or a moderator was defined as a third variable 
that changes the association between an independent variable and an outcome variable (Baron and 
Kenny, 1986). Analysis of mediator and moderator effects may provide more in-depth information 
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about a phenomenon under investigation, with consideration of these processes allowing a more 
precise description of the relationship between the variables (Bennett, 2000).  
An essential mediator within the communication pathway was identified as family and social 
support, with companions providing instrumental help, encouragement and advocacy in gaining 
access to and effectively utilising health services (Epstein and Street, 2007). Companions are seen as 
mediators providing direct (when present with the professional) or indirect (when they suggest 
topics for the patient to discuss) input into clinical conversations to facilitate communication 
between patient and clinician (Shields et al, 2005). Equally, companions (and the social environment) 
were also identified as essential moderators who served to operate at multiple levels, influencing 
the link between communication and health outcomes. Subsequently, the patient’s social 
environment consisting of companions can both mediate and moderate the relationship between 
patient-professional communication outcomes (Epstein and Street, 2007). Further evidence of the 
potential for mediating and moderating companions comes from two systematic reviews (Wolf and 
Roter, 2011; Laidsaar-Powell et al, 2013) which each outline some facilitative and controlling 
components related to companion presence. 
Thus companion influence may have a mediating or moderating impact on information exchange, 
but there is little evidence relating to cancer care generally or within the lung cancer context 
specifically. The objective of the study was to explore the information exchange process within lung 
cancer consultations. This paper will explore the analytical construct that emerged of companion 
influence on the consultation. 
The Study 
Aim 
The aim was to investigate the information exchange process within lung cancer consultations. 
Within case study design theoretical propositions are used to direct analysis.  In this study an 
iterative theoretical proposition relating to companion influence emerged.  The proposition aimed to 
specify which particular constructs of information exchange companions influenced with their 
presence at the clinical encounter and to describe the perspective of study participants to 
companion accompaniment.  
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Design 
A qualitative, multiple case study methodology grounded in a constructivist paradigm guided the 
empirical inquiry (Anthony and Jack, 2009). The case study design sought to understanding complex 
social systems (Bennet and Elman, 2006; Denscombe, 2003), with the intention to comprehend the 
current processes in a previously little-studied area (Cresswell, 2004). Multiple case designs was 
used as analytical conclusions from more than one case provided more powerful data than from a 
single case (Yin, 2009). Multiple case design was useful for predicting similar results (literal 
replication) or contrasting results but for predictable reasons (theoretical replications) (Baxter and 
Jack, 2008).  
Composition of a case 
A case included the patient with lung cancer, the health professionals they consulted with and 
anyone else who the patient brought with them to the consultation. Multiple sources of evidence 
relating to each case were considered relative and important to case composition and these 
included demographic data and transcripts from consultations and interviews. Researcher field 
notes and case sheets devised for each case were also considered essential to the case.  
Participants 
In total 12 companions accompanied 7 patients with lung cancer to clinical consultations in two 
study sites. Patients were accompanied by companion combinations which comprised, adult children 
(n=7) spouse or ex-spouse or partner (n= 4) or a sibling (n=1). Companion combinations are shown in 
table 1. 
Table one here 
Ethical considerations 
The study was approved by the Ethics Review Committee at the Department of Nursing and 
Midwifery at the University of Stirling and permission was granted from West of Scotland Research 
Ethics Service (REC 1) and Research and Development (R & D) Management. Informed consent was 
obtained from all participants prior to the clinical consultations. Participants were aware of their 
right to withdraw from the study at any time. Pseudonyms were used to protect their identities.  
Data collection 
The data collection was carried out from January 2010 to December 2011. A key strength of this case 
study design was the use of multiple sources and techniques in the data collection process (Yin, 
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2009). Significant volumes of data would be collected from the clinical encounters where the 
information exchanges were being executed and from the interviews (both de-brief and in-depth). A 
clinic room was provided to take written consent and answer questions, as well as conduct any de-
brief interviews. The researcher (AS) remained in the clinic area, (but not the consultation room) for 
as long as necessary to collect data for all participants in each case. 
Clinical consultations 
With permission consultations were recorded, using a digital recorder placed away from the 
participants, but able to still accurately record the exchange. The professionals were asked to 
operate the equipment, after instruction by the researcher.  
De-brief interviews 
De-brief interviews were viewed as a powerful means of extracting valuable information from 
participants in the immediate aftermath of the clinical encounter, when recall of events is strong and 
first impressions can be captured. De-brief duration ranged from 1 – 5 minutes and were carried out 
post-consultation in privacy. No patient participant declined to be de-briefed. Only one professional 
de-brief was declined due to clinical commitment. 
In-depth interviews 
In-depth interviews were digitally recorded with patient participants.  They were conducted in a 
place of the participants choosing and focussed on the patients (and if present their companions) 
views on the information exchange in the consultation. 
Case sheets and field notes 
Field notes permitted a record of researcher feelings and intuitive hunches, in addition to allowing a 
reflective document of the work in progress. They were prepared after each case encounter. 
Annotations were made about aspects of the information exchange process requiring clarification, 
observing the minutiae of what happened. An interpretive commentary was prepared (Stake, 1995). 
These first analytical notes gave rise to the start of data analysis at the beginning of the 
interpretative process providing insight and depth into early cross case evaluations (Payne, Field, 
Rolls, Hawker and Kerr, 2007; Hammersley and Atkinson, 2005).  
Data analysis 
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These multiple sources of evidence required to be referenced and coded in order that converging 
lines of inquiry and patterns could be uncovered (Stake, 1995). All data were transcribed, checked 
for accuracy and organised using the software package NVivo 9. To start the analysis the basic 
principles stipulated by Thomas (2011, p171) were followed in order to manage the volume of data 
generated and to provide a robust and clear synthesis of the raw data. Case study analysis involving 
coding and pattern matching was then undertaken (Yin, 2009).  
The analysis involved an iterative process of description, analysis and interpretation (Liu, 2013). The 
first stage involved reading the transcripts and assigning a code to each construct. In the second 
stage it was important to look for similar codes, whilst discarding those deemed redundant. The 
major themes of the coding were guided by the principle themes of Mediating and Moderating 
influences (Epstein and Street, 2007). Constant comparison of the data allowed for identification of 
relationships between the codes. Data collected from both consultations and all de-brief interviews 
for each case were analysed collectively. When coding was complete across all companion cases, 
they were then compared across cases and categorised using NVivo9. 
The audio-tapes and transcriptions were reviewed again to identify, more inductively, any themes or 
connections to substantiate any new emerging theory. The explanation building process (Yin, 2009) 
whereby the eventual theory is likely to be series of iterations was the guiding principle: 
 Make an initial theoretical statement or proposition
 Compare the findings of one case against the proposition
 Revise the proposition
 Compare the revision of the facts with a 2nd, 3rd or more cases
Before substantive analysis could be undertaken, the constructs pertinent to companion influence 
were refined. Reasons for this were two-fold: 
1. To further refine and describe codes relating to the new theory
2. Build evidence between data and that reviewed empirically to support the constructs
identified – moderating and mediating influence
Quality 
Quality was assured using three concepts: 
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(i) Confirmability: was enhanced through the selection of appropriate operational measures,
data collection tools and methodology for the study under investigation. Three tactics were
employed to increase confirmability (Yin, 2009). Firstly, convergent lines of enquiry with
triangulation of multiple sources of evidence was observable with the inclusion of all
interview transcript narratives, field note annotations as well as demographic data compiled
for each case. A chain of evidence was established whereby all documentation was
computerised and all stages of the analytical process logged both within document folders
and in Nvivo 9®. Finally a case study database was established and stored for peer review
and scrutiny. Transcripts and drafts of the evolving case study were reviewed by university
supervisors for consistency and accuracy.
(ii) Dependability: was enhanced through adherence to the study protocol. Development of a
case study database not only inferred dependability but also enhanced reliability with the
provision of transparent and accurate documentation. Within the database all data collected
during the study was organised to facilitate retrieval for peer review (Yin, 2009) and to
facilitate replication of the study (Leonard-Barton, 1990). To enhance the reliability of
interview data management, all interviews were audio-taped, carefully transcribed and the
narratives presented for each case’s experience and perspective with extracts of pertinent
statements in the research report
(iii) Credibility: was enhanced with the use of triangulation techniques. Credibility was further
evidenced through pattern matching and constant comparative analysis of the data. The
data followed a credible line of evidence which was documented and analysed in Nvivo.
Findings 
Theory was emergent in that it was situated in and developed by recognising patterns of 
relationships among constructs within and across cases and their underlying logical arguments. Data 
analysis led to the theoretical proposition of companions as either a mediating or moderating 
influence on information exchange. Mediating and moderating companion influences are shown in 
table 2. 
Mediating influence 
There were examples in every case where companions exerted a mediating influence on information 
exchange. Data demonstrated that mediating influences were identified across three constructs, 
physical, emotional and informational. However, companion mediating effect was not consistent 
across themes and ranged from limited to enhanced influence. Informational influence was the most 
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significant construct identified. Companions exerted a positive influence acting as an aide memoire 
and also within the role of clarification and information seeking.  
Significantly data analysis illustrated that although patients appreciated companion accompaniment 
and involvement, in some cases the preference of the patient would have been to be 
unaccompanied. A key finding in this study indicated that companion accompaniment to the clinic 
consultation was often a negotiated process with three levels:  
 Never negotiated: a mutual understanding without discussion where companion
accompaniment was taken as a given
 Partial negotiation/negotiated coercion: a negotiated discussion between patient and
companions where companion petition prevailed
 Non-negotiable: where companions did not broker discussion or consent
A crucial finding identified that the level of negotiated accompaniment appeared to be associated 
with companion influence on information exchange. 
Moderating influence 
The negotiated presence of companions and the strongly moderating role of non-negotiated 
companions, emerged as a major finding in the data. A moderating influence was shown in five of 
the seven cases and could be categorised into three main sub-themes of controlling companion, 
companion agenda and companion as expert.  The sub-themes were linked with recurring patterns, 
demonstrated across all three constructs. The more controlling the companion, the more they 
influenced the information exchange process with their own agenda. This was particularly so when 
the companion may have a perceived expert companion role. Companions did not need to have a 
healthcare background to exert their own agenda, only a persuasive desire to have their questions 
answered.  
 Companion control
Companions were seen to control the exchange of information in various ways, predominantly by 
answering patient intended questions and through interruption. Although five cases exhibited this 
behaviour, in some cases it was seen to be throughout all encounters with various healthcare 
professionals. In one case (C) the companion controlled patient access to clinical trial material: 
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Och, a lot of this is just, you know, it’s information sheets – it’s just to give you an idea of what it’s 
about. But it’s just confirming what they’ve already told you, that’s all. It’s just to see if… It’s just 
to tell you what it is. Honestly, I’ll take these papers home, have a wee look through them – there’s 
no point in you having more paperwork than you need. Yeah, it’s just information. There’s nothing 
that has to be filled out. I’ll just hang on to that for you (Case C companion, Ref 11) 
 Companion agenda
In the cases where companions used controlling behaviour to moderate information exchange, they 
regulated the clinical encounter by addressing their own agenda. In certain cases there was evidence 
that companions raised concerns and discussed topics which appeared to satisfy their own 
communication and information needs. Such agenda setting was evident throughout the clinical 
consultations: 
No, because if you don’t hear it, you’re gonnae do it, and I’m not gonnae know, so that’s why I 
thought, I’m gonnae have to. I’ve got a wee checklist of questions, and they’re all about things I 
know you’re gonnae do! And that was the major one, because I know what you’re 
like…(Companion Grace,  Ref 4) 
 Expert companion
In this study expert companion was conceptualised within a broad categorisation and ranged from 
companions who had a healthcare background (Companions B, C and F) to those with previous 
knowledge and experience of caring for someone with the illness (Companions A and D). There was 
also evidence that in some cases (E), companions became ‘expert’ through reading and 
familiarisation around the subject matter: 
No, well, I don’t know if this is your department, or if it would be this other fellow – but I think 
there’s just a few wee things. Sorry, I don’t mean to be rude by writing things down. Yeah, I do 
think Celia is much more breathless than even just a week ago. Is oxygen therapy a consideration? 
(Companion C, Ref 1) 
When companions did mediate within the physical/emotional and informational sub-constructs, 
their influence seemed intended to enhance patient health status. The provision of current, 
contextual health details added to the clinical picture and provided improved knowledge for 
professional, enhancing care for the patient. In contrast, when companions were seen to moderate 
the information exchange process, there was potential for patient care to be compromised. 
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Perception of companion accompaniment 
Within the mediating influence construct, patients expressed positive opinions regarding companion 
impact on information exchange. But, professional perspective was absent for this domain. 
However, the reverse was identified for moderating influence. Despite evidence that companions 
influenced information exchange in a controlling and moderating fashion, overall patient perspective 
was not critical of this effect. Professionals were more vocal for this domain and study data 
illustrated that, for some cases, there was a negative perception noted regarding companion 
accompaniment: 
There seems to be a lot of antagonism between her and the son…and is nagging her …regarding 
smoking…and harassing her, and she’s feeling very stressed with that. So the consultation was 
interrupted about three times just for that (Oncologist, Companion E, Ref 2) 
Discussion 
When accompaniment was reciprocal or partially negotiated; companions predominantly 
demonstrated a mediating or enhancing influence on information exchange. Conversely non-
negotiated accompaniment was associated with powerful and expert companions with a significant 
moderating and controlling influence on information exchange. 
The current research identified the ‘expert’ role of non-negotiated companions who significantly 
moderated and consequently disrupted features of the information exchange process. The 
companions in this study adopted the role of expert, independent of any other individual, in direct 
contrast to Rosenthal and colleagues’ (1980) findings that professionals cast companions in the 
expert role. In line with the findings of others, study data suggested that expertise was often 
conferred through a companion’s established relationship and intimate health knowledge of the 
patient (Allen, 2000); as well as past experience, healthcare training and the self-development of 
considerable disease and treatment related knowledge (Nolan et al, 1996; Taraborelli, 1994; Twigg 
and Atkin, 1994). All factors which could theoretically have been instrumental in determining the 
moderating companion’s decision not to negotiate their presence at clinic in the first place.  
There was no indication in this study that the expert companions felt subordinated, with a need to 
negotiate or relinquish control to other members of the triad. Companions came to the clinical 
encounter without negotiating their presence and promoted their own agenda for structuring 
information exchange and in some cases, directly organising and controlling communication. They 
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did so independently of any other member of the triad. As singular individuals, they seemed both 
confident and powerful in their own right to control the information exchange process, independent 
of coalition formation.  
Coalitions occur when two individuals in a triad adopt a common strategy to achieve a mutually-
desired decision despite the active or passive resistance of the third individual (Coe and Prendergast, 
1985). Coe and Prendergast’s analysis of interactions among physicians, elderly patients and their 
companions revealed each encounter involved several coalitions, where the majority of companions 
made efforts to form coalitions with physicians. Physicians are viewed as an important ally for 
companions because of their power and status within the triad. This is contrary to current study data 
which demonstrated that companions seemed unconcerned about the amount of power and 
expertise held by other individuals, relying instead on their own perceived expert status within the 
triad. 
In contrast to Allen (2000) and Simmell and Wolff (1950), findings suggested that the powerful, 
expert companions did not play any of their identified roles. Likewise there was no indication of 
negotiation within the triad at the oncology out-patient consultation. Clinical context may be an 
important consideration for negotiating and relinquishing control. Allen’s study was in-patient based 
where triadic exchanges could be more prolonged (over days and weeks). Within that clinical 
context, companions may recognise the severity of the patient’s condition and the nature of 
continual care renders the patient particularly dependent on other members of the triad. 
Subsequently companion expert role is less defined.  
Data was consistent with the findings of Hasselkus (1992) whereby companions have moved beyond 
viewing themselves merely as fonts of medical information and historical details, content with either 
forming coalitions with or relinquishing control to other triad participants. In her study Hasselkus 
analysed topical themes and exchanges of meaning between physicians, older patients and family 
caregivers during medical appointments. She found that caregivers contributed to traditional 
physician domains of care such as diagnosis, interpretation of symptoms and treatment 
recommendations much more than anticipated. In line with current findings, companions exchanged 
information around medical aspects of care whilst bringing very little social context to the exchange. 
Companions viewed themselves as integral primary healthcare providers, with their long-term 
experience in monitoring symptoms, controlling medication and taking an active role in the health of 
317
13 
the patient. This presentation of their role and place within the clinical consultation differs markedly 
from the model of coalitions (Coe and Prendergast, 1985; Roscoe, 1981).  
In this present research companions acted more as independent practitioners, often as an expert 
and powerful individual for the purpose of furthering their own agenda rather than in contention or 
even negotiation with the other members of the triad. In her study Hasselkus’s sample was derived 
from an elderly population and it could be considered that companions would be more engaged in 
care activities requiring a high level of involvement when patients were both elderly and of poorer 
health status (Wolff and Roter, 2011; Wolff, 2008). The clinical context within which negotiation 
transpires is an under-researched area and one worthy of further consideration. 
Current findings of the expert, powerful and controlling, non-negotiating companion were distinct to 
research undertaken by Morris and Thomas (2001). Their research primarily focused on how carers 
negotiated their relationship within the medical setting. Unlike our study there was no indication 
that patients and companions negotiated companion presence pre-consultation. Also in direct 
contrast to the non-negotiated accompaniment found within our study, companions in their work 
were diffident about their place at the consultation and required to be ‘invited in’ both by the 
patient and the professional. Morris and Thomas found carers were reticent of entering the 
consultation, ‘stood back’ without contributing to the exchange, were uncertain of their role and 
reserved about disturbing the privilege of the doctor-patient relationship. Carer diffidence about 
their role and accompaniment was due to concern about issues of confidentiality as well as 
maintaining a sense of independence for the patient. In my research even when companions 
displayed more neutral influence (Cases B and D) they still contributed to information exchange 
within the clinical encounter, although there was a greater sense of deference to the patient rather 
than diffidence. However, this respect for patient self-determination found in the neutral cases in 
our study was not evident in the replication analysis of some of the mediating cases and appeared to 
be absent in the moderating cases.  
Our data did not identify with any of the concerns of negotiated identity, support and sharing, 
among the powerful, expert companions, recognised in the research by Morris and Thomas (2001). 
There is no immediate explanation as to why companions in our study were different to those of 
Morris and Thomas (especially as their sample included 10 patients with various stages of a lung 
cancer diagnosis). It has previously hypothesised that both personal characteristics and relationship 
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alliances may have a significant influence within our study and the contrast between the two studies 
points to such variables.  
Limitations 
One limitation of the study relates to sample size. Yin (2009) stated that one replication can support 
analytical generalisation and Eisenhardt (1989) specified each case serves as a distinct experiment 
that stands on its own as an analytical unit. Although each of the seven cases studies emphasized 
the rich, real-world context in which information exchange and companion influence occurred and 
the aim was not to generalise the findings to the wider population, and while new knowledge 
emerged from the analysis, case size was limited and the findings considered judiciously. 
Another limitation concerned collection of companion demographic data. Companion data was 
collated retrospectively from transcription narratives and researcher field notes. Collection of 
additional demographic data such as age, professional background and educational status would 
have been invaluable information when analysing companion demographic effect on preference for 
accompaniment and companion influence on information exchange and consequent roles. This 
reflects the true nature of case study research in that the true significance of companion role and 
influence was only identified during the substantive analysis period when emerging theoretical 
propositions were inductively identified. 
Conclusion 
The findings provided new insight into companion presence during cancer consultations as 
mediating and moderating influences. In terms of emerging theory this study conceptualised and 
refined these constructs to specify the distinctive role companions of patients with lung cancer 
assumed.  Companion presence at lung cancer consultations was often found to be a non-negotiated 
accompaniment. Three significant interrelating factors influencing non-negotiated companion 
accompaniment emerged. These emerging concepts had clinic relevance in terms of contemporary 
cancer practice. 
Recognising the significant yet fundamental influence companions have on information content and 
direction is crucial. The positive influence of accompanying companions on patient-professional 
interactions supports the value of family members being present during consultations. Equally useful 
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is identifying when the role is non-supportive and challenging to information exchange and deviates 
from important clinical interactions.  
Table 1: Companion combinations 
Cases Consultation 1 Consultation 2 In-depth interview 
Alex Daughter Ann Daughter Ann Partner Agnes 
Ben Daughter Betty Daughter Betty 
Celia Brother Colin Brother Colin 
Delia Husband Davie 
Daughter Diane 
Husband Davie 
Daughter Diane 
Husband Davie 
Eve Son Eric Son Eric 
Daughter Elaine 
Son Eric 
Son Ewen 
Flora Husband Frank 
Daughter Fiona 
Husband Frank 
Gordon Ex – wife Grace Ex-wife Grace 
Table 2: Mediating and moderating influences on information exchange 
Constructs Actions Cases 
Mediating (facilitative) influence Physical Logistical – provides 
transport 
Physical presence 
C G 
A B C D E F G  
Emotional Provides reassurance 
Seeks reassurance 
Being supportive 
Physical comfort 
A B  
D G 
G 
F (Frank only) 
Informational Remembering/ Aid 
memoir 
Clarification/seeking 
Provides context 
A B C D E F G  
A C D E F G 
A C D E G 
Moderating (controlling) 
influence 
Companion control Answers for patient 
Interrupts 
Dismissive 
C E F G 
C E F 
C F 
Companion agenda Companion agenda 
setting 
A C E F G 
Companion as expert Healthcare profession 
education 
Previous experience in 
cancer 
Learned expertise 
B C F 
A D  
E 
Neutral Prior knowledge & experience B D 
Relationships B D 
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